"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A1,US 2020/0202263 A1,111-732-529-763-015,2020-06-25,2020,US 202016749639 A,2020-01-22,US 202016749639 A;;US 201816157535 A;;US 201213454581 A;;US 201161478902 P,2011-04-25,INCIDENT RESOURCE MANAGEMENT,"In an embodiment, a system may comprise a communications network and processing logic. The processing logic may acquire information regarding an incident, identify a first mobile resource (MR) that may respond to the incident based on a type of the incident and a capability associated with the first MR. The processing logic may further identify a generic path scenario to the incident based on a location of the MR and a location of the incident. The processing logic may identify that the first MR is preferred over a second MR with respect to responding to the incident and assign the first MR to the incident. The processing logic may send a message via the communications network to the first MR to notify the first MR that it has been assigned to the incident.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/111-732-529-763-015,Patent Application,yes,5,0,7,7,0,G06Q10/025;;G06Q10/025;;G06Q10/06;;G06Q10/06;;G06Q10/06311;;G06Q10/06311;;G06Q10/063112;;G06Q10/063112;;G06Q10/063116;;G06Q10/063116;;G06Q10/06312;;G06Q10/06312;;G06Q10/1097;;G06Q10/1097;;G08B25/003;;G08B25/003;;G08B25/004;;G08B25/004;;G08B25/006;;G08B25/006;;G08B25/016;;G08B25/016;;G08B27/001;;G08B27/001,G06Q10/02;;G06Q10/06;;G08B25/00;;G08B25/01;;G08B27/00,,0,0,,,,ACTIVE
2,DE,A1,DE 3826315 A1,155-656-885-625-449,1989-02-16,1989,DE 3826315 A,1988-08-03,GB 8718644 A,1987-08-06,VERFAHREN UND VORRICHTUNG ZUM MESSEN DER TEMPERATUR IN UNTERSCHIEDLICH GELEGENEN ZONEN IN EINEM STROEMUNGSFAEHIGEN MEDIUM,,ATOMIC ENERGY AUTHORITY UK,CONROY PETER JOSEPH,,https://lens.org/155-656-885-625-449,Patent Application,no,0,2,9,9,0,G01K11/24;;G01K11/24,G01K11/24;;G21C17/02,,0,0,,,,DISCONTINUED
3,US,A1,US 2019/0050760 A1,041-405-660-068-59X,2019-02-14,2019,US 201816157535 A,2018-10-11,US 201816157535 A;;US 201213454581 A;;US 201161478902 P,2011-04-25,INCIDENT RESOURCE MANAGEMENT,"In an embodiment, a system may comprise a communications network and processing logic. The processing logic may acquire information regarding an incident, identify a first mobile resource (MR) that may respond to the incident based on a type of the incident and a capability associated with the first MR. The processing logic may further identify a generic path scenario to the incident based on a location of the MR and a location of the incident. The processing logic may identify that the first MR is preferred over a second MR with respect to responding to the incident and assign the first MR to the incident. The processing logic may send a message via the communications network to the first MR to notify the first MR that it has been assigned to the incident.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/041-405-660-068-59X,Patent Application,yes,4,0,7,7,0,G06Q10/025;;G06Q10/025;;G06Q10/06;;G06Q10/06;;G06Q10/06311;;G06Q10/06311;;G06Q10/063112;;G06Q10/063112;;G06Q10/063116;;G06Q10/063116;;G06Q10/06312;;G06Q10/06312;;G06Q10/1097;;G06Q10/1097;;G08B25/003;;G08B25/003;;G08B25/004;;G08B25/004;;G08B25/006;;G08B25/006;;G08B25/016;;G08B25/016;;G08B27/001;;G08B27/001,G06Q10/02;;G06Q10/06;;G06Q10/10,,0,0,,,,ACTIVE
4,US,B2,US 11068807 B2,023-802-283-005-53X,2021-07-20,2021,US 202017030155 A,2020-09-23,US 202017030155 A;;US 202016749639 A;;US 201816157535 A;;US 201213454581 A;;US 201161478902 P,2011-04-25,Incident resource management,"In an embodiment, a system may comprise a communications network and processing logic. The processing logic may acquire information regarding an incident, identify a first mobile resource (MR) that may respond to the incident based on a type of the incident and a capability associated with the first MR. The processing logic may further identify a generic path scenario to the incident based on a location of the MR and a location of the incident. The processing logic may identify that the first MR is preferred over a second MR with respect to responding to the incident and assign the first MR to the incident. The processing logic may send a message via the communications network to the first MR to notify the first MR that it has been assigned to the incident.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/023-802-283-005-53X,Granted Patent,yes,5,0,7,7,0,G06Q10/025;;G06Q10/025;;G06Q10/06;;G06Q10/06;;G06Q10/06311;;G06Q10/06311;;G06Q10/063112;;G06Q10/063112;;G06Q10/063116;;G06Q10/063116;;G06Q10/06312;;G06Q10/06312;;G06Q10/1097;;G06Q10/1097;;G08B25/003;;G08B25/003;;G08B25/004;;G08B25/004;;G08B25/006;;G08B25/006;;G08B25/016;;G08B25/016;;G08B27/001;;G08B27/001,G06Q10/06;;G06Q10/02;;G06Q10/10;;G08B25/00;;G08B25/01;;G08B27/00,,0,0,,,,ACTIVE
5,US,A1,US 2008/0029194 A1,063-145-809-283-336,2008-02-07,2008,US 49870206 A,2006-08-02,US 49870206 A,2006-08-02,Pressure control system,"A pressure control includes a body, a fitting, a valve, and a tube. The body has a first opening, second opening, and passage connecting the first and second openings. The body is secured to an axle. A tire containing pressurized gas is mounted on the wheel. The fitting is mounted on the wheel. The fitting has a proximal end and a distal end and includes a passage therethrough. The proximal end of the fitting is in communication with the gas in the tire. The valve is secured to the body. The tube extends between the fitting and body and is retained within the fitting. The gas inside the tire passes through the coupling and tube to the valve. The valve releases the gas to the atmosphere when the gas is above a predetermined pressure.",CONROY JOSEPH P,CONROY JOSEPH P,,https://lens.org/063-145-809-283-336,Patent Application,yes,12,1,1,1,0,B60C29/06;;B60C29/06;;B60C29/02;;B60C29/02,B60C29/00,152/415,0,0,,,,DISCONTINUED
6,US,B1,US 10108912 B1,168-726-055-241-262,2018-10-23,2018,US 201213454581 A,2012-04-24,US 201213454581 A;;US 201161478902 P,2011-04-25,Incident resource management,"In an embodiment, a system may comprise a communications network and processing logic. The processing logic may acquire information regarding an incident, identify a first mobile resource (MR) that may respond to the incident based on a type of the incident and a capability associated with the first MR. The processing logic may further identify a generic path scenario to the incident based on a location of the MR and a location of the incident. The processing logic may identify that the first MR is preferred over a second MR with respect to responding to the incident and assign the first MR to the incident. The processing logic may send a message via the communications network to the first MR to notify the first MR that it has been assigned to the incident.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/168-726-055-241-262,Granted Patent,yes,5,3,7,7,0,G06Q10/025;;G06Q10/025;;G06Q10/06;;G06Q10/06;;G06Q10/06311;;G06Q10/06311;;G06Q10/063112;;G06Q10/063112;;G06Q10/063116;;G06Q10/063116;;G06Q10/06312;;G06Q10/06312;;G06Q10/1097;;G06Q10/1097;;G08B25/003;;G08B25/003;;G08B25/004;;G08B25/004;;G08B25/006;;G08B25/006;;G08B25/016;;G08B25/016;;G08B27/001;;G08B27/001,G06Q10/06;;G06Q10/02;;G06Q10/10,,0,0,,,,ACTIVE
7,US,B2,US 10740700 B2,132-369-165-356-205,2020-08-11,2020,US 201816157535 A,2018-10-11,US 201816157535 A;;US 201213454581 A;;US 201161478902 P,2011-04-25,Incident resource management,"In an embodiment, a system may comprise a communications network and processing logic. The processing logic may acquire information regarding an incident, identify a first mobile resource (MR) that may respond to the incident based on a type of the incident and a capability associated with the first MR. The processing logic may further identify a generic path scenario to the incident based on a location of the MR and a location of the incident. The processing logic may identify that the first MR is preferred over a second MR with respect to responding to the incident and assign the first MR to the incident. The processing logic may send a message via the communications network to the first MR to notify the first MR that it has been assigned to the incident.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/132-369-165-356-205,Granted Patent,yes,4,0,7,7,0,G06Q10/025;;G06Q10/025;;G06Q10/06;;G06Q10/06;;G06Q10/06311;;G06Q10/06311;;G06Q10/063112;;G06Q10/063112;;G06Q10/063116;;G06Q10/063116;;G06Q10/06312;;G06Q10/06312;;G06Q10/1097;;G06Q10/1097;;G08B25/003;;G08B25/003;;G08B25/004;;G08B25/004;;G08B25/006;;G08B25/006;;G08B25/016;;G08B25/016;;G08B27/001;;G08B27/001,G06Q10/06;;G06Q10/02;;G06Q10/10;;G08B25/00;;G08B25/01;;G08B27/00,,0,0,,,,ACTIVE
8,US,B1,US 11828608 B1,058-009-686-704-032,2023-11-28,2023,US 202217712912 A,2022-04-04,US 202217712912 A;;US 202163170239 P,2021-04-02,Controlling vehicles in a complex ecosystem,"At least one three-dimensional roadway segment cuboid nodal system and at least one stationary resource node subsystem(s) includes a computing device comprising at least a memory, a processor, and processing logic for execution in the processor. The processing logic is configured to acquire information regarding a mobile node and the three-dimensional roadway segment cuboid subsystem(s). The information includes a location of the mobile node and a location of the roadway segment cuboid subsystem(s) and a type of use of the mobile node and roadway segment cuboid subsystem(s) to identify and determine acceptable usage.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/058-009-686-704-032,Granted Patent,yes,10,0,3,3,0,G01C21/3867;;G01C21/3438;;G06Q10/04;;G06Q10/06;;G06Q50/06;;G06Q50/40;;G06Q50/26;;G06Q2240/00;;G01C21/3438;;G01C21/3461;;G01C21/3484,G01C21/34,,0,0,,,,ACTIVE
9,US,B2,US 10817808 B2,022-346-027-890-768,2020-10-27,2020,US 202016749639 A,2020-01-22,US 202016749639 A;;US 201816157535 A;;US 201213454581 A;;US 201161478902 P,2011-04-25,Incident resource management,"In an embodiment, a system may comprise a communications network and processing logic. The processing logic may acquire information regarding an incident, identify a first mobile resource (MR) that may respond to the incident based on a type of the incident and a capability associated with the first MR. The processing logic may further identify a generic path scenario to the incident based on a location of the MR and a location of the incident. The processing logic may identify that the first MR is preferred over a second MR with respect to responding to the incident and assign the first MR to the incident. The processing logic may send a message via the communications network to the first MR to notify the first MR that it has been assigned to the incident.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/022-346-027-890-768,Granted Patent,yes,5,0,7,7,0,G06Q10/025;;G06Q10/025;;G06Q10/06;;G06Q10/06;;G06Q10/06311;;G06Q10/06311;;G06Q10/063112;;G06Q10/063112;;G06Q10/063116;;G06Q10/063116;;G06Q10/06312;;G06Q10/06312;;G06Q10/1097;;G06Q10/1097;;G08B25/003;;G08B25/003;;G08B25/004;;G08B25/004;;G08B25/006;;G08B25/006;;G08B25/016;;G08B25/016;;G08B27/001;;G08B27/001,G06Q10/06;;G06Q10/02;;G06Q10/10;;G08B25/00;;G08B25/01;;G08B27/00,,0,0,,,,ACTIVE
10,US,A,US 1418286 A,094-645-665-522-486,1922-06-06,1922,US 35522620 A,1920-01-30,US 35522620 A,1920-01-30,Rail-securing instrumentality,,JOSEPH CONROY PETER,JOSEPH CONROY PETER,,https://lens.org/094-645-665-522-486,Granted Patent,no,0,0,1,1,0,E01B9/12;;E01B9/46;;E01B9/46;;E01B9/12,E01B9/12;;E01B9/46,,0,0,,,,EXPIRED
11,WO,A1,WO 2023/196332 A1,196-900-240-609-811,2023-10-12,2023,US 2023/0017468 W,2023-04-04,US 202217712912 A,2022-04-04,CONTROLLING VEHICLES IN A COMPLEX ECOSYSTEM,"At least one three-dimensional roadway segment cuboid nodal system and at least one stationary resource node subsystem(s) includes a computing device comprising at least a memory, a processor, and processing logic for execution in the processor. The processing logic is configured to acquire information regarding a mobile node and the threedimensional roadway segment cuboid subsystem(s). The information includes a location of the mobile node and a location of the roadway segment cuboid subsystem(s) and a type of use of the mobile node and roadway segment cuboid subsystem(s) to identify and determine acceptable usage.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/196-900-240-609-811,Patent Application,yes,3,0,3,3,0,G01C21/3867;;G01C21/3438;;G06Q10/04;;G06Q10/06;;G06Q50/06;;G06Q50/40;;G06Q50/26;;G06Q2240/00;;G01C21/3438;;G01C21/3461;;G01C21/3484,G01C21/26;;G01C21/32;;G01C21/34;;G01C21/36;;G05D1/00;;G05D1/02,,0,0,,,,PENDING
12,US,A,US 722814 A,076-839-171-816-794,1903-03-17,1903,US 1902/0125379 A,1902-09-30,US 1902/0125379 A,1902-09-30,BOTTLE-STOPPER.,,CONROY MICHAEL JOSEPH,CONROY MICHAEL JOSEPH,,https://lens.org/076-839-171-816-794,Granted Patent,no,0,3,1,1,0,B65D39/12;;B65D39/12,,,0,0,,,,EXPIRED
13,GB,B,GB 2207755 B,110-311-586-499-650,1991-06-05,1991,GB 8816735 A,1988-07-14,GB 8718644 A,1987-08-06,TEMPERATURE MEASUREMENT,,ATOMIC ENERGY AUTHORITY UK,CONROY PETER JOSEPH,,https://lens.org/110-311-586-499-650,Granted Patent,no,0,0,9,9,0,G01K11/24;;G01K11/24,G01K11/24;;G21C17/02,G1G GPW           PW;;U1S S1905,0,0,,,,EXPIRED
14,US,A1,US 2021/0004734 A1,018-421-311-003-591,2021-01-07,2021,US 202017030155 A,2020-09-23,US 202017030155 A;;US 202016749639 A;;US 201816157535 A;;US 201213454581 A;;US 201161478902 P,2011-04-25,INCIDENT RESOURCE MANAGEMENT,"In an embodiment, a system may comprise a communications network and processing logic. The processing logic may acquire information regarding an incident, identify a first mobile resource (MR) that may respond to the incident based on a type of the incident and a capability associated with the first MR. The processing logic may further identify a generic path scenario to the incident based on a location of the MR and a location of the incident. The processing logic may identify that the first MR is preferred over a second MR with respect to responding to the incident and assign the first MR to the incident. The processing logic may send a message via the communications network to the first MR to notify the first MR that it has been assigned to the incident.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/018-421-311-003-591,Patent Application,yes,0,1,7,7,0,G06Q10/025;;G06Q10/025;;G06Q10/06;;G06Q10/06;;G06Q10/06311;;G06Q10/06311;;G06Q10/063112;;G06Q10/063112;;G06Q10/063116;;G06Q10/063116;;G06Q10/06312;;G06Q10/06312;;G06Q10/1097;;G06Q10/1097;;G08B25/003;;G08B25/003;;G08B25/004;;G08B25/004;;G08B25/006;;G08B25/006;;G08B25/016;;G08B25/016;;G08B27/001;;G08B27/001,G06Q10/02;;G06Q10/06;;G08B25/00;;G08B25/01;;G08B27/00,,0,0,,,,ACTIVE
15,DE,A1,DE 2612830 A1,164-041-727-801-852,1977-09-29,1977,DE 2612830 A,1976-03-26,DE 2612830 A,1976-03-26,Padding for vehicle seat belt - has sheathing of soft elastic material with slide fastener on part of webbing length,"The soft padding is used on part of the seat belt webbing which is in contact with the wearers neck part, to reduce skin injuries in accident cases caused by the relatively rough edges of the webbing. The padding (10) extends over the length of the webbing which covers the shoulder part of the wearer. It consists of a strip (12) of soft elastic material, pref. non-combustible foam material. The strip is shaped to surround the webbing (11) nearly completely, with only a gap (13) left at the top. The foam material strip is fitted with a sheathing (14), the two opposing edges of which are fitted with a slide fastener (15). The sheathing is moulded-on onto the foam material, so that it can be removed from the webbing in one piece.",FINNIGAN JOSEPH CONROY,FINNIGAN JOSEPH CONROY,,https://lens.org/164-041-727-801-852,Patent Application,no,0,3,1,1,0,B60R22/00,B60R22/00,,0,0,,,,DISCONTINUED
16,US,A1,US 2024/0068822 A1,039-562-616-214-251,2024-02-29,2024,US 202318386495 A,2023-11-02,US 202318386495 A;;US 202217712912 A;;US 202163170239 P,2021-04-02,CONTROLLING VEHICLES IN A COMPLEX ECOSYSTEM,"At least one three-dimensional roadway segment cuboid nodal system and at least one stationary resource node subsystem(s) includes a computing device comprising at least a memory, a processor, and processing logic for execution in the processor. The processing logic is configured to acquire information regarding a mobile node and the three-dimensional roadway segment cuboid subsystem(s). The information includes a location of the mobile node and a location of the roadway segment cuboid subsystem(s) and a type of use of the mobile node and roadway segment cuboid subsystem(s) to identify and determine acceptable usage.",CONROY JOSEPH E,CONROY JOSEPH E,,https://lens.org/039-562-616-214-251,Patent Application,yes,0,0,3,3,0,G01C21/3867;;G01C21/3438;;G06Q10/04;;G06Q10/06;;G06Q50/06;;G06Q50/40;;G06Q50/26;;G06Q2240/00;;G01C21/3438;;G01C21/3461;;G01C21/3484,G01C21/34,,0,0,,,,PENDING
17,GB,A,GB 2207755 A,195-121-211-948-68X,1989-02-08,1989,GB 8816735 A,1988-07-14,GB 8718644 A,1987-08-06,TEMPERATURE MEASUREMENT IN A FLUID BY MEANS OF REFLECTED STRESS WAVES,,ATOMIC ENERGY AUTHORITY UK,CONROY PETER JOSEPH,,https://lens.org/195-121-211-948-68X,Patent Application,no,0,2,9,9,0,G01K11/24;;G01K11/24,G01K11/24;;G21C17/02,G1G GPW           PW;;U1S S1905,0,0,,,,EXPIRED
18,CA,A,CA 337383 A,096-667-418-776-876,1933-11-21,1933,CA 337383D A,,CA 337383T A,,ELECTRICAL COMMUNICATION SYSTEM,,WESTERN ELECTRIC CO,FIELD JOSEPH CONROY,,https://lens.org/096-667-418-776-876,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
19,US,A,US 5954084 A,153-468-129-357-425,1999-09-21,1999,US 5474498 A,1998-04-03,US 5474498 A;;US 63000596 A,1996-04-08,Pneumatic control,A pneumatic control apparatus and method controls gas pressure inside a tire (40) mounted on a wheel (32) which rotates about the centerline of an axle (30). A bleeder valve (28) is mounted on a body coaxially aligned with the axle centerline and is in fluid connection with a pneumatic fitting (23) on the tire. The bleeder valve allows gas inside the tire to be relieved to the atmosphere when the gas is above a set pressure. The coaxial alignment of the bleeder valve with the axle centerline permits the bleeder valve to relieve gas pressure unaffected by centrifugal forces.,"CONROY, SR.; JOSEPH P.",CONROY SR JOSEPH P,DAVIS CHARLES WILLIAM JR (2013-06-27),https://lens.org/153-468-129-357-425,Granted Patent,yes,9,10,1,3,0,B60C29/06;;B60C29/06;;B60C23/004;;B60C23/004;;B60C23/0496;;B60C23/0496;;B60C29/064;;B60C29/064;;Y10T137/36;;Y10T137/36;;Y10T137/3709;;Y10T137/3709,B60C23/00;;B60C29/06,137/230;;137/224,0,0,,,,EXPIRED
20,US,A,US 3307840 A,153-963-555-986-134,1967-03-07,1967,US 33755964 A,1964-01-14,US 33755964 A,1964-01-14,Continuous calcination of gypsum,,GEORGIA PACIFIC CORP,CONROY JR JOSEPH E,,https://lens.org/153-963-555-986-134,Granted Patent,no,7,18,2,2,0,C04B11/028;;C04B11/028,C04B11/028,,0,0,,,,EXPIRED
21,US,A,US 6161565 A,105-885-476-987-436,2000-12-19,2000,US 33798099 A,1999-06-22,US 33798099 A;;US 63000596 A;;US 5474498 A,1996-04-08,Pneumatic control,"A pneumatic control apparatus and method controls gas pressure inside a tire (40) mounted on a wheel (32) which rotates about the centerline of an axle (30). A bleeder valve (28) is mounted on a body coaxially aligned with the axle centerline and is in fluid connection through passages (14, 18) in the billet and tubing (24) with a pneumatic fitting (23) on the tire. The bleeder valve allows gas inside the tire to be relieved to the atmosphere when the gas is above a set pressure. The coaxial alignment of the bleeder valve with the axle centerline permits the bleeder valve to relieve gas pressure unaffected by centrifugal forces.","CONROY, SR.; JOSEPH P.",CONROY SR JOSEPH P,,https://lens.org/105-885-476-987-436,Granted Patent,yes,10,14,1,3,0,B60C23/004;;B60C23/004;;B60C23/0496;;B60C23/0496;;B60C29/06;;B60C29/06;;B60C29/064;;B60C29/064;;Y10T137/36;;Y10T137/36;;Y10T137/3709;;Y10T137/3709,B60C23/00;;B60C29/06,137/230;;137/224,0,0,,,,EXPIRED
22,US,A,US 5832951 A,111-708-963-782-139,1998-11-10,1998,US 63000596 A,1996-04-08,US 63000596 A,1996-04-08,Pneumatic control,A pneumatic control apparatus and method controls gas pressure inside a tire mounted on a wheel which rotates about the centerline of an axle. A bleeder valve is mounted on a body coaxially aligned with the axle centerline and is in fluid connection with a pneumatic fitting on the tire. The bleeder valve allows gas inside the tire to be relieved to the atmosphere when the gas is above a set pressure. The coaxial alignment of the bleeder valve with the axle centerline permits the bleeder valve to relieve gas pressure unaffected by centrifugal forces.,"CONROY, SR.; JOSEPH P.",CONROY SR JOSEPH P,,https://lens.org/111-708-963-782-139,Granted Patent,yes,6,10,1,3,0,B60C23/004;;B60C23/0496;;B60C29/06;;B60C29/064;;Y10T137/3709;;Y10T137/36;;Y10T137/3709;;Y10T137/36;;B60C23/0496;;B60C29/064;;B60C23/004;;B60C29/06,B60C23/00;;B60C29/06,137/230;;137/224,0,0,,,,EXPIRED
23,CA,A,CA 764340 A,168-232-041-523-269,1967-08-01,1967,CA 764340D A,,CA 764340T A,,CONTINUOUS CALCINATION OF GYPSUM,,GEORGIA PACIFIC CORP,CONROY JOSEPH E JR,,https://lens.org/168-232-041-523-269,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
24,CA,A,CA 310627 A,068-657-549-442-02X,1931-04-21,1931,CA 310627D A,,CA 310627T A,,ELECTRO-MAGNETIC MICROPHONE,,MARCONI CO CANADA,CONROY JOSEPH MATHEW;;LETTS RALPH,,https://lens.org/068-657-549-442-02X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
25,AU,A,AU 1977/023024 A,133-707-928-433-578,1978-09-14,1978,AU 1977/023024 A,1976-03-11,AU PC518676 A,1976-03-11,BRACKET FOR SWINGING STAGE,,LINDLEY R;;CONROY J J,LINDLEY ROGER;;CONROY JOSEPH JAMES,,https://lens.org/133-707-928-433-578,Patent Application,no,0,0,1,1,0,E04G3/34,E04G3/34,,0,0,,,,DISCONTINUED
26,US,A1,US 2011/0110466 A1,085-058-634-268-881,2011-05-12,2011,US 201113005263 A,2011-01-12,US 201113005263 A;;US 56556706 A,2006-11-30,Method and System for a Sliding Window Phase Estimator for Wideband Code Division Multiple Access (WCDMA) Automatic Frequency Correction,"Aspects of a method and system for a sliding window phase estimator for wideband code division multiple access (WCDMA) automatic frequency correction are presented. Aspects of the system may include one or more circuits that enable adjustment of a current demodulation frequency for receiving at least one subsequent symbol based on a computed weighted sum of a plurality of computed frequency error values. Each of the plurality of computed frequency error values may be derived from a current symbol, a corresponding previous symbol, and/or a previous frequency error value. The current symbol may include a current received symbol segment and one or more previously received symbol segments.",CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH,CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH,AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD (2017-01-20);;AVAGO TECHNOLOGIES INTERNATIONAL SALES PTE. LIMITED (2018-05-09),https://lens.org/085-058-634-268-881,Patent Application,yes,3,3,5,5,0,H04B1/70754;;H04B7/0669;;H04L27/22;;H04L2027/003;;H04L2027/0057;;H04L2027/0065;;H04L27/22;;H04B7/0669;;H04L2027/003;;H04B1/70754;;H04L2027/0065;;H04L2027/0057,H04L27/06,375/340,0,0,,,,INACTIVE
27,US,A,US 1183633 A,089-338-998-173-076,1916-05-16,1916,US 1914/0836659 A,1914-05-06,US 1914/0836659 A,1914-05-06,DITCHING-MACHINE.,,CONROY JOHN L;;SHIMON JOSEPH,CONROY JOHN L;;SHIMON JOSEPH,,https://lens.org/089-338-998-173-076,Granted Patent,no,0,1,1,1,0,E02F3/181;;E02F3/181,E02F5/08,,0,0,,,,EXPIRED
28,CA,A,CA 297056 A,077-502-133-870-16X,1930-01-28,1930,CA 297056D A,,CA 297056T A,,AMPLIFIER FOR ELECTRICAL OSCILLATIONS,,MARCONI CO CANADA,LETTS RALPH;;CONROY JOSEPH MATTHEW,,https://lens.org/077-502-133-870-16X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
29,CA,A,CA 297268 A,187-972-664-556-609,1930-02-04,1930,CA 297268D A,,CA 297268T A,,AMPLIFIER FOR WIRELESS TELEGRAPHY AND TELEPHONY,,MARCONI CO CANADA,CONROY JOSEPH MATTHEW;;LETTS RALPH,,https://lens.org/187-972-664-556-609,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
30,US,B2,US 8068568 B2,093-462-955-674-885,2011-11-29,2011,US 201113005263 A,2011-01-12,US 201113005263 A;;US 56556706 A,2006-11-30,Method and system for a sliding window phase estimator for wideband code division multiple access (WCDMA) automatic frequency correction,"Aspects of a method and system for a sliding window phase estimator for wideband code division multiple access (WCDMA) automatic frequency correction are presented. Aspects of the system may include one or more circuits that enable adjustment of a current demodulation frequency for receiving at least one subsequent symbol based on a computed weighted sum of a plurality of computed frequency error values. Each of the plurality of computed frequency error values may be derived from a current symbol, a corresponding previous symbol, and/or a previous frequency error value. The current symbol may include a current received symbol segment and one or more previously received symbol segments.",CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH;;BROADCOM CORP,CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH,AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD (2017-01-20);;AVAGO TECHNOLOGIES INTERNATIONAL SALES PTE. LIMITED (2018-05-09),https://lens.org/093-462-955-674-885,Granted Patent,yes,3,1,5,5,0,H04B1/70754;;H04B7/0669;;H04L27/22;;H04L2027/003;;H04L2027/0057;;H04L2027/0065;;H04L27/22;;H04B7/0669;;H04L2027/003;;H04B1/70754;;H04L2027/0065;;H04L2027/0057,H03L27/06,375/344;;375/349,0,0,,,,INACTIVE
31,US,B2,US 7873125 B2,113-350-989-835-250,2011-01-18,2011,US 56556706 A,2006-11-30,US 56556706 A,2006-11-30,Method and system for sliding window phase estimator for WCDMA automatic frequency correction,"Aspects of a method and system for a sliding window phase estimator for wideband code division multiple access (WCDMA) automatic frequency correction are presented. Aspects of the system may include one or more circuits that enable adjustment of a current demodulation frequency for receiving at least one subsequent symbol based on a computed weighted sum of a plurality of computed frequency error values. Each of the plurality of computed frequency error values may be derived from a current symbol, a corresponding previous symbol, and/or a previous frequency error value. The current symbol may include a current received symbol segment and one or more previously received symbol segments.",BROADCOM CORP,CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH,AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD (2017-01-20);;AVAGO TECHNOLOGIES INTERNATIONAL SALES PTE. LIMITED (2018-05-09);;BROADCOM CORPORATION (2006-11-30),https://lens.org/113-350-989-835-250,Granted Patent,yes,9,3,5,5,0,H04B1/70754;;H04B7/0669;;H04L27/22;;H04L2027/003;;H04L2027/0057;;H04L2027/0065;;H04L27/22;;H04B7/0669;;H04L2027/003;;H04B1/70754;;H04L2027/0065;;H04L2027/0057,H04L27/06,375/344;;375/349,0,0,,,,INACTIVE
32,US,A1,US 2008/0130802 A1,168-237-836-787-682,2008-06-05,2008,US 56556706 A,2006-11-30,US 56556706 A,2006-11-30,Method and System for Sliding Window Phase Estimator for WCDMA Automatic Frequency Correction,"Aspects of a method and system for a sliding window phase estimator for wideband code division multiple access (WCDMA) automatic frequency correction are presented. Aspects of the system may include one or more circuits that enable adjustment of a current demodulation frequency for receiving at least one subsequent symbol based on a computed weighted sum of a plurality of computed frequency error values. Each of the plurality of computed frequency error values may be derived from a current symbol, a corresponding previous symbol, and/or a previous frequency error value. The current symbol may include a current received symbol segment and one or more previously received symbol segments.",CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH,CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH,AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD (2017-01-20);;AVAGO TECHNOLOGIES INTERNATIONAL SALES PTE. LIMITED (2018-05-09);;BROADCOM CORPORATION (2006-11-30),https://lens.org/168-237-836-787-682,Patent Application,yes,9,14,5,5,0,H04B1/70754;;H04B7/0669;;H04L27/22;;H04L2027/003;;H04L2027/0057;;H04L2027/0065;;H04L27/22;;H04B7/0669;;H04L2027/003;;H04B1/70754;;H04L2027/0065;;H04L2027/0057,H03D1/04,375/346,0,0,,,,INACTIVE
33,US,A1,US 2012/0128108 A1,112-449-381-858-909,2012-05-24,2012,US 201113302035 A,2011-11-22,US 201113302035 A;;US 201113005263 A;;US 56556706 A,2006-11-30,Method and System for a Sliding Window Phase Estimator for Wideband Code Division Multiple Access (WCDMA) Automatic Frequency Correction,"Aspects of a method and system for a sliding window phase estimator for wideband code division multiple access (WCDMA) automatic frequency correction are presented. Aspects of the system may include one or more circuits that enable adjustment of a current demodulation frequency for receiving at least one subsequent symbol based on a computed weighted sum of a plurality of computed frequency error values. Each of the plurality of computed frequency error values may be derived from a current symbol, a corresponding previous symbol, and/or a previous frequency error value. The current symbol may include a current received symbol segment and one or more previously received symbol segments.",CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH;;BROADCOM CORP,CONROY HENDRIK JOHANNES;;BOCCUZZI JOSEPH,AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD (2017-01-20);;BROADCOM CORPORATION (2006-11-30),https://lens.org/112-449-381-858-909,Patent Application,yes,16,0,5,5,0,H04B1/70754;;H04B7/0669;;H04L27/22;;H04L2027/003;;H04L2027/0057;;H04L2027/0065;;H04L27/22;;H04B7/0669;;H04L2027/003;;H04B1/70754;;H04L2027/0065;;H04L2027/0057,H04L27/06,375/344,0,0,,,,DISCONTINUED
34,CN,A,CN 104460360 A,011-981-108-253-115,2015-03-25,2015,CN 201410471092 A,2014-09-16,US 201314028368 A,2013-09-16,Control system simulation system and method,"The invention provides a control system simulation system and a method. A non-transitory tangible computer-readable medium may include instructions executable by a processor in a simulation system to perform a simulation. The instructions may include to wait for a plurality of virtual controllers to complete a previous simulation step, write a result of the previous simulation step from each of the plurality of virtual controllers to a shared memory, read an input from the memory to each of the plurality of virtual controllers, initiate a simulation step on each of the plurality of virtual controllers, and upon initiation of the simulation step in each of the plurality of virtual controllers, indicate completion of the simulation, in which the plurality of virtual controllers include a controller model having a plurality of simulation steps and the instructions are configured to be executed by the processor in parallel.",GEN ELECTRIC,PATRICK JOSEPH CONROY;;TERENCE DAVID CLOUGHLEY,,https://lens.org/011-981-108-253-115,Patent Application,no,10,5,8,8,0,G05B19/042;;G05B2219/23456;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02;;G06F9/455;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02,G05B19/04,,3,0,,,"陈国良等: ""《并行计算机体系结构》"", 30 September 2002, 高等教育出版社;;王霞等: ""工业自动化网络虚拟实验平台的研究与实现"", 《电气电子教学学报》;;周泽伟: ""基于虚拟现实的流程工业过程模拟仿真系统"", 《计算机工程与应用》",ACTIVE
35,EP,A1,EP 3225550 A1,176-702-917-244-023,2017-10-04,2017,EP 17161552 A,2017-03-17,GB 201604654 A,2016-03-18,SEAT,"Described herein is a seat (1) which comprises a seat base, a seat back (2) and a seat frame (3). The seat back comprises a first connector (4), a second connector (5) and a securing means (6). The first and second connectors are for securing the seat back in pivotable engagement with the seat and the securing means is for controlling pivotal movement of the seat back relative to the seat and for preventing disengagement of the first and second connectors from the seat.
",ACRO AIRCRAFT SEATING LTD,CHALLENOR ADAM;;HODGKINSON ALEX;;CONROY JOSEPH,,https://lens.org/176-702-917-244-023,Patent Application,yes,4,0,5,24,0,B64D11/064;;B64D11/06395;;B64D11/064;;B60N2/20;;B60N2/3009;;B64D11/064;;B60N2/01,B64D11/06,,0,0,,,,DISCONTINUED
36,EP,A1,EP 3222525 A1,012-652-639-477-096,2017-09-27,2017,EP 17161570 A,2017-03-17,GB 201604653 A;;GB 201604654 A;;GB 201604655 A;;GB 201605285 A,2016-03-18,SEAT BACK COMPRISING AN INSERT,"Described is a seat back (1) comprising a rear wall (2) bordered by side walls (3a, 3b) projecting forward from the rear wall. The rear wall and side walls define a cavity (4) in front of the rear wall and between opposing surfaces of the side walls. The seat back comprises an insert (5) disposed at least partially within the cavity which is for supporting the back of a person leaning against the front of the seat back. The seat back and insert are shaped such that when the insert is positioned within the cavity, movement of the insert towards the base of the seat back is restricted.
",ACRO AIRCRAFT SEATING LTD,CHALLENOR ADAM;;HODGKINSON ALEX;;CONROY JOSEPH,,https://lens.org/012-652-639-477-096,Patent Application,yes,3,0,4,24,0,B60N2/70;;B64D11/0647;;B60N2/643;;B60N2/686;;B64D11/0647;;B64D11/0649;;B60N2/6027;;B60N2/7011;;B60N2/7035;;B60N2002/684;;B60N2/70;;B64D11/0647;;B64D11/064;;B60N2/643;;B60N2/686;;B64D11/06,B64D11/06;;B60N2/70,,0,0,,,,DISCONTINUED
37,EP,B1,EP 2849006 B1,183-315-312-207-645,2019-09-11,2019,EP 14184541 A,2014-09-12,US 201314028368 A,2013-09-16,Control system simulation system and method,,GEN ELECTRIC,CONROY PATRICK JOSEPH;;CLOUGHLEY TERENCE DAVID,"GENERAL ELECTRIC TECHNOLOGY GMBH, CH (2023-11-23)",https://lens.org/183-315-312-207-645,Granted Patent,yes,3,0,8,8,0,G05B19/042;;G05B2219/23456;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02;;G06F9/455;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02,G05B17/02;;G05B19/418,,1,0,,,"Blaise Barney: ""Introduction to Parallel Computing"", , 4 March 2010 (2010-03-04), pages 1-39, XP055166364, Retrieved from the Internet: URL:http://www.math.ntu.edu.tw/~wwang/cola _lab/knowledge/download/Parallel_Computing /LLNL_Introduction_to_Parallel_Computing.p df [retrieved on 2015-02-02]",ACTIVE
38,EP,A1,EP 2849006 A1,065-366-127-299-703,2015-03-18,2015,EP 14184541 A,2014-09-12,US 201314028368 A,2013-09-16,Control system simulation system and method,"A non-transitory tangible computer-readable medium may include instructions executable by a processor in a simulation system 30 to perform a simulation. The instructions may include to wait 58 for a plurality of virtual controllers 42 to complete a previous simulation step, write 60 a result of the previous simulation step from each of the plurality of virtual controllers 42 to a shared memory 50, read 64 an input from the memory 50 to each of the plurality of virtual controllers 42, initiate a simulation step on each of the plurality of virtual controllers 42, and upon initiation of the simulation step in each of the plurality of virtual controllers 42, indicate 74 completion of the simulation, in which the plurality of virtual controllers 42 include a controller model having a plurality of simulation steps and the instructions are configured to be executed by the processor in parallel.
",GEN ELECTRIC,CONROY PATRICK JOSEPH;;CLOUGHLEY TERENCE DAVID,"GENERAL ELECTRIC TECHNOLOGY GMBH, CH (2023-11-23)",https://lens.org/065-366-127-299-703,Patent Application,yes,3,2,8,8,0,G05B19/042;;G05B2219/23456;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02;;G06F9/455;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02,G05B17/02;;G05B19/418,,1,0,,,"BLAISE BARNEY: ""Introduction to Parallel Computing"", 4 March 2010 (2010-03-04), pages 1 - 39, XP055166364, Retrieved from the Internet <URL:http://www.math.ntu.edu.tw/~wwang/cola_lab/knowledge/download/Parallel_Computing/LLNL_Introduction_to_Parallel_Computing.pdf> [retrieved on 20150202]",ACTIVE
39,GB,A8,GB 2548410 A8,182-630-181-169-135,2017-09-27,2017,GB 201604654 A,2016-03-18,GB 201604654 A,2016-03-18,Seat,"A seat (e.g. aircraft seat) comprises seat back 2 and seat frame (3, figure 1). The seat back comprises first 4 and second 5 connectors pivotably securing the back 2 with the seat (1). Securing means 6 control pivotal movement of the seat back relative to the seat and prevent disengagement of first and second connectors 4, 5. The seatback 2 may be moveable between first and second positions, and the securing means may secure the seat back in the first position. First and second connects may be shaped for preventing and allowing removal of the seat back from the seat in first and second positions respectively. The securing means 6 may comprise a recline mechanism 13. The connectors may comprise a female mating part 4a, 5a, e.g. bearing block 7 comprising an L-shaped channel (8, figure 3A). The seat frame or a seat base may comprise a male mating part 4b, 5b, e.g. bars, protrusions, pivot pin 10. A snap-fitting retainer insert plug (12, figure 3E) may prevent disengagement. The seatback width may taper between the connectors 4, 5 towards a second width at the central securing means 6. A female mating part for a seat is also disclosed.",ACRO AIRCRAFT SEATING LTD,ADAM CHALLENOR;;ALEX HODGKINSON;;JOSEPH CONROY,,https://lens.org/182-630-181-169-135,Patent Application,no,0,0,5,24,0,B64D11/064;;B64D11/06395;;B64D11/064;;B60N2/20;;B60N2/3009;;B64D11/064;;B60N2/01,B64D11/06;;B60N2/20;;B60N2/30,,0,0,,,,DISCONTINUED
40,GB,A,GB 2548415 A,158-564-483-127-659,2017-09-20,2017,GB 201605285 A,2016-03-30,GB 201604653 A;;GB 201604655 A;;GB 201604654 A,2016-03-18,Seat back and insert,"A seat back 1 comprises a rear wall (2, figure 1A) bordered by side walls (3a, 3b, figure 1A) projecting forward from the rear wall. An insert 5 for supporting the back of a person, is disposed at least partially in a cavity (4, figure 1A) defined in front of the rear wall and between opposing surfaces of the side walls. The seat back and insert are shaped to restrict downward movement of the insert 5 towards the base of the seat back (e.g. forming a geometric lock, requiring no mechanical fasteners or connectors). Preferably the seat back comprises recesses 7a, 7b in the forward facing surface 9a, 9b of a perimeter wall (3, figure 1A) for engaging lateral tabs or protrusions 8a, 8b of the insert. The cavity and insert may taper. Preferably, the insert comprises a curved recess 10 in its bottom edge and the base of the cavity is not filled by the insert, e.g. for accommodating a seat base (11, figure 3). The insert may be resiliently deformable, e.g. made of foam. A row of vehicle seats, e.g. aircraft seats comprising the seat back is disclosed.",ACRO AIRCRAFT SEATING LTD,ALEX HODGKINSON;;JOSEPH CONROY;;ADAM CHALLENOR,,https://lens.org/158-564-483-127-659,Patent Application,no,8,0,4,24,0,B60N2/70;;B64D11/0647;;B60N2/643;;B60N2/686;;B64D11/0647;;B64D11/0649;;B60N2/6027;;B60N2/7011;;B60N2/7035;;B60N2002/684;;B60N2/70;;B64D11/0647;;B64D11/064;;B60N2/643;;B60N2/686;;B64D11/06,B64D11/06;;B60N2/60;;B60N2/70,,0,0,,,,DISCONTINUED
41,US,A1,US 2015/0081267 A1,013-781-990-527-975,2015-03-19,2015,US 201314028368 A,2013-09-16,US 201314028368 A,2013-09-16,CONTROL SYSTEM SIMULATION SYSTEM AND METHOD,"A non-transitory tangible computer-readable medium may include instructions executable by a processor in a simulation system to perform a simulation. The instructions may include to wait for a plurality of virtual controllers to complete a previous simulation step, write a result of the previous simulation step from each of the plurality of virtual controllers to a shared memory, read an input from the memory to each of the plurality of virtual controllers, initiate a simulation step on each of the plurality of virtual controllers, and upon initiation of the simulation step in each of the plurality of virtual controllers, indicate completion of the simulation, in which the plurality of virtual controllers include a controller model having a plurality of simulation steps and the instructions are configured to be executed by the processor in parallel.",GEN ELECTRIC,CONROY PATRICK JOSEPH;;CLOUGHLEY TERENCE DAVID,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2013-09-13),https://lens.org/013-781-990-527-975,Patent Application,yes,5,12,8,8,0,G05B19/042;;G05B2219/23456;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02;;G06F9/455;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02,G06F9/455,703/21,0,0,,,,ACTIVE
42,CA,A,CA 339212 A,005-031-809-565-414,1934-02-06,1934,CA 339212D A,,CA 339212T A,,ELECTRICAL REMOTE CONTROL,,MARCONI CO CANADA,THOMPSON JOHN HENRY;;CONROY JOSEPH MATTHEW,,https://lens.org/005-031-809-565-414,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
43,US,B2,US 9501300 B2,111-252-872-287-463,2016-11-22,2016,US 201314028368 A,2013-09-16,US 201314028368 A,2013-09-16,Control system simulation system and method,"A non-transitory tangible computer-readable medium may include instructions executable by a processor in a simulation system to perform a simulation. The instructions may include to wait for a plurality of virtual controllers to complete a previous simulation step, write a result of the previous simulation step from each of the plurality of virtual controllers to a shared memory, read an input from the memory to each of the plurality of virtual controllers, initiate a simulation step on each of the plurality of virtual controllers, and upon initiation of the simulation step in each of the plurality of virtual controllers, indicate completion of the simulation, in which the plurality of virtual controllers include a controller model having a plurality of simulation steps and the instructions are configured to be executed by the processor in parallel.",GEN ELECTRIC,CONROY PATRICK JOSEPH;;CLOUGHLEY TERENCE DAVID,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2013-09-13),https://lens.org/111-252-872-287-463,Granted Patent,yes,13,0,8,8,0,G05B19/042;;G05B2219/23456;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02;;G06F9/455;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02,G06G7/62;;G05B17/02;;G05B19/418;;G06F9/455,,2,0,,,"Barney, ""Introduction to Parallel Computing"", pp. 1-39, Mar. 4, 2010.;;European Search Report and Opinion issued in connection with corresponding EP Application No. 14184541.2 on Feb. 9, 2015.",ACTIVE
44,JP,A,JP 2015057697 A,090-380-546-364-327,2015-03-26,2015,JP 2014181828 A,2014-09-08,US 201314028368 A,2013-09-16,CONTROL SYSTEM SIMULATION SYSTEM AND METHOD,"PROBLEM TO BE SOLVED: To provide a simulation system for simulating operation of a control system useful in controlling plants, equipment, and processes.SOLUTION: A computer-readable medium may include instructions executable by a processor in a simulation system. The instructions may be configured to wait for a plurality of virtual controllers to complete a previous simulation step, write a result of the previous simulation step from each of the plurality of virtual controllers to a shared memory, read from the shared memory an input to each of the plurality of virtual controllers, initiate a simulation step on the plurality of virtual controllers, and, upon initiation of the simulation step in the plurality of virtual controllers, indicate completion of the simulation. The plurality of virtual controllers include a controller model having a plurality of simulation steps, and the instructions are executed by the processor in parallel.",GEN ELECTRIC,PATRICK JOSEPH CONROY;;TERENCE DAVID CLOUGHLEY,,https://lens.org/090-380-546-364-327,Patent Application,no,7,0,8,8,0,G05B19/042;;G05B2219/23456;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02;;G06F9/455;;G05B17/02;;G05B19/41885;;G05B2219/32345;;G05B2219/34333;;Y02P80/10;;Y02P90/02,G05B13/04,,0,0,,,,ACTIVE
45,CA,A,CA 764901 A,191-738-690-989-773,1967-08-08,1967,CA 764901D A,,CA 764901T A,,CONTINUOUS CALCINATION OF GYPSUM,,GEORGIA PACIFIC CORP,CONROY JOSEPH E JR;;JORGENSEN J SHARLAND,,https://lens.org/191-738-690-989-773,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
46,US,A,US 3307915 A,087-518-591-479-394,1967-03-07,1967,US 33939064 A,1964-01-22,US 33939064 A,1964-01-22,Apparatus for continuous calcination of gypsum,,GEORGIA PACIFIC CORP,CONROY JR JOSEPH E;;SHARLAND JORGENSEN J,,https://lens.org/087-518-591-479-394,Granted Patent,no,3,15,2,2,0,C04B11/0281;;C04B11/0281,C04B11/028,,0,0,,,,EXPIRED
47,US,A,US 5911405 A,115-736-137-289-32X,1999-06-15,1999,US 85403397 A,1997-05-09,US 85403397 A,1997-05-09,Multi-ported diverter valve assembly,The metallic housing of a diverter valve assembly has a plurality of thredly positioned inserts therein through which different port passage paths are established with a multi-ported ball valve element angularly displaceable inside the housing while sealingly enclosed within a tube through which the inserts project into adjusted seating engagement with the ball valve element.,US NAVY,KORCZYNSKI JR JOSEPH F;;CONROY PATRICK D,NAVY UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SECRETARY OF THE (1997-05-05),https://lens.org/115-736-137-289-32X,Granted Patent,yes,3,20,1,1,0,F16K11/0873;;F16K27/067;;F16K27/067;;F16K11/0873,F16K11/087;;F16K27/06,251/315.05;;251/315.11,0,0,,,,EXPIRED
48,US,A,US 2726464 A,113-042-748-773-146,1955-12-13,1955,US 36115653 A,1953-06-12,US 36115653 A,1953-06-12,Land leveler,,BE GE MFG CO,WHITE JR JOHN A;;CONROY JOSEPH P,,https://lens.org/113-042-748-773-146,Granted Patent,no,8,3,1,1,0,E02F3/7672;;E02F3/7672,E02F3/76,,0,0,,,,EXPIRED
49,EP,A1,EP 3235725 A1,087-908-070-717-370,2017-10-25,2017,EP 17161559 A,2017-03-17,GB 201604655 A,2016-03-18,SEAT BACK,"Described is a seat back (1) comprising a curved rear wall (3) bordered by a perimeter wall (4) projecting forward from the rear wall. The curved rear wall and perimeter wall define a cavity (5) in front of the rear wall and between opposing surfaces (4a, 4b) of the perimeter wall. The seat back comprises an upper part (1a) and a lower part (1b). The lower part comprises a surface of the rear wall which is curved forward toward each side wall of the lower part and curved forward toward the base of the lower part. The width of the seat back tapers from a first width towards a second width at the base (6) of the seat back.
",ACRO AIRCRAFT SEATING LTD,CHALLENOR ADAM;;HODGKINSON ALEX;;BOWKER JAMES;;CONROY JOSEPH,,https://lens.org/087-908-070-717-370,Patent Application,yes,4,0,7,24,0,B60N2/643;;B60N2/643;;B64D11/06;;B60N2/00;;B60N2/20;;B60N2/22;;B60N2/22;;B60N2/68;;B60N2/68;;B60N2/686;;B60N2/686;;B64D11/06;;B64D11/06;;B64D11/064;;B64D11/064;;B64D11/064;;B64D11/0649,B64D11/06;;B60N2/22;;B60N2/68,,0,0,,,,ACTIVE
50,GB,A,GB 2548411 A,104-565-109-333-327,2017-09-20,2017,GB 201604655 A,2016-03-18,GB 201604655 A,2016-03-18,Seat back,"A seat back (1, figure 1) comprises a curved rear wall (3) bordered by a perimeter wall (4) projecting forward from the rear wall. A cavity (5) is defined in front of the rear wall (3) and between opposing surfaces 4a, 4b of the perimeter wall (4). The seatback (1) comprises an upper part 1a and a lower part 1b. The lower part 1b comprises a rear wall surface, curved forward toward the base 6 and each side wall 4a, 4b of the lower part 1b. The seat back (1) tapers from a first width towards a second width at the base of the seatback. Preferably, the cavity (5) is greater at the base 6 than in the upper part 1a. The rear wall may be curved and convex. The seat back may be secured in pivotable engagement with a seat frame (2, figure 1) via first and second connectors 7, 8. Centrally positioned securing means 9 may comprise a third connector or a recline mechanism (10) of a seat (e.g. aircraft seat). A seat back (1) comprising deformable foam material (12, figure 3) disposed within a cavity (5) defined between rear (3) and perimeter (4) walls is also disclosed.",ACRO AIRCRAFT SEATING LTD,ADAM CHALLENOR;;ALEX HODGKINSON;;JAMES BOWKER;;JOSEPH CONROY,,https://lens.org/104-565-109-333-327,Patent Application,no,6,0,7,24,0,B60N2/643;;B60N2/643;;B64D11/06;;B60N2/00;;B60N2/20;;B60N2/22;;B60N2/22;;B60N2/68;;B60N2/68;;B60N2/686;;B60N2/686;;B64D11/06;;B64D11/06;;B64D11/064;;B64D11/064;;B64D11/064;;B64D11/0649,B64D11/06;;B60N2/00;;B60N2/20,,1,0,,,"Aliexpress, [online], Available from: http://pt.aliexpress.com/store/product/Garden-Egg-Chair-fiberglass-shell-eggs-outdoor-leisure-garden-chair-Peter-Ghyczy/1195082_2021077331.html [Accessed 13/09/2016]",INACTIVE
51,GB,B,GB 2548411 B,076-181-865-003-175,2019-12-25,2019,GB 201604655 A,2016-03-18,GB 201604655 A,2016-03-18,Seat back,,ACRO AIRCRAFT SEATING LTD,ADAM CHALLENOR;;ALEX HODGKINSON;;JAMES BOWKER;;JOSEPH CONROY,,https://lens.org/076-181-865-003-175,Granted Patent,no,6,0,7,24,0,B60N2/643;;B60N2/643;;B64D11/06;;B60N2/00;;B60N2/20;;B60N2/22;;B60N2/22;;B60N2/68;;B60N2/68;;B60N2/686;;B60N2/686;;B64D11/06;;B64D11/06;;B64D11/064;;B64D11/064;;B64D11/064;;B64D11/0649,B64D11/06;;B60N2/00;;B60N2/20,,1,0,,,"Aliexpress, [online], Available from: http://pt.aliexpress.com/store/product/Garden-Egg-Chair-fiberglass-shell-eggs-outdoor-leisure-garden-chair-Peter-Ghyczy/1195082_2021077331.html [Accessed 13/09/2016]",INACTIVE
52,WO,A1,WO 2019/069099 A1,172-161-238-356-221,2019-04-11,2019,GB 2018052860 W,2018-10-05,GB 201716245 A,2017-10-05,CABINET WITH MULTI-PART BACK PANEL,"A cabinet comprising a base, a back panel and a side panel, the back panel comprising an upper part and a lower part, the cabinet being configured for attachment to a supporting structure via at least one fixing; wherein the fixing is relatively accessible when the upper part of the back panel is not in place and is relatively inaccessible when the upper part of the back panel is in place.",HOWDEN JOINERY LTD,CONROY ANDREW KELVIN;;SNOW ADAM;;HIBBEN ANTHONY JOSEPH,,https://lens.org/172-161-238-356-221,Patent Application,yes,3,0,4,4,0,A47B77/02;;A47B77/02;;A47B47/00;;A47B47/042;;A47B95/008,A47B47/04;;A47B77/02,,0,0,,,,PENDING
53,EP,B1,EP 3235725 B1,180-717-947-492-278,2018-12-26,2018,EP 17161559 A,2017-03-17,GB 201604655 A,2016-03-18,SEAT BACK,,ACRO AIRCRAFT SEATING LTD,CHALLENOR ADAM;;HODGKINSON ALEX;;BOWKER JAMES;;CONROY JOSEPH,,https://lens.org/180-717-947-492-278,Granted Patent,yes,4,0,7,24,0,B60N2/643;;B60N2/643;;B64D11/06;;B60N2/00;;B60N2/20;;B60N2/22;;B60N2/22;;B60N2/68;;B60N2/68;;B60N2/686;;B60N2/686;;B64D11/06;;B64D11/06;;B64D11/064;;B64D11/064;;B64D11/064;;B64D11/0649,B64D11/06;;B60N2/22;;B60N2/68,,0,0,,,,ACTIVE
54,EP,A1,EP 3691492 A1,108-966-050-527-399,2020-08-12,2020,EP 18785734 A,2018-10-05,GB 201716245 A;;GB 2018052860 W,2017-10-05,CABINET WITH MULTI-PART BACK PANEL,,HOWDEN JOINERY LTD,CONROY ANDREW KELVIN;;SNOW ADAM;;HIBBEN ANTHONY JOSEPH,,https://lens.org/108-966-050-527-399,Patent Application,yes,0,0,4,4,0,A47B77/02;;A47B77/02;;A47B47/00;;A47B47/042;;A47B95/008,A47B47/04;;A47B77/02,,1,0,,,See references of WO 2019069099A1,DISCONTINUED
55,GB,A,GB 2567182 A,023-045-802-007-284,2019-04-10,2019,GB 201716245 A,2017-10-05,GB 201716245 A,2017-10-05,Cabinet with multi-part back panel,"The cabinet has a base 30, a back panel and a side panel 31, where the back panel is formed of a lower and upper part 32a, 32b. The cabinet can be attached to a supporting structure 40, e.g. a wall, via a fixing 41. The fixing 41 is relatively accessible when the upper part 32b is not in place and relatively inaccessible when the upper part 32b is in place. The lower and upper parts 32a, 32b may be separable and not fixedly connected when assembled. A worktop 50 may be installed over the top of the cabinet to fix the upper part 32b in place. The fixing 41 may connect either of the side panel 31 or the lower part 32a to a wall 40. Also disclosed is a method of assembling a cabinet of assembling a base, lower part of back panel and side panel together to form a carcass, fixing the carcass to a support structure and then mating an upper part of back panel to the lower part.",HOWDEN JOINERY LTD,ANDREW KELVIN CONROY;;ADAM SNOW;;ANTHONY JOSEPH HIBBEN,,https://lens.org/023-045-802-007-284,Patent Application,no,4,0,4,4,0,A47B77/02;;A47B77/02;;A47B47/00;;A47B47/042;;A47B95/008,A47B77/02;;A47B47/00;;A47B95/00,,0,0,,,,DISCONTINUED
56,US,B2,US 10266085 B2,145-883-679-332-175,2019-04-23,2019,US 201715462678 A,2017-03-17,GB 201604655 A,2016-03-18,Seat back,Described is a seat back comprising a curved rear wall bordered by a perimeter wall projecting forward from the rear wall. The curved rear wall and perimeter wall define a cavity in front of the rear wall and between opposing surfaces of the perimeter wall. The seat back comprises an upper part and a lower part. The lower part comprises a surface of the rear wall which is curved forward toward each side wall of the lower part and curved forward toward the base of the lower part. The width of the seat back tapers from a first width towards a second width at the base of the seat back.,ACRO AIRCRAFT SEATING LTD,CHALLENOR ADAM;;HODGKINSON ALEX;;BOWKER JAMES;;CONROY JOSEPH,ACRO AIRCRAFT SEATING LIMITED (2018-01-19),https://lens.org/145-883-679-332-175,Granted Patent,yes,30,0,7,24,0,B60N2/643;;B60N2/643;;B64D11/06;;B60N2/00;;B60N2/20;;B60N2/22;;B60N2/22;;B60N2/68;;B60N2/68;;B60N2/686;;B60N2/686;;B64D11/06;;B64D11/06;;B64D11/064;;B64D11/064;;B64D11/064;;B64D11/0649,B60N2/22;;B60N2/64;;B60N2/68;;B64D11/06,,3,0,,,"Aliexpress (downloaded from https://pt.aliexpress.com/store/product/Garden-Egg-Chair-fiberglass-shell-eggs-outdoor-leisure-garden-chair-Peter-Ghyczy/1195082_2021077331.html), downloaded Mar. 31, 2017), 3 pp.;;Combined Search and Examination Report issued by the Intellectual Property Office of the United Kingdom for UK Patent Application No. GB 1604655.9, 9 pp.;;Extended European Search Report dated Sep. 21, 2017, by the European Patent Office for corresponding European Patent Application No. 17161559.4, 8 pp.",ACTIVE
57,EP,A1,EP 2397942 A1,048-437-817-055-22X,2011-12-21,2011,EP 11163457 A,2011-04-21,US 76915910 A,2010-04-28,"Systems, methods, and apparatus for deploying application code change configurations for multiple target controllers","Certain embodiments of the invention may include systems and methods for deploying application code change configurations for multiple target controllers (130). According to an exemplary embodiment of the invention, a method for is provided for updating configurations associated with one or more controllers (130). The method can include updating one or more library user blocks, associating corresponding user block instances with the one or more library user blocks, and modifying one or more application code configurations associated with the one or more controllers (130) based at least in part on the association.
",GEN ELECTRIC,KREFT DANA ROBERT;;CONROY PATRICK JOSEPH;;DEMAURICE ANDRE STEVEN,,https://lens.org/048-437-817-055-22X,Patent Application,yes,0,0,5,5,0,G06F9/44505;;G06F9/44505,G06F9/445,,1,0,,,No Search,DISCONTINUED
58,EP,B1,EP 3033653 B1,085-627-696-948-759,2022-05-25,2022,EP 14755504 A,2014-08-12,US 201313969459 A;;US 2014/0050610 W,2013-08-16,SYSTEMS AND METHODS FOR INTERFACING AUTOMATION CONTROL SYSTEMS TO EXTERNAL SYSTEMS,,GEN ELECTRIC,ROMANIK CHRISTINA ANN;;GARDINER TOMAS CHRISTOPHER;;CONROY PATRICK JOSEPH,"GENERAL ELECTRIC TECHNOLOGY GMBH, CH (2023-11-23)",https://lens.org/085-627-696-948-759,Granted Patent,yes,4,0,7,7,0,H04L67/125;;Y04S40/18;;Y02P90/02;;H04L67/125;;Y04S40/18;;Y02P90/02;;G05B11/01,G05B19/042;;G05B19/418,,0,0,,,,ACTIVE
59,EP,A1,EP 3033653 A1,023-847-529-637-377,2016-06-22,2016,EP 14755504 A,2014-08-12,US 201313969459 A;;US 2014/0050610 W,2013-08-16,SYSTEMS AND METHODS FOR INTERFACING AUTOMATION CONTROL SYSTEMS TO EXTERNAL SYSTEMS,,GEN ELECTRIC,ROMANIK CHRISTINA ANN;;GARDINER TOMAS CHRISTOPHER;;CONROY PATRICK JOSEPH,"GENERAL ELECTRIC TECHNOLOGY GMBH, CH (2023-11-23)",https://lens.org/023-847-529-637-377,Patent Application,yes,0,2,7,7,0,H04L67/125;;Y04S40/18;;Y02P90/02;;H04L67/125;;Y04S40/18;;Y02P90/02;;G05B11/01,G05B19/042;;G05B19/418,,0,0,,,,ACTIVE
60,CA,A,CA 250765 A,054-809-355-100-234,1925-06-16,1925,CA 250765D A,,CA 250765T A,,MICROPHONE,,MARCONI WIRELESS TELEGRAPH CO,SCANTLEBURY REGINALD AVERY;;CONROY JOSEPH MATTHEW;;MAURE OSWALD GOLIE,,https://lens.org/054-809-355-100-234,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
61,US,B2,US 9727505 B2,052-938-217-723-554,2017-08-08,2017,US 201514709336 A,2015-05-11,US 201514709336 A;;US 5714608 A,2008-03-27,Clock control for DMA busses,"A method and system is disclosed for accessing I/O and memory devices utilizing a DMA controller. Each device may be connected to the DMA controller through an individual channel. Clocking circuitry in the DMA may allow the DMA controller to send signals to each device at a prescribed frequency. Furthermore, the DMA controller is capable of activating and deactivating a channel clock, used in sending signals to the devices, based on the operational status of the individual devices. The DMA controller is also capable of tuning the channel clock dependant on the capabilities of any active devices. In this manner, the amount of bandwidth used during a DMA data transfer can be tailored to the specific requirements of the devices involved with the data transfer.",APPLE INC,CONROY DAVID G;;MILLET TIMOTHY J;;BRATT JOSEPH P,APPLE INC (2016-01-05),https://lens.org/052-938-217-723-554,Granted Patent,yes,45,1,4,4,0,G06F13/34;;G06F13/34;;G06F1/12;;G06F1/12;;G06F1/3203;;G06F1/3203;;G06F1/324;;G06F1/324;;G06F1/3253;;G06F1/3253;;G06F1/3287;;G06F1/3287;;G06F13/1673;;G06F13/1673;;G06F13/28;;G06F13/28;;Y02D10/00;;Y02D10/00,G06F13/28;;G06F1/12;;G06F1/32;;G06F13/16;;G06F13/34,,1,0,,,"Harvey et al. “DMA Fundamentals on Various PC Platforms”, Publisher: National Instruments Corp., Date: Apr. 1991, pp. 1-18.",ACTIVE
62,CA,A,CA 250764 A,101-874-067-786-773,1925-06-16,1925,CA 250764D A,,CA 250764T A,,MICROPHONE,,MARCONI WIRELESS TELEGRAPH CO,SCANTLEBURY REGINALD AVERY;;MAURO OSWALD GOLIE;;CONROY JOSEPH MATTHEW,,https://lens.org/101-874-067-786-773,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
63,US,A1,US 2015/0278134 A1,023-144-299-405-19X,2015-10-01,2015,US 201514709336 A,2015-05-11,US 201514709336 A;;US 5714608 A,2008-03-27,CLOCK CONTROL FOR DMA BUSSES,"A method and system is disclosed for accessing I/O and memory devices utilizing a DMA controller. Each device may be connected to the DMA controller through an individual channel. Clocking circuitry in the DMA may allow the DMA controller to send signals to each device at a prescribed frequency. Furthermore, the DMA controller is capable of activating and deactivating a channel clock, used in sending signals to the devices, based on the operational status of the individual devices. The DMA controller is also capable of tuning the channel clock dependant on the capabilities of any active devices. In this manner, the amount of bandwidth used during a DMA data transfer can be tailored to the specific requirements of the devices involved with the data transfer.",APPLE INC,CONROY DAVID G;;MILLET TIMOTHY J;;BRATT JOSEPH P,APPLE INC (2016-01-05),https://lens.org/023-144-299-405-19X,Patent Application,yes,10,3,4,4,0,G06F13/34;;G06F13/34;;G06F1/12;;G06F1/12;;G06F1/3203;;G06F1/3203;;G06F1/324;;G06F1/324;;G06F1/3253;;G06F1/3253;;G06F1/3287;;G06F1/3287;;G06F13/1673;;G06F13/1673;;G06F13/28;;G06F13/28;;Y02D10/00;;Y02D10/00,G06F13/34;;G06F13/16,,0,0,,,,ACTIVE
64,US,A1,US 2009/0240959 A1,082-867-397-604-722,2009-09-24,2009,US 5380708 A,2008-03-24,US 5380708 A,2008-03-24,BLOCK BASED POWER MANAGEMENT,"A system and method is disclosed for efficiently managing power distribution among the various functional blocks used within portable electronic devices. The method includes allowing each functional block to be independently controlled, containing its own low-level software and power controls for setting the local power state of the functional block. For each power control domain in the implementation, hardware uses these local power states and sets the actual operating state of the power control domain accordingly.",APPLE INC,CONROY DAVID G;;MILLET TIMOTHY J;;BRATT JOSEPH P,APPLE INC (2008-03-19),https://lens.org/082-867-397-604-722,Patent Application,yes,30,10,4,4,0,G06F1/3203;;G06F1/3287;;Y02D10/00;;G06F1/3287;;G06F1/3203;;Y02D10/00;;G06F1/30,G06F1/00,713/300,0,0,,,,ACTIVE
65,WO,A1,WO 2000/006127 A1,049-657-316-866-383,2000-02-10,2000,US 9912691 W,1999-06-08,US 12647798 A,1998-07-30,CENTERFILL DELIVERY SYSTEM FOR NUTRACEUTICALS,"The present invention relates to a delivery system to control the dosing of nutraceuticals using centerfill confectionery and chewing gum technology. The centerfill has a shell which is a hard confectionery or a chewing gum and a soft core. The shell and the core may each have one or more nutraceuticals. The nutraceuticals are released from the shell by slow dissolution of the hard confection or by mastication of the chewing gum in the oral cavity, and are released from the core by rapid dissolution of core after the shell has been penetrated. The nutraceutical is a botanical, a mineral, a mineral salt or a mixture thereof. Preferably the shell contains one or more mineral or mineral salts, and the core contains one or more botanicals.",WARNER LAMBERT CO,BELL ANTHONY JOHN;;DELLA POSTA JOSEPH;;SALMON CLIVE CONROY,,https://lens.org/049-657-316-866-383,Patent Application,yes,6,31,6,6,0,A23G3/48;;A23G3/362;;A23G3/54;;A23G4/064;;A23G4/068;;A23G4/20;;A61K9/0058;;A61K9/209;;A61P3/02,A23G3/00;;A23G3/36;;A23G3/48;;A23G3/54;;A23G4/00;;A23G4/06;;A23G4/20;;A61K9/24;;A61K9/68,,0,0,,,,PENDING
66,US,B2,US 9625883 B2,076-731-769-215-585,2017-04-18,2017,US 201313969459 A,2013-08-16,US 201313969459 A,2013-08-16,Systems and methods for interfacing automation control systems to external systems,"A system includes an industrial controller comprising a first processor. The first processor is configured to execute a substantially deterministic control process. The first processor is further configured to communicate with a second processor included in a communications interface system and communicatively coupled to the first processor, wherein the first processor is configured to communicate an asynchronous data to the second processor via an industrial communications protocol during the execution of the control process, and the second processor is configured to retrieve external data from an external system based on the asynchronous signal, and to communicate the external data to the control system via an Ethernet-based communications protocol.",GEN ELECTRIC,ROMANIK CHRISTINA ANN;;GARDINER TOMAS CHRISTOPHER;;CONROY PATRICK JOSEPH,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2013-06-13),https://lens.org/076-731-769-215-585,Granted Patent,yes,5,0,7,7,0,H04L67/125;;Y04S40/18;;Y02P90/02;;H04L67/125;;Y04S40/18;;Y02P90/02;;G05B11/01,G05B11/01;;H04L29/08,,1,0,,,"PCT Search Report and Written Opinion issued Feb. 5, 2015 in relation to corresponding PCT application No. PCT/US2014/050610.",ACTIVE
67,CO,A1,CO 5210938 A1,109-643-851-802-063,2002-10-30,2002,CO 99048003 A,1999-07-29,US 12647798 A,1998-07-30,SISTEMA DE LIBERACION DE RELLENO CENTRAL PARA NEUTRACEUTICOS,"Una confitura de relleno central para uso dentro de la cavidad oral con el fin de controlar la dosificación de nutracéuticos que comprendea) una vaina externa de confitura dura que contiene desde un mínimo mayor que cero, de una cantidad funcionalmente eficaz hasta un máximo de 5% en peso de la vaina de uno o más nutracéuticos caracterizada porque dichos nutracéuticos se liberan mediante disolución lenta de dicha vaina en la cavidad oral. Rango (0,5]. 0 ANDlt; nutracéuticos ANDlt; 5% en peso b) - Un núcleo blando contenido dentro de dicha vaina que contiene desde un mínimo mayor que cero, de una cantidad funcionalmente eficaz hasta un máximo de 50% en peso del núcleo de uno o más nutracéuticos caracterizada porque dichos nutracéuticos se liberan mediante disolución rápida de dicho núcleo. Rango (0,50]. 0 ANDlt; nutracéuticos ANDlt; 5% en peso.",WARNER LAMBERT CO,BELL ANTHONY JOHN;;DELLA POSTA JOSEPH;;SALMON CLIVE CONROY,,https://lens.org/109-643-851-802-063,Patent Application,no,0,0,6,6,0,A23G3/48;;A23G3/362;;A23G3/54;;A23G4/064;;A23G4/068;;A23G4/20;;A61K9/0058;;A61K9/209;;A61P3/02,A23G3/00;;A23G3/36;;A23G3/48;;A23G3/54;;A23G4/00;;A23G4/06;;A23G4/20;;A61K9/24;;A61K9/68,,0,0,,,,DISCONTINUED
68,CN,A,CN 105518549 A,113-232-224-699-35X,2016-04-20,2016,CN 201480051031 A,2014-08-12,US 2014/0050610 W;;US 201313969459 A,2013-08-16,Systems and methods for interfacing automation control systems to external systems,"A system includes an industrial controller comprising a first processor. The first processor is configured to execute a substantially deterministic control process. The first processor is further configured to communicate with a second processor included in a communications interface system and communicatively coupled to the first processor, wherein the first processor is configured to communicate an asynchronous data to the second processor via an industrial communications protocol during the execution of the control process, and the second processor is configured to retrieve external data from an external system based on the asynchronous signal, and to communicate the external data to the control system via an Ethernet-based communications protocol.",GEN ELECTRIC,ROMANIK CHRISTINA ANN;;GARDINER TOMAS CHRISTOPHER;;CONROY PATRICK JOSEPH,,https://lens.org/113-232-224-699-35X,Patent Application,no,5,2,7,7,0,H04L67/125;;Y04S40/18;;Y02P90/02;;H04L67/125;;Y04S40/18;;Y02P90/02;;G05B11/01,G05B19/042;;G05B19/418,,0,0,,,,ACTIVE
69,US,A1,US 2014/0101488 A1,053-520-350-814-509,2014-04-10,2014,US 201213647342 A,2012-10-08,US 201213647342 A,2012-10-08,SYSTEM AND METHOD FOR APPLICATION DEBUGGING,"A system includes a client system comprising a memory and a processor configured to execute a debugging tool. The debugging tool is communicatively coupled to an OPC Unified Architecture (UA) server. Furthermore, the debugging tool is configured to monitor and control, from the client system, debugging of an application executing on the OPC UA server.",GEN ELECTRIC,CONROY PATRICK JOSEPH;;SHAW RICHARD WILLIAM;;ROMANIK CHRISTINA ANN,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2012-10-04),https://lens.org/053-520-350-814-509,Patent Application,yes,10,8,2,2,0,G06F11/3664;;G06F11/3664,G06F11/36,714/38.1;;X714E1121,0,0,,,,ACTIVE
70,US,A1,US 2015/0051714 A1,072-760-187-408-667,2015-02-19,2015,US 201313969459 A,2013-08-16,US 201313969459 A,2013-08-16,SYSTEMS AND METHODS FOR INTERFACING AUTOMATION CONTROL SYSTEMS TO EXTERNAL SYSTEMS,"A system includes an industrial controller comprising a first processor. The first processor is configured to execute a substantially deterministic control process. The first processor is further configured to communicate with a second processor included in a communications interface system and communicatively coupled to the first processor, wherein the first processor is configured to communicate an asynchronous data to the second processor via an industrial communications protocol during the execution of the control process, and the second processor is configured to retrieve external data from an external system based on the asynchronous signal, and to communicate the external data to the control system via an Ethernet-based communications protocol.",GEN ELECTRIC,ROMANIK CHRISTINA ANN;;GARDINER TOMAS CHRISTOPHER;;CONROY PATRICK JOSEPH,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2013-06-13),https://lens.org/072-760-187-408-667,Patent Application,yes,2,3,7,7,0,H04L67/125;;Y04S40/18;;Y02P90/02;;H04L67/125;;Y04S40/18;;Y02P90/02;;G05B11/01,G05B11/01,700/2;;700/89,0,0,,,,ACTIVE
71,GB,B,GB 2567183 B,156-416-915-232-165,2021-11-24,2021,GB 201716246 A,2017-10-05,GB 201716246 A,2017-10-05,Kitchen extractor unit,,HOWDEN JOINERY LTD,ANDREW KELVIN CONROY;;TONY RONALD HARRIS;;ANTHONY JOSEPH HIBBEN,,https://lens.org/156-416-915-232-165,Granted Patent,no,5,0,4,4,0,F24C15/2042;;F24C15/2071;;F24C15/20;;F24C15/2042,F24C15/20,,0,0,,,,INACTIVE
72,US,B2,US 8533513 B2,191-625-010-091-580,2013-09-10,2013,US 201113160234 A,2011-06-14,US 201113160234 A;;US 5380708 A,2008-03-24,Hardware-based power management of functional blocks,"A system and method is disclosed for efficiently managing power distribution among the various functional blocks used within portable electronic devices. The method includes allowing each functional block to be independently controlled, containing its own low-level software and power controls for setting the local power state of the functional block. For each power control domain in the implementation, hardware uses these local power states and determines and sets the actual operating state of the power control domain accordingly.",CONROY DAVID G;;MILLETT TIMOTHY J;;BRATT JOSEPH P;;APPLE INC,CONROY DAVID G;;MILLETT TIMOTHY J;;BRATT JOSEPH P,,https://lens.org/191-625-010-091-580,Granted Patent,yes,36,0,4,4,0,G06F1/3203;;G06F1/3287;;Y02D10/00;;G06F1/3287;;G06F1/3203;;Y02D10/00;;G06F1/30,G06F1/30,713/340;;713/324,0,0,,,,ACTIVE
73,US,B2,US 9032113 B2,051-980-020-193-249,2015-05-12,2015,US 5714608 A,2008-03-27,US 5714608 A,2008-03-27,Clock control for DMA busses,"A method and system is disclosed for accessing I/O and memory devices utilizing a DMA controller. Each device may be connected to the DMA controller through an individual channel. Clocking circuitry in the DMA may allow the DMA controller to send signals to each device at a prescribed frequency. Furthermore, the DMA controller is capable of activating and deactivating a channel clock, used in sending signals to the devices, based on the operational status of the individual devices. The DMA controller is also capable of tuning the channel clock dependant on the capabilities of any active devices. In this manner, the amount of bandwidth used during a DMA data transfer can be tailored to the specific requirements of the devices involved with the data transfer.",CONROY DAVID G;;MILLET TIMOTHY J;;BRATT JOSEPH P;;APPLE INC,CONROY DAVID G;;MILLET TIMOTHY J;;BRATT JOSEPH P,APPLE INC (2008-03-21),https://lens.org/051-980-020-193-249,Granted Patent,yes,35,14,4,4,0,G06F13/34;;G06F13/34;;G06F1/12;;G06F1/12;;G06F1/3203;;G06F1/3203;;G06F1/324;;G06F1/324;;G06F1/3253;;G06F1/3253;;G06F1/3287;;G06F1/3287;;G06F13/1673;;G06F13/1673;;G06F13/28;;G06F13/28;;Y02D10/00;;Y02D10/00,G06F13/28;;G06F1/12;;G06F1/32,710/22,1,0,,,"Harvey et al. ""DMA Fundamentals on Various PC Platforms"", Publisher: National Instruments Corp., Date: Apr. 1991.",ACTIVE
74,AU,A,AU 1999/045496 A,063-744-111-679-237,2000-02-21,2000,AU 1999/045496 A,1999-06-08,US 12647798 A;;US 9912691 W,1998-07-30,Centerfill delivery system for nutraceuticals,,WARNER LAMBERT CO,BELL ANTHONY JOHN;;POSTA JOSEPH DELLA;;SALMON CLIVE CONROY,,https://lens.org/063-744-111-679-237,Patent Application,no,0,0,6,6,0,A23G3/48;;A23G3/362;;A23G3/54;;A23G4/064;;A23G4/068;;A23G4/20;;A61K9/0058;;A61K9/209;;A61P3/02,A23G3/00;;A23G3/36;;A23G3/48;;A23G3/54;;A23G4/00;;A23G4/06;;A23G4/20;;A61K9/24;;A61K9/68,,0,0,,,,DISCONTINUED
75,US,A1,US 2011/0271266 A1,184-742-783-764-045,2011-11-03,2011,US 76915910 A,2010-04-28,US 76915910 A,2010-04-28,"SYSTEMS, METHODS, AND APPARATUS FOR DEPLOYING APPLICATION CODE CHANGE CONFIGURATIONS FOR MULTIPLE TARGET CONTROLLERS","Certain embodiments of the invention may include systems and methods for deploying application code change configurations for multiple target controllers. According to an example embodiment of the invention, a method for is provided for updating configurations associated with one or more controllers. The method can include updating one or more library user blocks, associating corresponding user block instances with the one or more library user blocks, and modifying one or more application code configurations associated with the one or more controllers based at least in part on the association.",GEN ELECTRIC,KREFT DANA ROBERT;;CONROY PATRICK JOSEPH;;DEMAURICE ANDRE STEVEN,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2010-04-22),https://lens.org/184-742-783-764-045,Patent Application,yes,43,10,5,5,0,G06F9/44505;;G06F9/44505,G06F9/44,717/168,6,2,033-091-994-931-34X;;063-212-743-158-790,10.1109/icsm.2003.1235414;;10.1145/1837110.1837112,"Yu, et al., ""A Framework for Live Software Upgrade""; 2002 IEEE; [retrieved on 2012-10-25]; Retrieved from Internet ;pp1-10.;;Barr, Eisenbach, ""Safe Upgrading without Restarting"", 2003 IEEE; [retrieved on 2012-10-26]; Retrieved from Internet ;pp1-9.;;Motiee, et al., ""Do Windows Users Follow the Principle of Least Privilege: Investigating User Account Control Practices""; 2010 ACM; [retrieved on 3-11-2015]; Retrieved from Internet ; pp1-13.;;D'Angelo, et al., ""Content Cloaking Preserving Privacy with Google Docs and other Web Applications""; 2010, ACM; [retrieved on 3-11-2015]; Retrieved from Internet ; pp826-830.;;Takahashi, et al., ""Customized Program Protection for a User Customized Data Protection Framework""; 2011, IEEE; [retrieved on 3-11-2015]; Retrieved from Internet ; pp643-649;;Yeager, ""Enterprise Strength Security on a JXTA P2P Network"", 2003, IEEE; [retrieved on 3-11-2015]; Retrieved from Internet ; pp1-2.",ACTIVE
76,WO,A1,WO 2015/023613 A1,159-967-222-828-812,2015-02-19,2015,US 2014/0050610 W,2014-08-12,US 201313969459 A,2013-08-16,SYSTEMS AND METHODS FOR INTERFACING AUTOMATION CONTROL SYSTEMS TO EXTERNAL SYSTEMS,"A system includes an industrial controller comprising a first processor. The first processor is configured to execute a substantially deterministic control process. The first processor is further configured to communicate with a second processor included in a communications interface system and communicatively coupled to the first processor, wherein the first processor is configured to communicate an asynchronous data to the second processor via an industrial communications protocol during the execution of the control process, and the second processor is configured to retrieve external data from an external system based on the asynchronous signal, and to communicate the external data to the control system via an Ethernet-based communications protocol.",GEN ELECTRIC,ROMANIK CHRISTINA ANN;;GARDINER TOMAS CHRISTOPHER;;CONROY PATRICK JOSEPH,,https://lens.org/159-967-222-828-812,Patent Application,yes,4,0,7,7,0,H04L67/125;;Y04S40/18;;Y02P90/02;;H04L67/125;;Y04S40/18;;Y02P90/02;;G05B11/01,G05B19/418;;G05B19/042,,0,0,,,,PENDING
77,JP,A,JP 2011233147 A,165-488-582-980-526,2011-11-17,2011,JP 2011097983 A,2011-04-26,US 76915910 A,2010-04-28,"SYSTEM, METHOD, AND APPARATUS FOR DEPLOYING APPLICATION CODE CHANGE CONFIGURATIONS FOR MULTIPLE TARGET CONTROLLERS","PROBLEM TO BE SOLVED: To facilitate a task of updating software or firmware.SOLUTION: A system and a method for deploying application code change configurations for multiple target controllers 130 are included. According to one embodiment of the invention, a method is provided for updating configurations associated with one or more controllers 130. The method includes a step for updating one or more library user blocks 118, a step for associating corresponding user block instances with the one or more library user blocks 118, and a step for modifying one or more application code configurations associated with the one or more controllers 130 based at least in part on the association.",GENERAL ELECTRIC CO GE,DANA ROBERT KREFT;;PATRICK JOSEPH CONROY;;ANDRE STEVEN DEMAURICE,,https://lens.org/165-488-582-980-526,Patent Application,no,1,0,5,5,0,G06F9/44505;;G06F9/44505,G05B19/05,,0,0,,,,ACTIVE
78,US,A1,US 2011/0246806 A1,189-403-059-258-745,2011-10-06,2011,US 201113160234 A,2011-06-14,US 201113160234 A;;US 5380708 A,2008-03-24,BLOCK BASED POWER MANAGEMENT,"A system and method is disclosed for efficiently managing power distribution among the various functional blocks used within portable electronic devices. The method includes allowing each functional block to be independently controlled, containing its own low-level software and power controls for setting the local power state of the functional block. For each power control domain in the implementation, hardware uses these local power states and determines and sets the actual operating state of the power control domain accordingly.",APPLE INC,CONROY DAVID G;;MILLET TIMOTHY J;;BRATT JOSEPH P,,https://lens.org/189-403-059-258-745,Patent Application,yes,6,3,4,4,0,G06F1/3203;;G06F1/3287;;Y02D10/00;;G06F1/3287;;G06F1/3203;;Y02D10/00;;G06F1/30,G06F1/28,713/340,0,0,,,,ACTIVE
79,PE,A1,PE 20000930 A1,134-702-399-821-885,2000-10-02,2000,PE 00075199 A,1999-07-27,US 12647798 A,1998-07-30,SISTEMA DE LIBERACION DE RELLENO CENTRAL PARA NUTRACEUTICOS,"SE REFIERE A UN SISTEMA DE LIBERACION DE NUTRACEUTICOS UTILIZANDO UNA CONFITURA DE RELLENO CENTRAL O UNA GOMA DE MASCAR PARA USO DENTRO DE LA CAVIDAD ORAL CON EL FIN DE CONTROLAR LA DOSIFICACION DE NUTRACEUTICOS; QUE COMPRENDE: a)UNA VAINA EXTERNA DE CONFITURA DURA QUE CONTIENE UNA CANTIDAD DE NUTRACEUTICOS QUE SE LIBERAN MEDIANTE DISOLUCION LENTA DE DICHA VAINA; CARACTERIZADA PORQUE CONTIENE HASTA 5% DE NUTRACEUTICO TOTAL EN PESO DE LA VAINA; b)UN NUCLEO BLANDO CONTIENE UNA CANTIDAD DE UNO O MAS NUTRACEUTICOS LOS QUE SE LIBERAN MEDIANTE DISOLUCION RAPIDA DE DICHO NUCLEO; EL NUCLEO SE CARACTERIZA PORQUE FLUYE AL MENOS A 20°C-37°C, LIQUIDO O SEMISOLIDO, TIENE UNA GAMA DE SOLIDOS DE 10% A 95% EN PESO DEL NUCLEO; 5% A 35% EN PESO TOTAL DE LA CONFITURA. EL NUTRACEUTICO ES BOTANICO (ECHINACEA, GINSENG, GUARANA, GINKO BILOBA, VALERIANA, EFEDRA, B-SITOSTEROL, TE NEGRO, ACIDO FOLICO, ACEITE GARLICO, FIBRA, ESTRACTO DE TE VERDE, ACEITE DE LIMON, MACIA, ORORUZ, MENTOL, ACEITE DE CEBOLLA, ACEITE DE NARANJA, EXTRACTO DE ROMERO, EXTRACTO DE CARDO DE LECHE, ST. JOHNS WORT, ENTRE OTROS), MINERAL (ZINC, CALCIO, HIERRO, SELENIO) O MEZCLAS DE LAS MISMAS. TAMBIEN SE REFIERE A UNA COMPOSICION DONDE LA VAINA CONTIENE UNO O MAS MINERALES Y EL NUCLEO CONTIENE UNO O MAS NUTRACEUTICOS BOTANICOS",WARNER LAMBERT CO,DELLA POSTA JOSEPH;;BELL ANTHONY JOHN;;SALMON CLIVE CONROY,,https://lens.org/134-702-399-821-885,Patent Application,no,0,0,6,6,0,A23G3/48;;A23G3/362;;A23G3/54;;A23G4/064;;A23G4/068;;A23G4/20;;A61K9/0058;;A61K9/209;;A61P3/02,A23G3/00;;A23G3/36;;A23G3/48;;A23G3/54;;A23G4/00;;A23G4/06;;A23G4/20;;A61K9/20;;A61K9/24;;A61K9/68,,0,0,,,,DISCONTINUED
80,EC,A,EC SP993081 A,180-629-084-391-227,1999-10-06,1999,EC SP993081 A,1999-07-29,EC SP993081 A,1999-07-29,SISTEMA DE LIBERACION DE RELLENO CENTRAL PARA NUTRACEUTICOS,"La presente inevnción se refiere a un sistema de liberación para controlar la dosificación de nutracéuticos utilizando tecnología de confitura y goma de mascar de relleno central. El relleno central tiene una vaina que es una confitura o goma de mascar dura y un núcleo balndo. La vaina y el núcleo tienen cada uno, uno o más nutracéuticos. Los nutracéuticos se liberan de la vaina mediante disolución lenta de la confitura dura o mediante masticación de la goma de mascar en la cavidad oral, y se liberan a partir del núcleo mediante disolución rápida del núcleo después de que se penetró la vaina. El nutracéutico es un batámico, un mineral, una sal mineral o una mezcla de los mismos. Preferentemente, la vaina contiene uno o más minerales o sales minerales, y el núcleo contiene uno o más botánicos.",,DELLA POSTA JOSEPH;;BELL ANTHONY JOHN;;SALMON CLIVE CONROY,,https://lens.org/180-629-084-391-227,Patent Application,no,0,0,1,1,0,,A23B7/16;;A23L1/09,,0,0,,,,PENDING
81,US,B2,US 7984317 B2,036-843-336-088-125,2011-07-19,2011,US 5380708 A,2008-03-24,US 5380708 A,2008-03-24,Hardware-based power management of functional blocks,"A system and method is disclosed for efficiently managing power distribution among the various functional blocks used within portable electronic devices. The method includes allowing each functional block to be independently controlled, containing its own low-level software and power controls for setting the local power state of the functional block. For each power control domain in the implementation, hardware uses these local power states and sets the actual operating state of the power control domain accordingly.",APPLE INC,CONROY DAVID G;;MILLET TIMOTHY J;;BRATT JOSEPH P,APPLE INC (2008-03-19),https://lens.org/036-843-336-088-125,Granted Patent,yes,30,15,4,4,0,G06F1/3203;;G06F1/3287;;Y02D10/00;;G06F1/3287;;G06F1/3203;;Y02D10/00;;G06F1/30,G06F1/28,713/340;;713/324,0,0,,,,ACTIVE
82,US,B2,US 9110690 B2,167-210-042-734-945,2015-08-18,2015,US 76915910 A,2010-04-28,US 76915910 A,2010-04-28,"Systems, methods, and apparatus for deploying application code change configurations for multiple target controllers","Certain embodiments of the invention may include systems and methods for deploying application code change configurations for multiple target controllers. According to an example embodiment of the invention, a method is provided for updating configurations associated with one or more controllers. The method can include updating one or more library user blocks, associating corresponding user block instances with the one or more library user blocks, and modifying one or more application code configurations associated with the one or more controllers based at least in part on the association.",KREFT DANA ROBERT;;CONROY PATRICK JOSEPH;;DEMAURICE ANDRE STEVEN;;GEN ELECTRIC,KREFT DANA ROBERT;;CONROY PATRICK JOSEPH;;DEMAURICE ANDRE STEVEN,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2010-04-22),https://lens.org/167-210-042-734-945,Granted Patent,yes,47,0,5,5,0,G06F9/44505;;G06F9/44505,G06F9/45;;G06F9/445,,7,2,033-091-994-931-34X;;063-212-743-158-790,10.1109/icsm.2003.1235414;;10.1145/1837110.1837112,"Yu, et al., ""A Framework for Live Software Upgrade""; 2002 IEEE; [retrieved on Oct. 25, 2012]; Retrieved from Internet ;pp. 1-10.;;Barr, Eisenbach, ""Safe Upgrading without Restarting"", 2003 IEEE; [retrieved on Oct. 26, 2012]; Retrieved from Internet ;pp. 1-9.;;Motiee, et al., ""Do Windows Users Follow the Principle of Least Privilege: Investigating User Account Control Practices""; 2010 ACM; [retrieved on Mar. 11, 2015]; Retrieved from Internet ; pp. 1-13.;;D'Angelo, et al., ""Content Cloaking Preserving Privacy with Google Docs and other Web Applications""; 2010, ACM; [retrieved on Mar. 11, 2015]; Retrieved from Internet ; pp. 826-830.;;Takahashi, et al., ""Customized Program Protection for a User Customized Data Protection Framework""; 2011, IEEE; [retrieved on Mar. 11, 2015]; Retrieved from Internet ; pp. 643-649.;;Yeager, ""Enterprise Strength Security on a JXTA P2P Network"", 2003, IEEE; [retrieved on Mar. 11, 2015]; Retrieved from Internet ; pp. 1-2.;;Notice of Preliminary Rejection dated Feb. 24, 2015 for Japanese Patent Application No. 2011-097983.",ACTIVE
83,GB,A,GB 2567183 A,033-915-025-482-871,2019-04-10,2019,GB 201716246 A,2017-10-05,GB 201716246 A,2017-10-05,Kitchen extractor unit,"A kitchen installation comprises a cabinet 1 supporting a worktop 4 where a rear wall 3 of the cabinet 1 confronts a building wall 11. A cooking hob 14 is mounted in the worktop 4. An inlet head 20 of an extractor unit is fixedly attached to the building wall 11, rearward of the cooking hob 14. The inlet head has an inlet 32 in a front face 42 for drawing air away from the hob. The installation may have a fan 21 located in a void 9 between a base 2 of the cabinet 1 for drawing air from the inlet head 20, through a duct 22 extending through a void 13 between the rear 3 of the cabinet 1 and the building wall 11. An air inlet head 20 for a kitchen extractor where the inlet head 20 comprises an enclosure with air inlets in a front wall, an impermeable rear wall, and an air outlet in a base is also claimed.",HOWDEN JOINERY LTD,ANDREW KELVIN CONROY;;TONY RONALD HARRIS;;ANTHONY JOSEPH HIBBEN,,https://lens.org/033-915-025-482-871,Patent Application,no,4,0,4,4,0,F24C15/2042;;F24C15/2071;;F24C15/20;;F24C15/2042,F24C15/20,,0,0,,,,INACTIVE
84,US,B2,US 8972797 B2,032-825-602-180-529,2015-03-03,2015,US 201213647342 A,2012-10-08,US 201213647342 A,2012-10-08,System and method for application debugging,"A system includes a client system comprising a memory and a processor configured to execute a debugging tool. The debugging tool is communicatively coupled to an OPC Unified Architecture (UA) server. Furthermore, the debugging tool is configured to monitor and control, from the client system, debugging of an application executing on the OPC UA server.",GEN ELECTRIC,CONROY PATRICK JOSEPH;;SHAW RICHARD WILLIAM;;ROMANIK CHRISTINA ANN,GE INFRASTRUCTURE TECHNOLOGY LLC (2023-11-10);;GENERAL ELECTRIC COMPANY (2012-10-04),https://lens.org/032-825-602-180-529,Granted Patent,yes,11,0,2,2,0,G06F11/3664;;G06F11/3664,G06F11/00,714/46;;714/38.1,0,0,,,,ACTIVE
85,US,A1,US 2009/0248911 A1,129-255-312-748-329,2009-10-01,2009,US 5714608 A,2008-03-27,US 5714608 A,2008-03-27,CLOCK CONTROL FOR DMA BUSSES,"A method and system is disclosed for accessing I/O and memory devices utilizing a DMA controller. Each device may be connected to the DMA controller through an individual channel. Clocking circuitry in the DMA may allow the DMA controller to send signals to each device at a prescribed frequency. Furthermore, the DMA controller is capable of activating and deactivating a channel clock, used in sending signals to the devices, based on the operational status of the individual devices. The DMA controller is also capable of tuning the channel clock dependant on the capabilities of any active devices. In this manner, the amount of bandwidth used during a DMA data transfer can be tailored to the specific requirements of the devices involved with the data transfer.",APPLE INC,CONROY DAVID G;;MILLET TIMOTHY J;;BRATT JOSEPH P,APPLE INC (2008-03-21),https://lens.org/129-255-312-748-329,Patent Application,yes,35,29,4,4,0,G06F13/34;;G06F13/34;;G06F1/12;;G06F1/12;;G06F1/3203;;G06F1/3203;;G06F1/324;;G06F1/324;;G06F1/3253;;G06F1/3253;;G06F1/3287;;G06F1/3287;;G06F13/1673;;G06F13/1673;;G06F13/28;;G06F13/28;;Y02D10/00;;Y02D10/00,G06F1/12,710/25,0,0,,,,ACTIVE
86,WO,A1,WO 2019/069092 A1,157-418-441-052-001,2019-04-11,2019,GB 2018052851 W,2018-10-05,GB 201716246 A,2017-10-05,KITCHEN EXTRACTOR UNIT,"A kitchen installation comprising: a cabinet supporting a worktop, the rear wall of the cabinet confronting a wall of a building; a cooking hob (14) mounted in the worktop; and an inlet head (20) for an extractor unit, the inlet head being fixedly attached to the building wall at a location rearward of the cooking hob, the extractor unit having an air inlet (32) in its front face for drawing air away from the hob.",HOWDEN JOINERY LTD,CONROY ANDREW KELVIN;;HARRIS TONY RONALD;;HIBBEN ANTHONY JOSEPH,,https://lens.org/157-418-441-052-001,Patent Application,yes,3,0,4,4,0,F24C15/2042;;F24C15/2071;;F24C15/20;;F24C15/2042,F24C15/20,,0,0,,,,PENDING
87,CN,A,CN 104640580 A,007-547-386-585-180,2015-05-20,2015,CN 201380031485 A,2013-06-07,US 2013/0044653 W;;US 201261659301 P,2012-06-13,Cured oil-hydrogel biomaterial compositions for controlled drug delivery,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na-CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,,https://lens.org/007-547-386-585-180,Patent Application,no,3,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61L27/40,,0,0,,,,INACTIVE
88,WO,A1,WO 2013/188222 A1,077-991-044-445-241,2013-12-19,2013,US 2013/0044653 W,2013-06-07,US 201261659301 P,2012-06-13,CURED OIL-HYDROGEL BIOMATERIAL COMPOSITIONS FOR CONTROLLED DRUG DELIVERY,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na-CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,,https://lens.org/077-991-044-445-241,Patent Application,yes,2,4,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61L27/40,,1,0,,,See also references of EP 2861269A4,PENDING
89,US,B2,US 10610593 B2,128-195-298-589-449,2020-04-07,2020,US 15819304,2017-11-21,,,Cured oil-hydrogel biomaterial compositions for controlled drug delivery,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na-CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORPORATION,Keith M. Faucher;;Suzanne Conroy;;Theresa K. Albergo;;Joseph Bienkiewicz,,https://lens.org/128-195-298-589-449,Granted Patent,yes,438,0,1,1,0,A61K47/12;;A61K47/22;;A61L27/14;;A61L27/34;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61K47/12;;A61K47/22;;A61L27/14;;A61L27/34;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16,,275,0,,,"Sannino et al. “Biodegradable Cellulose-based Hydrogels: Design and Applications” Apr. 16, 2009.;;Office Action issued in counterpart EP Application No. 13804477.1, dated Jul. 19, 2017.;;Office Action issued in counterpart EP Application No. 13804477.1, dated Jun. 25, 2018.;;Final Office Action dated Mar. 30, 2017 for related U.S. Appl. No. 11/237,420, 20 pages.;;Henderson, R. James et al., “Hydrolysis of Fish Oils Containing Polymers of Triacylglycerols by Pancreatic Lipase in vitro”, Lipids, vol. 28, No. 4, 1993, pp. 313-319.;;H. Fineberg et al., Industrial Use of Fish Oils, pp. 222-238, http://spo.nmfs.noaa.gov/Circulars/CIRC278.pdf, downloaded Aug. 3, 2015.;;Lewis, Richard J., Sr., Hawley's Condensed Chemical Dictionary, 2001, pp. 308, 309 and 896-898, 14th edision, John Wiley & Sons, Inc., New York.;;Webster's II New College Dictionary (1995), 1075, Houghton Mifflin Company, New York, US.;;Polymers made from multiple monomers, A Natural Approach to Chemistry, Chapter 8, 241, http://lab-aids.com/assets/uploads/NAC/NAC_student_book/Texas%20Student%20Edition%20253.pdf (downloaded Dec. 3, 2015).;;Polymer, Encyclopedia Britannica. Encyclopedia Britannica Online, Encyclopedia Britannica Inc., 105, Web. Dec. 2, 2015, http://www.britannica.com/print/article/468696 (downloaded Dec. 2, 2015).;;Triglycerides, https://www.lipid.org/sites/default/files/triglycerides.pdf (downloaded Sep. 24, 2015).;;Fish Oil Triglycerides vs. Ethyl Esters: A Comparative Review of Absorption, Stability and Safety Concerns (Ascenta Health Ltd. 2010 at http://www.ascentaprofessional.com/science/articles/fish-oil-triglycerides-vs-ethyl-esters (downloaded Sep. 24, 2015).;;Swanson, Danielle, et al., Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life, 3 Advances in Nutrition 1-7 (American Society for Nutrition 2012).;;Fats & Oils (2008) at http://scifun.chem.wisc.edu/chemweek/pdf/fats&oils.pdf (downloaded Sep. 24, 2015).;;Bacteria in Water, The USGS Water Science School, http://water.usgs.gov/edu/bacteria.html (downloaded Nov. 9, 2015).;;Novotny, L. et al., Fish: a potential source of bacterial pathogens for human beings, Vet. Med.—Czech, 49, 2004, vol. 9, pp. 343-358.;;Allergies, Asthma and Allergy Foundation of America (2011), http://www.aafa.org/page/types-of-allergies,aspx (downloaded Oct. 5, 2015).;;Urakaze, Masaharu et al., “Infusion of fish oil emulsion: effects on platelet aggregation and fatty acid composition in phospholipids of plasma, platelets and red blood cell membranes in rabbits”, Am. J. Clin. Nutr., vol. 46, pp. 936-940 (! 987).;;Singh, Alok, et al., “Facilitated Stent Delivery Using Applied Topical Lubrication”, Catherization and Cardiovascular Interventions, vol. 69, pp. 218-222 (2007).;;Sicherer, Scott H., Food Allergies: A Complete Guide for Eating When Your Life Depends on it, 2013, 15, Johns Hopkins University Press, Baltimore, MD, USA.;;Omega-3 DHA—The Problem May Be the Quality of Your Fish Oil, Not Your Allergy to Fish, Fatty Acids Hub, http://www.fattyacidshub.com/fatty-acids/omega-3-dha/ (downloaded Nov. 10, 2015).;;Soy Allergy, Asthma and Allergy Foundation of America (2005), http://www.aafa.org/display.cfm?id=9&sub=20&cont=522 (downloaded Nov. 10, 2015).;;Refined soybean oil not an allergen, say food scientists, Food navigator-usa.com (2005), http://www.foodnavigator-usa.com/content/view/print/127438 (downloaded Nov. 10, 2015).;;Yahyaee, R. et al., Waste fish oil biodiesel as a source of renewable fuel in Iran, Renewable and Sustainable Energy Reviews, 2013, pp. 312-319, 17, Elsevier Ltd.;;Biological evaluation of medical devices—Part 1: Evaluation and testing, International Standard ISO 109931-1, Aug. 1, 2003, Third Edition, Switzerland.;;Mayo Clinic (http://www.mayoclinic.org/drugs-supplements/omega-3-fatty-acids-fish-oil-alpha-linolenic-acids/safety/hrb-20059372?p=1 (downloaded Sep. 28, 2015).;;Milk allergy, at http://www.mayoclinic.org/diseases-conditions/milk-allergy/basics/definition/con-20032147?p=1 (downloaded Jul. 29, 2015).;;Soy allergy, at http://www.mayoclinic.org/diseases-conditions/soy-allergy/basics/definition/con-20031370?p=1 (downloaded Jul. 29, 2015).;;F.D. Gunstone, Fatty Acid and Lipid Chemistry 72 (1999).;;Hawley's Condensed Chemical Dictionary 315, 316, 332, 333, 334, 825 and 826 (2001).;;Hutlin, Herbert O. et al., Chemical Composition and Stability of Fish Oil (International Association of Fish Meal Manufacturers Apr. 10, 1991).;;F.V.K Young, The Chemical & Physical Properties of Crude Fish Oils for Refiners and Hydrogenators, 18 Fish Oil Bulletin 1-18 (1986).;;Karrick, Neva L., Nutritional Value of Fish Oils as Animal Feed, Circular 281 (Fish and Wildlife Service Bureau of Commercial Fisheries 1967), reprinted from M.E. Stansby (ed.), Fish Oils 362-382 (Avi Publishing Company 1967).;;Luley et al., Fatty acid composition and degree of peroxidation in fish oil and cod liver oil preparations, Arzneimittelforschung. Dec. 1998, vol. 38, No. 12, pp. 1783-1786.;;Drying Oil, http://en.wikipedia.org/wiki/drying_oil (downloaded Jun. 28, 2013).;;Szebeni et al., “Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study”, Journal of the National Cancer Institute, 1998, vol. 90, No. 4, pp. 300-306.;;Birsan, et al., “The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro”, Transpl. Int., 2005, vol. 17, pp. 767-771.;;About.com, “Orthopedics, Synvisc injections,” retrieved online at http://orthopedics.about.com/cs/treatment/a/synvisc_2.htm (2005).;;Cath Lab Digest, “Olive Oil Emulsion Helps With Problem Heart Arteries”, retrieved online at http://www.cathlabdigest.com/displaynews.cfm?newsid=0103073 (2007).;;Doctor's Guide to Medical and Other News, “AAOS Meeting: Synvisc Delays Total Knee Replacement in Osteoarthritis Patients”, retrieved online at http://www.docguide.com/dg.nsf/PrintPrint/4585EC355198EEF08525670E006B10FF (1999).;;Methodist, “Evaluation of Biocompatibility and Antirestenotic Potential of Drug Eluting Stents Employing Polymer-free Highly-Hydrogenated Lipid-Based Stent Coatings in Porcine Coronary Arteries”, Transcatheter Cardiovascular Therapeutics (TCT), sponsored by the Cardiovascular Research Foundation®, Oct. 22-27, 2006, Washington Convention Center, Washington, D.C.;;Novavax, retrieved online at http://www.novavax.com/go.cfm?do=Page.View&pid=3 (2006).;;Orthovisc, “New Treatment Option is Potential Alternative to OTC Pain Medications for Osteoarthritis of the Knee” retrieved online at http://www.jnj.com/innovations/new_features/ORTHOVISC.htm:iessionid=33N2RBQDV0DZKCQPCCEGU3AKB2IIWTT1 (2006).;;Orthovisc, “What is ORTHOVISC®?” retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=about_orthovisc (2005).;;Orthovisc, “Your Knees and Osteoarthritis”, retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=understanding_knee_oa (2003).;;Orthovisc, “What to expect from your treatment,” retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=what_to_expect (2007).;;Orthovisc, “Tools and Resources for Managing Your Osteoarthritis”, retrieved online at http://www.orthovisc.com/khtmlbgdisplay.jhtml?itemname=patient_resources (2007).;;Pohibinska, A., et al., “Time to reconsider saline as the ideal rinsing solution during abdominal surgery”, The American Journal of Surgery, vol. 192, pp. 281-222 (2007).;;Hortolam, Juliane G., et al., “Connective tissue diseases following silicone breast implantation: where do we stand?”, Clinics, 2013, vol. 3, p. 281.;;Lidar, M. et al., “Silicone and sclerodema revisited”, Lupus, 2012, vol. 21, pp. 121-127.;;“Lead”, Article by Centers for Disease Control and Prevention (CDC), Nov. 2009, 2 pages.;;“Cure” in Academic Press Dictionary of Science and Technology, 1992.;;Extended European Search Report dated Dec. 10, 2015 issued for corresponding EP Patent Application No. 13804477, 8 pages.;;SepraFilm Adhesion Barrier package insert (Genzyme Biosurgery 2008).;;Alessandro Sannino et al., Biodegradeable Cellulose-based Hydrogels: Design and Applications, 2 Materials 353-373 (2009).;;Thomas Heinz, Carboxymethyl Ethers of Cellulose and Starch—A Review, Center of Excellence for Polysaccharide Reseach, Friedrich Schiller University of Jena (Germany), pp. 13-29 (2005).;;H. Omidian et al., Swelling Agents and Devices in Oral Drug Delivery, J. Drug. Del. Sci. Tech., 18 (2) 83-93 (2008).;;S. Kamel et al., Pharmaceutical Significance of Cellulose: a Review, eXPRESS Polymer Letters vol. 2, No. 11 pp. 758-778 (2008).;;A. M. Adel et al. Carboxymethylated Cellulose Hydrogel; Sorption Behavior and Characterization, Nature and Science, 8(8), pp. 244-256, (2010).;;Wicks et al. Organic Coatings:Science and Technology 1999 New York:Wiley Interscience, pp. 258-267.;;Mills et al. Oils and Fats. “The Organic Chemistry of Museum Objects” London:Buttersworth and Co. 1987, pp. 26-40.;;Erhardt Paints Based on Drying Oil Media. Painted Wood: History & Conservation. Ed. Berland Singapore: The J. Paul Getty Trust 1998. pp. 17-32.;;Wexler et al. Chemical Reviews 1964, vol. 64, No. 6, pp. 591-611.;;Polymer—The Chambers 21st Century Dictionary M. Robinson and G. Davidson (Eds.), London, United Kingdom: Chambers Harrap. Retrieved from http://search.credoreference.com/content/entry/chambdict!polymer/O.;;Polymer—Academic Press Dictionary of Science and TechnologyC. Morris (Ed.), Academic Press Dictionary of Science and Technology. Oxford, United Kingdom: Elsevier Science & Technology. Retrieved from http://search.credoreference.com/content/entry/apdst!polymer/O.;;Falagas et al. European Society of Clinical Microbiology and Infection Diseases, 2005, vol. 11, pp. 3-8.;;Bimbo, Inform 1998, vol. 9, No. 5, pp. 473-483.;;Wikipedia, Sunflower oil, https://en.wikipedia.org/wiki/Sunflower_oil, accessed Jul. 23, 2015 by Examiner Lyndsey Beckhardt in related U.S. Appl. No. 14/252,671, pp. 1-7.;;Esoteric Oils, Peppermint essential oil information, http://www.essentialoils.co.za/essential-oils/peppermint.htm, accessed Jul. 23, 2015 by Examiner Lyndsey Beckhardt in related U.S. Appl. No. 14/252,671, pp. 1-7.;;Orthomolecular, Fish Oil, Jun. 29, 2004, http://orthomolecular.org/nutrients/fishoil.html, accessed Jul. 22, 2015 by Examiner Lyndsey Beckhardt in related U.S. Appl. No. 14/252,671, p. 1.;;Final Office Action for U.S. Appl. No. 13/184,512, dated Apr. 28, 2015.;;Final Office Action for U.S. Appl. No. 11/701,799, dated Mar. 12, 2015.;;Final Office Action for U.S. Appl. No. 12/581,582, dated Jan. 8, 2015.;;Non-Final Office Action for U.S. Appl. No. 12/401,243, dated Jan. 16, 2015.;;Non-Final Office Action for U.S. Appl. No. 11/237,420, dated Jan. 21, 2015.;;Notice of Allowance for U.S. Appl. No. 13/943,489, dated Jan. 29, 2015.;;Non-Final Office Action for U.S. Appl. No. 11/980,155, dated Nov. 7, 2014.;;Notice of Allowance for U.S. Appl. No. 12/364,763 (listed on SB-08 as U.S. Publication No. US-2009-0208552), dated Dec. 5, 2014.;;Notice of Allowance for U.S. Appl. No. 12/325,546 (listed on SB-08 as U.S. Publication No. US-2009-0181937), dated Dec. 8, 2014.;;Uchida, et al., “Swelling Process and Order-Disorder Transition of Hydrogel Containing Hydrophobic Ionizable Groups”, Macromolecules, 28, 4583-4586 (1995).;;Gutfinger, et al., “Polyphenols in Olive Oils”, Journal of the American Oil Chemists Society, 58(11): 966-968 (1981).;;Portilla, et al., “Prevention of Peritoneal Adhesions by Intraperitoneal Administration of Vitamin E: An Experimental Study in Rats”, Diseases of the Colon and Rectum, 47; 2157-2161 (2005).;;Sano, et al., “A controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease”, The New England Journal of Medicine, 336; 1216-1222 (1997).;;Supplementary European Search Report for Application No. EP 10825447, dated Mar. 31, 2014.;;Non Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as U.S. Publication 2010-0183697), dated May 29, 2014.;;Non-Final Office Action for U.S. Appl. No. 13/943,489, dated Jul. 1, 2014.;;Final Office Action for U.S. Appl. No. 11/980,155, dated Jul. 21, 2014.;;Final Office Action for U.S. Appl. No. 11/237,420, dated Jul. 22, 2014.;;Final Office Action for U.S. Appl. No. 12/075,223, dated Jul. 22, 2014.;;Non Final Office Action for U.S. Appl. No. 12/325,546 (listed on SB-08 as U.S. Publication No. US-2009-181937), dated Apr. 22, 2014.;;Non Final Office Action for U.S. Appl. No. 12/364,763 (listed on SB-08 as U.S. Publication No. US-2009-0208552), dated Apr. 23, 2014.;;Non Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated May 8, 2014.;;Non-Final Office Action for U.S. Appl. No. 11/701,799, dated Jul. 22, 2014.;;Notice of Allowance for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. Publication No. US-2006-0067975), dated Oct. 6, 2014.;;Non-Final Office Action for U.S. Appl. No. 13/184,512, dated Oct. 10, 2014.;;Non-Final Office Action for U.S. Appl. No. 12/075,223, dated Oct. 29, 2014.;;Notice of Allowance for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. Publication No. US-2006-0067983), dated Mar. 27, 2014.;;Notice of Allowance for U.S. Appl. No. 11/237,263 (listed on SB-08 as U.S. Publication No. US-2006-0110457), dated Mar. 27, 2014.;;Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. Publication No. US-2006-0067975), dated Dec. 4, 2013.;;Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. Publication No. US-2006-0067983), dated Dec. 17, 2013.;;Notice of Allowance for U.S. Appl. No. 13/593,656 (listed on SB-08 as U.S. Publication 2012-03115219), dated Jan. 24, 2014.;;Mallegol, “Long-Term Behavior of Oil-Based Varnishes and Paints Photo-and Thermooxidation of Cured Linseed Oil”, Journal of the American Oil Chemists' Society, 77:257-263 (2000).;;International Search Report for International Application PCT/US2013/044653, dated Sep. 4, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB-08 as U.S. Publication No. US-2006-0078586), dated Nov. 12, 2013.;;Non-Final Office Action for U.S. Appl. No. 12/075,223 (listed on SB-08 as U.S. Publication No. US-2008-0206305), dated Nov. 12, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/980,155 (listed on SB-08 as U.S. Publication No. US-2008-0113001), dated Nov. 12, 2013.;;Notice of Allowance for U.S. Appl. No. 13/682,991 (listed on SB-08 as U.S. Publication No. US 2013-0074452), dated Aug. 1, 2013.;;Notice of Allowance for U.S. Appl. No. 11/978,840 (listed on SB-08 as U.S. Publication No. US-2008-0118550), dated Aug. 6, 2013.;;Ackman, R.G., “Fish Oils”, Bailey's Industrial Oil and Fat Products, 6th Edition, 279-317 (2005).;;Ahuja et al. Journal of Indian Pediatric Surgery 2002 7:15-20.;;Andes, et al. “Antiproliferative Strategies for the Treatment of Vascular Proliferative Disease”, Current Vascular Pharmacology, 1)1): 85-98 (2003).;;A paper entitled “Evaluation of the Biocompatibility and Drug Delivery Capabilities of Biological Oil Based Stent Coatings” by Shengqio Li of the Katholieke Universiteit Leuven.;;Autosuture, “ParietexTM Composite OS Series Mesh,” retrieved online at http://www.autosuture.com/AutoSuture/pagebuilder.aspx?topicID=135734&breadcrumbs=135 601:0 (2007).;;Binder et al., “Chromatographic Analysis of Seed Oils. Fatty Acid Composition of Castor Oil,” The Journal of the American Oil Chemists' Society, vol. 39:513-517 (1962).;;Camurus, “In our endeavors to create the unique, we start with the best. Your product.”;;CECW-EE, “Ch. 4: Coating Types and Characteristics,” Engineering and Design—Painting: New Construction and Maintenance, pp. 4-1 to 4-24 (1995).;;Crivello et al., “Epoxidized triglycerides as renewable monomers in photoinitiated cationic polymerization,” Chem. Mater, 1992:692-699.;;De Scheerder, Ivan K., et al. “Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries,” Atherosclerosis, vol. 114:105-114.;;Drummond, Calum J., et al., “Surfactant self-assembly objects as novel drug delivery vehicles,” Current Opinion in Colliod & Interface Science, vol. 4:449-456 (2000).;;Encylopedia Britannica Online, “Surface Coating,” available online at http://www.britannica.com/Ebchecked/topic/575029/surface-coating>, date accessed Jun. 17, 2011.;;Engstrom, Sven, “Drug Delivery from Cubic and Other Lipid-water Phases,” Lipid Technology, vol. 2(2):42-45 (1990).;;Guler, et al. “Some empirical equations for oxopolymerization of linseed oil,” Progress in Organic Coatings, vol. 51:365-371 (2004).;;Hwang, Chao-Wei, et al, “Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery,” Circulation, vol. 104:600-605 (2001).;;Jonasson, Lena et al., “Cyclosporon A inhibits smooth muscle proliferation in the vascular response to injury,” Proc. Natl. Acad. Sci. USA, vol. 85: 2303-2306 (1988).;;Jorge, N., “Grasas y Aceites”, 48(1): 17-24, (1997).;;Lipids, Chapter 19, pp. 1-12 (2002).;;Mallegol, et al., “Drier Influence on the Curing of Linseed Oil,” Progress in Organic Coatings 39:107-113 (2000).;;Morse, Richard “Molecular Distillation of Polymerized Drying Oils,” Industrial and Engineering Chemisry 33:1039-1043 (1941).;;Oberhoff, Martin, et al, “Local and Systemic Delivery of Low Molecular Weight Heparin Following PTCA: Acute Results and 6-Month Follow-Up of the Initial Clinical Experience With the Porous Balloon (PILOT-Study),” Catheterization and Cardiovascular Diagnosis, vol. 44:267-274 (1998).;;Ogunniyi, D.S., “Castor oil: A vital industrial raw material,” Biosource Technology, vol. 97: 1086-1091 (2006).;;Polymerization Merriam-Webster Online Dictionary, retrieved from <www.merriam-webster.com> on Dec. 13, 2009; Merriam-Webster's Inc. 2009; pp. 1.;;Redman, L.V. et al., “The drying rate of raw paint oils—a comparison,” The Journal of Industrial and Engineering Chemistry, vol. 5: 630-636 (1913).;;Rutkow, Ira M. et al., “‘Tension-free’ inguinal herniorrhaphy: A preliminary report on the ‘mesh plug’ technique,” Surgery, vol. 114:3-8 (1993).;;Salu, Koen J., et al, “Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model,” Coronary Artery Disease, vol. 14(8):545-555 (2003).;;Scheller, Bruno, et al, “Addition of Paclitaxel to Contrast Media Prevents Restenosis After Coronary Stent Implantation,” Journal of the American College of Cardiology, vol. 42(8):1415-1420 (2003).;;Shahidi, Fereidoon ed.; “Bailey's Industrial Oil and Fats Products” 2005; John Wiley and Sons; vol. 5, Edible Oil and Fat Products: Processing Technologies, pp. 1-15.;;Timar-Balizsy et al., “Chemical Principals of Textile Conservation,” Oxford: Elsevier Science Ltd., 1998:117-119.;;Van der Giessen, Willem J., et al, “Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries,” Circulation, vol. 94:1690-1697 (1996).;;Websters Dictionary Online, Accessed on Feb. 13, 2009, entry for “polymer” p. 1 of 1.;;Wikipedia, “Sirolimus,” pp. 1-13, available online at http://en.wikipedia.org/wiki/Sirolimus, date accessed May 11, 2011.;;Winter, et al., “Physical and Chemical Gelation” Encyclopedia of Materials—Science and Technology, vols. 1-11: 6691-6999 (2001).;;International Search Report for International Application PCT/US05/034601, dated Apr. 10, 2006.;;International Search Report for International Application PCT/US05/034610, dated Mar. 16, 2006.;;International Search Report for International Application PCT/US05/034614, dated Aug. 29, 2006.;;International Search Report for International Application PCT/US05/034615, dated May 16, 2006.;;International Search Report for International Application PCT/US05/034678, dated Aug. 28, 2006.;;International Search Report for International Application PCT/US05/034681, dated Jul. 26, 2006.;;International Search Report for International Application PCT/US05/034682, dated Jul. 20, 2006.;;International Search Report for International Application PCT/US05/034836, dated Jul. 6, 2006.;;International Search Report for International Application PCT/US06/037184, dated Feb. 22, 2007.;;International Preliminary Report on Patentability for International Application PCT/US06/040753, dated Oct. 3, 2008.;;International Search Report for International Application PCT/US06/040753, dated Sep. 24, 2007.;;International Search Report for International Application PCT/US07/019978, dated May 7, 2009.;;International Search Report for International Application PCT/US07/022860, dated Apr. 22, 2009.;;International Search Report for International Application PCT/US07/022944, dated Apr. 8, 2009.;;International Search Report for International Application PCT/US08/000565, dated May 4, 2009.;;International Preliminary Examination Report for International Application PCT/US08/071547, dated Aug. 26, 2010.;;International Search Report for International Application PCT/US08/071547, dated Oct. 22, 2008.;;International Preliminary Report on Patentability for International Application PCT/US08/071565, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US08/071565, dated Nov. 10, 2008.;;International Search Report for International Application PCT/US08/085386, dated Feb. 4, 2009.;;International Search Report for International Application PCT/US09/037364, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US10/026521, dated Jun. 23, 2010.;;International Search Report for International Application PCT/US10/052899, dated Jan. 10, 2011.;;Supplementary European Search Report for Application No. EP 05 80 2894, dated Jul. 27, 2011.;;Supplementary European Search Report in Application No. 05 800 844, dated Aug. 19, 2011.;;Supplementary European Search Report in Application No. EP 05 80 4291, dated Jul. 26, 2011.;;Supplementary European Search Report in Application No. EP 05 85 8430, dated Aug. 18, 2011.;;International Search Report for International Application No. PCT/US05/34941, dated May 4, 2006.;;Supplementary European Search Report for Application No. EP 08877338.7, dated Aug. 16, 2012.;;Supplementary European Search Report for Application No. EP09819594.4, dated Aug. 14, 2012.;;International Search Report for PCT/US2011/44292, dated Dec. 6, 2011.;;Supplementary European Search Report for Application No. EP 12004057, dated Apr. 10, 2013.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated Mar. 25, 2006.;;Final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated May 17, 2011.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated Aug. 24, 2009.;;Non-final Office Action for U.S. Appl. No. 11/236,977 (listed on SB/08 as US 2006/0088596), dated Aug. 3, 2009.;;Final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), dated Jul. 7, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), dated Oct. 7, 2009.;;Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), dated Jun. 2, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), dated Oct. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Nov. 23, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Mar. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Nov. 4, 2009.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Dec. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), dated Mar. 30, 2009.;;Final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), dated Sep. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated May 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated Oct. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated May 1, 2009.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated Jul. 25, 2008.;;Non-final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), dated Apr. 16, 2008.;;Final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), dated Aug. 6, 2009.;;Non-final Office Action for U.S. Appl. No. 11/239,555 (listed on SB/08 as US 2006/0067977), dated Mar. 30, 2009.;;Non-final Office Action for U.S. Appl. No. 11/525,328 (listed on SB/08 as US 2007/0084144), dated Apr. 30, 2007.;;Non-final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Jul. 14, 2010.;;Final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Feb. 21, 2011.;;Final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated May 12, 2011.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated Nov. 9, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated Jan. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated May 12, 2009.;;Non-final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Apr. 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), dated Dec. 3, 2010.;;Non-final Office Action for U.S. Appl. No. 11/980,155 (listed on SB/08 as US 2008/0113001), dated Mar. 24, 2011.;;Non-final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305), dated Dec. 8, 2010.;;Non-final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937), dated Feb. 25, 2010.;;Final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937), dated Aug. 31, 2010.;;Non-final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552), dated Dec. 11, 2009.;;Final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552), dated Sep. 21, 2010.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) dated May 5, 2009.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) dated Dec. 2, 2010.;;Interview summary for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586) dated May 5, 2009.;;Interview summary for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149) dated Dec. 7, 2010.;;Interview summary for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937) dated Dec. 2, 2010.;;Interview summary for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552) dated Dec. 2, 2010.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Jul. 13, 2011.;;Final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), dated Jun. 22, 2011.;;Final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305), dated Aug. 11, 2011.;;Non-final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Jul. 11, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Aug. 17, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US-2007-0202149), dated Oct. 14, 2011.;;Final Office Action for U.S. Appl. No. 11/980,155 (listed on SB/08 as US-2008-0113001), dated Oct. 21, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US-2006-0067974), dated Dec. 2, 2011.;;Non-Final Office Action for U.S Appl. No. 12/182,261 (listed on SB/08 as US 2009-0047414), dated Dec. 21, 2011.;;Non-Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated Jan. 5, 2012.;;Notice of Allowance for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007-0202149), dated Jan. 9, 2012.;;Non-Final Office Action for U.S. Appl. No. 12/182,165 (listed on SB/08 as US 2009-0011116), dated Jan. 5, 2012.;;Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Feb. 13, 2012.;;Non-Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB/08 as US 2010-0183697), dated Mar. 14, 2012.;;Final Office Action for U.S. Appl. No. 12/182,165 (listed on SB/08 as US 2009-0011116), dated Apr. 6, 2012.;;Final Office Action for U.S. Appl. No. 12/182,261 (listed on SB-08 as US 2009/0047414) dated Apr. 30, 2012.;;Notice of Allowance for U.S. Appl. No. 11/236,908 (listed on SB/08 as US-2006-0067974), dated May 11, 2012.;;Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US-2010-0233232), dated Jun. 11, 2012.;;Notice of Allowance for U.S. Appl. No. 12/182,261 (listed on SB/08 as US-2009-0047414), dated Jul. 23, 2012.;;Advisory Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated Aug. 27, 2012.;;Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as US 2010/0183697) dated Aug. 29, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB/08 as US-2007/0071798), dated Oct. 4, 2012.;;Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB/08 as US 2006/0067975), dated Dec. 23, 2009.;;Non-Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB/08 as US 2006/0067975), dated Mar. 5, 2009.;;Advisory Action for U.S. Appl. No. 12/581,582 (listed on SB/08 as US 2010-0183697), dated Nov. 14, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/404,487 (listed on SB/08 as 2012-0213839), dated Dec. 20, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB/08 as US-2007/0071798), dated Nov. 20, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB/08 as US-2007/0071798), dated Nov. 30, 2012.;;Advisory Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as U.S. Publication No. 2010-0183697), dated Nov. 14, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB-08 as U.S. Publication No. US-2007-0071798), dated Nov. 20, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/404,487 (listed on SB-08 as US 2012-0213839), dated Dec. 20, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/184,512 (listed on SB-08 as 2012-0016038), dated Jan. 31, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/978,840 (listed on SB-08 as U.S. No. US-2008-0118550), dated Feb. 19, 2013.;;Non-Final Office Action for U.S. Appl. No. 13/682,991 (listed on SB-08 as U.S. No. US-2013-0074452), dated Mar. 18, 2013.;;Notice of Allowance for U.S. Appl. No. 13/404,487 (listed on SB-08 as U.S. No. US-2012-0213839), dated Apr. 2, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. No. US-2006-0067975), dated Apr. 22, 2013.;;Final Office Action for U.S. Appl. No. 13/184,512 (listed on SB-08 as U.S. No. U.S. 2012-0016038), dated Jun. 25, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. No. US-2006-0067983), dated Jul. 3, 2013.;;Non-Final Office Action for U.S. Appl. No. 13/593,656 (listed on SB-08 as U.S. No. US-2012-03115219), dated Jul. 15, 2013.;;Evans, D.F. et al., Measurement of gastrointestinal pH profiles in normal ambulant human subjects, GUT, 1988, 1035-1041, 29.;;Examination Report issued in IN Application No. 3605/DELNP/2012, dated Mar. 23, 2018.;;Non-Final Office Action issued in U.S. Appl. No. 15/817,018, dated Sep. 19, 2018.;;Erhan et al., Vegetable-oil-based printing ink formulation and degradation, Industrial Crops and Products, 1995, 237-246, 3.;;Non-Final Office Action issued in U.S. Appl. No. 15/710,514, dated Sep. 17, 2018.;;Non-Final Office Action issued in U.S. Appl. No. 13/843,068, dated Sep. 29, 2014.;;Final Office Action issued in U.S. Appl. No. 13/843,068, dated Apr. 23, 2015.;;Non-Final Office Action issued in U.S. Appl. No. 13/843,068, dated Mar. 11, 2016.;;Final Office Action issued in U.S. Appl. No. 13/843,068, dated Sep. 22, 2016.;;Non-Final Office Action issued in U.S. Appl. No. 13/843,068, dated Mar. 9, 2017. et al.",UNKNOWN
90,US,A1,US 2018/0140705 A1,169-195-567-922-383,2018-05-24,2018,US 201715819304 A,2017-11-21,US 201715819304 A;;US 201313843068 A;;US 201261659301 P,2012-06-13,CURED OIL-HYDROGEL BIOMATERIAL COMPOSITIONS FOR CONTROLLED DRUG DELIVERY,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na-CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,,https://lens.org/169-195-567-922-383,Patent Application,yes,0,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61K47/12;;A61K47/22;;A61L27/14;;A61L27/34;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16,,0,0,,,,ACTIVE
91,EP,B1,EP 2861269 B1,086-150-376-300-938,2020-04-29,2020,EP 13804477 A,2013-06-07,US 201261659301 P;;US 2013/0044653 W,2012-06-13,CURED OIL-HYDROGEL BIOMATERIAL COMPOSITIONS FOR CONTROLLED DRUG DELIVERY,,ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,"ATRIUM MEDICAL CORPORATION (2020-06-03);;ATRIUM MEDICAL CORP., MERRIMACK, US (2020-05-25)",https://lens.org/086-150-376-300-938,Granted Patent,yes,4,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61L27/40;;A61L27/14;;A61L27/34;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16,,0,0,,,,ACTIVE
92,US,B2,US 10089501 B2,183-136-557-138-55X,2018-10-02,2018,US 201715456470 A,2017-03-10,US 201715456470 A;;US 201662306808 P,2016-03-11,"Multi-media reader apparatus, secure transaction system and methods thereof","A multi-media reader (MMR) apparatus, secure transaction system and methods thereof are provided. The MMR apparatus includes a slot to receive a card and a near field communication (NFC) antenna to communicate with other NFC enabled devices and cards. The system is provided for securely sharing information over a network to complete one or more transactions using the MMR apparatus and a mobile device. The shared information may be separated and reassembled using on or more servers to increase security.",PARABIT SYSTEMS INC,LEIPONIS ROBERT J;;RANDOLPH JOSEPH P;;CONROY DAVID;;MOISANU CATALIN,PARABIT SYSTEMS INC (2017-03-11),https://lens.org/183-136-557-138-55X,Granted Patent,yes,50,1,3,3,0,G07F19/20;;G06K7/10128;;G06K7/0078;;G07F19/2055;;G06K7/0004;;G06K7/10316;;G06K7/0004;;G06K7/10316;;G07F19/20;;G06K7/10128;;G06K7/0078;;G07F19/2055,G06K7/00;;G06K7/10;;G07F19/00,,4,0,,,"International Search Report for PCT/US2017/021977; dated Jul. 19, 2017; 17 pages.;;Crowe et al.; “Is Payment Tokenization Ready for Primetime?”; Federal Reserve Bank of Boston; dated Jun. 11, 2015; 51 pages.;;English Machine Translation of CN101561953 obtained from Espacenet of the European Patent Office on Mar. 21, 2017, 25 total pages including abstract, description and claims.;;International Preliminary Report on Patentability for PCT/US2017/021977; dated Feb. 23, 2018; 4 pages.",ACTIVE
93,EP,A4,EP 2861269 A4,192-952-582-833-249,2016-01-13,2016,EP 13804477 A,2013-06-07,US 201261659301 P;;US 2013/0044653 W,2012-06-13,CURED OIL-HYDROGEL BIOMATERIAL COMPOSITIONS FOR CONTROLLED DRUG DELIVERY,,ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,"ATRIUM MEDICAL CORPORATION (2020-06-03);;ATRIUM MEDICAL CORP., MERRIMACK, US (2020-05-25)",https://lens.org/192-952-582-833-249,Search Report,no,2,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61L27/40;;A61L27/14;;A61L27/34;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16,,1,0,,,See also references of WO 2013188222A1,ACTIVE
94,US,A1,US 2017/0262664 A1,196-496-095-652-693,2017-09-14,2017,US 201715456470 A,2017-03-10,US 201715456470 A;;US 201662306808 P,2016-03-11,"MULTI-MEDIA READER APPARATUS, SECURE TRANSACTION SYSTEM AND METHODS THEREOF","A multi-media reader (MMR) apparatus, secure transaction system and methods thereof are provided. The MMR apparatus includes a slot to receive a card and a near field communication (NFC) antenna to communicate with other NFC enabled devices and cards. The system is provided for securely sharing information over a network to complete one or more transactions using the MMR apparatus and a mobile device. The shared information may be separated and reassembled using on or more servers to increase security.",PARABIT SYSTEMS INC,LEIPONIS ROBERT J;;RANDOLPH JOSEPH P;;CONROY DAVID;;MOISANU CATALIN,PARABIT SYSTEMS INC (2017-03-11),https://lens.org/196-496-095-652-693,Patent Application,yes,4,6,3,3,0,G07F19/20;;G06K7/10128;;G06K7/0078;;G07F19/2055;;G06K7/0004;;G06K7/10316;;G06K7/0004;;G06K7/10316;;G07F19/20;;G06K7/10128;;G06K7/0078;;G07F19/2055,G06K7/00;;G06K7/10,,0,0,,,,ACTIVE
95,WO,A1,WO 2017/156504 A1,092-839-730-653-216,2017-09-14,2017,US 2017/0021977 W,2017-03-10,US 201662306808 P,2016-03-11,"MULTI-MEDIA READER APPARATUS, SECURE TRANSACTION SYSTEM AND METHODS THEREOF","A multi-media reader (MMR) apparatus, secure transaction system and methods thereof are provided. The MMR apparatus includes a slot to receive a card and a near field communication (NFC) antenna to communicate with other NFC enabled devices and cards. The system is provided for securely sharing information over a network to complete one or more transactions using the MMR apparatus and a mobile device. The shared information may be separated and reassembled using on or more servers to increase security.",PARABIT SYSTEM INC,LEIPONIS ROBERT J;;RANDOLPH JOSEPH P;;CONROY DAVID;;MOISANU CATALIN,,https://lens.org/092-839-730-653-216,Patent Application,yes,6,0,3,3,0,G07F19/20;;G06K7/10128;;G06K7/0078;;G07F19/2055;;G06K7/0004;;G06K7/10316;;G06K7/0004;;G06K7/10316;;G07F19/20;;G06K7/10128;;G06K7/0078;;G07F19/2055,G06K7/10;;G06K7/00;;G06K7/01;;G07F19/00;;G08B21/18;;G08B25/10,,0,0,,,,PENDING
96,US,B2,US 10888617 B2,183-902-575-855-376,2021-01-12,2021,US 201715819304 A,2017-11-21,US 201715819304 A;;US 201313843068 A;;US 201261659301 P,2012-06-13,Cured oil-hydrogel biomaterial compositions for controlled drug delivery,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na-CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,,https://lens.org/183-902-575-855-376,Granted Patent,yes,623,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61K47/12;;A61K47/22;;A61L27/14;;A61L27/34;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16,,357,75,125-647-566-817-299;;039-789-653-495-925;;190-113-176-326-786;;003-327-828-059-912;;022-414-594-928-576;;129-228-869-080-22X;;039-405-805-990-138;;019-715-735-775-026;;040-548-329-033-663;;020-318-656-057-946;;138-861-484-533-646;;096-774-227-861-342;;043-462-681-410-597;;125-647-566-817-299;;042-336-761-097-701;;032-919-350-438-964;;025-906-530-941-35X;;085-950-189-639-353;;073-151-968-408-638;;004-470-065-863-328;;093-197-727-511-414;;011-316-452-166-993;;082-892-872-068-848;;093-811-289-675-626;;089-276-889-719-390;;100-176-598-076-477;;048-810-042-623-799;;087-516-990-109-332;;121-518-616-187-47X;;062-869-359-643-29X;;012-224-721-274-561;;169-123-655-792-862;;183-299-871-235-178;;061-647-378-924-636;;107-683-021-659-003;;065-142-893-532-911;;064-537-834-566-45X;;111-219-182-232-532;;009-415-282-876-854;;074-774-683-240-998;;005-252-447-646-653;;171-964-352-982-114;;056-271-909-597-918;;156-705-635-276-121;;123-229-163-260-583;;002-419-807-488-402;;021-973-309-588-643;;099-236-345-518-968;;037-867-504-059-044;;029-973-649-886-488;;029-172-943-105-515;;167-730-244-332-10X;;048-098-804-626-325;;016-857-435-788-567;;038-103-754-606-916;;063-246-296-927-732;;036-901-663-339-828;;047-840-400-955-744;;060-207-231-677-911;;116-345-037-579-109;;009-396-178-813-377;;092-252-552-811-396;;080-470-395-375-964;;005-977-129-957-841;;003-165-556-474-039;;079-370-424-651-734;;065-530-843-010-802;;015-381-902-539-387;;082-293-897-848-117;;084-724-321-137-456;;054-882-980-906-816;;066-407-393-309-358;;014-869-845-026-149;;001-504-976-379-338;;011-243-908-688-446,10.3390/ma2020353;;10.1007/bf02536316;;8487623;;10.1001/jama.279.17.1409-jbk0506-6-1;;10.3945/an.111.000893;;pmc3262608;;22332096;;10.1093/ajcn/46.6.936;;2825504;;17167791;;10.1002/ccd.20943;;10.1016/j.rser.2012.09.025;;2854466;;9486816;;10.1093/jnci/90.4.300;;10.1111/j.1432-2277.2004.tb00509.x;;15827754;;10.1007/s00147-004-0799-z;;16920418;;10.1016/j.amjsurg.2005.05.047;;23644844;;pmc3611753;;10.6061/clinics/2013(03)e01;;10.1177/0961203311430703;;22235041;;10.3390/ma2020353;;10.1016/s1773-2247(08)50016-5;;10.3144/expresspolymlett.2008.90;;10.1016/b978-0-408-11810-1.50008-8;;10.1111/j.1469-0691.2004.01014.x;;15649297;;10.1021/ma00117a031;;10.1007/bf02659771;;15657668;;10.1007/s10350-004-0741-6;;9110909;;10.1056/nejm199704243361704;;10.1007/s11746-000-0042-4;;10.1002/047167849x.bio078;;15320855;;10.2174/1570161033386763;;10.1007/bf02672540;;10.1021/cm00021a036;;7605369;;10.1016/0021-9150(94)05472-u;;10.1016/s1359-0294(00)00020-0;;10.1016/j.porgcoat.2004.07.024;;10.1161/hc3101.092214;;11479260;;pmc279979;;3258426;;10.1073/pnas.85.7.2303;;10.1016/s0300-9440(00)00126-0;;10.1021/ie50380a016;;9676794;;10.1002/(sici)1097-0304(199807)44:3<267::aid-ccd4>3.0.co;2-3;;15919203;;10.1016/j.biortech.2005.03.028;;10.1021/ie50056a004;;8356522;;10.1097/00019501-200312000-00005;;14646676;;14563585;;10.1016/s0735-1097(03)01056-8;;8840862;;10.1161/01.cir.94.7.1690;;10.1016/b0-08-043152-6/01239-0;;pmc1433896;;3410329;;10.1136/gut.29.8.1035;;10.1016/0926-6690(94)00040-6;;17699247;;10.2215/cjn.01020905;;10.2527/jas.2008-0964;;19098239;;10.1177/0148607197021004224;;9252949;;10.5767/anurs.cmat.100101.en.039p;;10.1080/00218464.2011.583588;;10.1002/1438-9312(200010)102:10<624::aid-ejlt624>3.0.co;2-i;;10.1016/0271-5317(95)00057-p;;10785709;;10.1161/01.cir.95.6.1549;;9118524;;1732351;;10.1016/0735-1097(92)90476-4;;10.1515/cclm.2008.118;;18605928;;10.1111/j.1745-4522.1998.tb00105.x;;10587187;;10.1016/s0002-9610(99)00181-6;;10.1016/0002-9610(76)90307-x;;782263;;10.1097/00129689-200104000-00007;;11330373;;10.1097/00019509-200104000-00007;;10.1021/jf0207934;;12670159;;21782615;;10.1016/s1382-6689(02)00003-0;;14627891;;10.1097/01.rli.0000084954.62318.19;;16198256;;10.1263/jbb.100.152;;10.1161/01.atv.2.2.87;;7039582;;12053215;;10.1007/s00268-001-0286-y;;3603343;;2815797;;10.1007/bf01658865;;11104648;;10.1006/jsre.2000.6020;;7612949;;10.1089/lps.1995.5.91;;10.1002/1097-4628(20001010)78:2<278::aid-app60>3.0.co;2-9;;12204574;;10.1016/s0378-5173(02)00325-3;;16162522;;10.3168/jds.s0022-0302(05)73033-2;;10.1038/jid.2009.93;;19387482;;pmc2772209;;10.1002/047167849x.bio039;;15922668;;10.1016/j.tube.2004.11.003,"Sannino et al. “Biodegradable Cellulose-based Hydrogels: Design and Applications” Apr. 16, 2009.;;Office Action issued in counterpart EP Application No. 13804477.1, dated Jul. 19, 2017.;;Office Action issued in counterpart EP Application No. 13804477.1, dated Jun. 25, 2018.;;Final Office Action dated Mar. 30, 2017 for related U.S. Appl. No. 11/237,420, 20 pages.;;Henderson, R. James et al., “Hydrolysis of Fish Oils Containing Polymers of Triacylglycerols by Pancreatic Lipase in vitro”, Lipids, vol. 28, No. 4, 1993, pp. 313-319.;;H. Fineberg et al., Industrial Use of Fish Oils, pp. 222-238, http://spo.nmfs.noaa.gov/Circulars/CIRC278.pdf, downloaded Aug. 3, 2015.;;Lewis, Richard J., Sr., Hawley's Condensed Chemical Dictionary, 2001, pp. 308, 309 and 896-898, 14th edision, John Wiley & Sons, Inc., New York.;;Webster's II New College Dictionary (1995), 1075, Houghton Mifflin Company, New York, US.;;Polymers made from multiple monomers, A Natural Approach to Chemistry, Chapter 8, 241, http://lab-aids.com/assets/uploads/NAC/NAC_student_book/Texas%20Student%20Edition%20253.pdf (downloaded Dec. 3, 2015).;;Polymer, Encyclopedia Britannica. Encyclopedia Britannica Online, Encyclopedia Britannica Inc., 105, Web. Dec. 2, 2015, http://www.britannica.com/print/article/468696 (downloaded Dec. 2, 2015).;;Triglycerides, https://www.lipid.org/sites/default/files/triglycerides.pdf (downloaded Sep. 24, 2015).;;Fish Oil Triglycerides vs. Ethyl Esters: A Comparative Review of Absorption, Stability and Safety Concerns (Ascenta Health Ltd. 2010 at http://www.ascentaprofessional.com/science/articles/fish-oil-triglycerides-vs-ethyl-esters (downloaded Sep. 24, 2015).;;Swanson, Danielle, et al., Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life, 3 Advances in Nutrition 1-7 (American Society for Nutrition 2012).;;Fats & Oils (2008) at http://scifun.chem.wisc.edu/chemweek/pdf/fats&oils.pdf (downloaded Sep. 24, 2015).;;Bacteria in Water, The USGS Water Science School, http://water.usgs.gov/edu/bacteria.html (downloaded Nov. 9, 2015).;;Novotny, L. et al., Fish: a potential source of bacterial pathogens for human beings, Vet. Med.—Czech, 49, 2004, vol. 9, pp. 343-358.;;Allergies, Asthma and Allergy Foundation of America (2011), http://www.aafa.org/page/types-of-allergies,aspx (downloaded Oct. 5, 2015).;;Urakaze, Masaharu et al., “Infusion of fish oil emulsion: effects on platelet aggregation and fatty acid composition in phospholipids of plasma, platelets and red blood cell membranes in rabbits”, Am. J. Clin. Nutr., vol. 46, pp. 936-940 (! 987).;;Singh, Alok, et al., “Facilitated Stent Delivery Using Applied Topical Lubrication”, Catherization and Cardiovascular Interventions, vol. 69, pp. 218-222 (2007).;;Sicherer, Scott H., Food Allergies: A Complete Guide for Eating When Your Life Depends on it, 2013, 15, Johns Hopkins University Press, Baltimore, MD, USA.;;Omega-3 DHA—The Problem May Be the Quality of Your Fish Oil, Not Your Allergy to Fish, Fatty Acids Hub, http://www.fattyacidshub.com/fatty-acids/omega-3-dha/ (downloaded Nov. 10, 2015).;;Soy Allergy, Asthma and Allergy Foundation of America (2005), http://www.aafa.org/display.cfm?id=9&sub=20&cont=522 (downloaded Nov. 10, 2015).;;Refined soybean oil not an allergen, say food scientists, Food navigator-usa.com (2005), http://www.foodnavigator-usa.com/content/view/print/127438 (downloaded Nov. 10, 2015).;;Yahyaee, R. et al., Waste fish oil biodiesel as a source of renewable fuel in Iran, Renewable and Sustainable Energy Reviews, 2013, pp. 312-319, 17, Elsevier Ltd.;;Biological evaluation of medical devices—Part 1: Evaluation and testing, International Standard ISO 109931-1, Aug. 1, 2003, Third Edition, Switzerland.;;Mayo Clinic (http://www.mayoclinic.org/drugs-supplements/omega-3-fatty-acids-fish-oil-alpha-linolenic-acids/safety/hrb-20059372?p=1 (downloaded Sep. 28, 2015).;;Milk allergy, at http://www.mayoclinic.org/diseases-conditions/milk-allergy/basics/definition/con-20032147?p=1 (downloaded Jul. 29, 2015).;;Soy allergy, at http://www.mayoclinic.org/diseases-conditions/soy-allergy/basics/definition/con-20031370?p=1 (downloaded Jul. 29, 2015).;;F.D. Gunstone, Fatty Acid and Lipid Chemistry 72 (1999).;;Hawley's Condensed Chemical Dictionary 315, 316, 332, 333, 334, 825 and 826 (2001).;;Hutlin, Herbert O. et al., Chemical Composition and Stability of Fish Oil (International Association of Fish Meal Manufacturers Apr. 10, 1991).;;F.V.K Young, The Chemical & Physical Properties of Crude Fish Oils for Refiners and Hydrogenators, 18 Fish Oil Bulletin 1-18 (1986).;;Karrick, Neva L., Nutritional Value of Fish Oils as Animal Feed, Circular 281 (Fish and Wildlife Service Bureau of Commercial Fisheries 1967), reprinted from M.E. Stansby (ed.), Fish Oils 362-382 (Avi Publishing Company 1967).;;Luley et al., Fatty acid composition and degree of peroxidation in fish oil and cod liver oil preparations, Arzneimittelforschung. Dec. 1998, vol. 38, No. 12, pp. 1783-1786.;;Drying Oil, http://en.wikipedia.org/wiki/drying_oil (downloaded Jun. 28, 2013).;;Szebeni et al., “Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study”, Journal of the National Cancer Institute, 1998, vol. 90, No. 4, pp. 300-306.;;Birsan, et al., “The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro”, Transpl. Int., 2005, vol. 17, pp. 767-771.;;About.com, “Orthopedics, Synvisc injections,” retrieved online at http://orthopedics.about.com/cs/treatment/a/synvisc_2.htm (2005).;;Cath Lab Digest, “Olive Oil Emulsion Helps With Problem Heart Arteries”, retrieved online at http://www.cathlabdigest.com/displaynews.cfm?newsid=0103073 (2007).;;Doctor's Guide to Medical and Other News, “AAOS Meeting: Synvisc Delays Total Knee Replacement in Osteoarthritis Patients”, retrieved online at http://www.docguide.com/dg.nsf/PrintPrint/4585EC355198EEF08525670E006B10FF (1999).;;Methodist, “Evaluation of Biocompatibility and Antirestenotic Potential of Drug Eluting Stents Employing Polymer-free Highly-Hydrogenated Lipid-Based Stent Coatings in Porcine Coronary Arteries”, Transcatheter Cardiovascular Therapeutics (TCT), sponsored by the Cardiovascular Research Foundation®, Oct. 22-27, 2006, Washington Convention Center, Washington, D.C.;;Novavax, retrieved online at http://www.novavax.com/go.cfm?do=Page.View&pid=3 (2006).;;Orthovisc, “New Treatment Option is Potential Alternative to OTC Pain Medications for Osteoarthritis of the Knee” retrieved online at http://www.jnj.com/innovations/new_features/ORTHOVISC.htm:iessionid=33N2RBQDV0DZKCQPCCEGU3AKB2IIWTT1 (2006).;;Orthovisc, “What is ORTHOVISC®?” retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=about_orthovisc (2005).;;Orthovisc, “Your Knees and Osteoarthritis”, retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=understanding_knee_oa (2003).;;Orthovisc, “What to expect from your treatment,” retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=what_to_expect (2007).;;Orthovisc, “Tools and Resources for Managing Your Osteoarthritis”, retrieved online at http://www.orthovisc.com/khtmlbgdisplay.jhtml?itemname=patient_resources (2007).;;Pohibinska, A., et al., “Time to reconsider saline as the ideal rinsing solution during abdominal surgery”, The American Journal of Surgery, vol. 192, pp. 281-222 (2007).;;Hortolam, Juliane G., et al., “Connective tissue diseases following silicone breast implantation: where do we stand?”, Clinics, 2013, vol. 3, p. 281.;;Lidar, M. et al., “Silicone and sclerodema revisited”, Lupus, 2012, vol. 21, pp. 121-127.;;“Lead”, Article by Centers for Disease Control and Prevention (CDC), Nov. 2009, 2 pages.;;“Cure” in Academic Press Dictionary of Science and Technology, 1992.;;Extended European Search Report dated Dec. 10, 2015 issued for corresponding EP Patent Application No. 13804477, 8 pages.;;SepraFilm Adhesion Barrier package insert (Genzyme Biosurgery 2008).;;Alessandro Sannino et al., Biodegradeable Cellulose-based Hydrogels: Design and Applications, 2 Materials 353-373 (2009).;;Thomas Heinz, Carboxymethyl Ethers of Cellulose and Starch—A Review, Center of Excellence for Polysaccharide Reseach, Friedrich Schiller University of Jena (Germany), pp. 13-29 (2005).;;H. Omidian et al., Swelling Agents and Devices in Oral Drug Delivery, J. Drug. Del. Sci. Tech., 18 (2) 83-93 (2008).;;S. Kamel et al., Pharmaceutical Significance of Cellulose: a Review, eXPRESS Polymer Letters vol. 2, No. 11 pp. 758-778 (2008).;;A. M. Adel et al. Carboxymethylated Cellulose Hydrogel; Sorption Behavior and Characterization, Nature and Science, 8(8), pp. 244-256, (2010).;;Wicks et al. Organic Coatings:Science and Technology 1999 New York:Wiley Interscience, pp. 258-267.;;Mills et al. Oils and Fats. “The Organic Chemistry of Museum Objects” London:Buttersworth and Co. 1987, pp. 26-40.;;Erhardt Paints Based on Drying Oil Media. Painted Wood: History & Conservation. Ed. Berland Singapore: The J. Paul Getty Trust 1998. pp. 17-32.;;Wexler et al. Chemical Reviews 1964, vol. 64, No. 6, pp. 591-611.;;Polymer—The Chambers 21st Century Dictionary M. Robinson and G. Davidson (Eds.), London, United Kingdom: Chambers Harrap. Retrieved from http://search.credoreference.com/content/entry/chambdict!polymer/O.;;Polymer—Academic Press Dictionary of Science and TechnologyC. Morris (Ed.), Academic Press Dictionary of Science and Technology. Oxford, United Kingdom: Elsevier Science & Technology. Retrieved from http://search.credoreference.com/content/entry/apdst!polymer/O.;;Falagas et al. European Society of Clinical Microbiology and Infection Diseases, 2005, vol. 11, pp. 3-8.;;Bimbo, Inform 1998, vol. 9, No. 5, pp. 473-483.;;Wikipedia, Sunflower oil, https://en.wikipedia.org/wiki/Sunflower_oil, accessed Jul. 23, 2015 by Examiner Lyndsey Beckhardt in related U.S. Appl. No. 14/252,671, pp. 1-7.;;Esoteric Oils, Peppermint essential oil information, http://www.essentialoils.co.za/essential-oils/peppermint.htm, accessed Jul. 23, 2015 by Examiner Lyndsey Beckhardt in related U.S. Appl. No. 14/252,671, pp. 1-7.;;Orthomolecular, Fish Oil, Jun. 29, 2004, http://orthomolecular.org/nutrients/fishoil.html, accessed Jul. 22, 2015 by Examiner Lyndsey Beckhardt in related U.S. Appl. No. 14/252,671, p. 1.;;Final Office Action for U.S. Appl. No. 13/184,512, dated Apr. 28, 2015.;;Final Office Action for U.S. Appl. No. 11/701,799, dated Mar. 12, 2015.;;Final Office Action for U.S. Appl. No. 12/581,582, dated Jan. 8, 2015.;;Non-Final Office Action for U.S. Appl. No. 12/401,243, dated Jan. 16, 2015.;;Non-Final Office Action for U.S. Appl. No. 11/237,420, dated Jan. 21, 2015.;;Notice of Allowance for U.S. Appl. No. 13/943,489, dated Jan. 29, 2015.;;Non-Final Office Action for U.S. Appl. No. 11/980,155, dated Nov. 7, 2014.;;Notice of Allowance for U.S. Appl. No. 12/364,763 (listed on SB-08 as U.S. Publication No. US-2009-0208552), dated Dec. 5, 2014.;;Notice of Allowance for U.S. Appl. No. 12/325,546 (listed on SB-08 as U.S. Publication No. US-2009-0181937), dated Dec. 8, 2014.;;Uchida, et al., “Swelling Process and Order-Disorder Transition of Hydrogel Containing Hydrophobic Ionizable Groups”, Macromolecules, 28, 4583-4586 (1995).;;Gutfinger, et al., “Polyphenols in Olive Oils”, Journal of the American Oil Chemists Society, 58(11): 966-968 (1981).;;Portilla, et al., “Prevention of Peritoneal Adhesions by Intraperitoneal Administration of Vitamin E: An Experimental Study in Rats”, Diseases of the Colon and Rectum, 47; 2157-2161 (2005).;;Sano, et al., “A controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease”, The New England Journal of Medicine, 336; 1216-1222 (1997).;;Supplementary European Search Report for Application No. EP 10825447, dated Mar. 31, 2014.;;Non Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as U.S. Publication 2010-0183697), dated May 29, 2014.;;Non-Final Office Action for U.S. Appl. No. 13/943,489, dated Jul. 1, 2014.;;Final Office Action for U.S. Appl. No. 11/980,155, dated Jul. 21, 2014.;;Final Office Action for U.S. Appl. No. 11/237,420, dated Jul. 22, 2014.;;Final Office Action for U.S. Appl. No. 12/075,223, dated Jul. 22, 2014.;;Non Final Office Action for U.S. Appl. No. 12/325,546 (listed on SB-08 as U.S. Publication No. US-2009-181937), dated Apr. 22, 2014.;;Non Final Office Action for U.S. Appl. No. 12/364,763 (listed on SB-08 as U.S. Publication No. US-2009-0208552), dated Apr. 23, 2014.;;Non Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated May 8, 2014.;;Non-Final Office Action for U.S. Appl. No. 11/701,799, dated Jul. 22, 2014.;;Notice of Allowance for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. Publication No. US-2006-0067975), dated Oct. 6, 2014.;;Non-Final Office Action for U.S. Appl. No. 13/184,512, dated Oct. 10, 2014.;;Non-Final Office Action for U.S. Appl. No. 12/075,223, dated Oct. 29, 2014.;;Notice of Allowance for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. Publication No. US-2006-0067983), dated Mar. 27, 2014.;;Notice of Allowance for U.S. Appl. No. 11/237,263 (listed on SB-08 as U.S. Publication No. US-2006-0110457), dated Mar. 27, 2014.;;Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. Publication No. US-2006-0067975), dated Dec. 4, 2013.;;Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. Publication No. US-2006-0067983), dated Dec. 17, 2013.;;Notice of Allowance for U.S. Appl. No. 13/593,656 (listed on SB-08 as U.S. Publication 2012-03115219), dated Jan. 24, 2014.;;Mallegol, “Long-Term Behavior of Oil-Based Varnishes and Paints Photo-and Thermooxidation of Cured Linseed Oil”, Journal of the American Oil Chemists' Society, 77:257-263 (2000).;;International Search Report for International Application PCT/US2013/044653, dated Sep. 4, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB-08 as U.S. Publication No. US-2006-0078586), dated Nov. 12, 2013.;;Non-Final Office Action for U.S. Appl. No. 12/075,223 (listed on SB-08 as U.S. Publication No. US-2008-0206305), dated Nov. 12, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/980,155 (listed on SB-08 as U.S. Publication No. US-2008-0113001), dated Nov. 12, 2013.;;Notice of Allowance for U.S. Appl. No. 13/682,991 (listed on SB-08 as U.S. Publication No. US 2013-0074452), dated Aug. 1, 2013.;;Notice of Allowance for U.S. Appl. No. 11/978,840 (listed on SB-08 as U.S. Publication No. US-2008-0118550), dated Aug. 6, 2013.;;Ackman, R.G., “Fish Oils”, Bailey's Industrial Oil and Fat Products, 6th Edition, 279-317 (2005).;;Ahuja et al. Journal of Indian Pediatric Surgery 2002 7:15-20.;;Andes, et al. “Antiproliferative Strategies for the Treatment of Vascular Proliferative Disease”, Current Vascular Pharmacology, 1)1): 85-98 (2003).;;A paper entitled “Evaluation of the Biocompatibility and Drug Delivery Capabilities of Biological Oil Based Stent Coatings” by Shengqio Li of the Katholieke Universiteit Leuven.;;Autosuture, “ParietexTM Composite OS Series Mesh,” retrieved online at http://www.autosuture.com/AutoSuture/pagebuilder.aspx?topicID=135734&breadcrumbs=135 601:0 (2007).;;Binder et al., “Chromatographic Analysis of Seed Oils. Fatty Acid Composition of Castor Oil,” The Journal of the American Oil Chemists' Society, vol. 39:513-517 (1962).;;Camurus, “In our endeavors to create the unique, we start with the best. Your product.”;;CECW-EE, “Ch. 4: Coating Types and Characteristics,” Engineering and Design—Painting: New Construction and Maintenance, pp. 4-1 to 4-24 (1995).;;Crivello et al., “Epoxidized triglycerides as renewable monomers in photoinitiated cationic polymerization,” Chem. Mater, 1992:692-699.;;De Scheerder, Ivan K., et al. “Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries,” Atherosclerosis, vol. 114:105-114.;;Drummond, Calum J., et al., “Surfactant self-assembly objects as novel drug delivery vehicles,” Current Opinion in Colliod & Interface Science, vol. 4:449-456 (2000).;;Encylopedia Britannica Online, “Surface Coating,” available online at http://www.britannica.com/Ebchecked/topic/575029/surface-coating>, date accessed Jun. 17, 2011.;;Engstrom, Sven, “Drug Delivery from Cubic and Other Lipid-water Phases,” Lipid Technology, vol. 2(2):42-45 (1990).;;Guler, et al. “Some empirical equations for oxopolymerization of linseed oil,” Progress in Organic Coatings, vol. 51:365-371 (2004).;;Hwang, Chao-Wei, et al, “Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery,” Circulation, vol. 104:600-605 (2001).;;Jonasson, Lena et al., “Cyclosporon A inhibits smooth muscle proliferation in the vascular response to injury,” Proc. Natl. Acad. Sci. USA, vol. 85: 2303-2306 (1988).;;Jorge, N., “Grasas y Aceites”, 48(1): 17-24, (1997).;;Lipids, Chapter 19, pp. 1-12 (2002).;;Mallegol, et al., “Drier Influence on the Curing of Linseed Oil,” Progress in Organic Coatings 39:107-113 (2000).;;Morse, Richard “Molecular Distillation of Polymerized Drying Oils,” Industrial and Engineering Chemisry 33:1039-1043 (1941).;;Oberhoff, Martin, et al, “Local and Systemic Delivery of Low Molecular Weight Heparin Following PTCA: Acute Results and 6-Month Follow-Up of the Initial Clinical Experience With the Porous Balloon (PILOT-Study),” Catheterization and Cardiovascular Diagnosis, vol. 44:267-274 (1998).;;Ogunniyi, D.S., “Castor oil: A vital industrial raw material,” Biosource Technology, vol. 97: 1086-1091 (2006).;;Polymerization Merriam-Webster Online Dictionary, retrieved from <www.merriam-webster.com> on Dec. 13, 2009; Merriam-Webster's Inc. 2009; pp. 1.;;Redman, L.V. et al., “The drying rate of raw paint oils—a comparison,” The Journal of Industrial and Engineering Chemistry, vol. 5: 630-636 (1913).;;Rutkow, Ira M. et al., “‘Tension-free’ inguinal herniorrhaphy: A preliminary report on the ‘mesh plug’ technique,” Surgery, vol. 114:3-8 (1993).;;Salu, Koen J., et al, “Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model,” Coronary Artery Disease, vol. 14(8):545-555 (2003).;;Scheller, Bruno, et al, “Addition of Paclitaxel to Contrast Media Prevents Restenosis After Coronary Stent Implantation,” Journal of the American College of Cardiology, vol. 42(8):1415-1420 (2003).;;Shahidi, Fereidoon ed.; “Bailey's Industrial Oil and Fats Products” 2005; John Wiley and Sons; vol. 5, Edible Oil and Fat Products: Processing Technologies, pp. 1-15.;;Timar-Balizsy et al., “Chemical Principals of Textile Conservation,” Oxford: Elsevier Science Ltd., 1998:117-119.;;Van der Giessen, Willem J., et al, “Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries,” Circulation, vol. 94:1690-1697 (1996).;;Websters Dictionary Online, Accessed on Feb. 13, 2009, entry for “polymer” p. 1 of 1.;;Wikipedia, “Sirolimus,” pp. 1-13, available online at http://en.wikipedia.org/wiki/Sirolimus, date accessed May 11, 2011.;;Winter, et al., “Physical and Chemical Gelation” Encyclopedia of Materials—Science and Technology, vols. 1-11: 6691-6999 (2001).;;International Search Report for International Application PCT/US05/034601, dated Apr. 10, 2006.;;International Search Report for International Application PCT/US05/034610, dated Mar. 16, 2006.;;International Search Report for International Application PCT/US05/034614, dated Aug. 29, 2006.;;International Search Report for International Application PCT/US05/034615, dated May 16, 2006.;;International Search Report for International Application PCT/US05/034678, dated Aug. 28, 2006.;;International Search Report for International Application PCT/US05/034681, dated Jul. 26, 2006.;;International Search Report for International Application PCT/US05/034682, dated Jul. 20, 2006.;;International Search Report for International Application PCT/US05/034836, dated Jul. 6, 2006.;;International Search Report for International Application PCT/US06/037184, dated Feb. 22, 2007.;;International Preliminary Report on Patentability for International Application PCT/US06/040753, dated Oct. 3, 2008.;;International Search Report for International Application PCT/US06/040753, dated Sep. 24, 2007.;;International Search Report for International Application PCT/US07/019978, dated May 7, 2009.;;International Search Report for International Application PCT/US07/022860, dated Apr. 22, 2009.;;International Search Report for International Application PCT/US07/022944, dated Apr. 8, 2009.;;International Search Report for International Application PCT/US08/000565, dated May 4, 2009.;;International Preliminary Examination Report for International Application PCT/US08/071547, dated Aug. 26, 2010.;;International Search Report for International Application PCT/US08/071547, dated Oct. 22, 2008.;;International Preliminary Report on Patentability for International Application PCT/US08/071565, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US08/071565, dated Nov. 10, 2008.;;International Search Report for International Application PCT/US08/085386, dated Feb. 4, 2009.;;International Search Report for International Application PCT/US09/037364, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US10/026521, dated Jun. 23, 2010.;;International Search Report for International Application PCT/US10/052899, dated Jan. 10, 2011.;;Supplementary European Search Report for Application No. EP 05 80 2894, dated Jul. 27, 2011.;;Supplementary European Search Report in Application No. 05 800 844, dated Aug. 19, 2011.;;Supplementary European Search Report in Application No. EP 05 80 4291, dated Jul. 26, 2011.;;Supplementary European Search Report in Application No. EP 05 85 8430, dated Aug. 18, 2011.;;International Search Report for International Application No. PCT/US05/34941, dated May 4, 2006.;;Supplementary European Search Report for Application No. EP 08877338.7, dated Aug. 16, 2012.;;Supplementary European Search Report for Application No. EP09819594.4, dated Aug. 14, 2012.;;International Search Report for PCT/US2011/44292, dated Dec. 6, 2011.;;Supplementary European Search Report for Application No. EP 12004057, dated Apr. 10, 2013.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated Mar. 25, 2006.;;Final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated May 17, 2011.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated Aug. 24, 2009.;;Non-final Office Action for U.S. Appl. No. 11/236,977 (listed on SB/08 as US 2006/0088596), dated Aug. 3, 2009.;;Final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), dated Jul. 7, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), dated Oct. 7, 2009.;;Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), dated Jun. 2, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), dated Oct. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Nov. 23, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Mar. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Nov. 4, 2009.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Dec. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), dated Mar. 30, 2009.;;Final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), dated Sep. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated May 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated Oct. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated May 1, 2009.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated Jul. 25, 2008.;;Non-final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), dated Apr. 16, 2008.;;Final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), dated Aug. 6, 2009.;;Non-final Office Action for U.S. Appl. No. 11/239,555 (listed on SB/08 as US 2006/0067977), dated Mar. 30, 2009.;;Non-final Office Action for U.S. Appl. No. 11/525,328 (listed on SB/08 as US 2007/0084144), dated Apr. 30, 2007.;;Non-final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Jul. 14, 2010.;;Final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Feb. 21, 2011.;;Final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated May 12, 2011.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated Nov. 9, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated Jan. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated May 12, 2009.;;Non-final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Apr. 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), dated Dec. 3, 2010.;;Non-final Office Action for U.S. Appl. No. 11/980,155 (listed on SB/08 as US 2008/0113001), dated Mar. 24, 2011.;;Non-final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305), dated Dec. 8, 2010.;;Non-final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937), dated Feb. 25, 2010.;;Final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937), dated Aug. 31, 2010.;;Non-final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552), dated Dec. 11, 2009.;;Final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552), dated Sep. 21, 2010.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) dated May 5, 2009.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) dated Dec. 2, 2010.;;Interview summary for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586) dated May 5, 2009.;;Interview summary for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149) dated Dec. 7, 2010.;;Interview summary for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937) dated Dec. 2, 2010.;;Interview summary for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552) dated Dec. 2, 2010.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Jul. 13, 2011.;;Final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), dated Jun. 22, 2011.;;Final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305), dated Aug. 11, 2011.;;Non-final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Jul. 11, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Aug. 17, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US-2007-0202149), dated Oct. 14, 2011.;;Final Office Action for U.S. Appl. No. 11/980,155 (listed on SB/08 as US-2008-0113001), dated Oct. 21, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US-2006-0067974), dated Dec. 2, 2011.;;Non-Final Office Action for U.S Appl. No. 12/182,261 (listed on SB/08 as US 2009-0047414), dated Dec. 21, 2011.;;Non-Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated Jan. 5, 2012.;;Notice of Allowance for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007-0202149), dated Jan. 9, 2012.;;Non-Final Office Action for U.S. Appl. No. 12/182,165 (listed on SB/08 as US 2009-0011116), dated Jan. 5, 2012.;;Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Feb. 13, 2012.;;Non-Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB/08 as US 2010-0183697), dated Mar. 14, 2012.;;Final Office Action for U.S. Appl. No. 12/182,165 (listed on SB/08 as US 2009-0011116), dated Apr. 6, 2012.;;Final Office Action for U.S. Appl. No. 12/182,261 (listed on SB-08 as US 2009/0047414) dated Apr. 30, 2012.;;Notice of Allowance for U.S. Appl. No. 11/236,908 (listed on SB/08 as US-2006-0067974), dated May 11, 2012.;;Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US-2010-0233232), dated Jun. 11, 2012.;;Notice of Allowance for U.S. Appl. No. 12/182,261 (listed on SB/08 as US-2009-0047414), dated Jul. 23, 2012.;;Advisory Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated Aug. 27, 2012.;;Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as US 2010/0183697) dated Aug. 29, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB/08 as US-2007/0071798), dated Oct. 4, 2012.;;Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB/08 as US 2006/0067975), dated Dec. 23, 2009.;;Non-Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB/08 as US 2006/0067975), dated Mar. 5, 2009.;;Advisory Action for U.S. Appl. No. 12/581,582 (listed on SB/08 as US 2010-0183697), dated Nov. 14, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/404,487 (listed on SB/08 as 2012-0213839), dated Dec. 20, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB/08 as US-2007/0071798), dated Nov. 20, 2012.;;Advisory Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as U.S. Publication No. 2010-0183697), dated Nov. 14, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB-08 as U.S. Publication No. US-2007-0071798), dated Nov. 20, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/404,487 (listed on SB-08 as US 2012-0213839), dated Dec. 20, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/184,512 (listed on SB-08 as 2012-0016038), dated Jan. 31, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/978,840 (listed on SB-08 as U.S. No. US-2008-0118550), dated Feb. 19, 2013.;;Non-Final Office Action for U.S. Appl. No. 13/682,991 (listed on SB-08 as U.S. No. US-2013-0074452), dated Mar. 18, 2013.;;Notice of Allowance for U.S. Appl. No. 13/404,487 (listed on SB-08 as U.S. No. US-2012-0213839), dated Apr. 2, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. No. US-2006-0067975), dated Apr. 22, 2013.;;Final Office Action for U.S. Appl. No. 13/184,512 (listed on SB-08 as U.S. No. U.S. 2012-0016038), dated Jun. 25, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. No. US-2006-0067983), dated Jul. 3, 2013.;;Non-Final Office Action for U.S. Appl. No. 13/593,656 (listed on SB-08 as U.S. No. US-2012-03115219), dated Jul. 15, 2013.;;Evans, D.F. et al., Measurement of gastrointestinal pH profiles in normal ambulant human subjects, GUT, 1988, 1035-1041, 29.;;Examination Report issued in IN Application No. 3605/DELNP/2012, dated Mar. 23, 2018.;;Non-Final Office Action issued in U.S. Appl. No. 15/817,018, dated Sep. 19, 2018.;;Erhan et al., Vegetable-oil-based printing ink formulation and degradation, Industrial Crops and Products, 1995, 237-246, 3.;;Non-Final Office Action issued in U.S. Appl. No. 15/710,514, dated Sep. 17, 2018.;;Non-Final Office Action issued in U.S. Appl. No. 13/843,068, dated Sep. 29, 2014.;;Final Office Action issued in U.S. Appl. No. 13/843,068, dated Apr. 23, 2015.;;Non-Final Office Action issued in U.S. Appl. No. 13/843,068, dated Mar. 11, 2016.;;Final Office Action issued in U.S. Appl. No. 13/843,068, dated Sep. 22, 2016.;;Non-Final Office Action issued in U.S. Appl. No. 13/843,068, dated Mar. 9, 2017.;;International Preliminary Report on Patentability issued in International Application No. PCT/US2013/044653, dated Dec. 24, 2014. et al.",ACTIVE
97,AU,B2,AU 2013/274587 B2,055-728-070-324-148,2017-02-02,2017,AU 2013/274587 A,2013-06-07,US 201261659301 P;;US 2013/0044653 W,2012-06-13,Cured oil-hydrogel biomaterial compositions for controlled drug delivery,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na-CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,,https://lens.org/055-728-070-324-148,Granted Patent,no,2,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61L27/40,,0,0,,,,INACTIVE
98,US,B1,US 6493208 B1,060-027-770-857-235,2002-12-10,2002,US 71624000 A,2000-11-21,US 71624000 A;;US 62723300 A;;US 14584499 P,1999-07-27,Triphenyl phosphine oxide polymer capacitors,"
    The present invention is a capacitor of a triphenyl phosphine oxide film as a base dielectric. More specifically, the base dielectric film is selected from the group consisting of Bisphenol-A (Bis-A PEPO). 4,4-biphenol (BP-PEPO), and Hydroquinone (HQ-PEPO). TPPO based polymers have a very high breakdown strength, dielectric constant, low dissipation factor and high energy density. An ultra-thin coating can leverage the capabilities of this new dielectric, and potentially other commercial polymer films, to make possible energy storage in excess of 1 J/cc. The triphenyl phosphine oxide film can be fabricated containing a conducting PolyANiline (PAN) polymer layer located between the electrode and core polymer, or by being dip coated with PAN. 
",EIKOS INC,PICHE JOSEPH;;MACK PATRICK;;GLATKOWSKI PAUL;;CONROY JEFFREY;;WINSOR PAUL,EIKOS INC (2002-09-27),https://lens.org/060-027-770-857-235,Granted Patent,yes,11,18,1,1,0,H01G4/18;;H01G4/18,H01G4/18,361/311;;364/306.1;;364/328;;364/321.1,0,0,,,,EXPIRED
99,EP,A1,EP 2861269 A1,084-026-001-398-659,2015-04-22,2015,EP 13804477 A,2013-06-07,US 201261659301 P;;US 2013/0044653 W,2012-06-13,CURED OIL-HYDROGEL BIOMATERIAL COMPOSITIONS FOR CONTROLLED DRUG DELIVERY,,ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,"ATRIUM MEDICAL CORPORATION (2020-06-03);;ATRIUM MEDICAL CORP., MERRIMACK, US (2020-05-25)",https://lens.org/084-026-001-398-659,Patent Application,yes,0,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61L27/40;;A61L27/14;;A61L27/34;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16,,0,0,,,,ACTIVE
100,US,A1,US 2013/0337029 A1,148-012-345-775-377,2013-12-19,2013,US 201313843068 A,2013-03-15,US 201313843068 A;;US 201261659301 P,2012-06-13,CURED OIL-HYDROGEL BIOMATERIAL COMPOSITIONS FOR CONTROLLED DRUG DELIVERY,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na—CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,ATRIUM MEDICAL CORPORATION (2013-04-17),https://lens.org/148-012-345-775-377,Patent Application,yes,0,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61K47/12;;A61K47/22,424/422;;514/449;;424/400,0,0,,,,ACTIVE
101,AU,A1,AU 2013/274587 A1,103-367-011-690-453,2015-01-22,2015,AU 2013/274587 A,2013-06-07,US 201261659301 P;;US 2013/0044653 W,2012-06-13,Cured oil-hydrogel biomaterial compositions for controlled drug delivery,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na-CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,,https://lens.org/103-367-011-690-453,Patent Application,no,0,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61L27/40,,0,0,,,,INACTIVE
102,US,B2,US 9867880 B2,147-355-121-667-906,2018-01-16,2018,US 201313843068 A,2013-03-15,US 201313843068 A;;US 201261659301 P,2012-06-13,Cured oil-hydrogel biomaterial compositions for controlled drug delivery,"The present invention is generally directed to materials, gels, coatings and films prepared using a biomaterial (e.g., a fatty acid-based material comprising a network of cross-linked fatty acids) and a fixating material, layer or film (e.g., a fixating material comprising Na—CMC). The materials, gels, coatings and films disclosed herein can be used to facilitate the delivery of one or more therapeutic agents to a targeted tissue and a desired rate of release.",ATRIUM MEDICAL CORP,FAUCHER KEITH M;;CONROY SUZANNE;;ALBERGO THERESA K;;BIENKIEWICZ JOSEPH,ATRIUM MEDICAL CORPORATION (2013-04-17),https://lens.org/147-355-121-667-906,Granted Patent,yes,410,0,12,12,0,A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606;;A61K47/12;;A61K47/22;;A61L27/34;;A61L27/14;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16;;A61L2300/606,A61K47/12;;A61K47/22;;A61L27/14;;A61L27/34;;A61L27/54;;A61L31/04;;A61L31/10;;A61L31/16,,251,41,093-811-289-675-626;;089-276-889-719-390;;100-176-598-076-477;;048-810-042-623-799;;087-516-990-109-332;;121-518-616-187-47X;;062-869-359-643-29X;;012-224-721-274-561;;169-123-655-792-862;;183-299-871-235-178;;061-647-378-924-636;;107-683-021-659-003;;065-142-893-532-911;;064-537-834-566-45X;;111-219-182-232-532;;009-415-282-876-854;;074-774-683-240-998;;005-252-447-646-653;;171-964-352-982-114;;082-892-872-068-848;;073-151-968-408-638;;004-470-065-863-328;;093-197-727-511-414;;011-316-452-166-993;;190-113-176-326-786;;003-327-828-059-912;;022-414-594-928-576;;129-228-869-080-22X;;039-405-805-990-138;;019-715-735-775-026;;040-548-329-033-663;;020-318-656-057-946;;138-861-484-533-646;;096-774-227-861-342;;043-462-681-410-597;;025-906-530-941-35X;;085-950-189-639-353;;125-647-566-817-299;;042-336-761-097-701;;032-919-350-438-964;;039-789-653-495-925,10.1002/047167849x.bio078;;15320855;;10.2174/1570161033386763;;10.1007/bf02672540;;10.1021/cm00021a036;;7605369;;10.1016/0021-9150(94)05472-u;;10.1016/s1359-0294(00)00020-0;;10.1016/j.porgcoat.2004.07.024;;10.1161/hc3101.092214;;11479260;;pmc279979;;3258426;;10.1073/pnas.85.7.2303;;10.1016/s0300-9440(00)00126-0;;10.1021/ie50380a016;;9676794;;10.1002/(sici)1097-0304(199807)44:3<267::aid-ccd4>3.0.co;2-3;;15919203;;10.1016/j.biortech.2005.03.028;;10.1021/ie50056a004;;8356522;;10.1097/00019501-200312000-00005;;14646676;;14563585;;10.1016/s0735-1097(03)01056-8;;8840862;;10.1161/01.cir.94.7.1690;;10.1016/b0-08-043152-6/01239-0;;10.1007/s11746-000-0042-4;;10.1021/ma00117a031;;10.1007/bf02659771;;15657668;;10.1007/s10350-004-0741-6;;9110909;;10.1056/nejm199704243361704;;10.1001/jama.279.17.1409-jbk0506-6-1;;10.3945/an.111.000893;;pmc3262608;;22332096;;10.1093/ajcn/46.6.936;;2825504;;17167791;;10.1002/ccd.20943;;10.1016/j.rser.2012.09.025;;2854466;;9486816;;10.1093/jnci/90.4.300;;10.1111/j.1432-2277.2004.tb00509.x;;15827754;;10.1007/s00147-004-0799-z;;16920418;;10.1016/j.amjsurg.2005.05.047;;23644844;;pmc3611753;;10.6061/clinics/2013(03)e01;;10.1177/0961203311430703;;22235041;;10.1016/b978-0-408-11810-1.50008-8;;10.1111/j.1469-0691.2004.01014.x;;15649297;;10.3390/ma2020353;;10.1016/s1773-2247(08)50016-5;;10.3144/expresspolymlett.2008.90;;10.1007/bf02536316;;8487623,"Notice of Allowance for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. Publication No. US-2006-0067983), dated Mar. 27, 2014.;;Notice of Allowance for U.S. Appl. 11/237,263 (listed on SB-08 as U.S. Publication No. US-2006-0110457), dated Mar. 27, 2014.;;Ackman, R.G., “Fish Oils”, Bailey's Industrial Oil and Fat Products, 6th Edition, 279-317 (2005).;;Ahuja et al. Journal of Indian Pediatric Surgery 2002 7:15-20.;;Andes, et al. “Antiproliferative Strategies for the Treatment of Vascular Proliferative Disease”, Current Vascular Pharmacology, 1)1): 85-98 (2003).;;A paper entitled “Evaluation of the Biocompatibility and Drug Delivery Capabilities of Biological Oil Based Stent Coatings” by Shengqio Li of the Katholieke Universiteit Leuven.;;Autosuture, “ParietexTM Composite OS Series Mesh,” retrieved online at http://www.autosuture.com/AutoSuture/pagebuilder.aspx?topicID=135734&breadcrumbs=135601:0 (2007).;;Binder et al., “Chromatographic Analysis of Seed Oils. Fatty Acid Composition of Castor Oil,” The Journal of the American Oil Chemists' Society, vol. 39:513-517 (1962).;;Camurus, “In our endeavors to create the unique, we start with the best. Your product.”;;CECW-EE, “Ch. 4: Coating Types and Characteristics,” Engineering and Design—Painting: New Construction and Maintenance, pp. 4-1 to 4-24 (1995).;;Crivello et al., “Epoxidized triglycerides as renewable monomers in photoinitiated cationic polymerization,” Chem. Mater, 1992:692-699.;;De Scheerder, Ivan K., et al. “Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries,” Atherosclerosis, vol. 114:105-114.;;Drummond, Calum J., et al., “Surfactant self-assembly objects as novel drug delivery vehicles,” Current Opinion in Colliod & Interface Science, vol. 4:449-456 (2000).;;Encylopedia Britannica Online, “Surface Coating,” available online at http://www.britannica.com/Ebchecked/topic/575029/surface-coating>, date accessed Jun. 17, 2011.;;Engstrom, Sven, “Drug Delivery from Cubic and Other Lipid-water Phases,” Lipid Technology, vol. 2(2):42-45 (1990).;;Guler, et al. “Some empirical equations for oxopolymerization of linseed oil,” Progress in Organic Coatings, vol. 51:365-371 (2004).;;Hwang, Chao-Wei, et al, “Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery,” Circulation, vol. 104:600-605 (2001).;;Jonasson, Lena et al., “Cyclosporon A inhibits smooth muscle proliferation in the vascular response to injury,” Proc. Natl. Acad. Sci. USA, vol. 85: 2303-2306 (1988).;;Jorge, N., “Grasas y Aceites”, 48(1): 17-24, (1997).;;Lipids, Chapter 19, pp. 1-12 (2002).;;Mallegol, et al., “Drier Influence on the Curing of Linseed Oil,” Progress in Organic Coatings 39:107-113 (2000).;;Morse, Richard “Molecular Distillation of Polymerized Drying Oils,” Industrial and Engineering Chemisry 33:1039-1043 (1941).;;Oberhoff, Martin, et al, “Local and Systemic Delivery of Low Molecular Weight Heparin Following PTCA: Acute Results and 6-Month Follow-Up of the Initial Clinical Experience With the Porous Balloon (PILOT-Study),” Catheterization and Cardiovascular Diagnosis, vol. 44:267-274 (1998).;;Ogunniyi, D.S., “Castor oil: A vital industrial raw material,” Biosource Technology, vol. 97: 1086-1091 (2006).;;Polymerization Merriam-Webster Online Dictionary, retrieved from <www.merriam-webster.com> on Dec. 13, 2009; Merriam-Webster's Inc. 2009; pp. 1.;;Redman, L.V. et al., “The drying rate of raw paint oils—a comparison,” The Journal of Industrial and Engineering Chemistry, vol. 5: 630-636 (1913).;;Rutkow, Ira M. et al., “‘Tension-free’ inguinal herniorrhaphy: A preliminary report on the ‘mesh plug’ technique,” Surgery, vol. 114:3-8 (1993).;;Salu, Koen J., et al, “Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model,” Coronary Artery Disease, vol. 14(8):545-555 (2003).;;Scheller, Bruno, et al, “Addition of Paclitaxel to Contrast Media Prevents Restenosis After Coronary Stent Implantation,” Journal of the American College of Cardiology, vol. 42(8):1415-1420 (2003).;;Shahidi, Fereidoon ed.; “Bailey's Industrial Oil and Fats Products” 2005; John Wiley and Sons; vol. 5, Edible Oil and Fat Products: Processing Technologies, pp. 1-15.;;Timar-Balizsy et al., “Chemical Principals of Textile Conservation,” Oxford: Elsevier Science Ltd., 1998:117-119.;;Van der Giessen, Willem J., et al, “Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries,” Circulation, vol. 94:1690-1697 (1996).;;Websters Dictionary Online, Accessed on Feb. 13, 2009, entry for “polymer” p. 1 of 1.;;Wikipedia, “Sirolimus,” pp. 1-13, available online at http://en.wikipedia.org/wiki/Sirolimus, date accessed May 11, 2011.;;Winter, et al., “Physical and Chemical Gelation” Encyclopedia of Materials—Science and Technology, vols. 1-11: 6691-6999 (2001).;;International Search Report for International Application PCT/US05/034601, dated Apr. 10, 2006.;;International Search Report for International Application PCT/US05/034610, dated Mar. 16, 2006.;;International Search Report for International Application PCT/US05/034614, dated Aug. 29, 2006.;;International Search Report for International Application PCT/US05/034615, dated May 16, 2006.;;International Search Report for International Application PCT/US05/034678, dated Aug. 28, 2006.;;International Search Report for International Application PCT/US05/034681, dated Jul. 26, 2006.;;International Search Report for International Application PCT/US05/034682, dated Jul. 20, 2006.;;International Search Report for International Application PCT/US05/034836, dated Jul. 6, 2006.;;International Search Report for International Application PCT/US06/037184, dated Feb. 22, 2007.;;International Preliminary Report on Patentability for International Application PCT/US06/040753, dated Oct. 3, 2008.;;International Search Report for International Application PCT/US06/040753, dated Sep. 24, 2007.;;International Search Report for International Application PCT/US07/019978, dated May 7, 2009.;;International Search Report for International Application PCT/US07/022860, dated Apr. 22, 2009.;;International Search Report for International Application PCT/US07/022944, dated Apr. 8, 2009.;;International Search Report for International Application PCT/US08/000565, dated May 4, 2009.;;International Preliminary Examination Report for International Application PCT/US08/071547, dated Aug. 26, 2010.;;International Search Report for International Application PCT/US08/071547, dated Oct. 22, 2008.;;International Preliminary Report on Patentability for International Application PCT/US08/071565, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US08/071565, dated Nov. 10, 2008.;;International Search Report for International Application PCT/US08/085386, dated Feb. 4, 2009.;;International Search Report for International Application PCT/US09/037364, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US10/026521, dated Jun. 23, 2010.;;International Search Report for International Application PCT/US10/052899, dated Jan. 10, 2011.;;Supplementary European Search Report for Application No. EP 05 80 2894, dated Jul. 27, 2011.;;Supplementary European Search Report in Application No. 05 800 844, dated Aug. 19, 2011.;;Supplementary European Search Report in Application No. EP 05 80 4291, dated Jul. 26, 2011.;;Supplementary European Search Report in Application No. EP 05 85 8430, dated Aug. 18, 2011.;;International Search Report for International Application No. PCT/US05/34941, dated May 4, 2006.;;Supplementary European Search Report for Application No. EP 08877338.7, dated Aug. 16, 2012.;;Supplementary European Search Report for Application No. EP09819594.4, dated Aug. 14, 2012.;;International Search Report for PCT/US2011/44292, dated Dec. 6, 2011.;;Supplementary European Search Report for Application No. EP 12004057, dated Apr. 10, 2013.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated Mar. 25, 2006.;;Final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated May 17, 2011.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), dated Aug. 24, 2009.;;Non-final Office Action for U.S. Appl. No. 11/236,977 (listed on SB/08 as US 2006/0088596), dated Aug. 3, 2009.;;Final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), dated Jul. 7, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), dated Oct. 7, 2009.;;Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), dated Jun. 2, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), dated Oct. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Nov. 23, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Mar. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Nov. 4, 2009.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Dec. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), dated Mar. 30, 2009.;;Final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), dated Sep. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated May 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated Oct. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated May 1, 2009.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), dated Jul. 25, 2008.;;Non-final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), dated Apr. 16, 2008.;;Final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), dated Aug. 6, 2009.;;Non-final Office Action for U.S. Appl. No. 11/239,555 (listed on SB/08 as US 2006/0067977), dated Mar. 30, 2009.;;Non-final Office Action for U.S. Appl. No. 11/525,328 (listed on SB/08 as US 2007/0084144), dated Apr. 30, 2007.;;Non-final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Jul. 14, 2010.;;Final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Feb. 21, 2011.;;Final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated May 12, 2011.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated Nov. 9, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated Jan. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), dated May 12, 2009.;;Non-final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Apr. 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), dated Dec. 3, 2010.;;Non-final Office Action for U.S. Appl. No. 11/980,155 (listed on SB/08 as US 2008/0113001), dated Mar. 24, 2011.;;Non-final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305), dated Dec. 8, 2010.;;Non-final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937), dated Feb. 25, 2010.;;Final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937), dated Aug. 31, 2010.;;Non-final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552), dated Dec. 11, 2009.;;Final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552), dated Sep. 21, 2010.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) dated May 5, 2009.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) dated Dec. 2, 2010.;;Interview summary for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586) dated May 5, 2009.;;Interview summary for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149) dated Dec. 7, 2010.;;Interview summary for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937) dated Dec. 2, 2010.;;Interview summary for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552) dated Dec. 2, 2010.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), dated Jul. 13, 2011.;;Final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), dated Jun. 22, 2011.;;Final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305), dated Aug. 11, 2011.;;Non-final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), dated Jul. 11, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Aug. 17, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US-2007-0202149), dated Oct. 14, 2011.;;Final Office Action for U.S. Appl. No. 11/980,155 (listed on SB/08 as US-2008-0113001), dated Oct. 21, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US-2006-0067974), dated Dec. 2, 2011.;;Non-Final Office Action for U.S. Appl. No. 12/182,261 (listed on SB/08 as US 2009-0047414), dated Dec. 21, 2011.;;Non-Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated Jan. 5, 2012.;;Notice of Allowance for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007-0202149), dated Jan. 9, 2012.;;Non-Final Office Action for U.S. Appl. No. 12/182,165 (listed on SB/08 as US 2009-0011116), dated Jan. 5, 2012.;;Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), dated Feb. 13, 2012.;;Non-Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB/08 as US 2010-0183697), dated Mar. 14, 2012.;;Final Office Action for U.S. Appl. No. 12/182,165 (listed on SB/08 as US 2009-0011116), dated Apr. 6, 2012.;;Final Office Action for U.S. Appl. No. 12/182,261 (listed on SB-08 as US 2009/0047414) dated Apr. 30, 2012.;;Notice of Allowance for U.S. Appl. No. 11/236,908 (listed on SB/08 as US-2006-0067974), dated May 11, 2012.;;Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US-2010-0233232), dated Jun. 11, 2012.;;Notice of Allowance for U.S. Appl. No. 12/182,261 (listed on SB/08 as US US-2009-0047414), dated Jul. 23, 2012.;;Advisory Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated Aug. 27, 2012.;;Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as US 2010/0183697) dated Aug. 29, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB/08 as US-2007/0071798), dated Oct. 4, 2012.;;Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB/08 as US 2006/0067975), dated Dec. 23, 2009.;;Non-Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB/08 as US 2006/0067975), dated Mar. 5, 2009.;;Advisory Action for U.S. Appl. No. 12/581,582 (listed on SB/08 as US 2010-0183697), dated Nov. 14, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/404,487 (listed on SB/08 as 2012-0213839), dated Dec. 20, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB/08 as US-2007/0071798), dated Nov. 20, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB/08 as US-2007/0071798), dated Nov. 30, 2012.;;Advisory Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as U.S. Publication No. 2010-0183697), dated Nov. 14, 2012.;;Notice of Allowance for U.S. Appl. No. 11/525,390 (listed on SB-08 as U.S. Publication No. US-2007-0071798), dated Nov. 20, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/404,487 (listed on SB-08 as US 2012-0213839), dated Dec. 20, 2012.;;Non-Final Office Action for U.S. Appl. No. 13/184,512 (listed on SB-08 as 2012-0016038), dated Jan. 31, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/978,840 (listed on SB-08 as U.S. No. US-2008-0118550), dated Feb. 19, 2013.;;Non-Final Office Action for U.S. Appl. No. 13/682,991 (listed on SB-08 as U.S. No. US-2013-0074452), dated Mar. 18, 2013.;;Notice of Allowance for U.S. Appl. No. 13/404,487 (listed on SB-08 as U.S. No. US-2012-0213839), dated Apr. 2, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. No. US-2006-0067975), dated Apr. 22, 2013.;;Final Office Action for U.S. Appl. No. 13/184,512 (listed on SB-08 as U.S. No. U.S. 2012-0016038), dated Jun. 25, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. No. US-2006-0067983), dated Jul. 3, 2013.;;Non-Final Office Action for U.S. Appl. No. 13/593,656 (listed on SB-08 as U.S. No. US-2012-03115219), dated Jul. 15, 2013.;;Mallegol, “Long-Term Behavior of Oil-Based Varnishes and Paints Photo-and Thermooxidation of Cured Linseed Oil”, Journal of the American Oil Chemists' Society, 77:257-263 (2000).;;International Search Report for International Application PCT/US2013/044653, dated Sep. 4, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB-08 as U.S. Publication No. US-2006-0078586), dated Nov. 12, 2013.;;Non-Final Office Action for U.S. Appl. No. 12/075,223 (listed on SB-08 as U.S. Publication No. US-2008-0206305), dated Nov. 12, 2013.;;Non-Final Office Action for U.S. Appl. No. 11/980,155 (listed on SB-08 as U.S. Publication No. US-2008-0113001), dated Nov. 12, 2013.;;Notice of Allowance for U.S. Appl. No. 13/682,991 (listed on SB-08 as U.S. Publication No. US 2013-0074452), dated Aug. 1, 2013.;;Notice of Allowance for U.S. Appl. No. 11/978,840 (listed on SB-08 as U.S. Publication No. US-2008-0118550), dated Aug. 6, 2013.;;Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. Publication No. US-2006-0067975), dated Dec. 4, 2013.;;Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB-08 as U.S. Publication No. US-2006-0067983), dated Dec. 17, 2013.;;Notice of Allowance for U.S. Appl. 13/593,656 (listed on SB-08 as U.S. Publication 2012-03115219), dated Jan. 24, 2014.;;Final Office Action for U.S. Appl. No. 12/581,582, dated Jan. 8, 2015.;;Non-Final Office Action for U.S. Appl. No. 12/401,243, dated Jan. 16, 2015.;;Non-Final Office Action for U.S. Appl. No. 11/237,420, dated Jan. 21, 2015.;;Notice of Allowance for U.S. Appl. No. 13/943,489, dated Jan. 29, 2015.;;Non-Final Office Action for U.S. Appl. No. 11/980,155, dated Nov. 7, 2014.;;Notice of Allowance for U.S. Appl. No. 12/364,763 (listed on SB-08 as U.S. Publication No. US-2009-0208552), dated Dec. 5, 2014.;;Notice of Allowance for U.S. Appl. No. 12/325,546 (listed on SB-08 as U.S. Publication No. US-2009-0181937), dated Dec. 8, 2014.;;Uchida, et al., “Swelling Process and Order-Disorder Transition of Hydrogel Containing Hydrophobic Ionizable Groups”, Macromolecules, 28, 4583-4586 (1995).;;Gutfinger, et al., “Polyphenols in Olive Oils”, Journal of the American Oil Chemists Society, 58(11): 966-968 (1981).;;Portilla, et al., “Prevention of Peritoneal Adhesions by Intraperitoneal Administration of Vitamin E: An Experimental Study in Rats”, Diseases of the Colon and Rectum, 47; 2157-2161 (2005).;;Sano, et al., “A controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease”, The New England Journal of Medicine, 336; 1216-1222 (1997).;;Supplementary European Search Report for Application No. EP 10825447, dated Mar. 31, 2014.;;Non Final Office Action for U.S. Appl. No. 12/581,582 (listed on SB-08 as U.S. Publication 2010-0183697), dated May 29, 2014.;;Non-Final Office Action for U.S. Appl. No. 13/943,489, dated Jul. 1, 2014.;;Final Office Action for U.S. Appl. No. 11/980,155, dated Jul. 21, 2014.;;Final Office Action for U.S. Appl. No. 11/237,420, dated Jul. 22, 2014.;;Final Office Action for U.S. Appl. No. 12/075,223, dated Jul. 22, 2014.;;Non Final Office Action for U.S. Appl. No. 12/325,546 (listed on SB-08 as U.S. Publication No. US-2009-0181937), dated Apr. 22, 2014.;;Non Final Office Action for U.S. Appl. No. 12/364,763 (listed on SB-08 as U.S. Publication No. US-2009-0208552), dated Apr. 23, 2014.;;Non Final Office Action for U.S. Appl. No. 12/401,243 (listed on SB/08 as US 2010-0233232), dated May 8, 2014.;;Non-Final Office Action for U.S. Appl. No. 11/701,799, dated Jul. 22, 2014.;;Notice of Allowance for U.S. Appl. No. 11/236,943 (listed on SB-08 as U.S. Publication No. US-2006-0067975), dated Oct. 6, 2014.;;Non-Final Office Action for U.S. Appl. No. 13/184,512, dated Oct. 10, 2014.;;Non-Final Office Action for U.S. Appl. No. 12/075,223, dated Oct. 29, 2014.;;Final Office Action for U.S. Appl. No. 11/701,799, dated Mar. 12, 2015.;;Final Office Action for U.S. Appl. No. 13/184,512, dated Apr. 28, 2015.;;H. Fineberg et al., Industrial Use of Fish Oils, pp. 222-238, http://spo.nmfs.noaa.gov/Circulars/CIRC278.pdf, downloaded Aug. 3, 2015.;;Lewis, Richard J., Sr., Hawley's Condensed Chemical Dictionary, 2001, pp. 308, 309 and 896-898, 14th edision, John Wiley & Sons, Inc., New York.;;Webster's II New College Dictionary (1995), 1075, Houghton Mifflin Company, New York, US.;;Polymers made from multiple monomers, A Natural Approach to Chemistry, Chapter 8, 241, http://lab-aids.com/assets/uploads/NAC/NAC—student—book/Texas%20Student%20Edition%20253.pdf (downloaded Dec. 3, 2015).;;Polymer, Encyclopedia Britannica. Encyclopedia Britannica Online, Encyclopedia Britannica Inc., 105, Web. Dec. 2, 2015, http://www.britannica.com/print/article/468696 (downloaded Dec. 2, 2015).;;Triglycerides, https://www.lipid.org/sites/default/files/triglycerides.pdf (downloaded Sep. 24, 2015).;;Fish Oil Triglycerides vs. Ethyl Esters: A Comparative Review of Absorption, Stability and Safety Concerns (Ascenta Health Ltd. 2010 at http://www.ascentaprofessional.com/science/articles/fish-oil-triglycerides-vs-ethyl-esters (downloaded Sep. 24, 2015).;;Swanson, Danielle, et al., Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life, 3 Advances in Nutrition 1-7 (American Society for Nutrition 2012).;;Fats & Oils (2008) at http://scifun.chem.wisc.edu/chemweek/pdf/fats&oils.pdf (downloaded Sep. 24, 2015).;;Bacteria in Water, The USGS Water Science School, http://water.usgs.gov/edu/bacteria.html (downloaded Nov. 9, 2015).;;Novotny, L. et al., Fish: a potential source of bacterial pathogens for human beings, VET. MED.—CZECH, 49, 2004, vol. 9, pp. 343-358.;;Allergies, Asthma and Allergy Foundation of America (2011), http://www.aafa.org/page/types-of-allergies,aspx (downloaded Oct. 5, 2015).;;Urakaze, Masaharu et al., “Infusion of fish oil emulsion: effects on platelet aggregation and fatty acid composition in phospholipids of plasma, platelets and red blood cell membranes in rabbits”, Am. J. Clin. Nutr., vol. 46, pp. 936-940 (! 987).;;Singh, Alok, et al., “Facilitated Stent Delivery Using Applied Topical Lubrication”, Catherization and Cardiovascular Interventions, vol. 69, pp. 218-222 (2007).;;Sicherer, Scott H., Food Allergies: A Complete Guide for Eating When Your Life Depends on it, 2013, 15, Johns Hopkins University Press, Baltimore, MD, USA.;;Omega-3 DHA—The Problem May Be the Quality of Your Fish Oil, Not Your Allergy to Fish, Fatty Acids Hub, http://www.fattyacidshub.com/fatty-acids/omega-3-dha/ (downloaded Nov. 10, 2015).;;Soy Allergy, Asthma and Allergy Foundation of America (2005), http://www.aafa.org/display.cfm?id=9&sub=20&cont=522 (downloaded Nov. 10, 2015).;;Refined soybean oil not an allergen, say food scientists, FOOD navigator-usa.com (2005), http://www.foodnavigator-usa.com/content/view/print/127438 (downloaded Nov. 10, 2015).;;Yahyaee, R. et al., Waste fish oil biodiesel as a source of renewable fuel in Iran, Renewable and Sustainable Energy Reviews, 2013, pp. 312-319, 17, Elsevier Ltd.;;Biological evaluation of medical devices—Part 1: Evaluation and testing, International Standard ISO 109931-1, Aug. 1, 2003, Third Edition, Switzerland.;;Mayo Clinic (http://www.mayoclinic.org/drugs-supplements/omega-3-fatty-acids-fish-oil-alpha-linolenic-acids/safety/hrb-20059372?p=1 (downloaded Sep. 28, 2015).;;Milk allergy, at http://www.mayoclinic.org/diseases-conditions/milk-allergy/basics/definition/con-20032147?p=1 (downloaded Jul. 29, 2015).;;Soy allergy, at http://www.mayoclinic.org/diseases-conditions/soy-allergy/basics/definition/con-20031370?p=1 (downloaded Jul. 29, 2015).;;F.D. Gunstone, Fatty Acid and Lipid Chemistry 72 (1999).;;Hawley's Condensed Chemical Dictionary 315, 316, 332, 333, 334, 825 and 826 (2001).;;Hutlin, Herbert O. et al., Chemical Composition and Stability of Fish Oil (International Association of Fish Meal Manufacturers Apr. 10, 1991).;;F.V.K Young, The Chemical & Physical Properties of Crude Fish Oils for Refiners and Hydrogenators, 18 Fish Oil Bulletin 1-18 (1986).;;Karrick, Neva L., Nutritional Value of Fish Oils as Animal Feed, Circular 281 (Fish and Wildlife Service Bureau of Commercial Fisheries 1967), reprinted from M.E. Stansby (ed.), Fish Oils 362-382 (Avi Publishing Company 1967).;;Luley et al., Fatty acid composition and degree of peroxidation in fish oil and cod liver oil preparations, Arzneimittelforschung. Dec. 1998, vol. 38, No. 12, pp. 1783-1786.;;Drying Oil, http://en.wikipedia.org/wiki/drying—oil (downloaded Jun. 28, 2013).;;Szebeni et al., “Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro Study”, Journal of the National Cancer Institute, 1998, vol. 90, No. 4, pp. 300-306.;;Birsan, et al., “The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro”, Transpl. Int., 2005, vol. 17, pp. 767-771.;;About.com, “Orthopedics, Synvisc injections,” retrieved online at http://orthopedics.about.com/cs/treatment/a/synvisc—2.htm (2005).;;Cath Lab Digest, “Olive Oil Emulsion Helps With Problem Heart Arteries”, retrieved online at http://www.cathlabdigest.com/displaynews.cfm?newsid=0103073 (2007).;;Doctor's Guide to Medical and Other News, “AAOS Meeting: Synvisc Delays Total Knee Replacement in Osteoarthritis Patients”, retrieved online at http://www.docguide.com/dg.nsf/PrintPrint/4585EC355198EEF08525670E006B10FF (1999).;;Methodist, “Evaluation of Biocompatibility and Antirestenotic Potential of Drug Eluting Stents Employing Polymer-free Highly-Hydrogenated Lipid-Based Stent Coatings in Porcine Coronary Arteries”, Transcatheter Cardiovascular Therapeutics (TCT), sponsored by the Cardiovascular Research Foundation®, Oct. 22-27, 2006, Washington Convention Center, Washington, D.C.;;Novavax, retrieved online at http://www.novavax.com/go.cfm?do=Page.View&pid=3 (2006).;;Orthovisc, “New Treatment Option is Potential Alternative to OTC Pain Medications for Osteoarthritis of the Knee” retrieved online at http://www.jnj.com/innovations/new—features/ORTHOVISC.htm: lessionid=33N2RBQDV0DZKCQPCCEGU3AKB2IIWTT1 (2006).;;Orthovisc, “What is Orthovisc®?” retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.html?itemname=about—orthovisc (2005).;;Orthovisc, “Your Knees and Osteoarthritis”, retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=understanding—knee—oa (2003).;;Orthovisc, “What to expect from your treatment,” retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=what—to—expect (2007).;;Orthovisc, “Tools and Resources for Managing Your Osteoarthritis”, retrieved online at http://www.orthovisc.com/xhtmlbgdisplay.jhtml?itemname=patient—resources (2007).;;Pohibinska, A., et al., “Time to reconsider saline as the ideal rinsing solution during abdominal surgery”, The American Journal of Surgery, vol. 192, pp. 281-222 (2007).;;Hortolam, Juliane G., et al., “Connective tissue diseases following silicone breast implantation: where do we stand?”, Clinics, 2013, vol. 3, p. 281.;;Lidar, M. et al., “Silicone and sclerodema revisited”, Lupus, 2012, vol. 21, pp. 121-127.;;“Lead”, Article by Centers for Disease Control and Prevention (CDC), Nov. 2009, 2 pages.;;“Cure” in Academic Press Dictionary of Science and Technology, 1992.;;Wikipedia, Sunflower oil, https://en.wikipedia.org/wiki/Sunflower—oil, accessed Jul. 23, 2015 in related U.S. Appl. No. 14/252,671, pp. 1-7.;;Esoteric Oils, Peppermint essential oil information, http://www.essentialoils.co.za/essential-oils/peppermint.htm, accessed Jul. 23, 2015 in related U.S. Appl. No. 14/252,671, pp. 1-7.;;Orthomolecular, Fish Oil, Jun. 29, 2004, http://orthomolecular.org/nutrients/fishoil.html, accessed Jul. 22, 2015 in related U.S. Appl. No. 14/252,671, p. 1.;;Wicks et al. Organic Coatings:Science and Technology 1999 New York:Wiley Interscience, pp. 258-267.;;Mills et al. Oils and Fats. “The Organic Chemistry of Museum Objects” London:Buttersworth and Co. 1987, pp. 26-40.;;Erhardt Paints Based on Drying Oil Media. Painted Wood: History & Conservation. Ed. Berland Singapore: The J. Paul Getty Trust 1998. pp. 17-32.;;Wexler et al. Chemical Reviews 1964, vol. 64, No. 6, pp. 591-611.;;Polymer—The Chambers 21st Century Dictionary M. Robinson and G. Davidson (Eds.), London, United Kingdom: Chambers Harrap. Retrieved from http://search.credoreference.com/content/entry/chambdict!polymer/O.;;Polymer—Academic Press Dictionary of Science and TechnologyC. Morris (Ed.), Academic Press Dictionary of Science and Technology. Oxford, United Kingdom: Elsevier Science & Technology. Retrieved from http://search.credoreference.com/content/entry/apdst!polymer/O.;;Falagas et al. European Society of Clinical Microbiology and Infection Diseases, 2005, vol. 11, pp. 3-8.;;Bimbo, INFORM 1998, vol. 9, No. 5, pp. 473-483.;;Extended European Search Report dated Dec. 10, 2015 issued for corresponding EP Patent Application No. 13804477, 8 pages.;;SepraFilm Adhesion Barrier package insert (Genzyme Biosurgery 2008).;;Alessandro Sannino et al., Biodegradeable Cellulose-based Hydrogels: Design and Applications, 2 Materials 353-373 (2009).;;Thomas Heinz, Carboxymethyl Ethers of Cellulose and Starch—A Review, Center of Excellence for Polysaccharide Reseach, Friedrich Schiller University of Jena (Germany), pp. 13-29 (2005).;;H. Omidian et al., Swelling Agents and Devices in Oral Drug Delivery, J. Drug. Del. Sci. Tech., 18 (2) 83-93 (2008).;;S. Kamel et al., Pharmaceutical Significance of Cellulose: A Review, eXPRESS Polymer Letters vol. 2, No. 11 pp. 758-778 (2008).;;A. M. Adel et al. Carboxymethylated Cellulose Hydrogel; Sorption Behavior and Characterization, Nature and Science, 8(8), pp. 244-256, (2010).;;Final Office Action dated Mar. 30, 2017 for related U.S. Appl. No. 11/237,420, 20 pages.;;Henderson, R. James et al., “Hydrolysis of Fish Oils Containing Polymers of Triacylglycerols by Pancreatic Lipase in vitro”, LIPIDS, vol. 28, No. 4, 1993, pp. 313-319.",ACTIVE
103,US,B2,US 11705704 B2,038-108-018-954-536,2023-07-18,2023,US 201916563333 A,2019-09-06,US 201916563333 A;;US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,Quick connect,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing along a frame of the electrical connector to a location within the internal volume of the housing. The assembly includes a disc mechanically secured to the housing relative to the opening to obstruct the insertion path. A retainer and a bushing including a membrane for the electrical connector as well as methods of making an electrical connector are also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;YEOLE SONALI VASANT;;CHAVAN VINAYAK MANOHAR,EATON INTELLIGENT POWER LIMITED (2019-10-10),https://lens.org/038-108-018-954-536,Granted Patent,yes,82,0,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/12;;F16B2/20;;F16M13/02;;H02G3/06;;H02G3/08;;H02G3/18;;H02G15/16,,0,0,,,,ACTIVE
104,US,A1,US 2009/0131554 A1,004-934-195-565-794,2009-05-21,2009,US 14262308 A,2008-06-19,US 14262308 A;;US 89487901 A;;US 25004799 A,1999-02-12,ELECTROMAGNETIC SHIELDING COMPOSITE COMPRISING NANOTUBES,"There is provided an electromagnetic (EM) shielding composite and its method of manufacture having low observability and a low loading level, e.g., 1.5 weight percent, of nanotubes mixed in a base host polymer, wherein the EM shielding composite is an effective shield and absorber for broadband plane wave EM radiation. The loading levels of nanotubes are sufficiently low to leave the mechanical properties of the base polymers essentially unchanged, making this approach widely applicable to a broad range of applications.",GLATKOWSKI PAUL;;MACK PATRICK;;CONROY JEFFREY L;;PICHE JOSEPH W;;WINSOR PAUL,GLATKOWSKI PAUL;;MACK PATRICK;;CONROY JEFFREY L;;PICHE JOSEPH W;;WINSOR PAUL,,https://lens.org/004-934-195-565-794,Patent Application,yes,4,2,3,3,0,G21F1/10;;G21F1/10;;Y10S977/734;;Y10S977/734;;Y10S977/742;;Y10S977/742;;Y10S977/753;;Y10S977/753;;Y10S977/788;;Y10S977/788;;Y10S977/847;;Y10S977/847;;Y10S977/902;;Y10S977/902,G21F1/10,523/137;;977/742,0,0,,,,DISCONTINUED
105,US,B2,US 7049353 B2,067-355-814-717-136,2006-05-23,2006,US 10561802 A,2002-03-26,US 10561802 A;;US 28045301 P,2001-04-02,Polymer nanocomposites and methods of preparation,"High-use temperature, lightweight polymer/inorganic nanocomposite materials are described having enhanced thermal stability and performance characteristics. These materials are made possible by new methods for synthesizing composite materials that enhance the thermal stability of the nanocomposite systems from 100–150° C. to over 450° C. These materials and techniques for their formation are enabled at least in part by the use of polar organic phthalonitrile monomers and oligomers that can exfoliate layered phyllosilicates, such as smectite clays, in percentages greater than 10% inorganic by weight. This approach offers a solvent-free direct melt intercalation technique that greatly reduces the cost of processing nanocomposites. Additionally, the use of unmodified phyllosilicates overcomes temperature limitations of prior art, which uses organically-modified layered silicates. The new technology provides hitherto unobtainable thermal stability and performance characteristics, and has numerous applications in the automotive, aerospace, electronic and marine industries.",EIKOS INC,CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H,EIKOS INC (2004-10-26),https://lens.org/067-355-814-717-136,Granted Patent,yes,10,25,9,9,0,C08F2/44;;C08K3/34;;Y10T428/2998;;Y10T428/2998;;C08F2/44;;C08K3/34,C01B33/40;;C08F2/44;;C08K9/04;;C08F291/00;;C08F292/00;;C08G65/00;;C08K3/34,523/216;;528/99;;523/206;;427/307;;428/407,0,0,,,,EXPIRED
106,US,B1,US 6265466 B1,043-203-593-259-923,2001-07-24,2001,US 25004799 A,1999-02-12,US 25004799 A,1999-02-12,Electromagnetic shielding composite comprising nanotubes,"An electromagnetic shielding composite having nanotubes and a method of making the same are disclosed. According to one embodiment of the present invention, the composite for providing electromagnetic shielding includes a polymeric material and an effective amount of oriented nanotubes for EM shielding, the nanotubes being oriented when a shearing force is applied to the composite. According to another embodiment of the present invention, the method for making an electromagnetic shielding includes the steps of (1) providing a polymer with an amount of nanotubes, and (2) imparting a shearing force to the polymer and nanotubes to orient the nanotubes.",EIKOS INC,GLATKOWSKI PAUL;;MACK PATRICK;;CONROY JEFFREY L;;PICHE JOSEPH W;;WINSOR PAUL,EIKOS INC (1999-04-09),https://lens.org/043-203-593-259-923,Granted Patent,yes,3,383,3,3,0,G21F1/10;;G21F1/10;;Y10S977/734;;Y10S977/734;;Y10S977/742;;Y10S977/742;;Y10S977/753;;Y10S977/753;;Y10S977/788;;Y10S977/788;;Y10S977/847;;Y10S977/847;;Y10S977/902;;Y10S977/902,G21F1/10,523/137,0,0,,,,EXPIRED
107,US,B2,US 6986853 B2,136-787-078-954-239,2006-01-17,2006,US 10562202 A,2002-03-26,US 10562202 A;;US 27841701 P,2001-03-26,Carbon nanotube fiber-reinforced composite structures for EM and lightning strike protection,"A method for repairing fiber-reinforced composite structures while maintaining original EM and lightning protection using carbon nanotubes, fibers, and thermoset resins is disclosed. According to one embodiment of the invention, the method comprises preparing a damaged area for repair; preparing a repair patch for the damaged area, the repair patch comprising nanotubes; applying the repair patch to the damaged area; and curing the repair patch. A repair patch for a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair patch includes a binder and nanotubes. A repair resin for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair layer includes a resin and nanotubes. A putty for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the putty includes a base and electrically conductive carbon nanotubes.",EIKOS INC,GLATKOWSKI PAUL J;;LANDIS DAVID H;;PICHE JOSEPH W;;CONROY JEFFREY L,EIKOS INC (2005-08-08),https://lens.org/136-787-078-954-239,Granted Patent,yes,39,114,10,10,0,A61K9/0092;;A61K9/0092;;B29C73/10;;B29C73/10;;B29L2031/3076;;B29L2031/3076;;B32B5/16;;B32B5/16;;B82Y30/00;;B82Y30/00;;C04B35/52;;C04B35/52;;C04B2235/3284;;C04B2235/3284;;C04B2235/3286;;C04B2235/3286;;C04B2235/3293;;C04B2235/3293;;C04B2235/424;;C04B2235/424;;C04B2235/5288;;C04B2235/5288;;H01B1/24;;H01B1/24;;H05K9/009;;H05K9/009;;Y10S977/902;;Y10S977/902;;Y10T428/20;;Y10T428/20,B29C73/00;;C01B31/02;;A61K9/00;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,264/36.19;;264/36.2;;264/104;;264/267,7,4,034-968-279-020-736;;010-521-075-271-371;;100-286-068-341-47X;;056-856-185-642-915,10.1002/adma.19950070520;;10.1016/s0032-3861(99)00166-4;;10.1021/jp002555m;;10.1088/0034-4885/60/10/001,"Peter Fairley, ""Nanotechnology: The Start of Something Big,"" Chemicalweek pp. 23-26 (Dec. 12, 2001).;;Pulickel M. Ajayan, ""Aligned Carbon Nanotubes in a Thin Polymer Film,"" Advanced Materials, vol. 7, No. 5, pp. 489-491 (1995).;;J. Sandler et al., ""Development of a Dispersion Process for Carbon Nanotubes in an Epoxy Matrix and the Resulting Electrical Properties,"" Polymer 40, pp. 5967-5971 (1999).;;Kevin Ausman et al., ""Organic Solvent Dispersions of Single-Walled Carbon Nanotubes: Toward Solutions of Pristine Nanotubes,"" Journal of Physical Chemistry, vol. 104, No. 38, pp. 8911-8915 (Sep. 28, 2000).;;Philip Ball, ""Through the Nanotube,"" New Scientist, pp. 28-31 (Jul. 6, 1996).;;B.I. Yakobson et al., ""Fullerene Nanotubes: C<SUB>1,000,000 </SUB>and Beyond,"" American Scientist, vol. 85, pp. 324-337 (Jul.-Aug. 1997).;;P.M. Ajayan et al., ""Nanometre-size tubes of carbon,"" Rep. Prog. Phys., vol. 60, pp. 1025-1062 (1997).",EXPIRED
108,US,A1,US 2002/0035170 A1,018-751-037-901-066,2002-03-21,2002,US 89487901 A,2001-06-29,US 89487901 A;;US 25004799 A,1999-02-12,Electromagnetic shielding composite comprising nanotubes,"
   There is provided an electromagnetic (EM) shielding composite and its method of manufacture having low observability and a low loading level, e.g., 1.5 weight percent, of nanotubes mixed in a base host polymer, wherein the EM shielding composite is an effective shield and absorber for broadband plane wave EM radiation. The loading levels of nanotubes are sufficiently low to leave the mechanical properties of the base polymers essentially unchanged, making this approach widely applicable to a broad range of applications. 
",GLATKOWSKI PAUL;;MACK PATRICK;;CONROY JEFFREY L.;;PICHE JOSEPH W.;;WINSOR PAUL,GLATKOWSKI PAUL;;MACK PATRICK;;CONROY JEFFREY L;;PICHE JOSEPH W;;WINSOR PAUL,,https://lens.org/018-751-037-901-066,Patent Application,yes,35,80,3,3,0,G21F1/10;;G21F1/10;;Y10S977/734;;Y10S977/734;;Y10S977/742;;Y10S977/742;;Y10S977/753;;Y10S977/753;;Y10S977/788;;Y10S977/788;;Y10S977/847;;Y10S977/847;;Y10S977/902;;Y10S977/902,G21F1/10,523/137;;524/495;;524/496,0,0,,,,DISCONTINUED
109,US,A1,US 2020/0083687 A1,105-782-967-337-444,2020-03-12,2020,US 201916563333 A,2019-09-06,US 201916563333 A;;US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,QUICK CONNECT,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing along a frame of the electrical connector to a location within the internal volume of the housing. The assembly includes a disc mechanically secured to the housing relative to the opening to obstruct the insertion path. A retainer and a bushing including a membrane for the electrical connector as well as methods of making an electrical connector are also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;YEOLE SONALI VASANT;;CHAVAN VINAYAK MANOHAR,EATON INTELLIGENT POWER LIMITED (2019-10-10),https://lens.org/105-782-967-337-444,Patent Application,yes,0,1,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/12;;F16B2/20;;F16M13/02;;H02G3/06;;H02G3/08;;H02G3/18,,0,0,,,,ACTIVE
110,US,A1,US 2002/0180077 A1,174-236-372-043-644,2002-12-05,2002,US 10562202 A,2002-03-26,US 10562202 A;;US 27841701 P,2001-03-26,Carbon nanotube fiber-reinforced composite structures for EM and lightning strike protection,"
   A method for repairing fiber-reinforced composite structures while maintaining original EM and lightning protection using carbon nanotubes, fibers, and thermoset resins is disclosed. According to one embodiment of the invention, the method comprises preparing a damaged area for repair; preparing a repair patch for the damaged area, the repair patch comprising nanotubes; applying the repair patch to the damaged area; and curing the repair patch. A repair patch for a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair patch includes a binder and nanotubes. A repair resin for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair layer includes a resin and nanotubes. A putty for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the putty includes a base and electrically conductive carbon nanotubes. 
",GLATKOWSKI PAUL J.;;LANDIS DAVID H.;;PICHE JOSEPH W.;;CONROY JEFFREY L.,GLATKOWSKI PAUL J;;LANDIS DAVID H;;PICHE JOSEPH W;;CONROY JEFFREY L,EIKOS INC (2005-08-08),https://lens.org/174-236-372-043-644,Patent Application,yes,34,49,10,10,0,A61K9/0092;;A61K9/0092;;B29C73/10;;B29C73/10;;B29L2031/3076;;B29L2031/3076;;B32B5/16;;B32B5/16;;B82Y30/00;;B82Y30/00;;C04B35/52;;C04B35/52;;C04B2235/3284;;C04B2235/3284;;C04B2235/3286;;C04B2235/3286;;C04B2235/3293;;C04B2235/3293;;C04B2235/424;;C04B2235/424;;C04B2235/5288;;C04B2235/5288;;H01B1/24;;H01B1/24;;H05K9/009;;H05K9/009;;Y10S977/902;;Y10S977/902;;Y10T428/20;;Y10T428/20,C01B31/02;;A61K9/00;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,264/36.1;;264/105,0,0,,,,EXPIRED
111,US,A1,US 2013/0040656 A1,147-508-960-724-662,2013-02-14,2013,US 201013508070 A,2010-11-08,US 201013508070 A;;US 25897309 P;;US 2010/0055813 W,2009-11-06,METHOD AND SYSTEM FOR DETERMINING RELATIVE DISPLACEMENT AND HEADING FOR NAVIGATION,"A system and method for determining a location of a mobile object is provided. The system determines the location of the mobile object by determining distances between a plurality of sensors provided on a first and second movable parts of the mobile object. A stride length, heading, and separation distance between the first and second movable parts are computed based on the determined distances and the location of the mobile object is determined based on the computed stride length, heading, and separation distance.",UNIV MARYLAND;;SHEIKH SUNEEL ISMAIL;;PINES DARRYLL J;;CONROY JOSEPH KIM;;SPIRIDONOV TIMOFEY N,SHEIKH SUNEEL ISMAIL;;PINES DARRYLL J;;CONROY JOSEPH KIM;;SPIRIDONOV TIMOFEY N,UNIVERSITY OF MARYLAND COLLEGE PARK (2012-09-21),https://lens.org/147-508-960-724-662,Patent Application,yes,7,4,4,4,0,G01C22/006;;G01S5/0284;;G01S5/0294;;G01C22/006;;G01S5/0284;;G01S5/0294,H04W4/02,455/456.1,0,0,,,,ACTIVE
112,US,A1,US 2006/0078705 A1,109-329-228-088-050,2006-04-13,2006,US 14615005 A,2005-06-07,US 14615005 A;;US 10562202 A;;US 27841701 P,2001-03-26,Carbon nanotube fiber-reinforced composite structures for EM and lightning strike protection,"A method for repairing fiber-reinforced composite structures while maintaining original EM and lightning protection using carbon nanotubes, fibers, and thermoset resins is disclosed. According to one embodiment of the invention, the method comprises preparing a damaged area for repair; preparing a repair patch for the damaged area, the repair patch comprising nanotubes; applying the repair patch to the damaged area; and curing the repair patch. A repair patch for a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair patch includes a binder and nanotubes. A repair resin for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair layer includes a resin and nanotubes. A putty for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the putty includes a base and electrically conductive carbon nanotubes.",GLATKOWSKI PAUL J;;LANDIS DAVID H;;PICHE JOSEPH W;;CONROY JEFFREY L,GLATKOWSKI PAUL J;;LANDIS DAVID H;;PICHE JOSEPH W;;CONROY JEFFREY L,,https://lens.org/109-329-228-088-050,Patent Application,yes,41,37,10,10,0,A61K9/0092;;A61K9/0092;;B29C73/10;;B29C73/10;;B29L2031/3076;;B29L2031/3076;;B32B5/16;;B32B5/16;;B82Y30/00;;B82Y30/00;;C04B35/52;;C04B35/52;;C04B2235/3284;;C04B2235/3284;;C04B2235/3286;;C04B2235/3286;;C04B2235/3293;;C04B2235/3293;;C04B2235/424;;C04B2235/424;;C04B2235/5288;;C04B2235/5288;;H01B1/24;;H01B1/24;;H05K9/009;;H05K9/009;;Y10S977/902;;Y10S977/902;;Y10T428/20;;Y10T428/20,B32B3/26;;C01B31/02;;A61K9/00;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,428/63;;156/98,0,0,,,,DISCONTINUED
113,US,B2,US 8954271 B2,033-335-254-373-432,2015-02-10,2015,US 201013508070 A,2010-11-08,US 201013508070 A;;US 25897309 P;;US 2010/0055813 W,2009-11-06,Method and system for determining relative displacement and heading for navigation,"A system and method for determining a location of a mobile object is provided. The system determines the location of the mobile object by determining distances between a plurality of sensors provided on a first and second movable parts of the mobile object. A stride length, heading, and separation distance between the first and second movable parts are computed based on the determined distances and the location of the mobile object is determined based on the computed stride length, heading, and separation distance.",SHEIKH SUNEEL ISMAIL;;PINES DARRYLL J;;CONROY JOSEPH KIM;;SPIRIDONOV TIMOFEY N;;UNIV MARYLAND,SHEIKH SUNEEL ISMAIL;;PINES DARRYLL J;;CONROY JOSEPH KIM;;SPIRIDONOV TIMOFEY N,UNIVERSITY OF MARYLAND COLLEGE PARK (2012-09-21),https://lens.org/033-335-254-373-432,Granted Patent,yes,18,0,4,4,0,G01C22/006;;G01S5/0284;;G01S5/0294;;G01C22/006;;G01S5/0284;;G01S5/0294,H04W4/02;;G01C22/00;;G01S5/02,701/494,0,0,,,,ACTIVE
114,WO,A3,WO 2011/057182 A3,176-417-520-056-064,2011-09-22,2011,US 2010/0055813 W,2010-11-08,US 25897309 P,2009-11-06,METHOD AND SYSTEM FOR DETERMINING RELATIVE DISPLACEMENT AND HEADING FOR NAVIGATION,"A system and method for determining a location of a mobile object is provided. The system determines the location of the mobile object by determining distances between a plurality of sensors provided on a first and second movable parts of the mobile object. A stride length, heading, and separation distance between the first and second movable parts are computed based on the determined distances and the location of the mobile object is determined based on the computed stride length, heading, and separation distance.",UNIV MARYLAND;;SHEIKH SUNEEL ISMAIL;;PINES DARRYLL J;;CONROY JOSEPH KIM;;SPIRIDONOV TIMOFEY N,SHEIKH SUNEEL ISMAIL;;PINES DARRYLL J;;CONROY JOSEPH KIM;;SPIRIDONOV TIMOFEY N,,https://lens.org/176-417-520-056-064,Search Report,yes,5,0,4,4,0,G01C22/006;;G01S5/0284;;G01S5/0294;;G01C22/006;;G01S5/0284;;G01S5/0294,G01S5/02;;G01S1/08,,0,0,,,,PENDING
115,US,A1,US 2008/0281030 A1,016-497-671-973-717,2008-11-13,2008,US 43776806 A,2006-05-22,US 43776806 A;;US 10561802 A;;US 28045301 P,2001-04-02,Polymer nanocomposites and methods of preparation,"High-use temperature, lightweight polymer/inorganic nanocomposite materials are described having enhanced thermal stability and performance characteristics. These materials are made possible by new methods for synthesizing composite materials that enhance the thermal stability of the nanocomposite systems from 100-150° C. to over 450° C. These materials and techniques for their formation are enabled at least in part by the use of polar organic phthalonitrile monomers and oligomers that can exfoliate layered phyllosilicates, such as smectite clays, in percentages greater than 10% inorganic by weight. This approach offers a solvent-free direct melt intercalation technique that greatly reduces the cost of processing nanocomposites. Additionally, the use of unmodified phyllosilicates overcomes temperature limitations of prior art, which uses organically-modified layered silicates. The new technology provides hitherto unobtainable thermal stability and performance characteristics, and has numerous applications in the automotive, aerospace, electronic and marine industries.",CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H,CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H,,https://lens.org/016-497-671-973-717,Patent Application,yes,0,1,9,9,0,C08F2/44;;C08K3/34;;Y10T428/2998;;Y10T428/2998;;C08F2/44;;C08K3/34,C01B33/40;;C08F2/44;;C08K3/34;;C08F291/00;;C08F292/00;;C08L71/12;;C08L79/00,524/442;;524/612;;524/611,0,0,,,,DISCONTINUED
116,WO,A2,WO 2011/057182 A2,094-534-225-353-242,2011-05-12,2011,US 2010/0055813 W,2010-11-08,US 25897309 P,2009-11-06,METHOD AND SYSTEM FOR DETERMINING RELATIVE DISPLACEMENT AND HEADING FOR NAVIGATION,"A system and method for determining a location of a mobile object is provided. The system determines the location of the mobile object by determining distances between a plurality of sensors provided on a first and second movable parts of the mobile object. A stride length, heading, and separation distance between the first and second movable parts are computed based on the determined distances and the location of the mobile object is determined based on the computed stride length, heading, and separation distance.",UNIV MARYLAND;;SHEIKH SUNEEL ISMAIL;;PINES DARRYLL J;;CONROY JOSEPH KIM;;SPIRIDONOV TIMOFEY N,SHEIKH SUNEEL ISMAIL;;PINES DARRYLL J;;CONROY JOSEPH KIM;;SPIRIDONOV TIMOFEY N,,https://lens.org/094-534-225-353-242,Patent Application,yes,0,0,4,4,0,G01C22/006;;G01S5/0284;;G01S5/0294;;G01C22/006;;G01S5/0284;;G01S5/0294,G01S5/02;;G01S1/08,,0,0,,,,PENDING
117,DE,A1,DE 2537195 A1,163-564-816-047-720,1976-03-11,1976,DE 2537195 A,1975-08-21,US 50163474 A;;US 59043075 A,1974-08-29,"HOMOGENE LOESUNG VON STYROL, MALEINSAEUREANHYDRID UND EINEM COPOLYMERISAT AUS STYROL UND MALEINSAEUREANHYDRID SOWIE VERFAHREN ZUR HERSTELLUNG DERSELBEN",,GULF OIL CORP,HEILMAN WILLIAM JOSEPH;;PETERSON FRANK CLYDE;;RENZ MICAL CONROY;;THEARD LESLIE PETER,"QUANTUM COMPOSITES, INC., MIDLAND, MICH., US (1984-10-18)",https://lens.org/163-564-816-047-720,Patent Application,no,1,0,10,25,0,C08J3/091;;C08J3/091;;C08F283/10;;C08F283/10;;C08J2335/06;;C08J2335/06;;C08K5/05;;C08K5/05;;C08K5/08;;C08K5/08;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;C08L35/06;;C08L35/06;;C08L63/00;;C08L63/00,C08L33/00;;C08F283/10;;C08J3/09;;C08K5/10;;C08K5/1539;;C08L25/00;;C08L33/02;;C08L35/00,,0,0,,,,EXPIRED
118,US,A1,US 2002/0143094 A1,197-144-061-096-542,2002-10-03,2002,US 10561802 A,2002-03-26,US 10561802 A;;US 28045301 P,2001-04-02,Polymer nanocomposites and methods of preparation,"
   High-use temperature, lightweight polymer/inorganic nanocomposite materials are described having enhanced thermal stability and performance characteristics. These materials are made possible by new methods for synthesizing composite materials that enhance the thermal stability of the nanocomposite systems from 100-150 C. to over 450 C. These materials and techniques for their formation are enabled at least in part by the use of polar organic phthalonitrile monomers and oligomers that can exfoliate layered phyllosilicates, such as smectite clays, in percentages greater than 10% inorganic by weight. This approach offers a solvent-free direct melt intercalation technique that greatly reduces the cost of processing nanocomposites. Additionally, the use of unmodified phyllosilicates overcomes temperature limitations of prior art, which uses organically-modified layered silicates. The new technology provides hitherto unobtainable thermal stability and performance characteristics, and has numerous applications in the automotive, aerospace, electronic and marine industries. 
",CONROY JEFFREY L.;;PICHE JOSEPH W.;;GLATKOWSKI PAUL J.;;LANDIS DAVID H.,CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H,EIKOS INC (2004-10-26),https://lens.org/197-144-061-096-542,Patent Application,yes,9,40,9,9,0,C08F2/44;;C08K3/34;;Y10T428/2998;;Y10T428/2998;;C08F2/44;;C08K3/34,C08F2/44;;C01B33/40;;C08F291/00;;C08F292/00;;C08K3/34,524/445;;524/449,0,0,,,,EXPIRED
119,DE,A1,DE 2537158 A1,185-921-226-337-390,1976-03-18,1976,DE 2537158 A,1975-08-21,US 50163474 A;;US 59046075 A,1974-08-29,"VERFAHREN ZUR HERSTELLUNG EINER MANIPULIERBAREN, WAERMEHAERTBAREN MASSE",,GULF OIL CORP,HEILMAN WILLIAM JOSEPH;;PETERSON FRANK CLYDE;;RENZ MICAL CONROY;;THEARD LESLIE PETER,"QUANTUM COMPOSITES, INC., MIDLAND, MICH., US (1984-10-18)",https://lens.org/185-921-226-337-390,Patent Application,no,0,0,11,25,0,C08F283/10;;C08G59/4261;;C08G59/4261;;C08F283/10,C08G59/00;;C08F283/10;;C08G59/17;;C08G59/40;;C08G59/42,,0,0,,,,DISCONTINUED
120,EP,A1,EP 1385481 A1,095-240-177-295-596,2004-02-04,2004,EP 02723597 A,2002-03-26,US 0209142 W;;US 27841701 P,2001-03-26,CARBON NANOTUBES IN STRUCTURES AND REPAIR COMPOSITIONS,,EIKOS INC,GLATKOWSKI PAUL J;;LANDIS DAVID H JR;;PICHE JOSEPH W;;CONROY JEFFREY L,,https://lens.org/095-240-177-295-596,Patent Application,yes,0,0,10,10,0,A61K9/0092;;A61K9/0092;;B29C73/10;;B29C73/10;;B29L2031/3076;;B29L2031/3076;;B32B5/16;;B32B5/16;;B82Y30/00;;B82Y30/00;;C04B35/52;;C04B35/52;;C04B2235/3284;;C04B2235/3284;;C04B2235/3286;;C04B2235/3286;;C04B2235/3293;;C04B2235/3293;;C04B2235/424;;C04B2235/424;;C04B2235/5288;;C04B2235/5288;;H01B1/24;;H01B1/24;;H05K9/009;;H05K9/009;;Y10S977/902;;Y10S977/902;;Y10T428/20;;Y10T428/20,B05D5/12;;C01B31/02;;A61K9/00;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,,0,0,,,,DISCONTINUED
121,EP,A2,EP 1412417 A2,123-723-398-834-530,2004-04-28,2004,EP 02721570 A,2002-03-26,US 0209145 W;;US 28045301 P,2001-04-02,POLYMER NANOCOMPOSITES AND METHODS OF PREPARATION,,EIKOS INC,CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H JR,,https://lens.org/123-723-398-834-530,Patent Application,yes,0,0,9,9,0,C08F2/44;;C08K3/34;;Y10T428/2998;;Y10T428/2998;;C08F2/44;;C08K3/34,C01B33/40;;C08F2/44;;C08F291/00;;C08F292/00;;C08K3/34,,0,0,,,,DISCONTINUED
122,US,B1,US 7195754 B1,127-907-690-741-878,2007-03-27,2007,US 37318103 A,2003-02-26,US 37318103 A;;US 35936202 P,2002-02-26,Nanotube based sunscreen,"This invention relates generally to the incorporation of carbon nanotubes into compositions for protection against damage from ultraviolet radiation. In particular, the invention is directed to sunscreen compositions and methods for the preparation of sunscreen compositions.",EIKOS INC,GLATKOWSKI PAUL J;;PICHE JOSEPH W;;CONROY JEFFREY L;;BOLDUC ROY;;LABLANC PIERRE,,https://lens.org/127-907-690-741-878,Granted Patent,yes,1,16,1,1,0,A61K8/02;;A61K8/19;;A61K2800/413;;A61Q17/04;;B82Y5/00;;B82Y30/00;;A61Q17/04;;B82Y5/00;;A61K2800/413;;A61K8/02;;B82Y30/00;;A61K8/19,A61Q17/00;;A61K8/00;;A61Q17/04;;A61Q19/00;;D01F9/12,424/59;;424/60;;424/400;;424/401;;423/447.1,0,0,,,,INACTIVE
123,WO,A3,WO 2002/079301 A3,046-010-256-482-372,2004-02-12,2004,US 0209145 W,2002-03-26,US 28045301 P,2001-04-02,POLYMER NANOCOMPOSITES AND METHODS OF PREPARATION,"High-use temperature, lightweight polymer/inorganic nanocomposite materials are described having enhanced thermal stability and performance characteristics. These materials are made possible by new methods for synthesizing composite materials that enhance the thermal stability of the nanocomposite systems from 100-150 °C to over 450 °C. These materials and techniques for their formation are enabled at least in part by the use of polar organic phthalonitrile monomers and oligomers that can exfoliate layered phyllosilicates, such as smectite clays, in percentages greater than 10 % inorganic by weight. This approach offers a solvent-free direct melt intercalation technique that greatly reduces the cost of processing nanocomposites. Additionally, the use of unmodified phyllosillicates overcomes temperature limitations of prior art, which uses organically-modified layered silicates. The new technology provides hitherto unobtainable thermal stability and performance characteristics, and has numerous applications in the automotive, aerospace, electronic and marine industries.",EIKOS INC;;CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H JR,CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H JR,,https://lens.org/046-010-256-482-372,Search Report,yes,4,0,9,9,0,C08F2/44;;C08K3/34;;Y10T428/2998;;Y10T428/2998;;C08F2/44;;C08K3/34,C08F2/44;;C08F291/00;;C08F292/00;;C01B33/40;;C08K3/34,,0,0,,,,PATENTED
124,CA,A1,CA 2443309 A1,036-460-362-723-956,2002-10-10,2002,CA 2443309 A,2002-03-26,US 28045301 P;;US 0209145 W,2001-04-02,POLYMER NANOCOMPOSITES AND METHODS OF PREPARATION,"High-use temperature, lightweight polymer/inorganic nanocomposite materials are described having enhanced thermal stability and performance characteristics. These materials are made possible by new methods for synthesizing composite materials that enhance the thermal stability of the nanocomposite systems from 100-150 ~C to over 450 ~C. These materials and techniques for their formation are enabled at least in part by the use of polar organic phthalonitrile monomers and oligomers that can exfoliate layer ed phyllosilicates, such as smectite clays, in percentages greater than 10 % inorganic by weight. This approach offers a solvent-free direct melt intercalation technique that greatly reduces the cost of processing nanocomposites. Additionally, the use of unmodified phyllosillicates overcom es temperature limitations of prior art, which uses organically-modified layere d silicates. The new technology provides hitherto unobtainable thermal stabili ty and performance characteristics, and has numerous applications in the automotive, aerospace, electronic and marine industries.",EIKOS INC,LANDIS DAVID H JR;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;CONROY JEFFREY L,,https://lens.org/036-460-362-723-956,Patent Application,no,0,0,9,9,0,C08F2/44;;C08K3/34;;Y10T428/2998;;Y10T428/2998;;C08F2/44;;C08K3/34,C01B33/40;;C08F2/44;;C08F291/00;;C08F292/00;;C08K3/34,,0,0,,,,DISCONTINUED
125,EP,A4,EP 1412417 A4,135-231-856-594-373,2005-02-02,2005,EP 02721570 A,2002-03-26,US 0209145 W;;US 28045301 P,2001-04-02,POLYMER NANOCOMPOSITES AND METHODS OF PREPARATION,,EIKOS INC,CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H JR,,https://lens.org/135-231-856-594-373,Search Report,no,0,0,9,9,0,C08F2/44;;C08K3/34;;Y10T428/2998;;Y10T428/2998;;C08F2/44;;C08K3/34,C01B33/40;;C08F2/44;;C08F291/00;;C08F292/00;;C08K3/34,,1,0,,,No further relevant documents disclosed,DISCONTINUED
126,WO,A1,WO 2002/076430 A1,094-862-551-148-626,2002-10-03,2002,US 0209142 W,2002-03-26,US 27841701 P,2001-03-26,CARBON NANOTUBES IN STRUCTURES AND REPAIR COMPOSITIONS,"A method for repairing fiber-reinforced composite structures while maintaining original EM and lightning protection using carbon nanotubes, fibers, and thermoset resins is disclosed. According to one embodiment of the invention, the method comprises preparing a damaged area for repair; preparing a repair patch for the damaged area, the repair patch comprising nanotubes; applying the repair patch to the damaged area; and curing the repair patch. A repair patch for a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair patch includes a binder and nanotubes. A repair resin for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair layer includes a resin and nanotubes. A putty for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the putty includes a base and electrically conductive carbon nanotubes.",EIKOS INC;;GLATKOWSKI PAUL J;;LANDIS DAVID H JR;;PICHE JOSEPH W;;CONROY JEFFREY L,GLATKOWSKI PAUL J;;LANDIS DAVID H JR;;PICHE JOSEPH W;;CONROY JEFFREY L,,https://lens.org/094-862-551-148-626,Patent Application,yes,4,0,10,10,0,A61K9/0092;;A61K9/0092;;B29C73/10;;B29C73/10;;B29L2031/3076;;B29L2031/3076;;B32B5/16;;B32B5/16;;B82Y30/00;;B82Y30/00;;C04B35/52;;C04B35/52;;C04B2235/3284;;C04B2235/3284;;C04B2235/3286;;C04B2235/3286;;C04B2235/3293;;C04B2235/3293;;C04B2235/424;;C04B2235/424;;C04B2235/5288;;C04B2235/5288;;H01B1/24;;H01B1/24;;H05K9/009;;H05K9/009;;Y10S977/902;;Y10S977/902;;Y10T428/20;;Y10T428/20,C01B31/02;;A61K9/00;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,,1,0,,,See also references of EP 1385481A4,PATENTED
127,JP,A,JP 2007290963 A,100-876-625-608-617,2007-11-08,2007,JP 2007182690 A,2007-07-11,US 27841701 P,2001-03-26,CARBON NANOTUBE IN STRUCTURE AND REPAIR COMPOSITION,"<P>PROBLEM TO BE SOLVED: To provide a method for repairing a fiber-reinforced composite structure using a carbon nanotube, a fiber and a thermosetting resin while maintaining original electromagnetic and lightning strike protection. <P>SOLUTION: The method according to an embodiment of the present invention comprises preparing a damaged area to be repaired, preparing a repair patch made of a nanotube for the damaged area, adhering the repair patch to the damaged area and curing the repair patch, wherein the repair patch is that for a composite structure having a conductive layer. According to the embodiment, the repair patch includes a binder and a nanotube and is a repair resin for repairing a composite structure having a conductive layer. According to the embodiment, the repair layer includes a resin and a nanotube and is a putty for repairing a composite structure having a conductive layer. According to the embodiment, the putty includes a base and a conductive carbon nanotube. <P>COPYRIGHT: (C)2008,JPO&INPIT",EIKOS INC,GLATKOWSKI PAUL J;;LANDIS DAVID H JR;;PICHE JOSEPH W;;CONROY JEFFREY L,,https://lens.org/100-876-625-608-617,Patent Application,no,0,0,10,10,0,A61K9/0092;;A61K9/0092;;B29C73/10;;B29C73/10;;B29L2031/3076;;B29L2031/3076;;B32B5/16;;B32B5/16;;B82Y30/00;;B82Y30/00;;C04B35/52;;C04B35/52;;C04B2235/3284;;C04B2235/3284;;C04B2235/3286;;C04B2235/3286;;C04B2235/3293;;C04B2235/3293;;C04B2235/424;;C04B2235/424;;C04B2235/5288;;C04B2235/5288;;H01B1/24;;H01B1/24;;H05K9/009;;H05K9/009;;Y10S977/902;;Y10S977/902;;Y10T428/20;;Y10T428/20,C01B31/02;;A61K9/00;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,,0,0,,,,PENDING
128,AU,B2,AU 2002/254368 B2,095-130-066-458-56X,2007-07-19,2007,AU 2002/254368 A,2002-03-26,US 27841701 P;;US 0209142 W,2001-03-26,Carbon nanotubes in structures and repair compositions,,EIKOS INC,GLATKOWSKI PAUL J;;CONROY JEFFREY L;;PICHE JOSEPH W;;LANDIS DAVID H JR,,https://lens.org/095-130-066-458-56X,Granted Patent,no,1,0,10,10,0,A61K9/0092;;A61K9/0092;;B29C73/10;;B29C73/10;;B29L2031/3076;;B29L2031/3076;;B32B5/16;;B32B5/16;;B82Y30/00;;B82Y30/00;;C04B35/52;;C04B35/52;;C04B2235/3284;;C04B2235/3284;;C04B2235/3286;;C04B2235/3286;;C04B2235/3293;;C04B2235/3293;;C04B2235/424;;C04B2235/424;;C04B2235/5288;;C04B2235/5288;;H01B1/24;;H01B1/24;;H05K9/009;;H05K9/009;;Y10S977/902;;Y10S977/902;;Y10T428/20;;Y10T428/20,C01B31/02;;A61K9/00;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,,0,0,,,,EXPIRED
129,EP,A4,EP 1385481 A4,124-177-364-000-889,2006-06-07,2006,EP 02723597 A,2002-03-26,US 0209142 W;;US 27841701 P,2001-03-26,CARBON NANOTUBES IN STRUCTURES AND REPAIR COMPOSITIONS,,EIKOS INC,GLATKOWSKI PAUL J;;LANDIS DAVID H JR;;PICHE JOSEPH W;;CONROY JEFFREY L,,https://lens.org/124-177-364-000-889,Search Report,no,1,0,10,10,0,A61K9/0092;;B29C73/10;;B29L2031/3076;;B32B5/16;;B82Y30/00;;C04B35/52;;C04B2235/3284;;C04B2235/3286;;C04B2235/3293;;C04B2235/424;;C04B2235/5288;;H01B1/24;;H05K9/009;;Y10S977/902;;Y10T428/20;;Y10T428/20;;B29C73/10;;A61K9/0092;;H05K9/009;;B32B5/16;;C04B35/52;;C04B2235/424;;B82Y30/00;;C04B2235/3293;;B29L2031/3076;;C04B2235/3284;;C04B2235/3286;;H01B1/24;;C04B2235/5288;;Y10S977/902,B05D5/12;;A61K9/00;;C01B31/02;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 2000, no. 04 31 August 2000 (2000-08-31);;See also references of WO 02076430A1",DISCONTINUED
130,WO,A2,WO 2002/079301 A2,154-351-304-756-798,2002-10-10,2002,US 0209145 W,2002-03-26,US 28045301 P,2001-04-02,POLYMER NANOCOMPOSITES AND METHODS OF PREPARATION,"High-use temperature, lightweight polymer/inorganic nanocomposite materials are described having enhanced thermal stability and performance characteristics. These materials are made possible by new methods for synthesizing composite materials that enhance the thermal stability of the nanocomposite systems from 100-150 °C to over 450 °C. These materials and techniques for their formation are enabled at least in part by the use of polar organic phthalonitrile monomers and oligomers that can exfoliate layered phyllosilicates, such as smectite clays, in percentages greater than 10 % inorganic by weight. This approach offers a solvent-free direct melt intercalation technique that greatly reduces the cost of processing nanocomposites. Additionally, the use of unmodified phyllosillicates overcomes temperature limitations of prior art, which uses organically-modified layered silicates. The new technology provides hitherto unobtainable thermal stability and performance characteristics, and has numerous applications in the automotive, aerospace, electronic and marine industries.",EIKOS INC;;CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H JR,CONROY JEFFREY L;;PICHE JOSEPH W;;GLATKOWSKI PAUL J;;LANDIS DAVID H JR,,https://lens.org/154-351-304-756-798,Patent Application,yes,0,0,9,9,0,C08F2/44;;C08K3/34;;Y10T428/2998;;Y10T428/2998;;C08F2/44;;C08K3/34,C08F2/44;;C01B33/40;;C08F291/00;;C08F292/00;;C08K3/34,,0,0,,,,PATENTED
131,CA,A1,CA 2442273 A1,019-160-497-816-024,2002-10-03,2002,CA 2442273 A,2002-03-26,US 27841701 P;;US 0209142 W,2001-03-26,CARBON NANOTUBES IN STRUCTURES AND REPAIR COMPOSITIONS,"A method for repairing fiber-reinforced composite structures while maintaining original EM and lightning protection using carbon nanotubes, fibers, and thermoset resins is disclosed. According to one embodiment of the invention, the method comprises preparing a damaged area for repair; preparing a repair patch for the damaged area, the repair patch comprising nanotubes; applying the repair patch to the damaged area; and curing the repair patch. A repair patch for a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair patch includes a binder and nanotubes. A repair resin for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the repair layer includes a resin and nanotubes. A putty for repairing a composite structure having a conductive layer is disclosed. According to one embodiment of the present invention, the putty includes a base and electrically conductive carbon nanotubes.",EIKON INC,CONROY JEFFREY L;;PICHE JOSEPH W;;LANDIS DAVID H JR;;GLATKOWSKI PAUL J,,https://lens.org/019-160-497-816-024,Patent Application,no,0,0,10,10,0,A61K9/0092;;A61K9/0092;;B29C73/10;;B29C73/10;;B29L2031/3076;;B29L2031/3076;;B32B5/16;;B32B5/16;;B82Y30/00;;B82Y30/00;;C04B35/52;;C04B35/52;;C04B2235/3284;;C04B2235/3284;;C04B2235/3286;;C04B2235/3286;;C04B2235/3293;;C04B2235/3293;;C04B2235/424;;C04B2235/424;;C04B2235/5288;;C04B2235/5288;;H01B1/24;;H01B1/24;;H05K9/009;;H05K9/009;;Y10S977/902;;Y10S977/902;;Y10T428/20;;Y10T428/20,C01B31/02;;A61K9/00;;B29C73/10;;B32B5/16;;C04B35/52;;H01B1/24;;H05K9/00,,0,0,,,,DISCONTINUED
132,CA,A1,CA 2471842 A1,181-365-081-056-124,2003-02-13,2003,CA 2471842 A,2002-07-24,US 30788501 P;;US 0223413 W,2001-07-27,CONFORMAL COATINGS COMPRISING CARBON NANOTUBES,"The invention is directed to conformal coatings that provide excellent shielding against electromagnetic interference (EMI). A conformal coating .comprises an insulating layer and a conducting layer containing electricall y conductive material. The insulating layer comprises materials for protecting a coated object. The conducting layer comprises materials that provide EMI shielding such as carbon black, carbon buckeyballs, carbon nanotubes, chemically-modified carbon nanotubes and combinations thereof. The insulatin g layer and the conductive layer may be the same or different, and may be applied to an object simultaneously or sequentially. Accordingly, the invention is also directed to objects that are partially or completely coate d with a conformal coating that provides EMI shielding.",EIKOS INC,CONROY JEFFREY;;GLATKOWSKI PAUL J;;LANDRAU NELSON;;PICHE JOSEPH W;;LANDIS DAVID H JR,,https://lens.org/181-365-081-056-124,Patent Application,no,0,0,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;G21F1/10;;H01B1/24;;H05K9/00,,0,0,,,,DISCONTINUED
133,US,A1,US 2020/0358273 A1,112-213-778-562-574,2020-11-12,2020,US 202016939185 A,2020-07-27,US 202016939185 A;;US 201916563305 A;;US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,QUICK CONNECT,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing to a location within the internal volume of the housing. The assembly includes a plug having a flange portion and a plurality of resilient legs. A method of installing an electrical assembly includes contacting the plug and removing the plug from an opening of a bushing positioned at least partially within a retainer coupled to a frame of the electrical connector.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,,https://lens.org/112-213-778-562-574,Patent Application,yes,0,0,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/12;;F16B2/20;;F16M13/02;;H02G3/06;;H02G3/08;;H02G3/18;;H02G15/16,,0,0,,,,ACTIVE
134,US,B2,US 11749979 B2,073-432-862-031-861,2023-09-05,2023,US 202217669947 A,2022-02-11,US 202217669947 A;;US 202117150053 A;;US 202016939185 A;;US 201916563305 A;;US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,Quick connect,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing along a frame of the electrical connector to a location within the internal volume of the housing. The assembly includes a disc mechanically secured to the housing relative to the opening to obstruct the insertion path. A retainer and a bushing including a membrane for the electrical connector as well as methods of making an electrical connector are also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,EATON INTELLIGENT POWER LIMITED (2019-09-05),https://lens.org/073-432-862-031-861,Granted Patent,yes,98,0,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,F16B2/20;;H02G3/08;;F16M13/02;;H02G3/06;;H02G3/12;;H02G3/18;;H02G15/16,,0,0,,,,ACTIVE
135,CA,A1,CA 3054215 A1,022-446-373-039-819,2020-03-06,2020,CA 3054215 A,2019-09-05,US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,QUICK CONNECT,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing to a location within the internal volume of the housing. The assembly includes a plug having a flange portion and a plurality of resilient legs. A bracket for mounting an electrical box to a structure includes a corner connecting a first flange with a second flange. An assembly including an electrical box and a bracket is also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,,https://lens.org/022-446-373-039-819,Patent Application,no,0,0,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/02;;H02G3/06,,0,0,,,,PENDING
136,EP,A2,EP 1444701 A2,186-139-803-905-455,2004-08-11,2004,EP 02791542 A,2002-07-24,US 0223413 W;;US 30788501 P,2001-07-27,CONFORMAL COATINGS COMPRISING CARBON NANOTUBES,,EIKOS INC,GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID JR H;;PICHE JOSEPH W;;CONROY JEFFREY,,https://lens.org/186-139-803-905-455,Patent Application,yes,0,0,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;G21F1/10;;H01B1/24;;H05K9/00,,0,0,,,,DISCONTINUED
137,US,A1,US 2015/0032905 A1,009-097-047-203-317,2015-01-29,2015,US 201313949335 A,2013-07-24,US 201313949335 A,2013-07-24,"METHOD AND SYSTEM FOR ASSOCIATING INTERNET PROTOCOL (IP) ADDRESS, MEDIA ACCESS CONTROL (MAC) ADDRESS AND LOCATION FOR A USER DEVICE","A method for associating an Internet Protocol (IP) address, a media access control (MAC) address and a location for a user device includes receiving IP to DHCP (dynamic host configuration protocol) bindings related to a user device from a domain name server (DNS), receiving a MAC address related to the user device from the DNS, associating the IP address and the MAC address for the user device, using the MAC address to obtain a geographic location of the user device, building a table having the IP:MAC address association, the location of the user device and a timestamp corresponding to the IP:MAC address association and the location of the user device, and using the IP:MAC address association and the location of the user device to deliver contextual content to the user device.",QUALCOMM INC,CELEBI LEYLA S;;JOSEPH GEORGE;;BILANGE ERIC P;;MARX PETER S;;CONROY CORMAC S,QUALCOMM INCORPORATED (2013-06-11),https://lens.org/009-097-047-203-317,Patent Application,yes,6,24,6,6,0,H04L61/103;;H04W4/029;;H04L61/4511;;H04L61/5014;;H04L2101/69;;H04L67/52;;H04W4/029;;H04L61/103;;H04L61/5014;;H04L61/4511;;H04L67/52;;H04L2101/69,H04L29/12;;H04W4/029,709/245,1,1,037-631-696-337-377,10.1109/icon.2003.1266251,"Author: Yen-Cheng Chen, Yao-Jung Chan, and Cheung-Wo She Title: Enabling Location-Based Services on Wireless LANs Department ofinformatioll Management. National Chi Nan University Puli, 545 Taiwan ycchen@ncnu.edu.tw Public: 09/28/2003",DISCONTINUED
138,AU,C1,AU 2002/332422 C1,055-758-802-718-570,2008-03-13,2008,AU 2002/332422 A,2002-07-24,US 30788501 P;;US 0223413 W,2001-07-27,Conformal coatings comprising carbon nanotubes,,EIKOS INC,LANDRAU NELSON;;PICHE JOSEPH W;;LANDIS DAVID JR H;;GLATKOWSKI PAUL J;;CONROY JEFFREY,,https://lens.org/055-758-802-718-570,Amended Patent,no,2,0,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,G21F1/10;;B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;H01B1/24;;H05K9/00,,0,0,,,,EXPIRED
139,WO,A1,WO 2015/013161 A1,040-967-066-931-168,2015-01-29,2015,US 2014/0047359 W,2014-07-21,US 201313949335 A,2013-07-24,"METHOD AND SYSTEM FOR ASSOCIATING INTERNET PROTOCOL (IP) ADDRESS, MEDIA ACCESS CONTROL (MAC) ADDRESS AND LOCATION FOR A USER DEVICE","A method for associating an Internet Protocol (IP) address, a media access control (MAC) address and a location for a user device includes receiving IP to DHCP (dynamic host configuration protocol) bindings related to a user device from a domain name server (DNS), receiving a MAC address related to the user device from the DNS, associating the IP address and the MAC address for the user device, using the MAC address to obtain a geographic location of the user device, building a table having the IP:MAC address association, the location of the user device and a timestamp corresponding to the IP:MAC address association and the location of the user device, and using the IP:MAC address association and the location of the user device to deliver contextual content to the user device.",QUALCOMM INC,CELEBI LEYLA S;;JOSEPH GEORGE;;BILANGE ERIC P;;MARX PETER S;;CONROY CORMAC S,,https://lens.org/040-967-066-931-168,Patent Application,yes,3,0,6,6,0,H04L61/103;;H04W4/029;;H04L61/4511;;H04L61/5014;;H04L2101/69;;H04L67/52;;H04W4/029;;H04L61/103;;H04L61/5014;;H04L61/4511;;H04L67/52;;H04L2101/69,H04L29/12;;H04L29/08;;H04W4/029,,1,1,037-631-696-337-377,10.1109/icon.2003.1266251,"YEN-CHENG CHEN ET AL: ""Enabling location-based services on wireless LANs"", 28 September 2003, NETWORKS, 2003. ICON2003. THE 11TH IEEE INTERNATIONAL CONFERENCE ON SEPT. 28-OCT. 1, 2003, PISCATAWAY, NJ, USA,IEEE, PAGE(S) 567 - 572, ISBN: 978-0-7803-7788-2, XP010682941",PENDING
140,US,A1,US 2022/0166201 A1,119-047-637-846-964,2022-05-26,2022,US 202217669947 A,2022-02-11,US 202217669947 A;;US 202117150053 A;;US 202016939185 A;;US 201916563305 A;;US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,QUICK CONNECT,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing along a frame of the electrical connector to a location within the internal volume of the housing. The assembly includes a disc mechanically secured to the housing relative to the opening to obstruct the insertion path. A retainer and a bushing including a membrane for the electrical connector as well as methods of making an electrical connector are also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,EATON INTELLIGENT POWER LIMITED (2019-09-05),https://lens.org/119-047-637-846-964,Patent Application,yes,2,0,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/12;;F16B2/20;;F16M13/02;;H02G3/06;;H02G3/08;;H02G3/18;;H02G15/16,,0,0,,,,ACTIVE
141,US,A1,US 2021/0135439 A1,022-726-478-950-269,2021-05-06,2021,US 202117150053 A,2021-01-15,US 202117150053 A;;US 202016939185 A;;US 201916563305 A;;US 201962807132 P;;US 201962807147 P;;US 201862727786 P,2018-09-06,QUICK CONNECT,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing along a frame of the electrical connector to a location within the internal volume of the housing. The assembly includes a disc mechanically secured to the housing relative to the opening to obstruct the insertion path. A retainer and a bushing including a membrane for the electrical connector as well as methods of making an electrical connector are also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,EATON INTELLIGENT POWER LIMITED (2019-09-05),https://lens.org/022-726-478-950-269,Patent Application,yes,0,0,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/12;;F16B2/20;;F16M13/02;;H02G3/06;;H02G3/08;;H02G3/18;;H02G15/16,,0,0,,,,ACTIVE
142,AU,B2,AU 2002/332422 B2,031-258-933-038-506,2007-09-13,2007,AU 2002/332422 A,2002-07-24,US 30788501 P;;US 0223413 W,2001-07-27,Conformal coatings comprising carbon nanotubes,,EIKOS INC,LANDRAU NELSON;;PICHE JOSEPH W;;LANDIS DAVID JR H;;GLATOWSKII PAUL J;;CONROY JEFFREY,,https://lens.org/031-258-933-038-506,Granted Patent,no,2,0,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,G21F1/10;;B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;H01B1/24;;H05K9/00,,0,0,,,,EXPIRED
143,CN,A,CN 110880683 A,103-567-409-706-781,2020-03-13,2020,CN 201910845656 A,2019-09-06,US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,QUICK CONNECT,The present invention provides quick connect. The present invention discloses an electrical connection assembly. The electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housingincludes an aperture having an opening defining an insertion path extending from a location external to the housing to a location within the internal volume of the housing. The assembly includes a plug having a flange portion and a plurality of resilient legs. A bracket for mounting an electrical box to a structure includes a corner connecting a first flange with a second flange. The present invention further provides an assembly including an electrical box and a bracket.,EATON INTELLIGENT POWER LTD,SHANE SEMPLE;;RONALD CONROY;;JOSEPH PLATT;;PRINCE KUMAR PANDEY;;HIMANSHU G KHOKLE;;GANGADHAR MESTRI,,https://lens.org/103-567-409-706-781,Patent Application,no,0,1,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02B1/46;;H01R4/48;;H01R9/00;;H01R9/24;;H02B1/34,,0,0,,,,PENDING
144,US,B2,US 10910803 B2,002-872-292-658-657,2021-02-02,2021,US 202016939185 A,2020-07-27,US 202016939185 A;;US 201916563305 A;;US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,Quick connect,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing to a location within the internal volume of the housing. The assembly includes a plug having a flange portion and a plurality of resilient legs. A method of installing an electrical assembly includes contacting the plug and removing the plug from an opening of a bushing positioned at least partially within a retainer coupled to a frame of the electrical connector.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,,https://lens.org/002-872-292-658-657,Granted Patent,yes,5,0,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/12;;F16B2/20;;F16M13/02;;H02G3/06;;H02G3/08;;H02G3/18;;H02G15/16,,0,0,,,,ACTIVE
145,WO,A2,WO 2003/013199 A2,025-618-864-436-330,2003-02-13,2003,US 0223413 W,2002-07-24,US 30788501 P,2001-07-27,CONFORMAL COATINGS COMPRISING CARBON NANOTUBES,"The invention is directed to conformal coatings that provide excellent shielding against electromagnetic interference (EMI). A conformal coating .comprises an insulating layer and a conducting layer containing electrically conductive material. The insulating layer comprises materials for protecting a coated object. The conducting layer comprises materials that provide EMI shielding such as carbon black, carbon buckeyballs, carbon nanotubes, chemically-modified carbon nanotubes and combinations thereof. The insulating layer and the conductive layer may be the same or different, and may be applied to an object simultaneously or sequentially. Accordingly, the invention is also directed to objects that are partially or completely coated with a conformal coating that provides EMI shielding.",EIKOS INC;;GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID JR H;;PICHE JOSEPH W;;CONROY JEFFREY,GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID JR H;;PICHE JOSEPH W;;CONROY JEFFREY,,https://lens.org/025-618-864-436-330,Patent Application,yes,0,0,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;G21F1/10;;H01B1/24;;H05K9/00,,0,0,,,,PENDING
146,WO,A3,WO 2003/013199 A3,032-480-572-535-366,2003-05-22,2003,US 0223413 W,2002-07-24,US 30788501 P,2001-07-27,CONFORMAL COATINGS COMPRISING CARBON NANOTUBES,"The invention is directed to conformal coatings that provide excellent shielding against electromagnetic interference (EMI). A conformal coating .comprises an insulating layer and a conducting layer containing electrically conductive material. The insulating layer comprises materials for protecting a coated object. The conducting layer comprises materials that provide EMI shielding such as carbon black, carbon buckeyballs, carbon nanotubes, chemically-modified carbon nanotubes and combinations thereof. The insulating layer and the conductive layer may be the same or different, and may be applied to an object simultaneously or sequentially. Accordingly, the invention is also directed to objects that are partially or completely coated with a conformal coating that provides EMI shielding.",EIKOS INC;;GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID JR H;;PICHE JOSEPH W;;CONROY JEFFREY,GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID JR H;;PICHE JOSEPH W;;CONROY JEFFREY,,https://lens.org/032-480-572-535-366,Search Report,yes,7,0,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;G21F1/10;;H01B1/24;;H05K9/00,,0,0,,,,PENDING
147,US,B2,US 11264785 B2,113-028-307-308-491,2022-03-01,2022,US 202117150053 A,2021-01-15,US 202117150053 A;;US 202016939185 A;;US 201916563305 A;;US 201962807132 P;;US 201962807147 P;;US 201862727786 P,2018-09-06,Quick connect,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing along a frame of the electrical connector to a location within the internal volume of the housing. The assembly includes a disc mechanically secured to the housing relative to the opening to obstruct the insertion path. A retainer and a bushing including a membrane for the electrical connector as well as methods of making an electrical connector are also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,EATON INTELLIGENT POWER LIMITED (2019-09-05),https://lens.org/113-028-307-308-491,Granted Patent,yes,93,0,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/08;;F16B2/20;;F16M13/02;;H02G3/06;;H02G3/12;;H02G3/18;;H02G15/16,,0,0,,,,ACTIVE
148,EP,A1,EP 3025485 A1,118-215-802-388-789,2016-06-01,2016,EP 14750841 A,2014-07-21,US 201313949335 A;;US 2014/0047359 W,2013-07-24,"METHOD AND SYSTEM FOR ASSOCIATING INTERNET PROTOCOL (IP) ADDRESS, MEDIA ACCESS CONTROL (MAC) ADDRESS AND LOCATION FOR A USER DEVICE",,QUALCOMM INC,CELEBI LEYLA S;;JOSEPH GEORGE;;BILANGE ERIC P;;MARX PETER S;;CONROY CORMAC S,,https://lens.org/118-215-802-388-789,Patent Application,yes,0,0,6,6,0,H04L61/103;;H04W4/029;;H04L61/4511;;H04L61/5014;;H04L2101/69;;H04L67/52;;H04W4/029;;H04L61/103;;H04L61/5014;;H04L61/4511;;H04L67/52;;H04L2101/69,H04L29/12;;H04L29/08;;H04W4/029,,0,0,,,,DISCONTINUED
149,US,A1,US 2004/0071949 A1,176-391-298-394-608,2004-04-15,2004,US 20156802 A,2002-07-24,US 20156802 A;;US 30788501 P,2001-07-27,Conformal coatings comprising carbon nanotubes,"
   The invention is directed to conformal coatings that provide excellent shielding against electromagnetic interference (EMI). A conformal coating comprises an insulating layer and a conducting layer containing electrically conductive material. The insulating layer comprises materials for protecting a coated object. The conducting layer comprises materials that provide EMI shielding such as carbon black, carbon buckeyballs, carbon nanotubes, chemically-modified carbon nanotubes and combinations thereof. The insulating layer and the conductive layer may be the same or different, and may be applied to an object simultaneously or sequentially. Accordingly, the invention is also directed to objects that are partially or completely coated with a conformal coating that provides EMI shielding. 
",GLATKOWSKI PAUL J.;;LANDRAU NELSON;;LANDIS DAVID H.;;PICHE JOSEPH W.;;CONROY JEFFREY L.,GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID H;;PICHE JOSEPH W;;CONROY JEFFREY L,EIKOS INC (2002-08-29),https://lens.org/176-391-298-394-608,Patent Application,yes,15,264,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;G21F1/10;;H01B1/24;;H05K9/00,428/313.3;;174/35;;428/408;;428/315.5,0,0,,,,EXPIRED
150,US,A1,US 2020/0083686 A1,160-704-982-335-982,2020-03-12,2020,US 201916563305 A,2019-09-06,US 201916563305 A;;US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,QUICK CONNECT,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing to a location within the internal volume of the housing. The assembly includes a plug having a flange portion and a plurality of resilient legs. A bracket for mounting an electrical box to a structure includes a corner connecting a first flange with a second flange. An assembly including an electrical box and a bracket is also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,EATON INTELLIGENT POWER LIMITED (2019-09-04),https://lens.org/160-704-982-335-982,Patent Application,yes,0,1,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/12;;H02G3/08;;H02G15/16,,0,0,,,,ACTIVE
151,US,A,US 4816833 A,004-341-210-038-084,1989-03-28,1989,US 6291287 A,1987-06-16,US 6291287 A,1987-06-16,Pulse doppler surveillance post signal processing and scan to scan correlation,"Post detection processing for a pulse doppler surveillance radar is disclosed wherein target reports having ambiguous ranges along with those containing unambiguous ranges are used for tracking targets. The tracking includes a maneuver recognition mechanism for adaptively weighting the range, range rate, and X and Y coordinate driving errors as a function of the maneuvering and non-maneuvering operations of the target.",WESTINGHOUSE ELECTRIC CORP,FERGUSON KENNETH H;;GATLIN BOBBY J;;REAL PHILIP;;CONROY JOSEPH L;;EHRMAN JAMES P,NORTHROP GRUMMAN CORPORATION (1996-03-01);;WESTINGHOUSE ELECTRIC CORPORATION (1987-06-03),https://lens.org/004-341-210-038-084,Granted Patent,yes,2,37,1,1,0,G01S13/20;;G01S13/20;;G01S13/5246;;G01S13/5246;;G01S13/72;;G01S13/72,G01S13/20;;G01S13/524;;G01S13/72,342/95;;342/90;;342/108;;342/145,1,0,,,"O Donnell et al, Automated Tracking for Aircraft Surveillance Systems, Jul. 1979, AES 15, No. 4, IEEE Trans. on Aero & Elec. Systems.",EXPIRED
152,EP,A4,EP 1444701 A4,038-528-519-245-966,2005-01-12,2005,EP 02791542 A,2002-07-24,US 0223413 W;;US 30788501 P,2001-07-27,CONFORMAL COATINGS COMPRISING CARBON NANOTUBES,,EIKOS INC,GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID JR H;;PICHE JOSEPH W;;CONROY JEFFREY,,https://lens.org/038-528-519-245-966,Search Report,no,0,0,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;G21F1/10;;H01B1/24;;H05K9/00,,1,0,,,No further relevant documents disclosed,DISCONTINUED
153,KR,A,KR 20160034930 A,046-377-212-586-250,2016-03-30,2016,KR 20167002644 A,2014-07-21,US 201313949335 A;;US 2014/0047359 W,2013-07-24,"METHOD AND SYSTEM FOR ASSOCIATING INTERNET PROTOCOL (IP) ADDRESS, MEDIA ACCESS CONTROL (MAC) ADDRESS AND LOCATION FOR A USER DEVICE","인터넷 프로토콜 (IP) 어드레스, 매체 액세스 제어 (MAC) 어드레스 및 사용자 디바이스에 대한 로케이션을 연관시키기 위한 방법은 도메인 네임 서버 (DNS) 로부터 사용자 디바이스에 관련된 IP 대 DHCP (dynamic host configuration protocol) 바인딩들을 수신하는 단계, DNS 로부터 사용자 디바이스에 관련된 MAC 어드레스를 수신하는 단계, 사용자 디바이스에 대한 MAC 어드레스 및 IP 어드레스를 연관시키는 단계, MAC 어드레스를 이용하여 사용자 디바이스의 지리적 로케이션을 획득하는 단계, IP:MAC 어드레스 연관성, 사용자 디바이스의 로케이션 및 IP:MAC 어드레스 연관성 및 사용자 디바이스의 로케이션에 대응하는 타임스탬프를 갖는 테이블을 구축하는 단계, 및 IP:MAC 어드레스 연관성 및 사용자 디바이스의 로케이션을 이용하여 사용자 디바이스에 맥락 콘텐츠를 전달하는 단계를 포함한다.",QUALCOMM INC,CELEBI LEYLA S;;JOSEPH GEORGE;;BILANGE ERIC P;;MARX PETER S;;CONROY CORMAC S,,https://lens.org/046-377-212-586-250,Patent Application,no,0,0,6,6,0,H04L61/103;;H04W4/029;;H04L61/4511;;H04L61/5014;;H04L2101/69;;H04L67/52;;H04W4/029;;H04L61/103;;H04L61/5014;;H04L61/4511;;H04L67/52;;H04L2101/69,H04L29/08;;H04W4/029,,0,0,,,,DISCONTINUED
154,US,B2,US 10742011 B2,087-399-736-509-146,2020-08-11,2020,US 201916563305 A,2019-09-06,US 201916563305 A;;US 201862727786 P;;US 201962807132 P;;US 201962807147 P,2018-09-06,Quick connect,An electrical connection assembly includes an electrical box including a housing having an internal surface defining an internal volume of the housing. An electrical connector is positioned outside the internal volume of the housing and fixed to the housing with a fastener. The housing includes an aperture having an opening defining an insertion path extending from a location external to the housing to a location within the internal volume of the housing. The assembly includes a plug having a flange portion and a plurality of resilient legs. A bracket for mounting an electrical box to a structure includes a corner connecting a first flange with a second flange. An assembly including an electrical box and a bracket is also provided.,EATON INTELLIGENT POWER LTD,SEMPLE SHANE;;CONROY RONALD;;PLATT JOSEPH;;PANDEY PRINCE KUMAR;;KHOKLE HIMANSHU G;;MESTRI GANGADHAR,EATON INTELLIGENT POWER LIMITED (2019-09-04),https://lens.org/087-399-736-509-146,Granted Patent,yes,79,1,14,14,0,H02B1/46;;H02B1/34;;H01R9/00;;H01R9/24;;H01R9/2416;;H01R13/73;;H01R43/00;;H02G3/085;;H02G3/0691;;H02G3/126;;F16B11/006;;F16B2/22;;F16B2/245;;F16B9/052;;H02G3/12;;H02G15/16;;H02G3/083;;F16B2/20;;F16M13/02;;H02G3/0691;;H02G3/126;;H02G3/18,H02G3/12;;F16B2/20;;F16M13/02;;H02G3/06;;H02G3/08;;H02G3/18;;H02G15/16,,0,0,,,,ACTIVE
155,CN,A,CN 105409188 A,140-136-434-426-105,2016-03-16,2016,CN 201480041545 A,2014-07-21,US 2014/0047359 W;;US 201313949335 A,2013-07-24,"Method and system for associating internet protocol (IP) address, media access control (MAC) address and location for a user device","A method for associating an Internet Protocol (IP) address, a media access control (MAC) address and a location for a user device includes receiving IP to DHCP (dynamic host configuration protocol) bindings related to a user device from a domain name server (DNS), receiving a MAC address related to the user device from the DNS, associating the IP address and the MAC address for the user device, using the MAC address to obtain a geographic location of the user device, building a table having the IP:MAC address association, the location of the user device and a timestamp corresponding to the IP:MAC address association and the location of the user device, and using the IP:MAC address association and the location of the user device to deliver contextual content to the user device.",QUALCOMM INC,CELEBI LEYLA S;;JOSEPH GEORGE;;BILANGE ERIC P;;MARX PETER S;;CONROY CORMAC S,,https://lens.org/140-136-434-426-105,Patent Application,no,3,2,6,6,0,H04L61/103;;H04W4/029;;H04L61/4511;;H04L61/5014;;H04L2101/69;;H04L67/52;;H04W4/029;;H04L61/103;;H04L61/5014;;H04L61/4511;;H04L67/52;;H04L2101/69,H04L29/12;;H04L29/08;;H04W4/029,,1,0,,,"YEN-CHENG CHEN等: ""Enabling Location-Based Services on Wireless LANs"", 《IEEE》",DISCONTINUED
156,AU,B8,AU 2002/332422 B8,176-226-300-059-982,2007-09-20,2007,AU 2002/332422 A,2002-07-24,US 30788501 P;;US 0223413 W,2001-07-27,Conformal coatings comprising carbon nanotubes,,EIKOS INC,LANDRAU NELSON;;PICHE JOSEPH W;;LANDIS DAVID JR H;;GLATKOWSKI PAUL J;;CONROY JEFFREY,,https://lens.org/176-226-300-059-982,Amended Patent,no,2,0,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,G21F1/10;;B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;H01B1/24;;H05K9/00,,0,0,,,,EXPIRED
157,CN,A,CN 104579861 A,056-656-069-094-396,2015-04-29,2015,CN 201410447403 A,2014-09-04,US 201314017341 A,2013-09-04,FFT tap WiFi extension device,"Techniques for adding WiFi capabilities to a region may include installing WiFi access points in a cable television (CATV) system. For easier installation of the WiFi access points, a WiFi access point extension devices may be integrated into existing taps in the CATV system. The WiFi extended taps are able to provide radio frequency (RF)/CATV signals to subscribers, provide power to the respectively integrated WiFi access point, and maintain power to the coaxial transmission line during installation. During installation, the WiFi access point extension devices can be integrated into the CATV outdoor distribution plant without having to splice into an existing coaxial transmission line. The multiplicity of existing tap locations in CATV distribution plants makes the positioning of new wireless access points extremely versatile for the cable provider.",ARRIS ENTPR INC,JAMIE J SWIFT;;DENNIS P CONROY;;CHRISTOPHER E JEBLONSKI;;DAVID C HARTRUM;;JOSEPH M COLUSSI,,https://lens.org/056-656-069-094-396,Patent Application,no,6,0,9,9,0,H04N21/64707;;H04N21/6168;;H04N21/41;;H04N21/64707;;Y10T29/49169;;H04N21/41;;H04N21/6168;;H04N21/6156;;H04N21/64707;;Y10T29/49169,H04L12/28;;H04W88/08,,1,0,,,"李峰等: ""“同轴电缆之上的802.11无线网络”"", 《通信技术》",ACTIVE
158,US,B2,US 8056062 B2,039-342-237-102-589,2011-11-08,2011,US 74840707 A,2007-05-14,US 74840707 A,2007-05-14,Methods and systems for converting application code in turbine control systems,"Embodiments of the invention are generally directed to systems and methods for converting application code in a turbine control system. According to one embodiment of the invention, a method for converting a turbine control system may be provided for. The method may include providing a first application code format including one or more elements, providing a second application code format including one or more elements, and identifying mappings of the one or more first application code format elements to the one or more second application code format elements. The method may further include retrieving a first control system application code written in the first application code format, and generating application data from the first control system application code based at least in part on the identified mappings. Additionally, the method may include converting the application data to a second control system application code written in the second application code format.",GEN ELECTRIC,BOWERS DAVID THOMAS;;KURELLA NAGESH LAXMINARAYANA;;CONROY PATRICK JOSEPH;;ANDREWS PETER FRANK;;LINDENMUTH MARC GAVIN,GENERAL ELECTRIC COMPANY (2007-06-15),https://lens.org/039-342-237-102-589,Granted Patent,yes,7,8,2,2,0,G06F8/41;;G06F8/41,G06F9/44,717/136,1,1,068-012-464-196-36X,10.1145/51634.51637,"Parsian et al., ""Ada Translation Tools Development: Automitic Translation of Fortran to Ada"", Jun. 30, 1988 Ada Letteres retrieved from http://delivery.acm.org/10.1145/60000/51637/p57-parsian.pdf?key1=51637&key2=8672888821&coll=DL&dl=ACM&CFID=111935301&CFTOKEN=38572468.",INACTIVE
159,BR,A2,BR 102014021944 A2,050-056-030-975-113,2021-07-27,2021,BR 102014021944 A,2014-09-04,US 201314017341 A,2013-09-04,dispositivo de extensão de wifi de derivação de fft,"dispositivo de extensão de wifi de derivação de fft. as técnicas para adição de capacidades de wifi a uma região podem incluir a instalação de pontos de acesso de wifi em um sistema de televisão a cabo (catv). para uma instalação mais fácil de pontos de acesso de wifi, dispositivos de extensão de ponto de acesso de wifi podem ser integrados nas derivações existentes no sistema de catv. as derivações estendidas de wifi são capazes de proverem sinais de frequência de rádi(rf)/catv para assinantes, prover potência para o ponto de acesso de wifi respectivamente integrado, e manter a potência para a linha de transmissão coaxial durante a instalação. durante a instalação, os dispositivos de extensão de ponto de acesso de wifi podem ser integrados na planta de distribuição de ambiente externo de catv, sem se ter que dividir em uma linha de transmissão coaxial existente. a multiplicidade de localizações de derivações existentes em plantas de distribuição de catv torna o posicionamento dos novos pontos de acesso de wifi sem fio extremamente versátil para o provedor de cabo.",ARRIS ENTPR INC,CHRISTOPHER E JEBLONSKI;;DAVID C HARTRUM;;DENNIS P CONROY;;JAMIE J SWIFT;;JOSEPH M COLUSSI,ARRIS ENTERPRISES LLC (US) (2022-12-20);;ARRIS INTERNATIONAL IP LTD. (GB) (2023-01-10),https://lens.org/050-056-030-975-113,Patent Application,no,0,0,9,9,0,H04N21/64707;;H04N21/6168;;H04N21/41;;H04N21/64707;;Y10T29/49169;;H04N21/41;;H04N21/6168;;H04N21/6156;;H04N21/64707;;Y10T29/49169,H04N21/41;;H04N21/61;;H04N21/647,,0,0,,,,ACTIVE
160,US,A1,US 2007/0120100 A1,121-578-055-448-805,2007-05-31,2007,US 48381706 A,2006-07-11,US 48381706 A;;US 20156802 A;;US 30788501 P,2001-07-27,Conformal coatings comprising carbon nanotubes,"The invention is directed to conformal coatings that provide excellent shielding against electromagnetic interference (EMI). A conformal coating comprises an insulating layer and a conducting layer containing electrically conductive material. The insulating layer comprises materials for protecting a coated object. The conducting layer comprises materials that provide EMI shielding such as carbon black, carbon buckeyballs, carbon nanotubes, chemically-modified carbon nanotubes and combinations thereof. The insulating layer and the conductive layer may be the same or different, and may be applied to an object simultaneously or sequentially. Accordingly, the invention is also directed to objects that are partially or completely coated with a conformal coating that provides EMI shielding.",GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID H JR;;PICHE JOSEPH W;;CONROY JEFFREY L,GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS DAVID H JR;;PICHE JOSEPH W;;CONROY JEFFREY L,,https://lens.org/121-578-055-448-805,Patent Application,yes,14,32,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,H01B1/04;;B05D5/12;;B05D7/00;;C09D5/00;;C09D5/24;;C09D7/62;;G21F1/10;;H01B1/24;;H05K9/00,252/502,0,0,,,,DISCONTINUED
161,BR,A8,BR 102014021944 A8,035-324-536-499-550,2022-12-20,2022,BR 102014021944 A,2014-09-04,US 201314017341 A,2013-09-04,DISPOSITIVO DE EXTENSÃO DE WIFI DE DERIVAÇÃO DE FFT,"DISPOSITIVO DE EXTENSÃO DE WIFI DE DERIVAÇÃO DE FFT. As técnicas para adição de capacidades de WiFi a uma região podem incluir a instalação de pontos de acesso de WiFi em um sistema de televisão a cabo (CATV). Para uma instalação mais fácil de pontos de acesso de WiFi, dispositivos de extensão de ponto de acesso de WiFi podem ser integrados nas derivações existentes no sistema de CATV. As derivações estendidas de WiFi são capazes de proverem sinais de frequência de rádi(RF)/CATV para assinantes, prover potência para o ponto de acesso de WiFi respectivamente integrado, e manter a potência para a linha de transmissão coaxial durante a instalação. Durante a instalação, os dispositivos de extensão de ponto de acesso de WiFi podem ser integrados na planta de distribuição de ambiente externo de CATV, sem se ter que dividir em uma linha de transmissão coaxial existente. A multiplicidade de localizações de derivações existentes em plantas de distribuição de CATV torna o posicionamento dos novos pontos de acesso de WiFi sem fio extremamente versátil para o provedor de cabo.",ARRIS ENTPR INC;;ARRIS ENTPR LLC,DENNIS P CONROY;;DAVID C HARTRUM;;JAMIE J SWIFT;;JOSEPH M COLUSSI;;CHRISTOPHER E JEBLONSKI,ARRIS ENTERPRISES LLC (US) (2022-12-20);;ARRIS INTERNATIONAL IP LTD. (GB) (2023-01-10),https://lens.org/035-324-536-499-550,Patent Application,no,0,0,9,9,0,H04N21/64707;;H04N21/6168;;H04N21/41;;H04N21/64707;;Y10T29/49169;;H04N21/41;;H04N21/6168;;H04N21/6156;;H04N21/64707;;Y10T29/49169,H04N21/647;;H04N21/41;;H04N21/61,,0,0,,,,ACTIVE
162,US,B2,US 7118693 B2,061-947-586-344-147,2006-10-10,2006,US 20156802 A,2002-07-24,US 20156802 A;;US 30788501 P,2001-07-27,Conformal coatings comprising carbon nanotubes,"The invention is directed to conformal coatings that provide excellent shielding against electromagnetic interference (EMI). A conformal coating comprises an insulating layer and a conducting layer containing electrically conductive material. The insulating layer comprises materials for protecting a coated object. The conducting layer comprises materials that provide EMI shielding such as carbon black, carbon buckeyballs, carbon nanotubes, chemically-modified carbon nanotubes and combinations thereof. The insulating layer and the conductive layer may be the same or different, and may be applied to an object simultaneously or sequentially. Accordingly, the invention is also directed to objects that are partially or completely coated with a conformal coating that provides EMI shielding.",EIKOS INC,GLATKOWSKI PAUL J;;LANDRAU NELSON;;LANDIS JR DAVID H;;PICHE JOSEPH W;;CONROY JEFFREY L,EIKOS INC (2002-08-29),https://lens.org/061-947-586-344-147,Granted Patent,yes,17,122,12,12,0,B05D5/12;;B05D7/52;;B82Y10/00;;B82Y30/00;;C08K3/04;;C09D5/00;;C09D5/24;;G21F1/10;;H01B1/24;;H05K9/0086;;Y10S977/742;;Y10S977/75;;Y10S428/922;;Y10S428/924;;C09D175/04;;C09D179/08;;C08K3/045;;C08K3/041;;C09D7/70;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;C09D7/62;;Y10T428/1393;;Y10T428/30;;Y10T428/25;;Y10T428/249971;;Y10T428/249978;;H05K9/0086;;B05D7/52;;C09D5/00;;B82Y10/00;;C09D5/24;;G21F1/10;;B82Y30/00;;C08K3/04;;H01B1/24;;B05D5/12;;Y10S428/922;;Y10S977/742;;Y10S428/924;;Y10S977/75;;C08K3/041;;C09D175/04;;C09D179/08;;C09D7/70;;C08K3/045;;C09D7/62,H01B1/24;;B05D5/12;;B05D7/00;;B32B3/26;;B32B9/00;;C09D5/00;;C09D5/24;;C09D7/62;;G21F1/10;;H05K1/00;;H05K9/00,252/502;;252/500;;252/511;;X174 35 R;;977/742;;977/750;;361/818;;428/36.91;;428/323;;428/313.3;;428/315.5;;428/408;;428/922;;428/924;;X423445 B;;423/447.3;;423/447.1,0,0,,,,EXPIRED
163,MX,A,MX 2014010564 A,128-601-770-304-138,2015-07-17,2015,MX 2014010564 A,2014-09-03,US 201314017341 A,2013-09-04,FFT TAP WIFI EXTENSION DEVICE.,"Techniques for adding WiFi capabilities to a region may include installing WiFi access points in a cable television (CATV) system. For easier installation of the WiFi access points, a WiFi access point extension devices may be integrated into existing taps in the CATV system. The WiFi extended taps are able to provide radio frequency (RF)/CATV signals to subscribers, provide power to the respectively integrated WiFi access point, and maintain power to the coaxial transmission line during installation. During installation, the WiFi access point extension devices can be integrated into the CATV outdoor distribution plant without having to splice into an existing coaxial transmission line. The multiplicity of existing tap locations in CATV distribution plants makes the positioning of new wireless access points extremely versatile for the cable provider.",ARRIS ENTPR INC,HARTRUM DAVID C;;CONROY DENNIS P;;SWIFT JAMIE J;;COLUSSI JOSEPH M;;JEBLONSKI CHRISTOPHER E,,https://lens.org/128-601-770-304-138,Patent Application,no,0,0,9,9,0,H04N21/64707;;H04N21/6168;;H04N21/41;;H04N21/64707;;Y10T29/49169;;H04N21/41;;H04N21/6168;;H04N21/6156;;H04N21/64707;;Y10T29/49169,H04N21/41;;H04N21/61,,0,0,,,,ACTIVE
164,US,B2,US 9113187 B2,129-165-036-956-981,2015-08-18,2015,US 201314017341 A,2013-09-04,US 201314017341 A,2013-09-04,FFT tap WiFi extension device,"Techniques for adding WiFi capabilities to a region may include installing WiFi access points in a cable television (CATV) system. For easier installation of the WiFi access points, a WiFi access point extension devices may be integrated into existing taps in the CATV system. The WiFi extended taps are able to provide radio frequency (RF)/CATV signals to subscribers, provide power to the respectively integrated WiFi access point, and maintain power to the coaxial transmission line during installation. During installation, the WiFi access point extension devices can be integrated into the CATV outdoor distribution plant without having to splice into an existing coaxial transmission line. The multiplicity of existing tap locations in CATV distribution plants makes the positioning of new wireless access points extremely versatile for the cable provider.",ARRIS ENTPR INC,CONROY DENNIS P;;COLUSSI JOSEPH M;;HARTUM DAVID C;;JEBLONSKI CHRISTOPHER E;;SWIFT JAMIE J,ARRIS ENTERPRISES LLC (2013-08-27),https://lens.org/129-165-036-956-981,Granted Patent,yes,8,10,9,9,0,H04N21/64707;;H04N21/6168;;H04N21/41;;H04N21/64707;;Y10T29/49169;;H04N21/41;;H04N21/6168;;H04N21/6156;;H04N21/64707;;Y10T29/49169,H04N7/16;;H04N21/41;;H04N21/61;;H04N21/647,,1,0,,,"BelAir Networks ""Belair100SP Strand Picocell"", retrieved from URL<http://www.linkedin.com/company/belair-networks/belair100sp-strand-picocell-83815/product?trk=biz-product> on Jan. 27, 2014.",ACTIVE
165,US,A1,US 2015/0067755 A1,143-157-069-810-329,2015-03-05,2015,US 201314017341 A,2013-09-04,US 201314017341 A,2013-09-04,FFT Tap WiFi Extension Device,"Techniques for adding WiFi capabilities to a region may include installing WiFi access points in a cable television (CATV) system. For easier installation of the WiFi access points, a WiFi access point extension devices may be integrated into existing taps in the CATV system. The WiFi extended taps are able to provide radio frequency (RF)/CATV signals to subscribers, provide power to the respectively integrated WiFi access point, and maintain power to the coaxial transmission line during installation. During installation, the WiFi access point extension devices can be integrated into the CATV outdoor distribution plant without having to splice into an existing coaxial transmission line. The multiplicity of existing tap locations in CATV distribution plants makes the positioning of new wireless access points extremely versatile for the cable provider.",ARRIS ENTPR INC,CONROY DENNIS P;;COLUSSI JOSEPH M;;HARTRUM DAVID C;;JEBLONSKI CHRISTOPHER E;;SWIFT JAMIE J,ARRIS ENTERPRISES LLC (2013-08-27),https://lens.org/143-157-069-810-329,Patent Application,yes,8,21,9,9,0,H04N21/64707;;H04N21/6168;;H04N21/41;;H04N21/64707;;Y10T29/49169;;H04N21/41;;H04N21/6168;;H04N21/6156;;H04N21/64707;;Y10T29/49169,H04N21/41;;H04N21/61,725/127;;29/854,0,0,,,,ACTIVE
166,MX,B,MX 345891 B,194-701-687-932-880,2017-02-21,2017,MX 2014010564 A,2014-09-03,US 201314017341 A,2013-09-04,FFT TAP WIFI EXTENSION DEVICE.,"Techniques for adding WiFi capabilities to a region may include installing WiFi access points in a cable television (CATV) system. For easier installation of the WiFi access points, a WiFi access point extension devices may be integrated into existing taps in the CATV system. The WiFi extended taps are able to provide radio frequency (RF)/CATV signals to subscribers, provide power to the respectively integrated WiFi access point, and maintain power to the coaxial transmission line during installation. During installation, the WiFi access point extension devices can be integrated into the CATV outdoor distribution plant without having to splice into an existing coaxial transmission line. The multiplicity of existing tap locations in CATV distribution plants makes the positioning of new wireless access points extremely versatile for the cable provider.",ARRIS ENTPR INC,DAVID C HARTRUM;;DENNIS P CONROY;;JAMIE J SWIFT;;JOSEPH M COLUSSI;;CHRISTOPHER E JEBLONSKI,,https://lens.org/194-701-687-932-880,Granted Patent,no,0,0,9,9,0,H04N21/64707;;H04N21/6168;;H04N21/41;;H04N21/64707;;Y10T29/49169;;H04N21/41;;H04N21/6168;;H04N21/6156;;H04N21/64707;;Y10T29/49169,H04N21/41;;H04N21/61,,0,0,,,,ACTIVE
167,BR,A8,BR 102014021944 A8,141-235-282-239-158,2023-01-10,2023,BR 102014021944 A,2014-09-04,US 201314017341 A,2013-09-04,DISPOSITIVO DE EXTENSÃO DE WIFI DE DERIVAÇÃO DE FFT,"DISPOSITIVO DE EXTENSÃO DE WIFI DE DERIVAÇÃO DE FFT. As técnicas para adição de capacidades de WiFi a uma região podem incluir a instalação de pontos de acesso de WiFi em um sistema de televisão a cabo (CATV). Para uma instalação mais fácil de pontos de acesso de WiFi, dispositivos de extensão de ponto de acesso de WiFi podem ser integrados nas derivações existentes no sistema de CATV. As derivações estendidas de WiFi são capazes de proverem sinais de frequência de rádi(RF)/CATV para assinantes, prover potência para o ponto de acesso de WiFi respectivamente integrado, e manter a potência para a linha de transmissão coaxial durante a instalação. Durante a instalação, os dispositivos de extensão de ponto de acesso de WiFi podem ser integrados na planta de distribuição de ambiente externo de CATV, sem se ter que dividir em uma linha de transmissão coaxial existente. A multiplicidade de localizações de derivações existentes em plantas de distribuição de CATV torna o posicionamento dos novos pontos de acesso de WiFi sem fio extremamente versátil para o provedor de cabo.",ARRIS ENTPR INC;;ARRIS ENTPR LLC;;ARRIS INT IP LTD,DENNIS P CONROY;;DAVID C HARTRUM;;JAMIE J SWIFT;;JOSEPH M COLUSSI;;CHRISTOPHER E JEBLONSKI,ARRIS ENTERPRISES LLC (US) (2022-12-20);;ARRIS INTERNATIONAL IP LTD. (GB) (2023-01-10),https://lens.org/141-235-282-239-158,Patent Application,no,0,0,9,9,0,H04N21/64707;;H04N21/6168;;H04N21/41;;H04N21/64707;;Y10T29/49169;;H04N21/41;;H04N21/6168;;H04N21/6156;;H04N21/64707;;Y10T29/49169,H04N21/647;;H04N21/41;;H04N21/61,,0,0,,,,ACTIVE
168,US,A1,US 2008/0288928 A1,164-889-557-895-718,2008-11-20,2008,US 74840707 A,2007-05-14,US 74840707 A,2007-05-14,Methods and Systems for Converting Application Code in Turbine Control Systems,"Embodiments of the invention are generally directed to systems and methods for converting application code in a turbine control system. According to one embodiment of the invention, a method for converting a turbine control system may be provided for. The method may include providing a first application code format including one or more elements, providing a second application code format including one or more elements, and identifying mappings of the one or more first application code format elements to the one or more second application code format elements. The method may further include retrieving a first control system application code written in the first application code format, and generating application data from the first control system application code based at least in part on the identified mappings. Additionally, the method may include converting the application data to a second control system application code written in the second application code format.",GEN ELECTRIC,BOWERS DAVID THOMAS;;KURELLA NAGESH LAXMINARAYANA;;CONROY PATRICK JOSEPH;;ANDREWS PETER FRANK;;LINDENMUTH MARC GAVIN,GENERAL ELECTRIC COMPANY (2007-06-15),https://lens.org/164-889-557-895-718,Patent Application,yes,7,21,2,2,0,G06F8/41;;G06F8/41,G06F9/45,717/136,0,0,,,,INACTIVE
169,US,A,US 4742477 A,155-671-879-210-437,1988-05-03,1988,US 64243884 A,1984-08-20,US 64243884 A,1984-08-20,Computer terminal controller and method,"The computer terminal controller makes it possible to operate a relatively large number of input-output terminals with a single mainframe computer. The controller has a basic configuration enabling it to control up to sixteen terminals. However, the user easily can increase its capacity by adding one or more expansion modules, each module consisting of a cable connector panel and a printed circuit card. Precise locating pins and support structure and hand-operable fasteners are used to mount the panel so that no tools or special skills are needed. Each circuit card preferably contains sufficient circuitry to handle a specific number of additional input/output terminals, and the panel has the same number of cable connectors. The card and the panel are connected to one another by simply plugging them together. The card is guided accurately into engagement with the panel by card guides. A comb-like cable holder structure is provided with flexible arms forming cable enclosures for holding and guiding the cables neatly and compactly within and into and out of the housing of the controller.",SCI SYSTEMS INC,PHILLIPS DARWIN E;;DUROSS ROBERT M;;CONROY WALTER J;;BETTERTON JR JOSEPH T;;GLOVER ALFRED H,SCI SYSTEMS INC (1984-08-14),https://lens.org/155-671-879-210-437,Granted Patent,yes,11,34,1,1,0,H05K7/1429;;H05K7/1429,H05K7/14,364/708;;361/380;;361/395;;361/400,1,0,,,"Panduit Plastic Wiring Duct advertisement the publication date of this date of this advertisement is unknown, but the applicant assumes it to be prior art. (pp. 3 through 5).",EXPIRED
170,US,S,US D0341583 S,079-278-361-680-682,1993-11-23,1993,US 54864290 F,1990-07-05,US 54864290 F,1990-07-05,Keyboard for telephone computer,,TRANSACTION TECH INC,BEVILACQUA ERNEST;;CONROY DAVID;;DOYLE WILLIAM;;HADDOCK ROBERT;;LANG ANNE;;MOYA JOSEPH;;NICHOLS ARTHUR;;THOMPSON CARL,TRANSACTION TECHNOLOGY INC. A CORP. OF DE (1990-04-06),https://lens.org/079-278-361-680-682,Design Right,yes,6,1,1,1,0,,,D14/115,0,0,,,,EXPIRED
171,WO,A2,WO 2006/036970 A2,015-208-704-149-231,2006-04-06,2006,US 2005/0034615 W,2005-09-28,US 61374504 P;;US 61380804 P,2004-09-28,METHOD OF THICKENING A COATING USING A DRUG,"A method for the provision of a coating on an implantable medical device results in a medical device having a bio-absorbable coating. The coating includes a bio&shy;absorbable carrier component. In addition to the bio-absorbable carrier component, a dissolved therapeutic agent component can also be provided. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the dissolved therapeutic agent, to the patient.",ATRIUM MEDICAL CORP;;LABRECQUE ROGER;;MOODIE GEOFFREY;;CONROY SUZANNE;;ROGERS LISA;;FERRARO JOSEPH;;KARWOSKI THEODORE;;HERWECK STEVE A;;MARTAKOS PAUL,LABRECQUE ROGER;;MOODIE GEOFFREY;;CONROY SUZANNE;;ROGERS LISA;;FERRARO JOSEPH;;KARWOSKI THEODORE;;HERWECK STEVE A;;MARTAKOS PAUL,,https://lens.org/015-208-704-149-231,Patent Application,yes,0,5,3,87,0,A61L31/08;;A61L31/08;;A61F2/07;;A61F2/07;;A61F2/885;;A61F2/885;;A61F2/90;;A61F2/90;;A61F2002/065;;A61F2002/065;;A61F2002/075;;A61F2002/075;;A61L31/10;;A61L31/10;;A61L31/16;;A61L31/16;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802,A61K35/60;;A61F2/00,,0,0,,,,PENDING
172,WO,A3,WO 2006/036970 A3,064-794-686-781-023,2006-08-17,2006,US 2005/0034615 W,2005-09-28,US 61374504 P;;US 61380804 P,2004-09-28,METHOD OF THICKENING A COATING USING A DRUG,"A method for the provision of a coating on an implantable medical device results in a medical device having a bio-absorbable coating. The coating includes a bio&shy;absorbable carrier component. In addition to the bio-absorbable carrier component, a dissolved therapeutic agent component can also be provided. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the dissolved therapeutic agent, to the patient.",ATRIUM MEDICAL CORP;;LABRECQUE ROGER;;MOODIE GEOFFREY;;CONROY SUZANNE;;ROGERS LISA;;FERRARO JOSEPH;;KARWOSKI THEODORE;;HERWECK STEVE A;;MARTAKOS PAUL,LABRECQUE ROGER;;MOODIE GEOFFREY;;CONROY SUZANNE;;ROGERS LISA;;FERRARO JOSEPH;;KARWOSKI THEODORE;;HERWECK STEVE A;;MARTAKOS PAUL,,https://lens.org/064-794-686-781-023,Search Report,yes,3,0,3,87,0,A61L31/08;;A61L31/08;;A61F2/07;;A61F2/07;;A61F2/885;;A61F2/885;;A61F2/90;;A61F2/90;;A61F2002/065;;A61F2002/065;;A61F2002/075;;A61F2002/075;;A61L31/10;;A61L31/10;;A61L31/16;;A61L31/16;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802,A61K6/00;;A61K8/02,,0,0,,,,PENDING
173,US,A1,US 2006/0083768 A1,098-735-843-613-802,2006-04-20,2006,US 23856405 A,2005-09-28,US 23856405 A;;US 61374504 P;;US 61380804 P,2004-09-28,Method of thickening a coating using a drug,"A method for the provision of a coating on an implantable medical device results in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a dissolved therapeutic agent component can also be provided. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the dissolved therapeutic agent, to the patient.",ATRIUM MEDICAL CORP,LABRECQUE ROGER;;MOODIE GEOFFREY;;CONROY SUZANNE;;ROGERS LISA;;FERRARO JOSEPH;;KARWOSKI THEODORE;;HERWECK STEVE A;;MARTAKOS PAUL,ATRIUM MEDICAL CORPORATION (2005-12-20),https://lens.org/098-735-843-613-802,Patent Application,yes,99,77,3,87,0,A61L31/08;;A61L31/08;;A61F2/07;;A61F2/07;;A61F2/885;;A61F2/885;;A61F2/90;;A61F2/90;;A61F2002/065;;A61F2002/065;;A61F2002/075;;A61F2002/075;;A61L31/10;;A61L31/10;;A61L31/16;;A61L31/16;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802,A61F2/00;;A61K48/00,424/423;;514/44;;514/291;;514/449;;514/460;;514/548;;514/458,0,0,,,,DISCONTINUED
174,CN,A,CN 103377416 A,117-966-277-960-177,2013-10-30,2013,CN 201310144200 A,2013-04-24,US 201213454350 A,2012-04-24,System and method for configuration and management of power plant assets,"Systems and methods for generating and maintaining configuration and management of power plant assets are described herein. A list of possible plant assets are received from a plant information model 324. One or more hardware assets describing a configuration of a particular power plant are selected, such as turbines, pumps, control interfaces, and so forth. Hierarchical relationships between at least a portion of the selected assets are defined. Asset configuration data 100 is generated based at least in part on the selection and the defined relationships.",GEN ELECTRIC,CONROY PATRICK JOSEPH;;DAMODAR DHANASHREE SADANAND;;BANERJEE ABHIK;;OJHA PRADYUMNA;;BOLLA VEERA PAPARAO;;GOLI BALAJOSE;;ROMANIK CHRISTINA ANN,,https://lens.org/117-966-277-960-177,Patent Application,no,4,1,4,4,0,G05B23/0208;;G05B23/0208;;G05B19/4188;;G05B19/4188;;G05B2219/31334;;G05B2219/31334;;Y02P90/02;;Y02P90/02,G06Q10/06;;G06Q50/06,,0,0,,,,DISCONTINUED
175,US,A1,US 2013/0282190 A1,047-532-018-200-741,2013-10-24,2013,US 201213454350 A,2012-04-24,US 201213454350 A,2012-04-24,SYSTEM AND METHOD FOR CONFIGURATION AND MANAGEMENT OF POWER PLANT ASSETS,"Systems and methods for generating and maintaining configuration and management of power plant assets are described herein. A list of possible plant assets are received from a plant information model. One or more hardware assets describing a configuration of a particular power plant are selected, such as turbines, pumps, control interfaces, and so forth. Hierarchical relationships between at least a portion of the selected assets are defined. Asset configuration data is generated based at least in part on the selection and the defined relationships.",CONROY PATRICK JOSEPH;;DAMODAR DHANASHREE SADANAND;;BANERJEE ABHIK;;OJHA PRADYUMNA;;BOLLA VEERA PAPARAO;;GOLI BALAJOSE;;ROMANIK CHRISTINA ANN;;GEN ELECTRIC,CONROY PATRICK JOSEPH;;DAMODAR DHANASHREE SADANAND;;BANERJEE ABHIK;;OJHA PRADYUMNA;;BOLLA VEERA PAPARAO;;GOLI BALAJOSE;;ROMANIK CHRISTINA ANN,GENERAL ELECTRIC COMPANY (2012-04-05),https://lens.org/047-532-018-200-741,Patent Application,yes,40,8,4,4,0,G05B23/0208;;G05B23/0208;;G05B19/4188;;G05B19/4188;;G05B2219/31334;;G05B2219/31334;;Y02P90/02;;Y02P90/02,G06F1/26,700/286,5,2,166-250-067-018-427;;092-742-289-229-199,10.1109/tec.2005.845528;;10.1016/j.compchemeng.2005.12.007,"Heo et al, ""Development of a Need-Oriented Steam Turbine Cycle Simulation Toolbox"", December 2005, pagess 859-869;;Rinard et al, ""ForeSee-A hierarchical dynamic modeling and simulation system of complex processes"", 2006, pages 1326-1345.;;Osisoft.com, ""The Power of Analysis Framework"", February 8, 2007, pages 6.;;Loncar et al, ""Sustainable Development of Croatian Capacity in CHP sector"", June 2002, pages 36.;;Osisoft, ""PI Analysis Framework User Guide"", 2006, pages 40.",DISCONTINUED
176,EP,A2,EP 2657802 A2,188-616-261-609-089,2013-10-30,2013,EP 13165070 A,2013-04-24,US 201213454350 A,2012-04-24,System and method for configuration and management of power plant assets,"Systems and methods for generating and maintaining configuration and management of power plant assets are described herein. A list of possible plant assets are received from a plant information model 324. One or more hardware assets describing a configuration of a particular power plant are selected, such as turbines, pumps, control interfaces, and so forth. Hierarchical relationships between at least a portion of the selected assets are defined. Asset configuration data 100 is generated based at least in part on the selection and the defined relationships.
",GEN ELECTRIC,CONROY PATRICK JOSEPH;;DAMODAR DHANASHREE SADANAND;;BANERJEE ABHIK;;OJHA PRADYUMNA;;BOLLA VEERA PAPARAO;;GOLI BALAJOSE;;ROMANIK CHRISTINA ANN,,https://lens.org/188-616-261-609-089,Patent Application,yes,0,0,4,4,0,G05B23/0208;;G05B23/0208;;G05B19/4188;;G05B19/4188;;G05B2219/31334;;G05B2219/31334;;Y02P90/02;;Y02P90/02,G05B23/02,,0,0,,,,DISCONTINUED
177,JP,A,JP 2013229025 A,136-104-080-344-434,2013-11-07,2013,JP 2013087925 A,2013-04-19,US 201213454350 A,2012-04-24,SYSTEM AND METHOD FOR CONSTITUTING AND MANAGING POWER PLANT ASSET,"PROBLEM TO BE SOLVED: To provide a system and method for managing physical plant assets in a power plant or relating to the power plant, and to provide a system and method for managing and constituting those assets in more detail.SOLUTION: Disclosed is a system 100 and method for generating and holding the constitution and management of power plant assets. The list of executable plant assets 102 is received from a plant information model. One or more hardware assets describing the constitution of a specific power plant such as a turbine, a pump and a control interface are selected. A hierarchical relation between at least a part of the selected assets is specified. On the basis of at least a part of the selected and specified relation, asset constitution data are generated.",GEN ELECTRIC,PATRICK JOSEPH CONROY;;DHANASHREE SADANAND DAMODAR;;ABHIK BANERJEE;;PRADYUMNA OJHA;;VEERA PAPARAO BOLLA;;BALAJOSE GOLI;;CHRISTINA ANN ROMANIK,,https://lens.org/136-104-080-344-434,Patent Application,no,0,1,4,4,0,G05B23/0208;;G05B23/0208;;G05B19/4188;;G05B19/4188;;G05B2219/31334;;G05B2219/31334;;Y02P90/02;;Y02P90/02,G05B23/02,,0,0,,,,PENDING
178,WO,A3,WO 2006/036983 A3,125-419-990-909-964,2006-09-14,2006,US 2005/0034681 W,2005-09-28,US 61374504 P,2004-09-28,PRE-DRIED DRUG DELIVERY COATING FOR USE WITH A STENT,"A method and apparatus for the provision of a coating for application to a medical device results in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component and solvent can also be provided. The solvent is removed from the coating before the coating is applied to the medical device. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the therapeutic agent, to the patient.",ATRIUM MEDICAL CORP;;LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,,https://lens.org/125-419-990-909-964,Search Report,yes,1,0,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,A61F2/02;;A61F2/82;;A61F2/86,,0,0,,,,PENDING
179,US,B2,US 9451418 B2,199-769-368-493-844,2016-09-20,2016,US 201313803598 A,2013-03-14,US 201313803598 A;;US 201261716361 P,2012-10-19,Group association based on network determined location,"Systems, methods, and devices enable group associations based on network determined location information. The various embodiments enable the ad-hoc creation of mobile device groups based on network determined locations. In an embodiment, a server may determine the location of a mobile device and based on the mobile device being located in a pairing zone may add the mobile device to a group. In an embodiment, the server may add the mobile device to the group following the occurrence of a trigger event, such as the mobile device pausing in a given pairing zone for a period of time. In an embodiment, the server may identify that mobile devices are located within a pairing zone and may add all the mobile devices in the pairing zone to the same group.",QUALCOMM INC,JOSEPH GEORGE;;MARX PETER S;;BILANGE ERIC P;;CELEBI LEYLA S;;LAMBA GAURAV;;CONROY CORMAC S;;DUA PRAVEEN;;MEHTA JAYAL M,QUALCOMM INCORPORATED (2013-05-06),https://lens.org/199-769-368-493-844,Granted Patent,yes,18,11,11,11,0,H04W4/021;;H04W4/023;;H04W4/08;;H04W8/186;;H04W8/186;;H04W4/021;;H04W4/023;;H04W4/08;;H04W4/08;;H04W8/186;;H04W4/021;;H04W4/023,H04B7/00;;H04W4/021;;H04W4/08;;H04W8/18,,1,0,,,"International Search Report and Written Opinion-PCT/US2013/065756-ISA/EPO-Mar. 3, 2014.",ACTIVE
180,US,A1,US 2014/0113674 A1,192-166-356-190-38X,2014-04-24,2014,US 201313803598 A,2013-03-14,US 201313803598 A;;US 201261716361 P,2012-10-19,GROUP ASSOCIATION BASED ON NETWORK DETERMINED LOCATION,"Systems, methods, and devices enable group associations based on network determined location information. The various embodiments enable the ad-hoc creation of mobile device groups based on network determined locations. In an embodiment, a server may determine the location of a mobile device and based on the mobile device being located in a pairing zone may add the mobile device to a group. In an embodiment, the server may add the mobile device to the group following the occurrence of a trigger event, such as the mobile device pausing in a given pairing zone for a period of time. In an embodiment, the server may identify that mobile devices are located within a pairing zone and may add all the mobile devices in the pairing zone to the same group.",QUALCOMM INC,JOSEPH GEORGE;;MARX PETER S;;BILANGE ERIC P;;CELEBI LEYLA S;;LAMBA GAURAV;;CONROY CORMAC S;;DUA PRAVEEN;;MEHTA JAYAL M,QUALCOMM INCORPORATED (2013-05-06),https://lens.org/192-166-356-190-38X,Patent Application,yes,11,78,11,11,0,H04W4/021;;H04W4/023;;H04W4/08;;H04W8/186;;H04W8/186;;H04W4/021;;H04W4/023;;H04W4/08;;H04W4/08;;H04W8/186;;H04W4/021;;H04W4/023,H04W4/08;;H04W4/021,455/519,0,0,,,,ACTIVE
181,US,A1,US 2011/0274823 A1,019-683-495-696-631,2011-11-10,2011,US 201113185135 A,2011-07-18,US 201113185135 A;;US 23855405 A;;US 61374504 P,2004-09-28,APPLICATION OF A COATING ON A MEDICAL DEVICE,"Methods and devices for the provision of a coating on an implantable medical device. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The methods and devices provide a coating having improved uniformity and coverage which in turn allow for greater control of the amount and dosage of the coating.",LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,ATRIUM MEDICAL CORPORATION (2005-11-15),https://lens.org/019-683-495-696-631,Patent Application,yes,2,19,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,B05D7/00;;A61F2/82;;A61F2/86;;B05D1/00;;B05D1/02;;B05D1/18;;B05D1/28;;B05D3/00,427/2.25;;427/2.1;;427/2.3,0,0,,,,INACTIVE
182,EP,A1,EP 2910037 A1,133-835-661-195-967,2015-08-26,2015,EP 13789090 A,2013-10-18,US 201261716361 P;;US 201313803598 A;;US 2013/0065756 W,2012-10-19,GROUP ASSOCIATION BASED ON A NETWORK DETERMINED LOCATION,,QUALCOMM INC,JOSEPH GEORGE;;MARX PETER S;;BILANGE ERIC P;;CELEBI LEYLA S;;LAMBA GAURAV;;CONROY CORMAC S;;DUA PRAVEEN;;MEHTA JAYAL M,,https://lens.org/133-835-661-195-967,Patent Application,yes,0,0,11,11,0,H04W4/021;;H04W4/023;;H04W4/08;;H04W8/186;;H04W8/186;;H04W4/021;;H04W4/023;;H04W4/08;;H04W4/08;;H04W8/186;;H04W4/021;;H04W4/023,H04W4/08;;H04W4/021;;H04W8/18,,0,0,,,,ACTIVE
183,KR,A,KR 20150074080 A,023-604-502-689-55X,2015-07-01,2015,KR 20157012924 A,2013-10-18,US 201261716361 P;;US 201313803598 A;;US 2013/0065756 W,2012-10-19,GROUP ASSOCIATION BASED ON NETWORK DETERMINED LOCATION,"본 출원은 네트워크 결정식 위치 정보에 기초하여 그룹 연관들을 가능케 하는 방법 및 서버를 제공한다. 다양한 실시형태들은 네트워크 결정식 위치들에 기초하여 모바일 디바이스 그룹들의 애드혹 생성을 가능케 한다. 일 실시형태에 있어서, 서버 (207) 는 모바일 디바이스 (214) 의 위치를 결정할 수도 있고, 모바일 디바이스가 페어링 존 (226) 에 위치된다는 것에 기초하여, 모바일 디바이스를 그룹 (214-220) 에 부가할 수도 있다. 일 실시형태에 있어서, 서버는, 모바일 디바이스가 일 시간 주기 동안 소정의 페어링 존에서 일시중지하는 것과 같은 트리거 이벤트의 발생 이후에 모바일 디바이스를 그룹에 부가할 수도 있다. 일 실시형태에 있어서, 서버는 모바일 디바이스들이 페어링 존 내에 위치됨을 식별할 수도 있으며, 페어링 존에서의 모든 모바일 디바이스들을 동일한 그룹에 부가할 수도 있다.",QUALCOMM INC,JOSEPH GEORGE;;MARX PETER S;;BILANGE ERIC P;;CELEBI LEYLA S;;LAMBA GAURAV;;CONROY CORMAC S;;DUA PRAVEEN;;MEHTA JAYAL M,,https://lens.org/023-604-502-689-55X,Patent Application,no,2,3,11,11,0,H04W4/021;;H04W4/023;;H04W4/08;;H04W8/186;;H04W8/186;;H04W4/021;;H04W4/023;;H04W4/08;;H04W4/08;;H04W8/186;;H04W4/021;;H04W4/023,H04W4/021;;H04W8/18,,0,0,,,,ACTIVE
184,US,A1,US 2006/0067977 A1,096-442-268-412-585,2006-03-30,2006,US 23955505 A,2005-09-28,US 23955505 A;;US 61374504 P,2004-09-28,Pre-dried drug delivery coating for use with a stent,"A method and apparatus for the provision of a coating for application to a medical device results in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component and solvent can also be provided. The solvent is removed from the coating before the coating is applied to the medical device. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the therapeutic agent, to the patient.",ATRIUM MEDICAL CORP,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,ATRIUM MEDICAL CORPORATION (2005-11-15),https://lens.org/096-442-268-412-585,Patent Application,yes,96,116,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,A61F2/00;;A61F2/82;;A61F2/86,424/426,0,0,,,,DISCONTINUED
185,WO,A3,WO 2006/037049 A3,116-274-886-981-017,2006-08-31,2006,US 2005/0034836 W,2005-09-28,US 61374504 P,2004-09-28,APPLICATION OF A COATING ON A MEDICAL DEVICE,"Methods and devices (300) for the provision of a coating on an implantable medical device (310). The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The methods and devices provide a coating having improved uniformity and coverage which in turn allow for greater control of the amount and dosage of the coating.",ATRIUM MEDICAL CORP;;LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,,https://lens.org/116-274-886-981-017,Search Report,yes,6,0,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,B05C13/02;;A61B1/32;;A61F2/82;;A61F2/86;;A61M25/00;;B05D5/08,,0,0,,,,PENDING
186,WO,A1,WO 2014/063100 A1,124-483-124-256-59X,2014-04-24,2014,US 2013/0065756 W,2013-10-18,US 201261716361 P;;US 201313803598 A,2012-10-19,GROUP ASSOCIATION BASED ON NETWORK DETERMINED LOCATION,"The application provides a method and a server for enabling group associations based on network determined location information. The various embodiments enable the ad-hoc creation of mobile device groups based on network determined locations. In an embodiment, a server (207) may determine the location of a mobile device (214) and based on the mobile device being located in a pairing zone (226) may add the mobile device to a group (214-220). In an embodiment, the server may add the mobile device to the group following the occurrence of a trigger event, such as the mobile device pausing in a given pairing zone for a period of time. In an embodiment, the server may identify that mobile devices are located within a pairing zone and may add all the mobile devices in the pairing zone to the same group.",QUALCOMM INC,JOSEPH GEORGE;;MARX PETER S;;BILANGE ERIC P;;CELEBI LEYLA S;;LAMBA GAURAV;;CONROY CORMAC S;;DUA PRAVEEN;;MEHTA JAYAL M,,https://lens.org/124-483-124-256-59X,Patent Application,yes,3,3,11,11,0,H04W4/021;;H04W4/023;;H04W4/08;;H04W8/186;;H04W8/186;;H04W4/021;;H04W4/023;;H04W4/08;;H04W4/08;;H04W8/186;;H04W4/021;;H04W4/023,H04W4/08;;H04W4/021;;H04W8/18,,0,0,,,,PENDING
187,US,B2,US 8722132 B2,077-330-352-871-367,2014-05-13,2014,US 201113185135 A,2011-07-18,US 201113185135 A;;US 23855405 A;;US 61374504 P,2004-09-28,Application of a coating on a medical device,"Methods and devices for the provision of a coating on an implantable medical device. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The methods and devices provide a coating having improved uniformity and coverage which in turn allow for greater control of the amount and dosage of the coating.",LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE;;ATRIUM MEDICAL CORP,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,ATRIUM MEDICAL CORPORATION (2005-11-15),https://lens.org/077-330-352-871-367,Granted Patent,yes,101,23,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,B05D3/00;;A61F2/82;;A61F2/86,427/2.1;;427/2.24;;427/2.25,21,5,121-518-616-187-47X;;012-224-721-274-561;;107-683-021-659-003;;009-415-282-876-854;;074-774-683-240-998,10.1016/s1359-0294(00)00020-0;;10.1161/hc3101.092214;;11479260;;9676794;;10.1002/(sici)1097-0304(199807)44:3<267::aid-ccd4>3.0.co;2-3;;10.1097/00019501-200312000-00005;;14646676;;14563585;;10.1016/s0735-1097(03)01056-8,"International Search Report for International Application PCT/US2008/071547, dated Oct. 22, 2008.;;International Search Report for International Application PCT/US2008/071565, dated Oct. 22, 2008.;;Supplementary European Search Report for European Application No. 08782511, dated Apr. 23, 2013.;;Non-Final Office Action of U.S. Appl. No. 11/238,554 (listed on SB-08 as U.S. Patent No. 8,001,922), dated Jul. 25, 2008.;;Final Office Action of U.S. Appl. No. 11/238,554 (listed on SB-08 as U.S. Patent No. 8,001,922), dated May 1, 2009.;;Advisory Action of U.S. Appl. No. 11/238,554 (listed on SB-08 as U.S. Patent No. 8,001,922), dated Jul. 10, 2009.;;Notice of Allowance of U.S. Appl. No. 11/238,554 (listed on SB-08 as U.S. Patent No. 8,001,922), dated Apr. 28, 2011.;;Non-Final Office Action of U.S. Appl. No. 12/182,165 (listed on SB-08 as U.S. Application Publication 2009-0011116), dated Jan. 5, 2012.;;Final Office Action of U.S. Appl. No. 12/182,165 (listed on SB-08 as U.S. Application Publication 2009-0011116), dated Apr. 6, 2012.;;Non-Final Office Action of U.S. Appl. No. 12/182,261 (listed on SB-08 as U.S. Patent No. 8,312,836), dated Dec. 21, 2011.;;Final Office Action of U.S. Appl. No. 12/182,261 (listed on SB-08 as U.S. Patent No. 8,312,836), dated Apr. 30, 2012.;;Notice of Allowance of U.S. Appl. No. 12/182,261 (listed on SB-08 as U.S. Patent No. 8,312,836), dated Jul. 23, 2012.;;Non-Final Office Action for U.S. Appl. No. 12/182,165 (listed on SB-08 as U.S. Publication US 2009-0011116), dated Jun. 24, 2013.;;Camurus, ""In our endeavors to create the unique, we start with the best. Your product."";;Drummond, Calum J. et al, ""Surfactant self-assembly objects as novel drug delivery vehicles,"" Current Opinion in Colloid & Interface Science, vol. 4:449-456 (2000).;;Engström, Sven, ""Drug Delivery from Cubic and Other Lipid-water Phases,"" Lipid Technology, vol. 2(2):42-45 (1990).;;Hwang, Chao-Wei et al, ""Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery,"" Circulation, vol. 104:600-605 (2001).;;Oberhoff, Martin et al, ""Local and Systemic Delivery of Low Molecular Weight Heparin Following PCTA: Acute Results and 6-Month Follow-Up of the Initial Clinical Experience With the Porous Balloon (Pilot-Study),"" Catheterization and Cardiovascular Diagnosis, vol. 44:267-274 (1998).;;Salu, Koen J. et al, ""Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model,"" Coronary Artery Disease, vol. 14(8):545-555 (2003).;;Scheller, Bruno et al, ""Addition of Paclitaxel to Contrast Media Prevents Restenosis After Coronary Stent Implantation,"" Journal of the American College of Cardiology, vol. 42(8):1415-1420 (2003).;;International Search Report for Application No. PCT/US05/34836, dated Jul. 6, 2006.",INACTIVE
188,EP,B1,EP 2910037 B1,176-647-794-486-057,2017-11-29,2017,EP 13789090 A,2013-10-18,US 201261716361 P;;US 201313803598 A;;US 2013/0065756 W,2012-10-19,GROUP ASSOCIATION BASED ON A NETWORK DETERMINED LOCATION,,QUALCOMM INC,JOSEPH GEORGE;;MARX PETER S;;BILANGE ERIC P;;CELEBI LEYLA S;;LAMBA GAURAV;;CONROY CORMAC S;;DUA PRAVEEN;;MEHTA JAYAL M,,https://lens.org/176-647-794-486-057,Granted Patent,yes,1,0,11,11,0,H04W4/021;;H04W4/023;;H04W4/08;;H04W8/186;;H04W8/186;;H04W4/021;;H04W4/023;;H04W4/08;;H04W4/08;;H04W8/186;;H04W4/021;;H04W4/023,H04W4/08;;H04W4/021;;H04W8/18,,0,0,,,,ACTIVE
189,CN,A,CN 104737563 A,107-129-528-766-416,2015-06-24,2015,CN 201380054391 A,2013-10-18,US 2013/0065756 W;;US 201261716361 P;;US 201313803598 A,2012-10-19,Group association based on network determined location,"The application provides a method and a server for enabling group associations based on network determined location information. The various embodiments enable the ad-hoc creation of mobile device groups based on network determined locations. In an embodiment, a server (207) may determine the location of a mobile device (214) and based on the mobile device being located in a pairing zone (226) may add the mobile device to a group (214-220). In an embodiment, the server may add the mobile device to the group following the occurrence of a trigger event, such as the mobile device pausing in a given pairing zone for a period of time. In an embodiment, the server may identify that mobile devices are located within a pairing zone and may add all the mobile devices in the pairing zone to the same group.",QUALCOMM INC,JOSEPH GEORGE;;MARX PETER S;;BILANGE ERIC P;;CELEBI LEYLA S;;LAMBA GAURAV;;CONROY CORMAC S;;DUA PRAVEEN;;MEHTA JAYAL M,,https://lens.org/107-129-528-766-416,Patent Application,no,6,2,11,11,0,H04W4/021;;H04W4/023;;H04W4/08;;H04W8/186;;H04W8/186;;H04W4/021;;H04W4/023;;H04W4/08;;H04W4/08;;H04W8/186;;H04W4/021;;H04W4/023,H04W4/08;;H04W4/021;;H04W8/18,,0,0,,,,INACTIVE
190,WO,A2,WO 2006/036983 A2,145-015-910-719-357,2006-04-06,2006,US 2005/0034681 W,2005-09-28,US 61374504 P,2004-09-28,PRE-DRIED DRUG DELIVERY COATING FOR USE WITH A STENT,"A method and apparatus for the provision of a coating for application to a medical device results in a medical device having a bio-absorbable coating. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component and solvent can also be provided. The solvent is removed from the coating before the coating is applied to the medical device. The coated medical device is implantable in a patient to effect controlled delivery of the coating, including the therapeutic agent, to the patient.",ATRIUM MEDICAL CORP;;LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,,https://lens.org/145-015-910-719-357,Patent Application,yes,0,4,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,A61K35/60;;A61F2/00;;A61F2/82;;A61F2/86,,0,0,,,,PENDING
191,US,B2,US 8001922 B2,186-825-565-063-992,2011-08-23,2011,US 23855405 A,2005-09-28,US 23855405 A;;US 61374504 P,2004-09-28,Application of a coating on a medical device,"Devices for the provision of a coating on an implantable medical device are provided. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The devices provide a coating having improved uniformity and coverage which in turn allow for greater control of the amount and dosage of the coating.",ATRIUM MEDICAL CORP,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,ATRIUM MEDICAL CORPORATION (2005-11-15),https://lens.org/186-825-565-063-992,Granted Patent,yes,101,14,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,B05C1/00;;A61F2/82;;A61F2/86,118/200;;427/2.1;;427/2.24,9,5,121-518-616-187-47X;;012-224-721-274-561;;107-683-021-659-003;;009-415-282-876-854;;074-774-683-240-998,10.1016/s1359-0294(00)00020-0;;10.1161/hc3101.092214;;11479260;;9676794;;10.1002/(sici)1097-0304(199807)44:3<267::aid-ccd4>3.0.co;2-3;;10.1097/00019501-200312000-00005;;14646676;;14563585;;10.1016/s0735-1097(03)01056-8,"A paper entitled, ""Evaluation of the Biocompatibility and Drug Delivery Capabilities of Biological Oil Based Stent Coatings,"" by Li, Shengqiao of the Katholieke Universiteit Leuven.;;International Search Report for Application No. PCT/US05/34836, dated Jul. 6, 2006.;;Camurus, ""In our endeavors to create the unique, we start with the best. Your product."";;Drummond, Calum J. et al, ""Surfactant self-assembly objects as novel drug delivery vehicles,"" Current Opinion in Colloid & Interface Science, vol. 4:449-456 (2000).;;Engström, Sven, ""Drug Delivery from Cubic and Other Lipid-water Phases,"" Lipid Technology, vol. 2(2):42-45 (1990).;;Hwang, Chao-Wei et al, ""Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery,"" Circulation, vol. 104:600-605 (2001).;;Oberhoff, Martin et al, ""Local and Systemic Delivery of Low Molecular Weight Heparin Following PTCA: Acute Results and 6-Month Follow-Up of the Initial Clinical Experience With the Porous Balloon (PILOT-Study),"" Catheterization and Cardiovascular Diagnosis, vol. 44:267-274 (1998).;;Salu, Koen J. et al, ""Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model,"" Coronary Artery Disease, vol. 14(8):545-555 (2003).;;Scheller, Bruno et al, ""Addition of Paclitaxel to Contrast Media Prevents Restenosis After Coronary Stent Implantation,"" Journal of the American College of Cardiology, vol. 42(8):1415-1420 (2003).",INACTIVE
192,US,A1,US 2006/0121081 A1,127-388-289-144-67X,2006-06-08,2006,US 23855405 A,2005-09-28,US 23855405 A;;US 61374504 P,2004-09-28,Application of a coating on a medical device,"Methods and devices for the provision of a coating on an implantable medical device. The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The methods and devices provide a coating having improved uniformity and coverage which in turn allow for greater control of the amount and dosage of the coating.",ATRIUM MEDICAL CORP,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,ATRIUM MEDICAL CORPORATION (2005-11-15),https://lens.org/127-388-289-144-67X,Patent Application,yes,99,34,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,A61F2/82;;A61F2/86;;A61M35/00;;B05D3/02,424/423;;623/1.15;;427/2.26;;604/1,0,0,,,,INACTIVE
193,WO,A2,WO 2006/037049 A2,198-558-882-600-140,2006-04-06,2006,US 2005/0034836 W,2005-09-28,US 61374504 P,2004-09-28,APPLICATION OF A COATING ON A MEDICAL DEVICE,"Methods and devices (300) for the provision of a coating on an implantable medical device (310). The coating includes a bio-absorbable carrier component. In addition to the bio-absorbable carrier component, a therapeutic agent component can also be provided. The methods and devices provide a coating having improved uniformity and coverage which in turn allow for greater control of the amount and dosage of the coating.",ATRIUM MEDICAL CORP;;LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,LABRECQUE ROGER;;MOODIE GEOFFREY;;FERRARO JOSEPH;;ROGERS LISA;;MARTAKOS PAUL;;KARWOSKI THEODORE;;HERWECK STEVE A;;CONROY SUZANNE;;SUNTER BRIAN;;HENRICH GEORGETTE,,https://lens.org/198-558-882-600-140,Patent Application,yes,0,2,21,87,0,A61L31/08;;A61L31/08;;A61F2/82;;A61F2/82;;A61F2/86;;A61F2/86;;A61F2250/0067;;A61F2250/0067;;A61K47/10;;A61K47/10;;A61K47/22;;A61K47/22;;A61K47/44;;A61K47/44;;A61L31/10;;A61L31/10;;A61L31/148;;A61L31/16;;A61L31/16;;A61L2300/22;;A61L2300/22;;A61L2300/416;;A61L2300/416;;A61L2300/428;;A61L2300/428;;A61L2300/45;;A61L2300/45;;A61L2300/606;;A61L2300/606;;A61L2300/802;;A61L2300/802;;A61L2420/02;;A61L2420/02;;A61M25/0009;;A61M25/0009;;A61M25/0045;;A61M25/0045;;A61P3/00;;A61P7/02;;A61P29/00;;A61P35/00,A61K35/60;;A61F2/00;;A61F2/82;;A61F2/86,,0,0,,,,PENDING
194,DE,C2,DE 2537195 C2,040-491-321-529-010,1987-04-09,1987,DE 2537195 A,1975-08-21,US 50163474 A;;US 59043075 A,1974-08-29,DE 2537195 C2,,"QUANTUM COMPOSITES, INC., MIDLAND, MICH., US","HEILMAN, WILLIAM JOSEPH, ALLISON PARK, PA., US;;PETERSON, FRANK CLYDE, ORANGE, TEX., US;;RENZ, MICAL CONROY;;THEARD, LESLIE PETER, HOUSTON, TEX., US","QUANTUM COMPOSITES, INC., MIDLAND, MICH., US (1984-10-18)",https://lens.org/040-491-321-529-010,Granted Patent,no,0,0,10,25,0,C08J3/091;;C08J3/091;;C08F283/10;;C08F283/10;;C08J2335/06;;C08J2335/06;;C08K5/05;;C08K5/05;;C08K5/08;;C08K5/08;;C08K5/09;;C08K5/09;;C08K5/17;;C08K5/17;;C08L35/06;;C08L35/06;;C08L63/00;;C08L63/00,C08L33/00;;C08F283/10;;C08J3/09;;C08K5/10;;C08K5/1539;;C08L25/00;;C08L33/02;;C08L35/00,,0,0,,,,EXPIRED
195,US,B1,US 10474330 B1,063-375-059-247-099,2019-11-12,2019,US 201414286861 A,2014-05-23,US 201414286861 A,2014-05-23,Supplementary content layers,"Some implementations include identifying conflicts between multiple layers of supplementary content associated with a digital work (e.g., an electronic book). For individual conflicts between layers of supplementary content at one or more locations within the digital work, conflicts between layers may be resolved in favor of a higher priority layer. Upon resolution of the conflict, information associated with the higher priority layer for supplementing content at a particular location in the digital work may be determined. A visual identifier of the higher priority layer may be displayed along with content associated with the digital work at the particular location.",AMAZON TECH INC,BROOKES CRAIG R;;KING JOSEPH;;YU WAINWRIGHT GREGORY SIADY;;MOORE CHARLES CONROY;;OLCOTT ANDREW;;MENNINGA ERIC ALLEN;;WATSON BRANDON LABRANCHE;;CRAFT ANDREW SCOTT,AMAZON TECHNOLOGIES INC (2014-05-29),https://lens.org/063-375-059-247-099,Granted Patent,yes,14,0,1,1,0,G06F3/0484;;G06F3/0484;;G06F40/103;;G06F40/106;;G06F40/169,G06F3/00;;G06F3/0484;;G06F17/21,,0,0,,,,ACTIVE
196,WO,A2,WO 2008/039308 A2,051-422-972-443-325,2008-04-03,2008,US 2007/0019978 W,2007-09-14,US 52539006 A,2006-09-22,PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME,"A bio-absorbable stand-alone film is derived at least in part from fatty acids. The bio-absorbable stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. The stand-alone film has one or more perforations or depressions formed therein. Corresponding methods of making the bio- absorbable stand-alone film with one or more perforations or depressions include molding, cutting, carving, puncturing or otherwise suitable methods to create the perforations or depressions in the bio-absorbable stand-alone film. The resulting stand alone film is bio-absorbable.",ATRIUM MEDICAL CORP;;HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,,https://lens.org/051-422-972-443-325,Patent Application,yes,0,17,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61L31/00;;A61L31/14,,0,0,,,,PENDING
197,US,A1,US 2007/0071798 A1,158-381-335-027-89X,2007-03-29,2007,US 52539006 A,2006-09-22,US 52539006 A;;US 23726405 A;;US 61380804 P;;US 72686905 P,2004-09-28,Perforated bioabsorbable oil film and methods for making the same,"A bio-absorbable stand-alone film is derived at least in part from fatty acids. The bio-absorbable stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. The stand-alone film has one or more perforations or depressions formed therein. Corresponding methods of making the bio-absorbable stand-alone film with one or more perforations or depressions include molding, cutting, carving, puncturing or otherwise suitable methods to create the perforations or depressions in the bio-absorbable stand-alone film. The resulting stand-alone film is bioabsorbable.",ATRIUM MEDICAL CORP,HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,ATRIUM MEDICAL CORPORATION (2006-12-05),https://lens.org/158-381-335-027-89X,Patent Application,yes,99,42,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61K9/70,424/443,0,0,,,,ACTIVE
198,US,B2,US 8574618 B2,116-251-970-437-08X,2013-11-05,2013,US 201213682991 A,2012-11-21,US 201213682991 A;;US 52539006 A;;US 23726405 A;;US 61380804 P;;US 72686905 P,2004-09-28,Perforated bioabsorbable oil film and methods for making the same,"A bio-absorbable stand-alone film is derived at least in part from fatty acids. The bio-absorbable stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. The stand-alone film has one or more perforations or depressions formed therein. Corresponding methods of making the bio-absorbable stand-alone film with one or more perforations or depressions include molding, cutting, carving, puncturing or otherwise suitable methods to create the perforations or depressions in the bio-absorbable stand-alone film. The resulting stand-alone film is bioabsorbable.",ATRIUM MEDICAL CORP,HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,ATRIUM MEDICAL CORPORATION (2005-11-07),https://lens.org/116-251-970-437-08X,Granted Patent,yes,100,2,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61F2/02,424/423,99,15,100-176-598-076-477;;064-537-834-566-45X;;121-518-616-187-47X;;062-869-359-643-29X;;012-224-721-274-561;;183-299-871-235-178;;061-647-378-924-636;;107-683-021-659-003;;009-415-282-876-854;;074-774-683-240-998;;005-252-447-646-653;;065-142-893-532-911;;048-810-042-623-799;;169-123-655-792-862;;111-219-182-232-532,10.1007/bf02672540;;10.1021/ie50056a004;;10.1016/s1359-0294(00)00020-0;;10.1016/j.porgcoat.2004.07.024;;10.1161/hc3101.092214;;11479260;;10.1016/s0300-9440(00)00126-0;;10.1021/ie50380a016;;9676794;;10.1002/(sici)1097-0304(199807)44:3<267::aid-ccd4>3.0.co;2-3;;10.1097/00019501-200312000-00005;;14646676;;14563585;;10.1016/s0735-1097(03)01056-8;;8840862;;10.1161/01.cir.94.7.1690;;15919203;;10.1016/j.biortech.2005.03.028;;10.1021/cm00021a036;;pmc279979;;3258426;;10.1073/pnas.85.7.2303;;8356522,"Autosuture, ""ParietexTM Composite OS Series Mesh,"" retrieved online at http://www.autosuture.com/AutoSuture/pagebuilder.aspx?topicID=135734&breadcrumbs=135 601:0 (2007).;;Binder et al., ""Chromatographic Analysis of Seed Oils. Fatty Acid Composition of Castor Oil,"" The Journal of the American Oil Chemists' Society, vol. 39:513-517 (1962).;;Redman, L.V. et al., ""The drying rate of raw paint oils-a comparison,"" The Journal of Industrial and Engineering Chemistry, vol. 5: 630-636 (1913).;;Drummond, Calum J., et al., ""Surfactant self-assembly objects as novel drug delivery vehicles,"" Current Opinion in Colliod & Interface Science, vol. 4:449-456 (2000).;;Engstrom, Sven, ""Drug Delivery from Cubic and Other Lipid-water Phases,"" Lipid Technology, vol. 2(2):42-45 (1990).;;Guler, et al. ""Some empirical equations for oxopolymerization of linseed oil,"" Progress in Organic Coatings, vol. 51:365-371 (2004).;;Hwang, Chao-Wei, et al, ""Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery,"" Circulation, vol. 104:600-605 (2001).;;Mallegol, et al., ""Drier Influence on the Curing of Linseed Oil,"" Progress in Organic Coatings 39:107-113 (2000).;;Morse, Richard ""Molecular Distillation of Polymerized Drying Oils,"" Industrial and Engineering Chemisry 33:1039-1043 (1941).;;Oberhoff, Martin, et al, ""Local and Systemic Delivery of Low Molecular Weight Heparin Following PTCA: Acute Results and 6-Month Follow-Up of the Initial Clinical Experience With the Porous Balloon (Pilot-Study),"" Catheterization and Cardiovascular Diagnosis, vol. 44:267-274 (1998).;;Salu, Koen J., et al, ""Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model,"" Coronary Artery Disease, vol. 14(8):545-555 (2003).;;Scheller, Bruno, et al, ""Addition of Paclitaxel to Contrast Media Prevents Restenosis After Coronary Stent Implantation,"" Journal of the American College of Cardiology, vol. 42(8):1415-1420 (2003).;;Van der Giessen, Willem J., et al, ""Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries,"" Circulation, vol. 94:1690-1697 (1996).;;Ogunniyi, D.S., ""Castor oil: A vital industrial raw material,"" Biosource Technology, vol. 97: 1086-1091 2006.;;Crivello et al., ""Epoxidized triglycerides as renewable monomers in photoinitiated cationic polymerization,"" Chem. Mater, 1992:692-699.;;Encylopedia Britannica Online, ""Surface Coating,"" available online at http://www.britannica.com/EBchecked/topic/575029/surface-coating>, date accessed Jun. 17, 2011.;;Timir-Balizsy et al., ""Chemical Principals of Textile Conservation,"" Oxford: Elsevier Science Ltd., 1998:117-119.;;""Polymerization"" Merriam-Webster Online Dictionary, retrieved from on Dec. 13, 2009; Merriam-Webster's Inc. 2009; pp. 1.;;Shahidi, Fereidoon ed.; ""Bailey's Industrial Oil and Fats Products"" 2005; John Wiley and Sons; vol. 5, Edible Oil and Fat Products: Processing Technologies, pp. 1-15.;;Ahtia et al. Journal of Indian Pediatric Surgery 2002 7:15-20.;;Jonasson, Lena et al., ""Cyclosporon A inhibits smooth muscle proliferation in the vascular response to injury,"" Proc. Natl. Acad. Sci. USA, vol. 85: 2303-2306 (1988).;;Wikipedia, ""Sirolimus,"" pp. 1-13, available online at http://en.wikipedia.org/wiki/Sirolimus, date accessed May 11, 2011.;;CECW-EE, ""Ch. 4: Coating Types and Characteristics,"" Engineering and Design-Painting: New Construction and Maintenance, pp. 4-1 to 4-24 (1995).;;Rutkow, Ira M. et al., ""'Tension-free' inguinal herniorrhaphy: A preliminary report on the 'mesh plug' technique,"" Surgery, vol. 114:3-8 (1993).;;Websters Dictionary Online, Accessed on Feb. 13, 2009, entry for ""polymer"" p. 1 of 1.;;International Search Report for International Application PCT/US05/034601, dated Apr. 10, 2006.;;International Search Report for International Application PCT/US05/034610, dated Mar. 16, 2006.;;International Search Report for International Application PCT/US05/034614, dated Aug. 29, 2006.;;International Search Report for International Appl cat on PCT/US05/034615, dated May 16, 2006.;;International Search Report for International Application PCT/US05/034678, dated Aug. 28, 2006.;;International Search Report for International Application PCT/US05/034681, dated Jul. 26, 2006.;;International Search Report for International Application PCT/US05/034682, dated Jul. 20, 2006.;;International Search Report for International Application PCT/US05/034836, dated Jul. 6, 2006.;;International Search Report for International Applicat on PCT/US06/037184, dated Feb. 22, 2007.;;International Preliminary Report on Patentability for International Application PCT/US06/040753, dated Oct. 3, 2008.;;International Search Report for International Application PCT/US06/040753, dated Sep. 24, 2007,.;;International Search Report for International Application PCT/US07/019978, dated May 7, 2009,.;;International Search Report for International Application PCT/US07/022860, dated Apr. 22, 2009.;;International Search Report for International Application PCT/US07/022944, dated Apr. 8, 2009.;;International Search Report for International Application PCT/US08/000565, dated May 4, 2009.;;International Preliminary Examination Report for International Application PCT/US08/071547, dated Aug. 26, 2010.;;International Search Report for International Application PCT/US08/071547, dated Oct. 22, 2008.;;International Preliminary Report on Patentability for International Application PCT/US08/071565, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US08/071565, dated Nov. 10, 2008.;;International Search Report for International Application PCT/US08/085386, dated Feb. 4, 2009.;;International Search Report for International Application PCT/US09/037364, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US10/026521, dated Jun. 23, 2010.;;International Search Report for International Application PCT/US10/052899, dated Jan. 10, 2011.;;Supplementary European Search Report for Application No. EP 05 80 2894, dated Jul. 27, 2011.;;Supplementary European Search Report in Application No. 05 800 844, dated Aug. 19, 2011.;;Supplementary European Search Report in Application No. EP 05 80 4291, dated Jul. 26, 2011.;;Supplementary European Search Report in Application No. EP 05 85 8430, dated Aug. 18, 2011.;;International Search Report for International Application No. PCT/U805/34941, dated May 4, 2006.;;Supplementary European Search Report for Application No, EP 08877338.7, dated Aug. 16, 2012.;;Supplementary European Search Report for Application No. EP09819594.4, dated Aug. 14, 2012.;;International Search Report for PCT/US2011/44292, dated Dec. 6, 2011.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), mailed Mar. 25, 2006.;;Final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), mailed May 17, 2011.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), mailed Aug. 24, 2009.;;Non-final Office Action for U.S. Appl. No. 11/236,977 (listed on SB/08 as US 2006/0088596), mailed Aug. 3, 2009.;;Final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), mailed Jul. 7, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), mailed Oct. 7, 2009.;;Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), mailed Jun. 2, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), mailed Oct. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), mailed Nov. 23, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), mailed Mar. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), mailed Nov. 4, 2009.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), mailed Dec. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), mailed Mar. 30, 2009.;;Final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), mailed Sep. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554, (listed on SB/08 as US 2006/0121081), mailed May 12, 2010.;;Non-final Office Action for U.S. Appl. No, 11/238,554 (listed on SB/08 as US 2006/0121081), mailed Oct. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), mailed May 1, 2009.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), mailed Jul. 25, 2008.;;Non-final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), mailed Apr. 16, 2008.;;Final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), mailed Aug. 6, 2009.;;Non-final Office Action for U.S. Appl. No. 11/239,555 (listed on SB/08 as US 2006/0067977), mailed Mar. 30, 2009.;;Non-final Office Action for U.S. Appl. No. 11/525,328 (listed on SB/08 as US 2007/0084144), mailed Apr. 30, 2007.;;Non-final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), mailed Jul. 14, 2010.;;Final Office Action for U.S. Appl. No. 11/525,390 (listed on SB/08 as US 2007/0071798), mailed Feb. 21, 2011.;;Final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), mailed May 12, 2011.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), mailed Nov. 9, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), mailed Jan. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), mailed May 12, 2009.;;Non-final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), mailed Apr. 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), mailed Dec. 3, 2010.;;Non-final Office Action for U.S. Appl. No. 11/980,155 (listed on SB/08 as US 2008/0113001), mailed Mar. 24, 2011.;;Non-final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305), mailed Dec. 8, 2010.;;Non-final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937), mailed Feb. 25, 2010.;;Final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937), mailed Aug. 31, 2010.;;Non-final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552), mailed Dec. 11, 2009.;;Final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552), mailed Sep. 21, 2010.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) mailed May 5, 2009.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) mailed Dec. 2, 2010.;;Interview summary for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586) mailed May 5, 2009.;;Interview summary for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149) mailed Dec. 7, 2010.;;Interview summary for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937) mailed Dec. 2, 2010.;;Interview summary for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552) mailed Dec. 2, 2010.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), mailed Jul. 13, 2011.",ACTIVE
199,EP,A2,EP 2086605 A2,177-995-479-569-570,2009-08-12,2009,EP 07838216 A,2007-09-14,US 2007/0019978 W;;US 52539006 A,2006-09-22,PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME,,ATRIUM MEDICAL CORP,HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,,https://lens.org/177-995-479-569-570,Patent Application,yes,0,0,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61L31/14;;A61L31/16,,0,0,,,,DISCONTINUED
200,BR,A2,BR PI0717412 A2,107-676-172-698-848,2013-11-12,2013,BR PI0717412 A,2007-09-14,US 52539006 A;;US 2007/0019978 W,2006-09-22,"FILME ÚNICO, E, MÉTODO PARA A PRODUÇÃO DE UM FILME ÚNICO",,ATRIUM MEDICAL CORP,HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,,https://lens.org/107-676-172-698-848,Patent Application,no,0,0,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61L31/14;;A61L31/16,,0,0,,,,DISCONTINUED
201,WO,A3,WO 2008/039308 A3,009-494-855-584-006,2009-06-18,2009,US 2007/0019978 W,2007-09-14,US 52539006 A,2006-09-22,PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME,"A bio-absorbable stand-alone film is derived at least in part from fatty acids. The bio-absorbable stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. The stand-alone film has one or more perforations or depressions formed therein. Corresponding methods of making the bio- absorbable stand-alone film with one or more perforations or depressions include molding, cutting, carving, puncturing or otherwise suitable methods to create the perforations or depressions in the bio-absorbable stand-alone film. The resulting stand alone film is bio-absorbable.",ATRIUM MEDICAL CORP;;HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,,https://lens.org/009-494-855-584-006,Search Report,yes,5,0,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61L31/14;;A61L31/16,,0,0,,,,PENDING
202,US,B2,US 8367099 B2,118-083-717-600-050,2013-02-05,2013,US 52539006 A,2006-09-22,US 52539006 A;;US 23726405 A;;US 61380804 P;;US 72686905 P,2004-09-28,Perforated fatty acid films,"A bio-absorbable stand-alone film is derived at least in part from fatty acids. The bio-absorbable stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. The stand-alone film has one or more perforations or depressions formed therein. Corresponding methods of making the bio-absorbable stand-alone film with one or more perforations or depressions include molding, cutting, carving, puncturing or otherwise suitable methods to create the perforations or depressions in the bio-absorbable stand-alone film. The resulting stand-alone film is bioabsorbable.",ATRIUM MEDICAL CORP;;HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,ATRIUM MEDICAL CORPORATION (2006-12-05),https://lens.org/118-083-717-600-050,Granted Patent,yes,100,56,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61L15/16,424/447,99,16,087-516-990-109-332;;121-518-616-187-47X;;062-869-359-643-29X;;012-224-721-274-561;;169-123-655-792-862;;183-299-871-235-178;;061-647-378-924-636;;107-683-021-659-003;;065-142-893-532-911;;064-537-834-566-45X;;111-219-182-232-532;;009-415-282-876-854;;074-774-683-240-998;;005-252-447-646-653;;048-810-042-623-799;;100-176-598-076-477,7605369;;10.1016/0021-9150(94)05472-u;;10.1016/s1359-0294(00)00020-0;;10.1016/j.porgcoat.2004.07.024;;10.1161/hc3101.092214;;11479260;;pmc279979;;3258426;;10.1073/pnas.85.7.2303;;10.1016/s0300-9440(00)00126-0;;10.1021/ie50380a016;;9676794;;10.1002/(sici)1097-0304(199807)44:3<267::aid-ccd4>3.0.co;2-3;;15919203;;10.1016/j.biortech.2005.03.028;;10.1021/ie50056a004;;8356522;;10.1097/00019501-200312000-00005;;14646676;;14563585;;10.1016/s0735-1097(03)01056-8;;8840862;;10.1161/01.cir.94.7.1690;;10.1021/cm00021a036;;10.1007/bf02672540,"A paper entitled, ""Evaluation of the Biocompatibility and Drug Delivery Capabilities of Biological Oil Based Stent Coatings,"" by Li, Shengqiao of the Katholieke Universiteit Leuven.;;European Office Action for Application No. 07838216.5, dated Feb. 11, 2010.;;International Search Report for Application No. PCT/US2007/019978, dated May 7, 2009.;;""cure"" in Academic Press Dictionary of Science and Technology (1992).;;""polymerization"" Merriam-Webster Online Dictionary, retrieved from on Dec. 13, 2009; Merriam-Webster's Inc. 2009; pp. 1.;;Ahuja et al. ""Prevention of Postoperative Intraperitoneal Adhesions-An Experimental Study in Rats,"" Journal of Indian Pediatric Surgery 2002 7:15-20.;;Autosuture, ""ParietexTM Composite OS Series Mesh,"" retrieved online at http://www.autosuture.com/AutoSuture/pagebuilder.aspx?topicID=135734&breadcrumbs=135 601:0 (2007).;;De Scheerder, Ivan K. et al. ""Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries,"" Atherosclerosis, vol. 114:105-114.;;Drummond, Calum J. et al., ""Surfactant self-assembly objects as novel drug delivery vehicles,"" Current Opinion in Colliod & Interface Science, vol. 4:449-456 (2000).;;Engstrom, Sven, ""Drug Delivery from Cubic and Other Lipid-water Phases,"" Lipid Technology, vol. 2(2):42-45 (1990).;;Guler et al. (Some empirical equations for oxopolymerization of linseed oil. Progress in Organic Coatings 2004, vol. 51, 365-371).;;Hwang, Chao-Wei et al, ""Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery,"" Circulation, vol. 104:600-605 (2001).;;Jonasson, Lena et al., ""Cyclosporon A inhibits smooth muscle proliferation in the vascular response to injury,"" Proc. Natl. Acad. Sci. USA, vol. 85: 2303-2306 (1988).;;Mallegol et al., ""Drier Influence on the Curing of Linseed Oil,"" Progress in Organic Coatings 39:107-113 (2000).;;Morse, Richard ""Molecular Distillation of Polymerized Drying Oils,"" Industrial and Engineering Chemisry 33:1039-1043 (1941).;;Oberhoff, Martin et al, ""Local and Systemic Delivery of Low Molecular Weight Heparin Following PTCA: Acute Results and 6-Month Follow-Up of the Initial Clinical Experience With the Porous Balloon (PILOT-Study),"" Catheterization and Cardiovascular Diagnosis, vol. 44:267-274 (1998).;;Ogunniyi, D.S., ""Castor oil: A vital industrial raw material,"" Biosource Technology, vol. 97: 1086-1091 (2006).;;Redman, L.V. et al., ""The drying rate of raw paint oils-a comparison,"" The Journal of Industrial and Engineering Chemistry, vol. 5: 630-636 (1913).;;Rutkow, Ira M. et al., ""'Tension-free' inguinal herniorrhaphy: A preliminary report on the 'mesh plug' technique,"" Surgery, vol. 114:3-8 (1993).;;Salu, Koen J. et al, ""Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model,"" Coronary Artery Disease, vol. 14(8):545-555 (2003).;;Scheller, Bruno et al, ""Addition of Paclitaxel to Contrast Media Prevents Restenosis After Coronary Stent Implantation,"" Journal of the American College of Cardiology, vol. 42(8):1415-1420 (2003).;;Shahidi, Fereidoon ed.; ""Bailey's Industrial Oil and Fats Products""2005; John Wiley and Sons; vol. 5, Edible Oil and Fat Products: Processing Technologies, pp. 1-15.;;Van der Giessen, Willem J. et al, ""Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries,"" Circulation, vol. 94:1690-1697 (1996).;;Websters Dictionary Online, Accessed on Feb. 13, 2009, entry for ""polymer"" p. 1 of 1.;;Crivello et al., ""Epoxidized triglycerides as renewable monomers in photoinitiated cationic polymerization,"" Chem. Mater, 1992:692-699.;;Encylopedia Britannica Online, ""Surface Coating,"" available online at http://www.britannica.com/EBchecked/topic/575029/surface-coating>, date accessed Jun. 17, 2011.;;Supplementary European Search Report in Application No. EP 05 80 4291, dated Jul. 26, 2011.;;Supplementary European Search Report for Application No. EP 05 80 2894, dated Jul. 27, 2011.;;Supplementary European Search Report in Application No. 05 800 844, dated Aug. 19, 2011.;;Supplementary European Search Report in Application No. EP 05 85 8430, dated Aug. 18, 2011.;;Final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), mailed Jun. 22, 2011,;;Final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305), mailed Aug. 11, 2011.;;Non-Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), mailed Aug. 17, 2011.;;Binder et al., ""Chromatographic Analysis of Seed Oils. Fatty Acid Composition of Castor Oil,"" The Journal of the American Oil Chemists' Society, vol. 39:513-517 (1962).;;Cecw-Ee, ""Ch. 4: Coating Types and Characteristics,"" Engineering and Design-Painting: New Construction and Maintenance, pp. 4-1 to 4-24 (1995).;;Wikipedia, ""Sirolimus,"" pp. 1-13, available online at http://en.wikipedia.org/wiki/Sirolimus, date accessed May 11, 2011.;;Timar Balzsy et al., ""Chemical Principals of Textile Conservation,"" Oxford: Elsevier Science Ltd., 117-119 (1998).;;International Search Report for International Application PCT/US05/034601, dated Apr. 10, 2006.;;International Search Report for International Application PCT/US05/034610, dated Mar. 16, 2006.;;International Search Report for International Application PCT/US05/034614, dated Aug. 29, 2006.;;International Search Report for International Application PCT/US05/034615, dated May 16, 2006.;;International Search Report for International Application PCT/US05/034678, dated Aug. 28, 2006.;;International Search Report for International Application PCT/US05/034681, dated Jul. 26, 2006.;;International Search Report for International Application PCT/US05/034682, dated Jul. 20, 2006.;;International Search Report for International Application PCT/US05/034836, dated Jul. 6, 2006.;;International Search Report for International Application PCT/US05/034941, dated May 4, 2006.;;International Search Report for International Application PCT/US06/037184, dated Feb. 22, 2007.;;International Preliminary Report on Patentability for International Application PCT/US06/040753, dated Sep. 9, 2008.;;International Search Report for International Application PCT/US06/040753, dated Sep. 24, 2007.;;International Search Report for International Application PCT/US07/022860, dated Apr. 22, 2009.;;International Search Report for International Application PCT/US07/022944, dated Apr. 8, 2009.;;International Search Report for International Application PCT/US08/000565, dated May 4, 2009.;;International Preliminary Examination Report for International Application PCT/US08/071547, dated Aug. 26, 2010.;;International Search Report for International Application PCT/US08/071547, dated Oct. 22, 2008.;;International Preliminary Report on Patentability for International Application PCT/US08/071565, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US08/071565, dated Nov. 10, 2008.;;International Search Report for International Application PCT/US08/085386, dated Feb. 4, 2009.;;International Search Report for International Application PCT/US09/037364, dated Aug. 27, 2009.;;International Search Report for International Application PCT/US10/026521, dated Jun. 23, 2010.;;International Search Report for International Application PCT/US10/052899, dated Jan. 10, 2011.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), mailed Mar. 25, 2006.;;Final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), mailed May 17, 2011.;;Non-final Office Action for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974), mailed Aug. 24, 2009.;;Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB/08 as US 2006/0067975), mailed Dec. 23, 2009.;;Non-Final Office Action for U.S. Appl. No. 11/236,943 (listed on SB/08 as US 2006/0067975), mailed Mar. 5, 009.;;Non-final Office Action for U.S. Appl. No. 11/236,977 (listed on SB/08 as US 2006/0088596), mailed Aug. 3, 2009.;;Final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), mailed Jul. 7, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,263 (listed on SB/08 as US 2006/0110457), mailed Oct. 7, 2009.;;Final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), mailed Jun. 2, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,264 (listed on SB/08 as US 2006/0067983), mailed Oct. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), mailed Nov. 23, 2010.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), mailed Mar. 5, 2009.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), mailed Nov. 4, 2009.;;Non-final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), mailed Dec. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), mailed Mar. 30, 2009.;;Final Office Action for U.S. Appl. No. 11/238,532 (listed on SB/08 as US 2006/0067976), mailed Sep. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), mailed May 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), mailed Oct. 9, 2009.;;Final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), mailed May 1, 2009.;;Non-final Office Action for U.S. Appl. No. 11/238,554 (listed on SB/08 as US 2006/0121081), mailed Jul. 25, 2008.;;Non-final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), mailed Apr. 16, 2008.;;Final Office Action for U.S. Appl. No. 11/238,564 (listed on SB/08 as US 2006/0083768), mailed Aug. 6, 2009.;;Non-final Office Action for U.S. Appl. No. 11/239,555 (listed on SB/08 as US 2006/0067977), mailed Mar. 30, 2009.;;Non-final Office Action for U.S. Appl. No. 11/525,328 (listed on SB/08 as US 2007/0084144), mailed Apr. 30, 2007.;;Final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), mailed May 12, 2011.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), mailed Nov. 9, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), mailed Jan. 6, 2010.;;Non-final Office Action for U.S. Appl. No. 11/582,135 (listed on SB/08 as US 2007/0202149), mailed May 12, 2009.;;Non-final Office Action for U.S. Appl. No. 11/701,799 (listed on SB/08 as US 2008/0109017), mailed Apr. 12, 2010.;;Non-final Office Action for U.S. Appl. No. 11/978,840 (listed on SB/08 as US 2008/0118550), mailed Dec. 3, 2010.;;Non-final Office Action for U.S. Appl. No. 11/980,155 (listed on SB/08 as US 2008/0113001.), mailed Mar. 24, 2011.;;Non-final Office Action for U.S. Appl. No. 12/075,223 (listed on SB/08 as US 2008/0206305.), mailed Dec. 8, 2010.;;Non-final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937.), mailed Feb. 25, 2010.;;Final Office Action for U.S. Appl. No. 12/325,546 (listed on SB/08 as US 2009/0181937.), mailed Aug. 31, 2010.;;Non-final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552.), mailed Dec. 11, 2009.;;Final Office Action for U.S. Appl. No. 12/364,763 (listed on SB/08 as US 2009/0208552.), mailed Sep. 21, 2010.;;Final Office Action for U.S. Appl. No. 11/237,420 (listed on SB/08 as US 2006/0078586), mailed Jul. 13, 2011.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) mailed May 5, 2009.;;Interview summary for U.S. Appl. No. 11/236,908 (listed on SB/08 as US 2006/0067974) mailed Dec. 2, 2010.",ACTIVE
203,US,A1,US 2013/0074452 A1,154-476-920-345-481,2013-03-28,2013,US 201213682991 A,2012-11-21,US 201213682991 A;;US 52539006 A;;US 23726405 A;;US 61380804 P;;US 72686905 P,2004-09-28,PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THE SAME,"A bio-absorbable stand-alone film is derived at least in part from fatty acids. The bio-absorbable stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. The stand-alone film has one or more perforations or depressions formed therein. Corresponding methods of making the bio-absorbable stand-alone film with one or more perforations or depressions include molding, cutting, carving, puncturing or otherwise suitable methods to create the perforations or depressions in the bio-absorbable stand-alone film. The resulting stand-alone film is bioabsorbable.",ATRIUM MEDICAL CORP;;ATRIUM MEDICAL CORP,HERWECK STEVE A;;SWANICK THOMAS M;;FERRARO JOSEPH;;MARTAKOS PAUL;;ROGERS LISA;;KARWOSKI THEODORE;;FAUCHER KEITH M;;MCNAMARA PHILIP;;LABRECQUE ROGER;;CONROY SUZANNE;;CARLTON TREVOR,ATRIUM MEDICAL CORPORATION (2005-11-07),https://lens.org/154-476-920-345-481,Patent Application,yes,1,2,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,B26F1/18;;B65B55/18;;B29C39/02;;B65B31/04,53/432;;264/299;;83/30;;53/396;;53/435,0,0,,,,ACTIVE
204,CA,A1,CA 2663741 A1,168-361-320-056-393,2008-04-03,2008,CA 2663741 A,2007-09-14,US 52539006 A;;US 2007/0019978 W,2006-09-22,PERFORATED BIOABSORBABLE OIL FILM AND METHODS FOR MAKING THESAME,"A bio-absorbable stand-alone film is derived at least in part from fatty acids. The bio-absorbable stand-alone film can have anti-adhesive, anti-infl ammatory, non-inflammatory, and wound healing properties, and can additional ly include one or more therapeutic agents incorporated therein. The stand-al one film has one or more perforations or depressions formed therein. Corresp onding methods of making the bio- absorbable stand-alone film with one or mo re perforations or depressions include molding, cutting, carving, puncturing or otherwise suitable methods to create the perforations or depressions in the bio-absorbable stand-alone film. The resulting stand alone film is bio-a bsorbable.",ATRIUM MEDICAL CORP,LABRECQUE ROGER;;SWANICK THOMAS M;;FAUCHER KEITH M;;MCNAMARA PHILIP;;HERWECK STEVE A;;MARTAKOS PAUL;;FERRARO JOSEPH;;ROGERS LISA;;CARLTON TREVOR;;KARWOSKI THEODORE;;CONROY SUZANNE,,https://lens.org/168-361-320-056-393,Patent Application,no,0,0,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61L31/00;;A61L31/14,,0,0,,,,DISCONTINUED
205,AU,A1,AU 2007/300608 A1,024-467-013-951-690,2008-04-03,2008,AU 2007/300608 A,2007-09-14,US 52539006 A;;US 2007/0019978 W,2006-09-22,Perforated bioabsorbable oil film and methods for making the same,,ATRIUM MEDICAL CORP,FAUCHER KEITH M;;LABRECQUE ROGER;;MARTAKOS PAUL;;CARLTON TREVOR;;HERWECK STEVE A;;NAMARA PHILIP MC;;SWANICK THOMAS M;;KARWOSKI THEODORE;;FERRARO JOSEPH;;ROGERS LISA;;CONROY SUZANNE,,https://lens.org/024-467-013-951-690,Patent Application,no,0,0,12,12,0,A61B2017/00004;;A61B2017/320044;;A61F2/0059;;A61L2/07;;A61L2/081;;A61L2/087;;A61L2/14;;A61L2/186;;A61L2/206;;A61L2/208;;A61L31/00;;A61L31/145;;A61L31/148;;A61L2202/24;;A61B2090/0816;;Y10T83/0481;;A61F2/0095;;A61P43/00;;Y10T83/0481;;A61B2017/00004;;A61L2/208;;A61L31/148;;A61L2/14;;A61L31/00;;A61L2202/24;;A61L31/145;;A61L2/186;;A61L2/087;;A61L2/206;;A61F2/0059;;A61L2/07;;A61L2/081;;A61B2017/320044;;A61B2090/0816;;B26F1/18;;B29C39/02;;B65B31/04;;B65B55/18,A61L31/00;;A61L31/14,,0,0,,,,DISCONTINUED
206,US,S,US D0417203 S,121-367-477-327-202,1999-11-30,1999,US 9630498 F,1998-11-09,US 9630498 F,1998-11-09,Computer housing,,SILICON GRAPHICS INC,FIGUEROA GILBERT;;BECK JONATHAN DAVID;;SIEFERT STEVEN G;;BARTHOLOMEW MARK E;;LENART CHRISTOPHER N;;BRUNNER ROBERT D;;CHIA BENJAMIN PEI-MING;;RICHET BRUNO;;CONROY MICHAEL JOSEPH,SGI INTERNATIONAL INC (2009-05-13);;SILICON GRAPHICS INC (1998-11-05);;MORGAN STANLEY & CO. INCORPORATED (2007-09-26);;HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP (2017-05-01);;SILICON GRAPHICS INTERNATIONAL CORP (2012-08-08),https://lens.org/121-367-477-327-202,Design Right,yes,3,0,1,1,0,,,D14/102;;1402,0,0,,,,EXPIRED
207,WO,A1,WO 2021/096565 A1,150-684-201-329-734,2021-05-20,2021,US 2020/0037203 W,2020-06-11,US 201962936065 P,2019-11-15,END-TO-END UNMANNED CONTROL SYSTEM OF AIRCRAFT NAVIGATION AND SURVEILLANCE SYSTEMS,A control system in communication with one of an aircraft navigational aid system and an aircraft surveillance system is described. The control system obtains measurement data associated with radio frequency (RF) signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system from an unmanned aerial vehicle (UAV) reporting the measurement data. The control system also determines whether the measurement data indicates the RF signals are within a range of values based on a location of the UAV in an airspace proximate to the one of the aircraft navigational aid system and the aircraft surveillance system. The control system further controls the RF signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system based on the measurement data and the location of the UAV. Methods performed by the control system are also described.,THALES USA INC,FERLA MASSIMILIANO;;CARSENAT DAVID;;CUCURACHI ANDREA;;DELOFFRE NATHAN;;MCGAHEE KEVIN;;GIACOPONELLO CHRISTOPHER;;HAUSWALD SCOTT;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFELDT HOLGER;;PROCOUDINE-GORSKY MICHEL;;SCHACKMANN EDWIN;;SORDELLI MARCELLO;;SCHÜTTPELZ ANDRÉ;;VELIMIROVIC ANDRIJA;;ROWSON STEPHEN;;CAGLE MARK;;MCNALLY MATTHEW;;PARSONS JOSEPH;;CONROY BRENDON;;ALBANESE ANTHONY,,https://lens.org/150-684-201-329-734,Patent Application,yes,6,2,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/00;;B64C39/02,,1,0,,,See also references of EP 4059005A4,PENDING
208,EP,A1,EP 4059005 A1,020-913-049-484-061,2022-09-21,2022,EP 20888616 A,2020-06-11,US 201962936065 P;;US 2020/0037203 W,2019-11-15,END-TO-END UNMANNED CONTROL SYSTEM OF AIRCRAFT NAVIGATION AND SURVEILLANCE SYSTEMS,,THALES USA INC,FERLA MASSIMILIANO;;CARSENAT DAVID;;CUCURACHI ANDREA;;DELOFFRE NATHAN;;MCGAHEE KEVIN L;;HAUSWALD SCOTT;;GIACOPONELLO CHRISTOPHER;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFELDT HOLGER;;PROCOUDINE-GORSKY MICHEL;;SCHACKMANN EDWIN;;SORDELLI MARCELLO;;SCHÜTTPELZ ANDRÉ;;VELIMIROVIC ANDRIJA;;ROWSON STEPHEN;;CAGLE MARK;;MCNALLY MATTHEW TIMOTHY;;PARSONS JOSEPH EUGENE;;CONROY BRENDON;;ALBANESE ANTHONY JAMES,,https://lens.org/020-913-049-484-061,Patent Application,yes,0,0,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/00;;B64C39/02,,0,0,,,,PENDING
209,EP,A4,EP 4059005 A4,129-083-444-713-744,2024-01-24,2024,EP 20888616 A,2020-06-11,US 201962936065 P;;US 2020/0037203 W,2019-11-15,END-TO-END UNMANNED CONTROL SYSTEM OF AIRCRAFT NAVIGATION AND SURVEILLANCE SYSTEMS,,THALES USA INC,FERLA MASSIMILIANO;;CARSENAT DAVID;;CUCURACHI ANDREA;;DELOFFRE NATHAN;;MCGAHEE KEVIN L;;GIACOPONELLO CHRISTOPHER;;HAUSWALD SCOTT;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFELDT HOLGER;;PROCOUDINE-GORSKY MICHEL;;SCHACKMANN EDWIN;;SORDELLI MARCELLO;;SCHÜTTPELZ ANDRÉ;;VELIMIROVIC ANDRIJA;;ROWSON STEPHEN;;CAGLE MARK;;MCNALLY MATTHEW TIMOTHY;;PARSONS JOSEPH EUGENE;;CONROY BRENDON;;ALBANESE ANTHONY JAMES,,https://lens.org/129-083-444-713-744,Search Report,no,3,0,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/00;;B64C39/02;;G01S1/00;;G08G5/02;;H04L67/125;;H04W24/10;;H04W88/02,,1,0,,,See also references of WO 2021096565A1,PENDING
210,AU,B2,AU 2020/382698 B2,006-183-907-016-805,2023-07-27,2023,AU 2020/382698 A,2020-06-11,US 201962936065 P;;US 2020/0037203 W,2019-11-15,End-to-end unmanned control system of aircraft navigation and surveillance systems,A control system in communication with one of an aircraft navigational aid system and an aircraft surveillance system is described. The control system obtains measurement data associated with radio frequency (RF) signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system from an unmanned aerial vehicle (UAV) reporting the measurement data. The control system also determines whether the measurement data indicates the RF signals are within a range of values based on a location of the UAV in an airspace proximate to the one of the aircraft navigational aid system and the aircraft surveillance system. The control system further controls the RF signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system based on the measurement data and the location of the UAV. Methods performed by the control system are also described.,THALES USA INC,FERLA MASSIMILIANO;;CARSENAT DAVID;;CUCURACHI ANDREA;;DELOFFRE NATHAN;;MCGAHEE KEVIN L;;GIACOPONELLO CHRISTOPHER;;HAUSWALD SCOTT;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFELDT HOLGER;;PROCOUDINE-GORSKY MICHEL;;SCHACKMANN EDWIN;;SORDELLI MARCELLO;;SCHÜTTPELZ ANDRÉ;;VELIMIROVIC ANDRIJA;;ROWSON STEPHEN;;CAGLE MARK;;MCNALLY MATTHEW TIMOTHY;;PARSONS JOSEPH EUGENE;;CONROY BRENDON;;ALBANESE ANTHONY JAMES,,https://lens.org/006-183-907-016-805,Granted Patent,no,6,0,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/00;;B64C39/02,,0,0,,,,ACTIVE
211,US,A1,US 2022/0406203 A1,108-839-707-518-314,2022-12-22,2022,US 202017776626 A,2020-06-11,US 202017776626 A;;US 201962936065 P;;US 2020/0037203 W,2019-11-15,END-TO-END UNMANNED CONTROL SYSTEM OF AIRCRAFT NAVIGATION AND SURVEILLANCE SYSTEMS,A control system in communication with one of an aircraft navigational aid system and an aircraft surveillance system is described. The control system obtains measurement data associated with radio frequency (RF) signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system from an unmanned aerial vehicle (UAV) reporting the measurement data. The control system also determines whether the measurement data indicates the RF signals are within a range of values based on a location of the UAV in an airspace proximate to the one of the aircraft navigational aid system and the aircraft surveillance system. The control system further controls the RF signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system based on the measurement data and the location of the UAV. Methods performed by the control system are also described.,THALES USA INC,FERLA MASSIMILIANO;;CARSENAT DAVID;;CUCURACHI ANDREA;;DELOFFRE NATHAN;;MCGAHEE KEVIN L;;GIACOPONELLO CHRISTOPHER;;HAUSWALD SCOTT;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFELDT HOLGER;;PROCOUDINE-GORSKY MICHEL;;SCHACKMANN EDWIN;;SORDELLI MARCELLO;;SCHÜTTPELZ ANDRÉ;;VELIMIROVIC ANDRIJA;;ROWSON STEPHEN;;CAGLE MARK;;MCNALLY MATTHEW TIMOTHY;;PARSONS JOSEPH EUGENE;;CONROY BRENDON;;ALBANESE ANTHONY JAMES,,https://lens.org/108-839-707-518-314,Patent Application,yes,0,0,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/02;;G08G5/00,,0,0,,,,PENDING
212,CA,A1,CA 3161671 A1,159-743-154-617-999,2021-05-20,2021,CA 3161671 A,2020-06-11,US 201962936065 P;;US 2020/0037203 W,2019-11-15,END-TO-END UNMANNED CONTROL SYSTEM OF AIRCRAFT NAVIGATION AND SURVEILLANCE SYSTEMS,A control system in communication with one of an aircraft navigational aid system and an aircraft surveillance system is described. The control system obtains measurement data associated with radio frequency (RF) signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system from an unmanned aerial vehicle (UAV) reporting the measurement data. The control system also determines whether the measurement data indicates the RF signals are within a range of values based on a location of the UAV in an airspace proximate to the one of the aircraft navigational aid system and the aircraft surveillance system. The control system further controls the RF signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system based on the measurement data and the location of the UAV. Methods performed by the control system are also described.,THALES USA INC,FERLA MASSIMILIANO;;CARSENAT DAVID;;CUCURACHI ANDREA;;DELOFFRE NATHAN;;MCGAHEE KEVIN L;;GIACOPONELLO CHRISTOPHER;;HAUSWALD SCOTT;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFELDT HOLGER;;PROCOUDINE-GORSKY MICHEL;;SCHACKMANN EDWIN;;SORDELLI MARCELLO;;SCHUTTPELZ ANDRE;;VELIMIROVIC ANDRIJA;;ROWSON STEPHEN;;CAGLE MARK;;MCNALLY MATTHEW TIMOTHY;;PARSONS JOSEPH EUGENE;;CONROY BRENDON;;ALBANESE ANTHONY JAMES,,https://lens.org/159-743-154-617-999,Patent Application,no,0,0,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/00;;B64C39/02,,0,0,,,,PENDING
213,KR,A,KR 20220101160 A,042-652-469-528-521,2022-07-19,2022,KR 20227020321 A,2020-06-11,US 201962936065 P;;US 2020/0037203 W,2019-11-15,항공기 내비게이션 및 감시 시스템들의 엔드-투-엔드 무인 제어 시스템,"항공기 내비게이션 보조 시스템 및 항공기 감시 시스템 중 하나와 통신하는 제어 시스템이 설명된다. 제어 시스템은 측정 데이터를 보고하는 무인 항공기(UAV)로부터 항공기 내비게이션 보조 시스템 및 항공기 감시 시스템 중 하나에 의해 송신된 라디오 주파수(RF) 신호들과 연관된 측정 데이터를 획득한다. 제어 시스템은 또한, 측정 데이터가 RF 신호들이 항공기 내비게이션 보조 시스템 및 항공기 감시 시스템 중 하나에 근접한 영공에서의 UAV의 위치에 기초한 값들의 범위 내에 있음을 나타내는지를 결정한다. 제어 시스템은 추가로, 측정 데이터 및 UAV의 위치에 기초하여 항공기 내비게이션 보조 시스템 및 항공기 감시 시스템 중 하나에 의해 송신된 RF 신호들을 제어한다. 제어 시스템에 의해 수행되는 방법들이 또한 설명된다.",THALES USA INC,FERLA MASSIMILIANO;;CARSENAT DAVID;;CUCURACHI ANDREA;;DELOFFRE NATHAN;;MCGAHEE KEVIN L;;GIACOPONELLO CHRISTOPHER;;HAUSWALD SCOTT;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFELDT HOLGER;;PROCOUDINE GORSKY MICHEL;;SCHACKMANN EDWIN;;SORDELLI MARCELLO;;SCHUETTPELZ ANDRE;;VELIMIROVIC ANDRIJA;;ROWSON STEPHEN;;CAGLE MARK;;MCNALLY MATTHEW TIMOTHY;;PARSONS JOSEPH EUGENE;;CONROY BRENDON;;ALBANESE ANTHONY JAMES,,https://lens.org/042-652-469-528-521,Patent Application,no,0,0,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/02;;G08G5/00;;H04W24/10,,0,0,,,,PENDING
214,AU,A1,AU 2020/382698 A1,150-744-412-181-428,2022-05-19,2022,AU 2020/382698 A,2020-06-11,US 201962936065 P;;US 2020/0037203 W,2019-11-15,End-to-end unmanned control system of aircraft navigation and surveillance systems,A control system in communication with one of an aircraft navigational aid system and an aircraft surveillance system is described. The control system obtains measurement data associated with radio frequency (RF) signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system from an unmanned aerial vehicle (UAV) reporting the measurement data. The control system also determines whether the measurement data indicates the RF signals are within a range of values based on a location of the UAV in an airspace proximate to the one of the aircraft navigational aid system and the aircraft surveillance system. The control system further controls the RF signals transmitted by the one of the aircraft navigational aid system and the aircraft surveillance system based on the measurement data and the location of the UAV. Methods performed by the control system are also described.,THALES USA INC,CARSENAT DAVID;;FERLA MASSIMILIANO;;CUCURACHI ANDREA;;DELOFFRE NATHAN;;MCGAHEE KEVIN L;;GIACOPONELLO CHRISTOPHER;;HAUSWALD SCOTT;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFELDT HOLGER;;PROCOUDINE-GORSKY MICHEL;;SCHACKMANN EDWIN;;SORDELLI MARCELLO;;SCHÜTTPELZ ANDRÉ;;VELIMIROVIC ANDRIJA;;ROWSON STEPHEN;;CAGLE MARK;;MCNALLY MATTHEW TIMOTHY;;PARSONS JOSEPH EUGENE;;CONROY BRENDON;;ALBANESE ANTHONY JAMES,,https://lens.org/150-744-412-181-428,Patent Application,no,0,1,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/00;;B64C39/02,,0,0,,,,ACTIVE
215,CN,A,CN 114945962 A,046-779-087-900-264,2022-08-26,2022,CN 202080092208 A,2020-06-11,US 201962936065 P;;US 2020/0037203 W,2019-11-15,End-to-end unmanned control system for aircraft navigation and monitoring system,"A control system in communication with one of an aircraft navigation assistance system and an aircraft monitoring system is described. A control system acquires measurement data associated with a radio frequency (RF) signal transmitted by one of an aircraft navigation assistance system and an aircraft surveillance system from an unmanned aerial vehicle (UAV) that reports the measurement data, and the measurement data is associated with a radio frequency (RF) signal transmitted by one of the aircraft navigation assistance system and the aircraft surveillance system. The control system also determines whether the measurement data indicates that the RF signal is within a range of values based on a position of the UAV in an airspace proximate one of the aircraft navigation assistance system and the aircraft surveillance system. The control system further controls RF signals transmitted by one of the aircraft navigation assistance system and the aircraft monitoring system based on the measurement data and the position of the UAV. A method performed by the control system is also described.",THALES USA INC,FERRA MASSIMILIANO;;CASENET DAVID;;KUCURACCI ANDREA;;DEROFRE NATHAN;;MCGAHEY KEVIN L;;GIACOBONERO CHRISTOPHER;;HAUSWALD SCOTT;;HUBERT WILLIAM;;LUNARDI PAOLO;;NEUFERT HOLGER;;GORSKI MICHEL PROKUDDIN;;SCHACKMAN EDWIN;;SOUDELLI MARCELLO;;SCHUTPELZ ANDR ¨;;VELIMIROVIC ANDREAS;;ROSEN STEFAN;;CAGLE MARK;;MCNALLY MATTHEW TIMOTHY;;PARSONS JOSEPH EUGENE;;CONROY BRENDAN;;ALBANESE ANTHONY JAMES,,https://lens.org/046-779-087-900-264,Patent Application,no,0,0,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,G08G5/00;;B64C39/02,,0,0,,,,PENDING
216,IL,A,IL 292953 A,075-421-721-220-676,2022-07-01,2022,IL 29295322 A,2022-05-11,US 201962936065 P;;US 2020/0037203 W,2019-11-15,End-to-end unmanned control system of aircraft navigation and surveillance systems,,THALES USA INC;;MASSIMILIANO FERLA;;DAVID CARSENAT;;ANDREA CUCURACHI;;NATHAN DELOFFRE;;KEVIN L MCGAHEE;;CHRISTOPHER GIACOPONELLO;;SCOTT HAUSWALD;;WILLIAM HUBERT;;PAOLO LUNARDI;;HOLGER NEUFELDT;;MICHEL PROCOUDINE GORSKY;;EDWIN SCHACKMANN;;MARCELLO SORDELLI;;ANDR? SCH?TTPELZ;;ANDRIJA VELIMIROVIC;;STEPHEN ROWSON;;MARK CAGLE;;MATTHEW TIMOTHY MCNALLY;;JOSEPH EUGENE PARSONS;;BRENDON CONROY;;ANTHONY JAMES ALBANESE,MASSIMILIANO FERLA;;DAVID CARSENAT;;ANDREA CUCURACHI;;NATHAN DELOFFRE;;KEVIN L MCGAHEE;;CHRISTOPHER GIACOPONELLO;;SCOTT HAUSWALD;;WILLIAM HUBERT;;PAOLO LUNARDI;;HOLGER NEUFELDT;;MICHEL PROCOUDINE-GORSKY;;EDWIN SCHACKMANN;;MARCELLO SORDELLI;;ANDR? SCH?TTPELZ;;ANDRIJA VELIMIROVIC;;STEPHEN ROWSON;;MARK CAGLE;;MATTHEW TIMOTHY MCNALLY;;JOSEPH EUGENE PARSONS;;BRENDON CONROY;;ANTHONY JAMES ALBANESE,,https://lens.org/075-421-721-220-676,Patent Application,no,0,0,11,24,0,G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/025;;G08G5/0069;;H04L67/125;;H04W24/10;;H04W88/02;;G08G5/0013;;H04L67/125;;H04W88/02;;G08G5/025;;G08G5/0021;;G08G5/0026;;H04W24/10;;G08G5/0069;;G08G5/025;;G08G5/0013;;G08G5/0021;;G08G5/0026;;G08G5/0069;;H04W24/10;;G08G5/0013;;G08G5/006;;G08G5/0069;;G08G5/025,H04L67/125;;H04W24/10;;H04W88/02,,0,0,,,,PENDING
217,AR,A1,AR 118085 A1,114-729-176-816-08X,2021-09-15,2021,AR P200100399 A,2020-02-13,GB 2019052359 W,2019-08-21,INHIBIDORES DE ENZIMAS,"La presente proporciona compuestos de fórmula (1), composiciones que comprenden dichos compuestos; el uso de dichos compuestos en terapia; y métodos para tratar pacientes con dichos compuestas; en donde R¹, R², R³, R⁴, R⁵, R⁶, R⁷, R⁸, R⁹ y R¹⁰ tienen la definición proporcionada en el presente documento. Reivindicación 1: Un compuesto de fórmula (1), donde: W, X, Y y Z se seleccionan independientemente de C y N de modo que el anillo que contiene W, X, Y y Z se selecciona de benceno, piridina, piridazina, pirimidina, pirazina y triazina; R¹, R⁴ y R⁵ están independientemente ausentes, o se seleccionan independientemente de H, alquilo, alcoxi, -CF₃, -OH, -CN, halo, -COOR¹² y -CONR¹⁴R¹⁵; cuando X es C, uno de R² y R³ es -L-V-R¹³ y el otro de R² y R³ se selecciona de H, alquilo, alcoxi, -CF₃, -OH, -CN, halo, -COOR¹² y -CONR¹⁴R¹⁵; o cuando X es N, R² es -L-V-R¹³ y R³ está ausente; R⁶, R⁷, R⁸, R⁹ y R¹⁰ se seleccionan independientemente de H, alquilo, alcoxi, -CF₃, -OH, -CN, halo, -COOR¹² y -CONR¹⁴R¹⁵; L se selecciona de un enlace, alquileno y -C(O)-; V está ausente, o seleccionado de O y NR¹²; R¹² se selecciona de H y alquiloᵇ; R¹³ es (CH₂)₀₋₃(heterociclilo); alquilo es un hidrocarburo saturado lineal que tiene hasta 4 átomos de carbono (C₁₋₄) o un hidrocarburo saturado ramificado de 3 ó 4 átomos de carbono (C₃₋₄); alquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente entre C₁₋₃ alcoxi, -OH, -CN, -NR¹⁴R¹⁵, -NHCOCH₃, halo, -COOR¹² y -CONR¹⁴R¹⁵; el alquiloᵇ es un hidrocarburo saturado lineal que tiene hasta 4 átomos de carbono (C₁₋₄) o un hidrocarburo saturado ramificado de 3 ó 4 átomos de carbono (C₃₋₄); el alquiloᵇ puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de -OH, -CN, -NHCOCH₃ y halo; el alquileno es un hidrocarburo saturado lineal bivalente que tiene de 1 a 4 átomos de carbono (C₁₋₄) o un hidrocarburo saturado bivalente ramificado que tiene de 3 a 4 átomos de carbono (C₃₋₄); alcoxi es un hidrocarburo lineal O-ligado de entre 1 y 3 átomos de carbono (C₁₋₃) o hidrocarburo ramificado vinculado a O de entre 3 y 4 átomos de carbono (C₃₋₄); el alcoxi puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de -OH, -CN, -CF₃, -N(R¹²)₂ y fluoro; halo es F, Cl, Br o I; heterociclilo es un anillo no aromático de 4, 5 ó 6 miembros que contiene carbono que contiene uno o dos miembros en el anillo que se seleccionan entre N, NR¹⁶ y O; heterociclilo puede estar opcionalmente sustituido con 1, 2, 3, ó 4 sustituyentes independientemente seleccionados de alquilo, alcoxi, oxo, -CF₃, -OH, -CN, halo, -COOR¹² y -CONR¹⁴R¹⁵; R¹⁴ y R¹⁵ se seleccionan independientemente de H y alquiloᵇ; R¹⁶ se selecciona de H y alquilo; y tautómeros, isómeros, estereoisómeros (incluidos enantiómeros, diastereoisómeros y mezclas racémicas y no racémicas de los mismos), isótopos deuterados y sus sales y/o solvatos farmacéuticamente aceptables.",KALVISTA PHARMACEUTICALS LTD,YANG XUEZHENG;;WRIGGLESWORTH JOSEPH WILLIAM;;SMITH ALUN JOHN;;SAMBROOK SMITH COLIN PETER;;PITTAWAY RACHAEL;;MILLER IAIN ROBERT;;CONROY MATTHEW ROBERT;;BAKER THOMAS MATTHEW;;PANCHAL TERENCE AARON;;LEVANTO STEFANO;;JANDU KARAMJIT SINGH;;HINCHLIFFE PAUL STUART;;HAMBLIN JULIE NICOLE;;GOLDSMITH ERICA LEE;;GANCIA EMANUELA;;CRIDLAND ANDREW PETER;;CLARK DAVID EDWARD;;STOCKS MICHAEL JOHN;;ROOKER DAVID PHILIP;;OBARA ALICJA STELA;;MAZZACANI ALESSANDRO;;MARSH SALLY LOUISE;;HODGSON SIMON TEANBY;;EVANS DAVID MICHAEL;;EDWARDS HANNAH JOY;;DAVIE REBECCA LOUISE;;CHILDS MITCHELL LEWIS,,https://lens.org/114-729-176-816-08X,Patent Application,no,0,0,15,15,0,C07D401/12;;C07D401/14;;A61P7/02;;A61P9/10;;A61P25/06;;A61P25/08;;A61P29/00;;A61P31/00;;A61P25/28;;C07D401/12;;A61P25/28;;C07D401/14;;A61P29/00;;A61P9/10;;A61P25/08;;A61P25/06;;A61P7/02;;A61P31/00;;C07D401/14;;A61K31/4725;;A61K31/513;;A61K31/497;;A61K31/501;;A61K31/5377;;A61P7/02;;A61P9/10;;A61P25/00;;A61P25/28;;A61P29/00;;A61P31/00;;C07D401/12;;C07D401/12;;C07D401/14,C07D401/12;;A61K31/47;;A61K31/497;;A61K31/506;;A61K31/5377;;A61P9/00;;C07D401/14,,0,0,,,,PENDING
218,AR,A1,AR 118084 A1,025-910-138-980-882,2021-09-15,2021,AR P200100398 A,2020-02-13,GB 2019052357 W,2019-08-21,INHIBIDORES DE ENZIMAS,"La presente proporciona compuestos de fórmula (1), composiciones que comprenden dichos compuestos; el uso de dichos compuestos en terapia; y métodos para tratar pacientes con dichos compuestos; en donde A, B y n son como se definen en el presente documento. Reivindicación 1: Un compuesto de fórmula (1), donde: n es 0, 1 ó 2; A es un heteroarilo de 6 miembros de formula (2), en donde X e Y se seleccionan independientemente de C y N, e donde al menos uno de X o Y es N; en la que R⁵ se selecciona de -NR¹²(CH₂)₀₋₃(heterociclilo), -NR¹²(CH₂)₀₋₃(heteroarilo), -NR¹²(CH₂)₀₋₃(arilo), -NR¹³R¹⁴, -O(CH₂)₀₋₃(arilo), -O(CH₂)₀₋₃(heterociclilo), -O-(CH₂)₁₋₄NR¹³R¹⁴ y -NR¹²(CH₂)₀₋₃O(arilo); en donde R² y R³ se seleccionan independientemente de H, halo, alcoxi, alquilo, cicloalquilo, arilo y heteroarilo; en donde R¹ y R⁴ están independientemente ausentes, o se seleccionan independientemente de H, halo, alcoxi, alquilo, cicloalquilo, arilo y heteroarilo; o en donde X e Y se seleccionan independientemente de C y N, en donde al menos uno de X o Y es N; en donde R¹, R⁴ y R⁵ están independientemente ausentes o seleccionados independientemente de H, halo y alquilo; en donde uno de R² o R³ es un resto de fórmula (3) y el otro de R² o R³ se selecciona de H, halo o alquilo; en donde R⁶ es H, alquilo o heteroariloᵇ; o en donde X e Y se seleccionan independientemente de C y N, en donde al menos uno de X o Y es N; en donde R¹ y R⁴ están independientemente ausentes o independientemente seleccionados de H, halo y alquilo; en donde R³ es halo; en donde R² es -NR¹³R¹⁴, -NR¹²(CH₂)₀₋₃(arilo), -NR¹²(CH₂)₀₋₃NR¹³R¹⁴, -(CH₂)NR¹²(CH₂)₀₋₃(heterociclilo), -O-(CH₂)₁₋₄NR¹³R¹⁴, -(CH₂)₀₋₃NR¹²(CH₂)₀₋₃(heteroarilo), -(CH₂)₀₋₃O(CH₂)₀₋₃(arilo), -O-(CH₂)₀₋₃(heterociclilo) y -O-(CH₂)₀₋₃(heteroarilo) y en donde R⁵ es H, alquilo y halo; o en donde X e Y son C; en donde R⁴ es H, halo, alquilo; en donde R⁵ es H o alquilo; en donde R³ es H o halo; en donde uno de R¹ y R² es -(CH₂)(heterociclilo) o -N(R¹²)CO(CH₂)₀₋₃(heterociclilo) y el otro de R¹ y R² se selecciona de H y alquilo; en donde X es C o N, e Y es C; R¹ está ausente, H o alquilo; R⁴ es H o alquilo; R⁵ es H o alquilo; en donde o bien: (a) R² y R³ junto con los átomos de carbono a los que están unidos forman fenilo o heteroarilo de 5 ó 6 miembros que contiene nitrógeno, en el que fenilo puede estar opcionalmente sustituido en cuanto al ariloᵇ y en el que el heteroarilo de 5 ó 6 miembros que contiene nitrógeno puede estar opcionalmente sustituido en cuanto al heteroariloᵇ o (b) R² y R³ se seleccionan independientemente de H y halo, en el que al menos uno de R² o R³ es halo, o (c) R² y R³ se seleccionan independientemente de H, ariloᵇ y heteroariloᵇ, en el que al menos uno de R² o R³ es ariloᵇ, o heteroariloᵇ; B es uno de: (i) un anillo bicíclico heteroaromático 6,5 ó 6,6 fusionado, que contiene N y, opcionalmente, uno o dos heteroátomos adicionales seleccionados independientemente de N, O y S; en donde el anillo bicíclico heteroaromático 6,5 ó 6,6 fusionado puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados de alquilo, alcoxi, OH, halo, CN, -COOR¹³, -CONR¹³R¹⁴, CF₃ y -NR¹³R¹⁴; en donde el anillo bicíclico heteroaromático 6,5 puede unirse mediante el anillo de 6 ó 5 miembros; (ii) fenilo, que puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente entre alquilo, heteroarilo, alcoxi, heterociclilo, OH, halo, CN, CF₃ y un anillo heterocíclico de 4, 5, 6 ó 7 miembros que contiene carbono que contiene 1, 2 ó 3 heteroátomos seleccionados independientemente de N y NR¹², que pueden estar saturados o insaturados con 1 ó 2 dobles enlaces y que pueden ser opcionalmente mono o disustituidos con sustituyentes seleccionados independientemente de oxo, alquilo, alcoxi, OH, halo y CF₃; o (iii) fenilo, en el que dos átomos de carbono adyacentes en el fenilo están unidos entre sí por -N=CN(R⁸)-C(=O)- para formar una quinazolinona o unidos por -CH₂-N(R⁸)-C(=O)- para formar una isoindolinona; o (iv) heteroarilo; o (v) un anillo bicíclico 6,5 ó 6,6 fusionado que contiene un anillo aromático fusionado a un anillo no aromático y que contiene N y, opcionalmente, uno o dos heteroátomos adicionales seleccionados independientemente de N, O y S; en el que el anillo bicíclico 6,5 ó 6,6 fusionado puede estar opcionalmente sustituido con 1, 2, ó 3 sustituyentes seleccionados de alquilo, alcoxi, OH, halo, CN, -COOR¹³, -CONR¹³R¹⁴, CF₃ y -NR¹³R¹⁴; en donde el anillo bicíclico 6,5 puede unirse mediante el anillo de 6 ó 5 miembros; alcoxi es un hidrocarburo lineal vinculado a O de entre 1 y 6 átomos de carbono (C₁₋₆) o un O ramificado - ligado hidrocarburo de entre 3 y 6 átomos de carbono (C₃₋₆); alcoxi pueden estar opcionalmente sustituidos con 1 ó 2 sustituyentes seleccionados independientemente de OH, CN, CF₃, -N(R¹²)₂ y fluoro; alquilo es un hidrocarburo saturado lineal que tiene hasta 10 átomos de carbono (C₁₋₁₀) o un hidrocarburo saturado ramificado de entre 3 y 10 átomos de carbono (C₃₋₁₀); el alquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alcoxi C₁₋₆, OH, -NR¹³R¹⁴, -NHCOCH₃, -CO(heterocicliloᵇ), -COOR¹³, -CONR¹³R¹⁴, CN, CF₃, halo, oxo y heterocicliloᵇ, alquiloᵇ es un hidrocarburo saturado lineal que tiene hasta 10 átomos de carbono (C₁₋₁₀) o un hidrocarburo saturado ramificado de entre 3 y 10 átomos de carbono (C₃₋₁₀); alquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente entre C₁₋₆alcoxi, OH, -N(R¹²)₂, -NHCOCH₃, CF₃, halo, oxo, heterocicliloᵇ y ciclopropano; alquileno es un hidrocarburo saturado lineal bivalente que tiene de 1 a 5 átomos de carbono (C₁₋₅); alquileno puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquilo, C₁₋₆alcoxi, OH, CN, CF₃ y halo; arilo es fenilo, bifenilo o naftilo; arilo puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de alquilo, alcoxi, OH, -SO₂CH₃, halo, CN, -(CH₂)₀₋₃-O-heteroariloᵇ, ariloᵇ, -O-ariloᵇ, -(CH₂)₀₋₃-heterocicliloᵇ, -(CH₂)₁₋₃-ariloᵇ, -(CH₂)₀₋₃-heteroariloᵇ, -COOR¹³, -CONR¹³R¹⁴, -(CH₂)₀₋₃-NR¹³R¹⁴, OCF₃ y CF₃, o dos átomos de carbono adyacentes en el anillo en el arilo pueden estar opcionalmente unidos por un heteroalquileno para formar un anillo no aromático que contiene 5, 6 ó 7 miembros; u opcionalmente en el que dos átomos de anillo adyacentes en arilo están unidos para formar un anillo aromático de 5 ó 6 miembros que contiene 1 ó 2 heteroátomos que se seleccionan de N, NR⁸, S y O, que pueden estar opcionalmente sustituidos en cuanto al heteroariloᵇ; ariloᵇ es fenilo, bifenilo o naftilo, que puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de metilo, etilo, propilo, isopropilo, alcoxi, OH, -SO₂CH₃, N(R¹²)₂, halo, CN y CF₃, o dos átomos del anillo de carbono adyacentes en el arilo pueden estar opcionalmente unidos por un heteroalquileno para formar un anillo no aromático que contiene 5, 6, ó 7 miembros de anillo; cicloalquilo es un anillo hidrocarburo monocíclico saturado de entre 3 y 6 átomos de carbono (C₃₋₆); cicloalquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquiloᵇ, C₁₋₆alcoxi, OH, CN, CF₃ y halo; halo es F, Cl, Br o I; heteroalquileno es un hidrocarburo saturado lineal bivalente que tiene de 2 a 5 átomos de carbono (C₂₋₅), en el que 1 ó 2 de los 2 a 5 átomos de carbono están reemplazados con NR⁸, S u O; heteroalquileno pueden estar opcionalmente sustituidos con 1 ó 2 sustituyentes seleccionados independientemente de alquilo C₁₋₆alcoxi, OH, CN, CF₃ y halo; heteroarilo es un anillo aromático de 5 ó 6 miembros que contiene carbono que contiene 1, 2, 3 ó 4 miembros de anillo que se seleccionan de N, NR⁸, S y O; heteroarilo puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente entre alquilo, alcoxi, ariloᵇ, OH, OCF₃, halo, heterocicliloᵇ, CN y CF₃; heteroariloᵇ es un anillo aromático de 5 ó 6 miembros que contiene carbono que contiene uno, dos o tres miembros de anillo que se seleccionan de N, NR⁸, S y O; heteroariloᵇ puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de metilo, etilo, propilo, isopropilo, alcoxi, CH₂, ariloᵇ, OH, OCF₃, halo, CN y CF₃; heterociclilo es un anillo no aromático de 4, 5, 6 ó 7 miembros que contiene carbono que contiene uno, dos o tres miembros en el anillo que se seleccionan de N, NR⁸, S, SO, SO₂ y O; el heterociclilo puede estar opcionalmente sustituido con 1, 2, 3 ó 4 sustituyentes seleccionados independientemente de alquiloᵇ, alcoxi, OH, OCF₃, halo, oxo, CN, -NR¹³R¹⁴, -O(ariloᵇ)-O(heteroariloᵇ) y CF₃; u opcionalmente en el que dos átomos en el anillo en heterociclilo están vinculados con un alquileno para formar un anillo no aromático que contiene 5, 6, ó 7 miembros; u opcionalmente en el que dos átomos de anillo adyacentes en heterociclilo están unidos para formar un anillo aromático de 5 ó 6 miembros que contiene 1 ó 2 heteroátomos que se seleccionan de N, NR⁸, S y O; u opcionalmente en donde un átomo de anillo de carbono en heterociclilo está sustituido con un heteroalquileno de tal manera que el átomo de anillo de carbono en heterociclilo junto con el heteroalquileno forma un heterocicliloᵇ que es espiro a anillo heterociclilo; heterocicliloᵇ es un anillo no aromático de 4, 5, 6 ó 7 miembros que contiene carbono que contiene uno, dos o tres miembros en el anillo que se seleccionan entre N, NR¹², S, SO, SO₂ y O; el heterocicliloᵇ puede estar opcionalmente sustituido con 1, 2, 3 ó 4 sustituyentes seleccionados independientemente de metilo, etilo, propilo, isopropilo, alcoxi, OH, OCF₃, halo, oxo, CN y CF₃; R¹³ y R¹⁴ se seleccionan independientemente de H, -SO₂CH₃, alquiloᵇ, heteroariloᵇ y cicloalquilo; o R¹³ y R¹⁴ junto con el átomo de nitrógeno al que están unidos forman un anillo heterocíclico de 4, 5, 6 ó 7 miembros que contiene carbono, que opcionalmente contiene un heteroátomo adicional seleccionado de N, NR⁸, S, SO, SO₂ y O, que pueden estar saturados o insaturados con 1 ó 2 dobles enlaces y que pueden estar mono o disustituidos opcionalmente con sustituyentes seleccionados independientemente entre oxo, alquiloᵇ, alcoxi, OH, halo, -SO₂CH₃ y CF₃, o R¹³ y R¹⁴ junto con el átomo de nitrógeno al que están unidos forman un anillo heterocíclico de 5 ó 6 miembros que contiene carbono, que se fusiona a un ariloᵇ o un heteroariloᵇ; R⁸ se selecciona independientemente de H, -SO₂CH₃, alquiloᵇ, -(CH₂)₀₋₃ariloᵇ, -(CH₂)₀₋₃heteroariloᵇ, -(CH₂)₀₋₃cicloalquilo y -(CH₂)₀₋₃heterocicliloᵇ; o R⁸ es un anillo heterocíclico de 4, 5, 6 ó 7 miembros que contiene carbono que contiene 1, 2 ó 3 heteroátomos seleccionados independientemente de N, NR¹², S, SO, SO₂ y O, que pueden estar saturados o insaturados con 1 ó 2 dobles enlaces y que pueden estar opcionalmente mono o disustituidos con sustituyentes seleccionados independientemente de oxo, alquiloᵇ, alcoxi, OH, halo, -SO₂CH₃ y CF₃; R¹² se selecciona independientemente de H, -SO₂CH₃, metilo, etilo, propilo, isopropilo y cicloalquilo; y tautómeros, isómeros, estereoisómeros (incluidos enantiómeros, diastereoisómeros y mezclas racémicas y no racémicas de los mismos), isótopos deuterados y sus sales y/o solvatos farmacéuticamente aceptables.",KALVISTA PHARMACEUTICALS LTD,YANG XUEZHENG;;WRIGGLESWORTH JOSEPH WILLIAM;;SMITH ALUN JOHN;;SAMBROOK SMITH COLIN PETER;;PITTAWAY RACHAEL;;MILLER IAIN ROBERT;;CONROY MATTHEW ROBERT;;BAKER THOMAS MATTHEW;;PANCHAL TERENCE AARON;;LEVANTO STEFANO;;JANDU KARAMJIT SINGH;;HINCHLIFFE PAUL STUART;;HAMBLIN JULIE NICOLE;;GOLDSMITH ERICA LEE;;GANCIA EMANUELA;;CRIDLAND ANDREW PETER;;CLARK DAVID EDWARD;;STOCKS MICHAEL JOHN;;ROOKER DAVID PHILIP;;OBARA ALICJA STELA;;MAZZACANI ALESSANDRO;;MARSH SALLY LOUISE;;HODGSON SIMON TEANBY;;EVANS DAVID MICHAEL;;EDWARDS HANNAH JOY;;DAVIE REBECCA LOUISE;;CHILDS MITCHELL LEWIS,,https://lens.org/025-910-138-980-882,Patent Application,no,0,0,14,14,0,C07D401/12;;C07D401/14;;C07D405/14;;C07D453/02;;C07D471/04;;C07D417/14;;C07D413/14;;C07D495/04;;A61P7/02;;A61P9/10;;A61P25/06;;A61P25/08;;A61P29/00;;A61P31/00;;A61P25/28;;C07D401/12;;A61P25/08;;A61P29/00;;A61P25/28;;C07D413/14;;C07D401/14;;A61P31/00;;C07D417/14;;C07D405/14;;A61P7/02;;C07D495/04;;C07D453/02;;A61P25/06;;A61P9/10;;C07D471/04;;C07D401/12;;A61K31/4725;;A61K31/5377;;A61K31/496;;A61K31/541;;A61P7/02;;A61P9/10;;A61P31/00;;A61P29/00;;A61P25/06;;A61P25/08;;A61P25/28;;C07D401/14;;C07D405/14;;C07D471/04;;C07D417/14;;C07D413/14;;C07D495/04;;A61P7/02;;C07D217/22;;C07D401/12;;C07D401/14;;C07D471/04,C07D401/12;;A61K31/47;;A61K31/5377;;A61K31/541;;A61K31/551;;A61P9/00;;C07D401/14;;C07D405/14;;C07D417/14;;C07D471/04;;C07D495/04,,0,0,,,,PENDING
219,AR,A1,AR 118082 A1,083-919-497-097-957,2021-09-15,2021,AR P200100396 A,2020-02-13,GB 2019052356 W,2019-08-21,INHIBIDORES DE ENZIMAS,"La presente proporciona compuestos de la fórmula (1), composiciones que comprenden dichos compuestos; el uso terapéutico de cada uno de dichos compuestos y métodos de tratamiento en pacientes con cada uno de dichos compuestos; en donde A, Y, n, R¹, R²A, R²B, R³ y *1 son definidos anteriormente en el presente documento. Reivindicación 1: Un compuesto de fórmula (1), en donde *1 denota un centro quiral; n = 0, 1 ó 2; A se selecciona de H, -(C=O)R⁴, -SO₂R⁶, y -(CH₂)-R¹³; Y es un enlace o -[CHR⁵]-; R¹ es H o alquiloᵇ; R²A se selecciona de H, alquilo, -(CH₂)₀₋₃arilo, -(CH₂)₀₋₃heteroarilo, -(CH₂)₀₋₃cicloalquilo, -(CH₂)₀₋₃-[benzotiofeno], -(CH₂)₀₋₃-[indol], y un resto de fórmula (3); o, cuando Y es un enlace, R¹ y R²A, junto con el átomo de nitrógeno al que está unido R¹ y el átomo de carbono al que está unido R²A, pueden estar unidos mediante alquileno para formar un heterociclo saturado de 4, 5 ó 6 miembros, en donde opcionalmente el heterociclo saturado de 4, 5 ó 6 miembros puede ser sustituido con arilo o en donde dos átomos de carbono adyacentes en el heterociclo saturado de 4, 5 ó 6 miembros pueden estar unidos para formar un anillo aromático de 6 miembros, o en donde dos átomos de carbono adyacentes en el heterociclo saturado de 4, 5 ó 6 miembros pueden estar unidos para formar un anillo de hidrocarburo saturado de 3, 4 ó 5 miembros el cual puede ser opcionalmente mono o disustituido por alquiloᵇ; cuando Y es -[CHR⁵]-, R⁵ es H; o, cuando Y es -[CHR⁵]-, junto con los átomos de carbono a los que cada uno de R⁵ y R²A están unidos, R⁵ y R²A pueden estar unidos mediante alquileno para formar un anillo saturado de 4, 5 y 6 miembros; o, cuando Y es -[CHR⁵]-, junto con el átomo de nitrógeno al que está unido R¹, el átomo de carbono al que está unido R⁵, y el átomo de carbono al que tanto R²A como R²B están unidos, R⁵ y R¹ pueden estar unidos mediante alquileno para formar un heterociclo saturado de 4, 5 y 6 miembros, en donde opcionalmente un átomo en el heterociclo saturado de 4, 5 ó 6 miembros puede estar unido mediante alquileno para unirse a R²A; R²B es H o alquiloᵇ; o, R²A y R²B, junto con el carbono al que tanto R²A como R²B están unidos, pueden estar unidos mediante alquileno o heteroalquileno para formar un anillo saturado de 3, 4, 5 y 6 miembros, en donde opcionalmente el anillo saturado de 3, 4, 5 ó 6 miembros contiene uno o dos miembros de anillo seleccionados entre N y O; R³ es: (i) un anillo bicíclico fusionado de 6,5 ó 6,6, que contiene un heteroátomo seleccionado de S y N, en donde al menos uno de los anillos es aromático y, opcionalmente, el anillo bicíclico contiene un heteroátomo adicional seleccionado independientemente de N, O y S; en donde opcionalmente el anillo bicíclico 6,5 ó 6,6 fusionado puede ser sustituido con 1, 2 ó 3 sustituyentes seleccionados de alquiloᵇ, alcoxi, OH, NH₂, halo, CN, y CF₃; en donde el anillo bicíclico 6,5 fusionado se puede unir a través del anillo de 6 ó 5 miembros; o (ii) fenilo, piridilo o tiofenilo, que pueden estar opcionalmente sustituidos con 1, 2 ó 3 sustituyentes seleccionados independientemente entre alquiloᵇ, alcoxi, OH, NH₂, halo, CN, CF₃, -C(=NH)NH₂, y heteroariloᵇ; en donde cuando n = 1, y R³ es sustituido con fenilo con como mínimo -(CH₂NH₂), R²A es alquilo y R²B es H; o (iii) un compuesto de fórmula (4); R⁴ es uno de: (i) un grupo de fórmula (2), en donde -[L]- es un enlace, -[(CH₂)₁₋₄]-, -[(CH₂)-O-(CH₂)]-, o -[O-(CH₂)]-; y P es alcoxi, OH o NR¹¹R¹²; en donde *2 denota un centro quiral, y en donde cuando -[L]- es un enlace, B es un hidrocarburo C₁₋₄ de cadena lineal o ramificada, y en donde cuando -[L]- es -[(CH₂)₁₋₄]-, -[(CH₂)-O-(CH₂)]-, o -[O-(CH₂)]-, B es OH, arilo heteroarilo heterociclilo, cicloalquilo o un resto de fórmula (5); o, (ii) -(CH₂)ₘ-[anillo bicíclico heteroaromático 6,5 ó 6,6 fusionado], en donde como mínimo un átomo de anillo es un heteroátomo seleccionado de O, N o S, y opcionalmente, 1, 2 ó 3 átomos de anillo adicionales pueden ser seleccionados de N o NH; en donde el anillo bicíclico heteroaromático 6,5 ó 6,6 fusionado puede ser sustituido opcionalmente con 1, 2 ó 3 sustituyentes seleccionados independientemente entre alquiloᵇ; en donde el anillo bicíclico heteroaromático 6,5 puede estar unido a -(CH₂)ₘ- a través del anillo de 6 ó 5 miembros; o, (iii) metilo, -C(CH₃)₂(OH), -C(CH₃)₂(NHMe), -(CH₂)ₘ-(arilo), -(CH₂)ₘ-(cicloalquilo), -(CH₂)ₘ-(heteroarilo), -(CH₂)ₘ-(heterociclilo), -(CH₂)-(alquilo), -(CH(halo)₂), -(CH₂)ₘ-(NR⁸R⁹), -(CH₂)ₘ-(NR¹⁰R⁷), -(CH₂)ₘ-O-(CH₂)ₖ-(arilo), -(CH₂)ₘ-(SO₂)-(CH₂)ₖ-(arilo), -(CH₂)ₘ-(alcoxi), -(CH₂)ₘ-O-(CH₂)ₖ-(heteroarilo), o -(CH₂)ₘ-[piridona, el cual puede ser opcionalmente sustituido por alquiloᵇ, o CF₃]; en donde k = 0, 1, 2 ó 3; en donde m = 0, 1, 2 ó 3; en donde: cuando Y es -[CHR⁵]- y R⁵ es H, R²A es CH₂arilo o H; y cuando Y es -[CHR⁵]-, R³ es un resto de fórmula (6); cuando A es H, R³ es el resto de fórmula (6); y cuando R³ es un compuesto de fórmula (7), R²A no es H; en donde: R⁶ es alquilo o -(CH₂)₀₋₃-(arilo); R⁷ se selecciona independientemente de H, -SO₂CH₃, metilo, etilo, propilo, isopropilo y cicloalquilo; R⁸ y R⁹ se selecciona independientemente de H, -SO₂CH₃, alquiloᵇ, heteroariloᵇ, y cicloalquilo; o R⁸ y R⁹ junto con el átomo de nitrógeno al cual están unidos forman un anillo heterocíclico de 4, 5, 6 ó 7 miembros que contiene carbono, que contiene opcionalmente un heteroátomo adicional seleccionado de N, NR¹⁰, S, y O, el cual puede ser saturado o insaturado con 1 ó 2 enlaces dobles y el cual puede ser opcionalmente mono o disustituido con sustituyentes seleccionados independientemente entre oxo, alquiloᵇ, alcoxi, OH, halo, -SO₂CH₃, y CF₃; o R⁸ y R⁹ junto con el átomo de nitrógeno al cual están unidos forman un anillo heterocíclico de 5 ó 6 miembros que contiene carbono, el cual se fusiona a un ariloᵇ o un heteroariloᵇ; R¹⁰ se selecciona independientemente de H, -SO₂R⁶, alquiloᵇ, -(CH₂)₀₋₃ariloᵇ, -(CH₂)₀₋₃heteroariloᵇ, cicloalquilo-(C=O)-(arilo), y -(CH₂)₀₋₃heterocicliloᵇ; o R¹⁰ es un anillo heterocíclico de 4, 5, 6 ó 7 miembros que contiene carbono, que contiene opcionalmente un heteroátomo adicional seleccionado de N, NR⁷, S, SO, SO₂, y O, el cual puede ser saturado o insaturado con 1 ó 2 enlaces dobles y el cual puede ser opcionalmente mono o disustituido con sustituyentes seleccionados independientemente entre oxo, alquiloᵇ, alcoxi, OH, halo, -SO₂CH₃, y CF₃; R¹¹ y R¹² se seleccionan independientemente de H, alquiloᵇ, -SO₂R⁶, cicloalquilo -(C=O)O-(alquiloᵇ), -(C=O)-fenilo, -CH₂-fenilo, y CH₂-COOH; o R¹¹ y R¹² junto con el átomo de nitrógeno al cual están unidos forman un anillo heterocíclico de 4, 5, 6 ó 7 miembros que contiene carbono que contiene opcionalmente un heteroátomo adicional seleccionado de N, O, y NR¹⁰, en donde el anillo heterocíclico puede ser opcionalmente mono o disustituido con sustituyentes seleccionados independientemente entre alquiloᵇ, OH, halo y CF₃; R¹³ se selecciona de heteroarilo cicloalquilo heterociclilo y ariloᵇ; en donde: alcoxi es un hidrocarburo lineal ligado a O de entre 1 y 6 átomos de carbono (C₁₋₆) o un hidrocarburo ramificado vinculado a O de entre 3 y 6 átomos de carbono (C₃₋₆); alcoxi puede sustituirse opcionalmente con 1 ó 2 sustituyentes seleccionados independientemente entre OH, CN, CF₃, -N(R⁷)₂ y fluoro; alquilo es un hidrocarburo saturado lineal que tiene hasta 6 átomos de carbono (C₁₋₆) o un hidrocarburo saturado ramificado de entre 3 y 6 átomos de carbono (C₃₋₆); el alquilo puede sustituirse opcionalmente con 1 ó 2 sustituyentes seleccionados independientemente entre C₁₋₆alcoxi, OH, -NR⁸R⁹, -NHCOCH₃, -CO(heterocicliloᵇ), -COOR⁸, -CONR⁸R⁹, CN, CF₃, halo, oxo y heterocicliloᵇ; alquiloᵇ es un hidrocarburo saturado lineal que tiene hasta 6 átomos de carbono (C₁₋₆) o un hidrocarburo saturado ramificado de entre 3 y 6 átomos de carbono (C₃₋₆); el alquilo puede sustituirse opcionalmente con 1 ó 2 sustituyentes seleccionados independientemente entre C₁₋₆alcoxi, OH, -N(R⁷)₂, -NHCOCH₃, CF₃, halo, oxo y ciclopropano; alquileno es un hidrocarburo saturado lineal bivalente que tiene 1 a 5 átomos de carbono (C₁₋₅); el alquileno puede sustituirse opcionalmente con 1 ó 2 sustituyentes seleccionados independientemente entre alquilo, C₁₋₆alcoxi, OH, CN, CF; y halo; arilo es fenilo, bifenilo o naftilo; el arilo puede ser sustituido opcionalmente con 1, 2 ó 3 sustituyentes seleccionados independientemente entre alquilo, alcoxi, OH, -SO₂CH₃, halo, -SO₂NR⁸R⁹, CN, -(CH₂)₀₋₃-O-heteroariloᵇ, ariloᵇ, -O-ariloᵇ, -(CH₂)₀₋₃-heterocicliloᵇ, -(CH₂)₁₋₃-ariloᵇ, -(CH₂)₀₋₃-heteroariloᵇ, -COOR⁸, -CONR⁸R⁹, -(CH₂)₀₋₃-NR⁸R⁹, OCF₃ y CF₃; o dos átomos de anillo de carbono adyacentes en él pueden estar unidos opcionalmente por un heteroalquileno para formar un anillo no aromático que contiene 5, 6 ó 7 miembros de anillo el cual puede ser sustituido opcionalmente con OH; o en donde opcionalmente dos átomos de anillo adyacentes en el arilo están unidos para formar un anillo aromático de 5 ó 6 miembros que contiene 1 ó 2 heteroátomos que se seleccionan entre N, NR¹⁰, S, y O; ariloᵇ es fenilo, bifenilo o naftilo, que puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente entre metilo, etilo, propilo, isopropilo, alcoxi, OH, -SO₂CH₃, N(R⁷)₂, halo, CN, y CF₃; o dos átomos de carbono adyacentes en el anillo en el arilo pueden estar opcionalmente unidos por un heteroalquileno para formar un anillo no aromático que contiene 5, 6 ó 7 miembros del anillo; cicloalquilo es un anillo de hidrocarburo saturado monocíclico de entre 3 y 6 átomos de carbono (C₃₋₆); el cicloalquilo puede sustituirse opcionalmente con 1 ó 2 sustituyentes seleccionados independientemente entre metilo, etilo, propilo, isopropilo, metoxi, etoxi, propoxi, isopropoxi, OH, CN, CF₃ y halo; en donde opcionalmente dos átomos de anillo adyacentes en el cicloalquilo están unidos para formar un anillo de hidrocarburo saturado de 5 ó 6 miembros; halo es F, Cl, Br, o I; heteroalquileno es un hidrocarburo saturado lineal bivalente que tiene 2 a 5 átomos de carbono (C₂₋₅), en donde 1 ó 2 de los 2 a 5 átomos de carbono son reemplazados con NR¹⁰, S u O; el heteroalquileno puede sustituirse opcionalmente con 1 ó 2 sustituyentes seleccionados independientemente entre alquilo, C₁₋₆alcoxi, OH, CN, CF₃ y halo; heteroarilo es un anillo aromático que contiene carbono de 5 ó 6 miembros que contiene uno, dos o tres miembros de anillo que se seleccionan entre N, NR¹⁰, S, y O; el heteroarilo puede ser sustituido opcionalmente con 1, 2 ó 3 sustituyentes seleccionados independientemente entre alquilo, alcoxi, heteroariloᵇ, fenilo, cicloalquilo, OH, OCF₃, halo, heterocicliloᵇ, CN, y CF₃; heteroariloᵇ es un anillo aromático que contiene carbono de 5 ó 6 miembros que contiene uno, dos o tres miembros de anillo que se seleccionan entre N, NR¹⁰, S, y O; heteroariloᵇ puede ser sustituido opcionalmente con 1, 2 ó 3 sustituyentes seleccionados independientemente entre metilo, etilo, propilo, isopropilo, alcoxi, OH, OCF₃, COOCH₃, COOCH₂CH₃, COO-(CH₂)₂-CH₃, COO-(iPr), halo, CN, y CF₃; heterociclilo es un anillo no aromático que contiene carbono de 4, 5, 6 ó 7 miembros que contiene uno, dos, tres o cuatro miembros de anillo que se seleccionan entre N, NR¹⁰, S, SO, SO₂ y O; el heterociclilo puede ser sustituido opcionalmente con 1, 2, 3, o 4 sustituyentes seleccionados independientemente entre alquilo, alcoxi, ariloᵇ, OH, OCF₃, halo, oxo, CN, NR⁸R⁹, -O(ariloᵇ), -O(heteroariloᵇ) y CF₃; o en donde opcionalmente dos átomos de anillo en el heterociclilo están enlazados con un alquileno para formar un anillo no aromático que contiene 5, 6 ó 7 miembros de anillo; o en donde opcionalmente dos átomos de anillo en el heterociclilo están enlazados con un heteroalquileno para formar un anillo no aromático que contiene 5, 6 ó 7 miembros de anillo; o en donde opcionalmente dos átomos de anillo adyacentes en el heterociclilo están unidos para formar un anillo aromático de 5 ó 6 miembros los cuales pueden contener opcionalmente 1 ó 2 heteroátomos que se seleccionan entre N, NR¹⁰, S, y O; heterocicliloᵇ es un anillo no aromático que contiene carbono de 4, 5, 6 ó 7 miembros que contiene uno, dos o tres miembros de anillo que se seleccionan entre N, NR⁷, S, SO, SO₂ y O; heterocicliloᵇ puede ser sustituido opcionalmente con 1, 2, 3 ó 4 sustituyentes seleccionados independientemente entre metilo, etilo, propilo, isopropilo, alcoxi, OH, OCF₃, halo, oxo, CN, y CF₃; y tautómeros, isómeros, estereoisómeros (que incluye enantiómeros, diastereoisómeros y mezclas racémicas y no racémicas de los mismos), isótopos deuterados y ventas y/o solvatos de los mismos aceptables farmacéuticamente.",KALVISTA PHARMACEUTICALS LTD,YANG XUEZHENG;;WRIGGLESWORTH JOSEPH WILLIAM;;SMITH ALUN JOHN;;SAMBROOK SMITH COLIN PETER;;PITTAWAY RACHAEL;;MILLER IAIN ROBERT;;CONROY MATTHEW ROBERT;;BAKER THOMAS MATTHEW;;PANCHAL TERENCE AARON;;LEVANTO STEFANO;;JANDU KARAMJIT SINGH;;HINCHLIFFE PAUL STUART;;HAMBLIN JULIE NICOLE;;GOLDSMITH ERICA LEE;;GANCIA EMANUELA;;CRIDLAND ANDREW PETER;;CLARK DAVID EDWARD;;STOCKS MICHAEL JOHN;;ROOKER DAVID PHILIP;;OBARA ALICJA STELA;;MAZZACANI ALESSANDRO;;MARSH SALLY LOUISE;;HODGSON SIMON TEANBY;;EVANS DAVID MICHAEL;;EDWARDS HANNAH JOY;;DAVIE REBECCA LOUISE;;CHILDS MITCHELL LEWIS,,https://lens.org/083-919-497-097-957,Patent Application,no,0,0,14,14,0,C07D401/12;;C07D413/12;;C07D217/22;;C07D401/14;;C07D471/04;;C07D513/04;;C07D487/04;;C07D417/12;;C07D405/12;;C07D409/12;;C07K5/06026;;C07D409/14;;C07K5/06034;;C07D495/04;;C07D405/14;;C07D403/12;;C07D213/81;;C07D333/38;;A61P9/10;;A61P25/28;;A61P25/06;;A61P25/08;;A61P29/00;;A61P31/00;;A61P7/02;;C07K5/06078;;C07K5/06139;;C07K5/06191;;C07D401/12;;C07K5/06191;;C07D487/04;;C07K5/06078;;C07D213/81;;C07D217/22;;C07D403/12;;A61P31/00;;A61P7/02;;C07D413/12;;C07D409/14;;C07D405/14;;C07D405/12;;C07D417/12;;C07D409/12;;C07D401/14;;C07D513/04;;A61P9/10;;A61P25/08;;A61P29/00;;C07D471/04;;C07K5/06034;;C07D495/04;;A61P25/28;;A61P25/06;;C07K5/06026;;C07K5/06139;;C07D333/38;;C07D401/14;;A61K31/454;;A61K31/4725;;A61P7/02;;A61P9/10;;A61P25/00;;A61P31/00;;A61P29/00;;A61P25/06;;A61P25/08;;A61P25/28;;C07D401/12;;C07D471/04;;C07C233/37;;C07D209/08;;C07D213/73;;C07D217/22;;C07D231/12;;C07D249/06;;C07D265/36;;C07D333/58;;C07D401/12;;C07D401/14;;C07D403/12;;C07D403/14;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04,C07D217/22;;A61K31/4365;;A61K31/47;;A61P9/00;;C07D401/12;;C07D413/12;;C07D487/04;;C07D495/04,,0,0,,,,PENDING
220,AR,A1,AR 118081 A1,002-668-289-731-747,2021-09-15,2021,AR P200100395 A,2020-02-13,GB 2019052252 W,2019-08-09,INHIBIDORES DE ENZIMAS,"La presente proporciona compuestos de fórmula (1), composiciones que comprenden dichos compuestos; el uso terapéutico de dichos compuestos (por ejemplo, en el tratamiento o prevención de una enfermedad o afección en la que está implicada la actividad de la calicreína plasmática); y métodos para tratar pacientes con dichos compuestos; en donde R⁵, R⁶, R⁷, A, B, W, X, Y y Z tienen la definición proporcionada en el presente documento. Reivindicación 1: Un compuesto de fórmula (1), donde W, X, Y y Z se seleccionan independientemente de C, C(R¹⁶)-C, C(R¹⁶)=C, C=N, O y N, de modo que el anillo que contiene W, X, Y y Z es un heteroarilo de 5 ó 6 miembros; R⁵, R⁶ y R⁷ están independientemente ausentes o se seleccionan independientemente de H, alquilo, cicloalquilo, alcoxi, halo, OH, CN, CF₃, arilo, heteroariloᵃ, pirrolidinilo vinculado a N, piperidinilo vinculado a N, morfolino vinculado a N, piperazinilo vinculado a N, -NR¹³R¹⁴, -COOR¹³, -CONR¹³R¹⁴ y -NR¹³COR¹⁴; R¹⁶ se selecciona independientemente de H, alquilo, cicloalquilo, alcoxi, halo, OH, CN, CF₃, arilo, heteroariloᵃ pirrolidinilo vinculado a N, piperidinilo vinculado a N, morfolinilo vinculado a N, piperazinilo vinculado a N, -NR¹³R¹⁴, -COOR¹³, -CONR¹³R¹⁴ y -NR¹³COR¹⁴; o W, X, Y y Z se seleccionan independientemente de C, C(R¹⁶)-C, C(R¹⁶)=C, C=N y N y uno de R⁵, R⁶, R⁷ o R¹⁶ es oxo de modo que el anillo que contiene W, X, Y y Z es 2-piridona o 4-piridona en donde los otros de R⁵, R⁶, R⁷ y R¹⁶ están independientemente ausentes o se seleccionan independientemente de H, alquilo, cicloalquilo, alcoxi, halo, OH, CN, CF₃, arilo, heteroariloᵃ, pirrolidinilo vinculado a N, piperidinilo vinculado a N, morfolinilo vinculado a N, piperazinilo vinculado a N, -NR¹³R¹⁴, -COOR¹³, -CONR¹³R¹⁴ y -NR¹³COR¹⁴; B es de fórmula (2) que comprende anillos aromáticos B y B que están unidos por un enlace; B es fenilo o piridilo; B es pirrol, pirazol, triazol o tetrazol; n es 0, 1 ó 2; R⁹ y R¹⁰ se seleccionan independientemente de H, alquilo, cicloalquilo, alcoxi, halo, OH, CN y CF₃; cada R¹¹ se selecciona independientemente entre alquilo, cicloalquilo, alcoxi, halo, OH, -COOR¹³, -CONR¹³NR¹⁴, CN y CF₃; A es un anillo heterocíclico de la fórmula (3) que comprende un anillo aromático (A) fusionado a un anillo no aromático (A); A¹ y A² son independientemente C o N; A es heteroarilo o fenilo, en donde el fenilo puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de alquilo, alcoxi, OH, OCF₃, halo, CN y CF₃ y en donde el heteroarilo puede estar opcionalmente sustituido según se indica más adelante; A es heterocicloalquilo; en donde opcionalmente un átomo de anillo de carbono en A está sustituido con un alquileno o un heteroalquileno de tal manera que el átomo de anillo de carbono en A junto con el alquileno o el heteroalquileno forma un cicloalquilo o heterocicloalquiloᵃ que es espiro con respecto al anillo A; y/o en donde opcionalmente dos átomos del anillo en A están unidos por un alquileno o heteroalquileno para formar un anillo no aromático que contiene 5, 6 ó 7 miembros del anillo; alquilo es un hidrocarburo saturado lineal que tiene hasta 10 átomos de carbono (C₁₋₁₀) o un hidrocarburo saturado ramificado de entre 3 y 10 átomos de carbono (C₃₋₁₀); el alquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente entre C₁₋₆alcoxi, OH, -NR¹³R¹⁴, -COOR¹³, -CONR¹³R¹⁴, CN, CF₃, halo; un alquiloᵇ es un hidrocarburo lineal saturado que tiene hasta 10 átomos de carbono (C₁₋₁₀) o un hidrocarburo ramificado saturado de entre 3 y 10 átomos de carbono (C₃₋₁₀); el alquiloᵇ puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente entre C₁₋₆alcoxi, OH, CN, CF₃, halo; alquileno es un hidrocarburo saturado lineal bivalente que tiene de 1 a 5 átomos de carbono (C₁₋₅); el alquileno puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquilo, C₁₋₆alcoxi, OH, CN, CF₃, halo; arilo es fenilo, bifenilo o naftilo; el arilo puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de alquilo, alcoxi, metilendioxi, etilendioxi, OH, halo, CN, heteroariloᵃ, -(CH₂)₀₋₃-O-heteroariloᵃ, ariloᵇ, -O-ariloᵇ, -(CH₂)₁₋₃-ariloᵇ, -(CH₂)₁₋₃-heteroariloᵃ, -COOR¹³, -CONR¹³R¹⁴, -(CH₂)₀₋₃-NR¹³R¹⁴, OCF₃ y CF₃; ariloᵇ es fenilo, bifenilo o naftilo; el ariloᵇ puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de alquiloᵇ, alcoxi, OH, halo, CN y CF₃; heteroalquileno es un hidrocarburo lineal bivalente saturado que tiene de 2 a 5 átomos de carbono (C₂₋₅), en el que al menos uno de los 2 a 5 átomos de carbono se reemplaza con NR⁸, S u O; el heteroalquileno puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquilo C₁₋₆alcoxi, OH, CN, CF₃, halo; cicloalquilo es un anillo hidrocarburo monocíclico saturado de entre 3 y 6 átomos de carbono (C₃₋₆); el cicloalquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquilo, C₁₋₆alcoxi, OH, CN, CF₃, halo; alcoxi es un hidrocarburo lineal con enlaces O de entre 1 y 6 átomos de carbono (C₁₋₆) o un hidrocarburo ramificado con enlaces O de entre 3 y 6 átomos de carbono (C₃₋₆); alcoxi puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de OH, CN, CF₃ y fluoro; halo es F, Cl, Br o I; heteroarilo es un anillo aromático de 5 ó 6 miembros que contiene carbono que contiene uno, dos o tres miembros de anillo que se seleccionan de N, NR⁸, S y O; el heteroarilo puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de alquilo, alcoxi, OH, OCF₃, halo, CN y CF₃; heteroariloᵃ es un anillo aromático mono o bicíclico de 5, 6, 9 ó 10 miembros que contiene, cuando es posible, 1, 2, 3 ó 4 miembros del anillo seleccionados independientemente de N, NR¹², S y O; el heteroariloᵃ puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de alquilo, alcoxi, OH, OCF₃, halo, CN, ariloᵇ, -(CH₂)₁₋₃-ariloᵇ, -(CH₂)₀₋₃-NR¹³R¹⁴, heteroariloᵇ, -COOR¹³, -CONR¹³R¹⁴ y CF₃; heteroariloᵇ es un anillo aromático mono o bicíclico de 5, 6, 9 ó 10 miembros, que contiene, cuando es posible, 1, 2 ó 3 miembros del anillo seleccionados independientemente de N, NR¹², S y O; en donde el heteroariloᵇ puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de alquiloᵇ, alcoxi, OH, halo, CN, ariloᵇ, -(CH₂)₁₋₃-ariloᵇ y CF₃; heterocicloalquilo es un anillo monocíclico que contiene 5, 6, ó 7 miembros de anillo, en el que uno o dos miembros del anillo se seleccionan independientemente de N, NR⁸, S, que contiene carbono no aromático SO, SO₂ y O; en donde heterocicloalquilo puede estar opcionalmente sustituido con 1, 2, ó 3 sustituyentes independientemente seleccionados de alquilo, alcoxi, OH, OCF₃, halo, oxo y CN; heterocicloalquiloᵃ es un anillo monocíclico que contiene 3, 4, 5, ó 6, miembros de anillo, donde al menos un miembro del anillo se selecciona independientemente de NR⁸, que contiene carbono no aromático S, SO, SO₂ y O; heterocicloalquiloᵃ puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquilo C₁₋₆alcoxi, OH, CN, CF₃, halo; R⁸ se selecciona independientemente de H, alquilo, cicloalquilo o heterocicloalquiloᵇ; heterocicloalquiloᵇ es un anillo monocíclico no aromático que contiene carbono que contiene 3, 4, 5 ó 6 miembros del anillo, en el que al menos un miembro del anillo se selecciona independientemente de N, NR¹², S y O; heterocicloalquiloᵇ puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquilo, C₁₋₆alcoxi, OH, CN, CF₃, halo; R¹² se selecciona independientemente de H, alquiloᵇ o cicloalquilo; R¹³ y R¹⁴ se seleccionan independientemente de H, alquiloᵇ, ariloᵇ y heteroariloᵇ o R¹³ y R¹⁴ junto con el átomo de nitrógeno al que están unidos forman un anillo heterocíclico de 4, 5, 6 ó 7 miembros que contiene carbono, que contiene opcionalmente un heteroátomo adicional seleccionado entre N, NR¹², S, SO, SO₂ y O, que puede ser saturado o insaturado con 1 ó 2 dobles enlaces y que puede estar opcionalmente mono o disustituido con sustituyentes seleccionados de oxo, alquiloᵇ, alcoxi, OH, halo y CF₃; y tautómeros, isómeros, estereoisómeros (incluidos enantiómeros, diastereoisómeros y mezclas racémicas y no racémicas de los mismos), isótopos deuterados y sus sales y/o solvatos farmacéuticamente aceptables.",KALVISTA PHARMACEUTICALS LTD,YANG XUEZHENG;;WRIGGLESWORTH JOSEPH WILLIAM;;SMITH ALUN JOHN;;SAMBROOK SMITH COLIN PETER;;PITTAWAY RACHAEL;;MILLER IAIN ROBERT;;CONROY MATTHEW ROBERT;;BAKER THOMAS MATTHEW;;PANCHAL TERENCE AARON;;LEVANTO STEFANO;;JANDU KARAMJIT SINGH;;HINCHLIFFE PAUL STUART;;HAMBLIN JULIE NICOLE;;GOLDSMITH ERICA LEE;;GANCIA EMANUELA;;CRIDLAND ANDREW PETER;;CLARK DAVID EDWARD;;STOCKS MICHAEL JOHN;;ROOKER DAVID PHILIP;;OBARA ALICJA STELA;;MAZZACANI ALESSANDRO;;MARSH SALLY LOUISE;;HODGSON SIMON TEANBY;;EVANS DAVID MICHAEL;;EDWARDS HANNAH JOY;;DAVIE REBECCA LOUISE;;CHILDS MITCHELL LEWIS,,https://lens.org/002-668-289-731-747,Patent Application,no,0,0,18,18,0,C07D401/14;;C07D405/14;;C07D403/14;;C07D487/04;;C07D471/04;;C07D491/107;;C07D491/20;;C07D491/147;;C07D413/14;;C07D513/04;;C07D417/14;;C07D487/08;;A61P29/00;;C07D401/14;;C07D487/04;;C07D491/147;;C07D491/107;;C07D405/14;;C07D413/14;;C07D513/04;;C07D487/08;;C07D403/14;;C07D417/14;;A61P29/00;;C07D471/04;;C07D491/20;;C07D403/14;;A61K31/55;;A61K31/4725;;A61P7/10;;A61P29/00;;C07D401/14;;C07D413/14;;C07D401/14;;C07D403/14;;C07D405/14;;C07D413/14;;C07D417/14;;C07D471/04;;C07D487/04;;C07D487/08;;C07D491/107;;C07D491/147;;C07D491/20,C07D403/14;;A61K31/4353;;A61K31/47;;A61K31/4985;;A61P27/00;;C07D413/14,,0,0,,,,PENDING
221,AR,A1,AR 118083 A1,033-991-273-765-170,2021-09-15,2021,AR P200100397 A,2020-02-13,GB 2019052358 W,2019-08-21,INHIBIDORES DE ENZIMAS,"La presente proporciona compuestos de fórmula (1) y (1a), composiciones que comprenden dichos compuestos; el uso de dichos compuestos en terapia; y métodos para tratar pacientes con dichos compuestos; en donde A, B, n, R², R³, R⁴, R⁵ y R⁶ tienen la definición proporcionada en el presente documento. Reivindicación 1: Un compuesto de fórmula (1) ó (1a), donde: n es 0, 1 ó 2; A es (i) un heteroarilo de 5 miembros de fórmula (2), en donde W es S; Z es C o N; X e Y son C; R¹ está ausente; R⁴ está ausente o H; R² y R³ se seleccionan independientemente de H, halo, alquilo, -SO₂NR¹³R¹⁴, -(CH₂)₀₋₃heterociclilo, -(CH₂)₀₋₃NR¹²(CH₂)₀₋₃(heterociclilo) y -(CH₂)₀₋₃arilo; y en donde uno de R² o R³ no es H; o en donde W es S; X, Y y Z son C; R¹ está ausente; R³ es halo o alquilo; R⁴ es H, halo o alquilo; y R² se selecciona de -(CH₂)₀₋₃NR¹³R¹⁴, -(CH₂)₀₋₃NR¹²(CH₂)₀₋₃(arilo), -(CH₂)₀₋₃NR¹²(CH₂)₀₋₃(heterociclilo), -(CH₂)₀₋₃-O-(CH₂)₀₋₃(arilo), -(CH₂)₀₋₃-O-(CH₂)₀₋₃(heterociclilo), -(CH₂)₀₋₃-O-(CH₂)₀₋₃(heteroarilo), -(CH₂)₀₋₃-O-(CH₂)₁₋₄NR¹³R¹⁴ y -(CH₂)₀₋₃heterociclilo; o en donde X, Y y Z son independientemente N, C o S; en donde al menos uno de X, Y y Z es N o S; W es C; R³ y R⁴ están independientemente ausentes o seleccionados independientemente de H, alquilo y halo; R² se selecciona de H, halo, alquilo y cicloalquilo; y R¹ se selecciona de -(CH₂)₀₋₃NR¹²(CH₂)₀₋₃(heterociclilo), -(CH₂)₀₋₃NR¹²CO(CH₂)₀₋₃(heterociclilo), -(CH₂)₀₋₃-O-(CH₂)₀₋₃(heterociclilo) y -(CH₂)₀₋₃heterociclilo; o en donde Y y Z son N; W y X son C; R¹ y R² se seleccionan de entre H, halo, alquilo, cicloalquilo y -(CH₂)₀₋₃arilo; R³ y R⁴ están independientemente ausentes o se seleccionan independientemente entre -(CH₂)₀₋₃heterociclilo y -(CH₂)₀₋₃arilo; y en el que al menos uno de R³ o R⁴ se selecciona de -(CH₂)₀₋₃heterociclilo y -(CH₂)₀₋₃arilo; o en donde Y o Z son independientemente C, N o S; en donde al menos uno de Y y Z es N o S; W y X son C; R¹ es H; R² se selecciona de H, alquilo, arilo y halo; R⁴ está ausente, o seleccionado de H y alquilo; y R³ es (CH₂)₀₋₃(heterociclilo); o en donde Y y X son independientemente C o N; en donde al menos uno de Y o X es N; W y Z son C; R¹ y R⁴ se seleccionan independientemente de H, alquilo y halo; y uno de R² y R³ está ausente y el otro de R² y R³ es un resto de fórmula (4); m es 0, 1, 2 ó 3; R⁹ se selecciona de H y alquilo; cada R¹⁰ se selecciona independientemente de alquilo y halo; o A es (ii) un biciclo heteroaromático de 9 miembros de fórmula (3) en donde X e Y se seleccionan independientemente de C, N o S; en donde al menos uno de X e Y es N o S; en la que R¹ y R⁶ están independientemente ausentes o independientemente seleccionados entre H y -(CH₂)₀₋₃heterociclilo; en donde R² se selecciona de H, halo, -(CH₂)₀₋₃NR¹²(CH₂)₀₋₃(heterociclilo) y -(CH₂)₀₋₃heterociclilo; R³, R⁴ y R⁵ se seleccionan independientemente de H, alquilo y halo; y en donde al menos uno de R², R³, R⁴, R⁵ no está ausente o H; o, fórmula (1a) en donde n es 0, 1 ó 2; en donde Z e Y son seleccionados independientemente de C y N; en donde R⁶ se selecciona de H y alquilo; en donde R⁴ y R⁵ están independientemente ausentes, o independientemente seleccionados de H, alquilo y halo; y en donde uno de R² y R⁵ es -(CH₂)₀₋₃NR¹²(CH₂)₀₋₃(heterociclilo) y el otro de R² y R⁵ se selecciona de H, alquilo y halo; B es: (i) un anillo bicíclico heteroaromático 6,5 ó 6,6 fusionado, que contiene N y, opcionalmente, uno o dos heteroátomos adicionales seleccionados independientemente de N, O y S; en donde el anillo bicíclico heteroaromático fusionado 6,5 ó 6,6 puede estar opcionalmente sustituido con 1, 2, ó 3 sustituyentes seleccionados de alquilo, alcoxi, OH, halo, CN, -COOR¹³, -CONR¹³R¹⁴, CF₃ y -NR¹³R¹⁴; en donde el anillo bicíclico heteroaromático 6,5 puede unirse mediante el anillo de 6 ó 5 miembros; o (ii) fenilo sustituido con -(CH₂)₁₋₃NH₂ y dos grupos seleccionados de metilo, etilo y propilo; o (iii) piridina sustituido con NH₂ y dos grupos seleccionados de metilo, etilo y propilo; (iv) un anillo bicíclico 6,5 ó 6,6 fusionado que contiene N y que contiene un anillo aromático fusionado a un anillo no aromático y, opcionalmente, uno o dos heteroátomos adicionales seleccionados independientemente de N, O y S; en el que el anillo bicíclico 6,5 ó 6,6 fusionado puede estar opcionalmente sustituido con 1, 2, ó 3 sustituyentes seleccionados de alquilo, alcoxi, OH, halo, CN, -COOR¹³, -CONR¹³R¹⁴, CF₃ y -NR¹³R¹⁴; en donde el anillo bicíclico 6,5 puede unirse mediante el anillo de 6 ó 5 miembros; alcoxi es un hidrocarburo lineal vinculado a O de entre 1 y 6 átomos de carbono (C₁₋₆) o un hidrocarburo ramificado vinculado a O entre 3 y 6 átomos de carbono (C₃₋₆); alcoxi puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de OH, CN, CF₃, -N(R¹²)₂ y fluoro; alquilo es un hidrocarburo saturado lineal que tiene hasta 10 átomos de carbono C₁₋₁₀ o un hidrocarburo saturado ramificado de entre 3 y 10 átomos de carbono C₃₋₁₀; el alquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alcoxi C₁₋₆, OH, -NR¹³R¹⁴, -NHCOCH₃, -CO(heterocicliloᵇ), -COOR¹³, -CONR¹³R¹⁴, CN, CF₃, halo, oxo y heterocicliloᵇ; alquiloᵇ es un hidrocarburo saturado lineal que tiene hasta 10 átomos de carbono (C₁₋₁₀) o un hidrocarburo saturado ramificado de entre 3 y 10 átomos de carbono (C₃₋₁₀); el alquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alcoxi C₁₋₆, OH, -N(R¹²)₂, -NHCOCH₃, CF₃, halo, oxo, ciclopropano, -O(ariloᵇ), ariloᵇ y heterocicliloᵇ; alquileno es un hidrocarburo saturado lineal bivalente que tiene de 1 a 5 átomos de carbono (C₁₋₅); alquileno puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquilo, C₁₋₆alcoxi, OH, CN, CF₃ y halo; arilo es fenilo, bifenilo o naftilo; arilo puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de alquilo, alcoxi, OH, -SO₂CH₃, halo, CN, -(CH₂)₀₋₃-O-heteroariloᵇ, ariloᵇ, -O -ariloᵇ, -(CH₂)₀₋₃-heterocicliloᵇ, -(CH₂)₁₋₃-ariloᵇ, -(CH₂)₀₋₃-heteroariloᵇ, -COOR¹³, -CONR¹³R¹⁴, -(CH₂)₀₋₃-NR¹³R¹⁴, OCF₃ y CF₃; o dos átomos de carbono adyacentes en el anillo en el arilo pueden estar opcionalmente unidos por un heteroalquileno para formar un anillo no aromático que contiene 5, 6 ó 7 miembros de anillo; u opcionalmente en el que dos átomos de anillo adyacentes en arilo están unidos para formar un anillo aromático de 5 ó 6 miembros que contiene 1 ó 2 heteroátomos que se seleccionan de N, NR⁸, S y O; ariloᵇ es fenilo, bifenilo o naftilo, que puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de metilo, etilo, propilo, isopropilo, alcoxi, OH, -SO₂CH₃, N (R¹²)₂, halo, CN y CF₃, o dos átomos del anillo de carbono adyacentes en el arilo pueden estar opcionalmente unidos por un heteroalquileno para formar un anillo no aromático que contiene 5, 6, ó 7 miembros de anillo; cicloalquilo es un anillo hidrocarburo monocíclico saturado de entre 3 y 6 átomos de carbono (C₃₋₆); cicloalquilo puede estar opcionalmente sustituido con 1 ó 2 sustituyentes seleccionados independientemente de alquiloᵇ, C₁₋₆alcoxi, OH, CN, CF₃ y halógeno; halo es F, Cl, Br o I; heteroalquileno es un hidrocarburo saturado lineal bivalente que tiene de 2 a 5 átomos de carbono (C₂₋₅), en el que 1 ó 2 de los 2 a 5 átomos de carbono están reemplazados con NR⁸, S u O; heteroalquileno pueden estar opcionalmente sustituidos con 1 ó 2 sustituyentes seleccionados independientemente de alquilo C₁₋₆alcoxi, OH, CN, CF₃ y halo; heteroarilo es un anillo aromático de 5 ó 6 miembros que contiene carbono que contiene 1, 2, 3 ó 4 miembros de anillo que se seleccionan de N, NR⁸, S y O; heteroarilo puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente entre alquilo, alcoxi, ariloᵇ, OH, OCF₃, halo, heterocicliloᵇ, CN y CF₃, heteroariloᵇ es un anillo aromático de 5 ó 6 miembros que contiene carbono que contiene uno, dos o tres miembros de anillo que se seleccionan de N, NR⁸, S y O; el heteroariloᵇ puede estar opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente de metilo, etilo, propilo, isopropilo, alcoxi, OH, OCF₃, halo, CN y CF₃; heterociclilo es un anillo no aromático de 4, 5, 6 ó 7 miembros que contiene carbono que contiene uno o dos miembros del anillo que se selecciona de N, NR⁸, S, SO, SO₂ y O; el heterociclilo puede estar opcionalmente sustituido con 1, 2, 3 ó 4 sustituyentes seleccionados independientemente de alquiloᵇ, alcoxi, OH, OCF₃, halo, oxo, CN, -NR¹³R¹⁴, -O(ariloᵇ), -O(heteroariloᵇ) y CF₃; u opcionalmente en el que dos átomos en el anillo en heterociclilo están vinculados con un alquileno para formar un anillo no aromático que contiene 5, 6, ó 7 del anillo miembros; u opcionalmente en el que dos átomos de anillo adyacentes en heterociclilo están unidos para formar un anillo aromático de 5 ó 6 miembros que contiene 1 ó 2 heteroátomos que se seleccionan de N, NR⁸, S y O; u opcionalmente en donde un átomo de anillo de carbono en heterociclilo está sustituido con un heteroalquileno de tal manera que el átomo de anillo de carbono en heterociclilo junto con el heteroalquileno forma un heterocicliloᵇ que es espiro a anillo heterociclilo; heterocicliloᵇ es un anillo no aromático de 4, 5, 6 ó 7 miembros que contiene carbono que contiene uno o dos miembros del anillo que se selecciona entre N, NR¹², S, SO, SO₂ y O; el heterocicliloᵇ puede estar opcionalmente sustituido con 1, 2, 3 ó 4 sustituyentes seleccionados independientemente de metilo, etilo, propilo, isopropilo, alcoxi, OH, OCF₃, halo, oxo, CN y CF₃; R¹³ y R¹⁴ se seleccionan independientemente de H, -SO₂CH₃, alquiloᵇ, heteroariloᵇ y cicloalquilo; o R¹³ y R¹⁴ junto con el átomo de nitrógeno al que están unidos forman un anillo heterociclilo de 4, 5, 6 ó 7 miembros que contiene carbono, que opcionalmente contiene un heteroátomo adicional seleccionado de N, NR⁸, S, SO, SO₂ y O, que pueden estar saturados o insaturados con 1 ó 2 dobles enlaces y que pueden estar mono o di-sustituidos opcionalmente con sustituyentes seleccionados independientemente entre oxo, alquiloᵇ, alcoxi, OH, halo, -SO₂CH₃ y CF₃, o R¹³ y R¹⁴ junto con el átomo de nitrógeno al que están unidos forman un anillo heterocíclico de 5 ó 6 miembros que contiene carbono, que se fusiona a un ariloᵇ o un heteroariloᵇ; R⁸ se selecciona independientemente de H, -SO₂CH₃, alquiloᵇ, -(CH₂)₀₋₃ariloᵇ, -(CH₂)₀₋₃heteroariloᵇ, -(CH₂)₀₋₃cicloalquilo y -(CH₂)₀₋₃heterocicliloᵇ; o R⁸ es un anillo heterocíclico de 4, 5, 6 ó 7 miembros que contiene carbono que contiene 1, 2 ó 3 heteroátomos seleccionados independientemente de N, NR¹², S, SO, SO₂ y O, que pueden estar saturados o insaturados con 1 ó 2 dobles enlaces y que pueden estar opcionalmente mono o disustituidos con sustituyentes seleccionados independientemente de oxo, alquiloᵇ, alcoxi, OH, halo, -SO₂CH₃ y CF₃; R¹² se selecciona independientemente de H, -SO₂CH₃, -COCH₃, metilo, etilo, propilo, isopropilo y cicloalquilo; y tautómeros, isómeros, estereoisómeros (incluidos enantiómeros, diastereoisómeros y mezclas racémicas y no racémicas de los mismos), isótopos deuterados y sus sales y/o solvatos farmacéuticamente aceptables.",KALVISTA PHARMACEUTICALS LTD,YANG XUEZHENG;;WRIGGLESWORTH JOSEPH WILLIAM;;SMITH ALUN JOHN;;SAMBROOK SMITH COLIN PETER;;PITTAWAY RACHAEL;;MILLER IAIN ROBERT;;CONROY MATTHEW ROBERT;;BAKER THOMAS MATTHEW;;PANCHAL TERENCE AARON;;LEVANTO STEFANO;;JANDU KARAMJIT SINGH;;HINCHLIFFE PAUL STUART;;HAMBLIN JULIE NICOLE;;GOLDSMITH ERICA LEE;;GANCIA EMANUELA;;CRIDLAND ANDREW PETER;;CLARK DAVID EDWARD;;STOCKS MICHAEL JOHN;;ROOKER DAVID PHILIP;;OBARA ALICJA STELA;;MAZZACANI ALESSANDRO;;MARSH SALLY LOUISE;;HODGSON SIMON TEANBY;;EVANS DAVID MICHAEL;;EDWARDS HANNAH JOY;;DAVIE REBECCA LOUISE;;CHILDS MITCHELL LEWIS,,https://lens.org/033-991-273-765-170,Patent Application,no,0,0,15,15,0,C07D409/12;;C07D409/14;;C07D471/04;;C07D491/113;;C07D495/04;;C07D401/14;;C07D401/12;;C07D417/14;;A61P7/02;;A61P9/10;;A61P25/06;;A61P25/08;;A61P29/00;;A61P31/00;;C07D409/12;;A61P25/06;;A61P29/00;;A61P31/00;;A61P9/10;;C07D417/14;;C07D401/12;;A61P25/08;;C07D471/04;;C07D495/04;;C07D409/14;;A61P7/02;;C07D491/113;;C07D401/14;;C07D409/12;;A61K31/4725;;A61K31/5377;;A61K31/541;;A61K31/55;;A61K31/506;;A61K31/4365;;A61P7/02;;A61P9/10;;A61P25/00;;A61P25/06;;A61P25/08;;A61P31/00;;A61P29/00;;C07D409/14;;C07D491/113;;C07D471/04;;C07D401/14;;C07D401/12;;C07D417/14;;C07D495/04;;C07D409/12;;C07D409/14;;C07D413/14;;C07D417/14;;C07D471/04;;C07D491/113;;C07D495/04,C07D409/12;;A61K31/4725;;A61K31/506;;A61K31/5377;;A61K31/54;;A61P9/00;;C07D409/14;;C07D471/04;;C07D491/113,,0,0,,,,PENDING
